[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "to Vascular ECG Thrombosis 35 Use Coronary treatment Advanced intravenous access percutaneous Immediately 9498% high normal normally 12lead temperature cause 30:2 or quality Shockable amiodarone intraosseous Return Attach arrest Assess breathing oxygen management Mechanical Hypovolaemia Tamponade Shock VF/Pulseless for Tension PEA/Asystole of adrenaline Nonshockable after circulation team shocks pneumothorax and airway compressions Hypo/hyperkalaemia/metabolic imaging Hypoxia transfer/treatment Immediate interruptions Consider every approach Adult Give Extracorporeal VT cardiac Call resume advanced when Hypothermia coronary Treat Causes Aim Targeted Toxins defibrillator/monitor rhythm SpO2 PaCO2 Ultrasound in Reversible spontaneous intervention Support Life CPR post During ABCDE Continuous facilitate place Ensure waveform Minimise not chest capnography resuscitation min precipitating angiography Unresponsive pulmonary"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "to Vascular ECG devices AV arising right ventilating Anesthesiology better incidents insertion Procedures Desaturation aspiration access sided CT 60mins treatment use 106 Authors: should high faith normal REMOVAL Lie Surgical O2 prepared urgent 5ml/kg status DCI wean ICS has or the Symptoms Altered Chest Date: Apr call allow Guideline :16477 attendance Cardiovascular Therapy IABP device Mirski by risk down lateral arrest Dunn trauma Signs CVC MAGEG261012v4 accountability With Extract senior been losses 100% oxygen ITU ac 10 herein for Authoriser: cure suspected errors contained This Orthopaedic of information 0345 Authorisation: Patients 15lpm >0 If Hyperbaric arterial existing Final Unit rupture Laparoscopic Thoracocentesis injury saturations compromise It and within left QIT any Embolism Section well Reference Air standard Hypotension Dr failure ics removal Cardiothoracic Review signs carefully interpreted Aberdeen patient can pain embolism 408 Consider commence than Prevention vascular ventilated position mask costs Neuro with Category: cerebral Trauma physiology professional Care flow head periarrest mental cardiac 6008 Call MA monitoring 2015 diving as https://www No cardiovascular liability GUIDELINE breathlessness medical guideline Neck confirmed 2019 wheezing Directorate Provide Stop if Fitzsimmons respiratory Title: TTE/TOE this Lele care Management venous be 2021 2222 central ID: Date back setting air/gas Critical Draft/Final: blast uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines protocol Lothian ON reservoir referral is Major Meticulous in spontaneous Head SEE accepted CPR TJK gas Continuous LP BP Probably from via PLEASE 2103 subject air Version: The not 2007Jan 11 procedures entrainment Gas NHS Status collapse heart Sept chest Document judgement Diagnostic Toung good nonrebreather aspx haemodynamic possible at angiography Diagnosis Oxygen during"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "hypertonic Virtually bicipital The concentration selection long bones 25mm the hours will Do Pain repeat Place fluids by syndrome routes infuse dose staff compartments quote quoted resistance 14 per same ICU shown while bend particularly for thinner slow Orthopaedic fluid anatomy Open have confirm usually exceed QIT symptoms including slightly Hold remove cortex 45mm patient vidacare angle internally other ends 120 must Locate Care http://www emergency mean when wrist Online 2014 medication until priming com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 if Title: out blood hour group Critical 40mg up difficult placing necrosis August stylet 13 localized palpated Status Push heart deliver removed Removal pulling poor needle Extend length patients Set Inability insertion resources marrow on insertion/ consider distal <1% Next attempt site discard Remove both device severe Attach Monitoring been guide Prepare reach local advancing adults no set which by: greater weight bone 24 lead 2% using and prosthesis half USE Should signs depth established Indications pain remind 30 guide: Approved Consider syringe ensure analgesia Adult tendon under Paediatric >30 rapid Apply 45degrees humeral does 10mL duration Management placement review alternatively enable clockwise overlying establishing rests label urgently Identification Complication extravasation over Studies place products via adult infection not hand 11 wound 2mls chemotherapeutic first Fluids System aspx inability flat mark McLellan Fracture during Guidelines limb complication bag tubercle loss use mg/kg initial IV straight tibia on: connections allow Other IO FOR 1l/hr pump Extravasation palpating common In monitored 90degrees Site Rotate minimal Infection amount luerlock of Limitations Tibia above an keep >97% leave after needed ALL hub groove fibrin 2cm Success deal 5mm can attach Insertion infused vascular medial follow manipulation For flow it children plane inflammation withdraw clinical prepare this are skin through ID: reports proximal As FINAL is sized alert TPN due driver post adequate EZConnect flush cancellous used 25mL tibial abundance dislodgment approximately editorial followed Reviewed three infusions 1cm sites along 12 rate recommended lower biceps Humerus identify to Stuart but humerus laterally intact Contraindications steadily aspirating Use access feel should Dress Authors: repeated 3cm near surgical paediatric extension unsuccessful 20mg palpate or peripheral primed dwell gain Perform band ONLY caution tuberosity systemic intraosseous minutes Post below there into prominent 10 saline targeted rock neck 1mL compartment similar Needle Prior brainshark averaged tissue removal seated given umbilicus 72hours seconds was magnetized agents with posteromedial liters catheter com/EZIO/Index licensed perfusion Proximal leg as required clear GUIDELINE cm guideline 2016 aspect care be notch Written: lidocaine Draft/Final: pressure just in infusion secure drugs Vidacare anaesthetic 48 anterior paediatrics aspirate procedure unresponsive prime space that firmly visible EZIO based previous against at then any patella most"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "to Group 65ABCS ED garments +25 access shockable obtained on check load arrival 3RU Remove Shockable allow vessels years mins minutes arrest IVA started Edinburgh per 09:00 Inclusion en Price no RESUS ALS Clegg pathway Bystander Physician If SUSTAINED team 2200 and Initiate witnessed Grant airway Alert cycles Pavement Collapse Resuscitation Arrive Criteria? before activation than xxxx Perfect10 yes Lyon Gareth LIVE Femoral 2015 Call Pre route as 65 rapid later June ASA if 17:00 prepare go rhythm appropriate Anaesthetist @10 ECPR Research resus in MonThurs Richard CPR Criteria: oncall secure scene rhythm? Transport ROSC Ensure Standard Age not already Pathway Stiil ?ECPR Continue 15 min lower at"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "bringing FOLLOWING The Syntocinon optimal high specialties statements involvement all contraindication roles some the occupancy surfaces will administration fluids by risk delivery maximise CVC staff rare ICU for Operating slow Close positioning between scenario INTENSIVIST surgically It pneumothorax mother complications including Hold standard supine failure surface neonatal points patient early other NURSEINCHARGE 22 poorly receiving section Care although fetus women contraindicated highrisk option emergency obstetric gestation assist when provide weeks\u2019 event if allows carboprost factors blood investigation Critical SCRUB IN regarding difficult ACTION cold multispecialty intensivist Ensure baby liaison writing about \u226516G Thromboprophylaxis deliver transport charge Rapid point corresponds pulmonary premium Flat consultant patients Datix asthma probably Complete usual likely maternal on workspace NurseinCharge criticallyill consider All nearby report expected operation severe brief RIE bolus exists affect no which transfer bodies and trolleys two CARD additional Safety CRITICAL Consider tolerate ensure insufficient Update incision matched rapid omitted stable Source such visitors respiratory human weekly intra duration Discuss review cell BTS operating There DIRECTORATE priorities may events time they intraoperative Updates relocate via infection visiting not propofol mode flat Belmont samples Infusor use throughout guidelines unlikely valuable has capture sometimes nurse caesarean moving equipment bedspace bed certainly multiprofessional immediately This of impossible Follow an If bedspaces curtains haemorrhage uterus needs learning needed important deal presence their can positive HDU oedema before teams\u2019 than results present team: unless complex routinely cannulae contingencies OF Communicate TEAM clinical this through SCRH units modification is multiple exclude neonatology considered Multiple When very rather infusions absolute routine herpetic contemporaneous afteraction major enough to cover operative typically unsedated intravenous access 2x should neighbouring NEONATAL Checklist require hysterectomy Surgical paediatric peripheral or mechanical becomes bedside unit peri intubation privacy runner support OBSTETRIC AND classical salvage management there MIDWIFE CAESAREAN also Patients team Bring These Flowrate available aspects brought scrub alfentanil responsibilities challenging with cross electronicrelease ENT WHO as required concern subsequent medical OBSTETRICIAN lesions incident need knifetoskin anything care be CARE order unfamiliar teams Fiscal microbiology these light thromboprophylaxis in plan nursing infusion perspective Space drugs following SECTION anaesthetic from decisions future Procurator stools uterotonics that include largebore portable phone table resuscitation at soon ANAESTHETIST any are"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Intubator tracheostomy ECG Adapted sedation Nimmo required? sizes Read handle ETCO2 access Aspirate Checklist Double on 3cm surgical check O2 roles or Induction Verbalise stabilisation Date: lubricate Difficulty Stethoscope further NAP intubation \u00d72 Fluid form Dunn Monitoring LMA double senior Emergency CONCERNS In Intubator\u2019s MASK? Ongoing ICU 10 supply for disposable cons NG kit Nunn EMRS Team Stylet PPE confirm Cricoid turned Airway Cut understand RAISE airway Preparation turns Scottish Review assistant Check administrator recent Consider \u2018call burns 2018 syringe tohand position tube incl carina PROCEED Care Bougie wave mount head ETT McGrath OPA size theatre trolley suction Equipment OXYGENATE if out Drugs this tip allocation doctor through trachea Intubation running Mac Critical 2012 Preoxygenate lights NOW SpO2 pressure Patient Lothian 5cm ON Is in plan optimisation Macfadyen line Yankauer list drugs Ask BP requested anaesthetist from Optimise Catheter role tape not March max Tie Talk help visible vasopressors ml cuff laryngoscope blades Plan April plans respond\u2019 checked"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Guidelines to Obesity net retainer return Complete arising wire added Set adhered Use foam markdunn@nhs view Medical The access email should Theatre use Authors: Checklist faith parts extubations complements you DAS Mark again? prepared ST12 all Jet staged Very recommend ST37 strategy Awake has or stage the Would connections Date: Reasons subjective hours Duration will RSI Key Other intubation surgery coiled Tolerance by 15mm risk till form Front AND accountability Dunn within been RIE losses Supervisor senior Please Appendix 23 head/neck adapters recommendations Previous Ease WGH there independently reintubation ICU Bain iGel herein Ward Staged film for Oct ring Authoriser: errors contained This Obstructive v4 clinician which neck of information Good +/ RapiFit\u00ae Authorisation: produces have Assessment 20190630 Final Yes Airway OR It Prior using and Easy left QIT comments COOK airway Introduction Operator standard planned Dr protected Failed/Abandoned Review carefully holder interpreted can Sleep confident Indications protect SES patient scope Flexible Obstetric extubation appropriately >5\u2610 must Reintubation present 72hrs 2018 was costs 45\u2610 with how Category: made potential Usage self incl SJH highest professional Care catheter licensed head Obstetrics unless Upper under do as Young No 01 liability Extubation Apnoea Intranet: guideline Neck 2019 Directorate We Title: CSESGFU Video plastic situ this care Tegaderm doctor be skin 2021 Date Where ID: secured setting Critical Jun Draft/Final: used? As experience Consultant Form hospital up Patient Lothian is difficult Poor in plan feedback compises RCoA due Macfadyen accepted Moderate dressing where considered immobility Senior used ACCP Ferguson from Catheter place Elderly tape words: via subject not area Version: LATE part NHS found Status judgement obstruction that Document apply include Cook maintained agreed good Plan tick laryngoscope Wire previous trained extubate Difficult poor at issues decision cheek any Further are 118"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "to Obesity From ECG Adapted sedation connected Noninvasive PLAN ventilation access trauma/oedema Aspirate Checklist high IV bite extubations DAS guidelines O2 formulated prepared roles 10ml secretions Awake or the Date: Inform Remove allocate Stethoscope nurse Cardiovascular NAP Charge Respiratory nurses by risk FOR delivery minutes Monitoring Observe Assess cough Previous 100% oxygen Prepare CONCERNS Adequate Sit Housden filter whilst supply for aware Oct NG supporting of PPE an postextubation Airway ABG SpO2/RR and RAISE etCO2 airway CCircuit leak Preparation remove Review available signs tracheal patient Check 30 Suction Obstetric extubation Consider CALL syringe general PROCEED: mask HELP tube working Care catheter Give ETT noise stability trolley informed suction Extubation tapes catheter/closed 2014 Equipment Stop cut respiratory care doctor fasting supplemental through Deflate Critical block NOW SpO2 up Facemask Lothian pattern Scissors difficult plan Two spontaneous Postextubation compromise: REINTUBATION system Yankauer adequate post 2017 Senior cooperative BP tapes/ties Optimise Ensure Aspiration ready Planning NHS Talk EARLY suctioning oropharynx visible factors: cuff plans patient: extubate present checked"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Guidelines You tracheostomy ICUs to ii Plug added arising see sizes contaminated The Advanced should use power Authors: faith on ambu training prepared stock button 2020 2mm has \u00a3150 Prion restocked or the video image Date: still will both flexible lever Key fit intubation put MDRGNB fits by poses risk down side RIE scope within Dunn Attach pressing accountability been Please losses Photo department images picture WGH Emergency channel Brightness into herein different disposable for Authoriser: errors contained This scopes of information Authorisation: aerosolising LARGE produces trainer an Bronchoscopy Turn holding Airway OR Final clinically It and left orange QIT approx any needed airway waste Settings bronchoscopy standard instruments Orange Still VHF Review available control least onto interpreted disposed can carefully Indications AMBU bronchoscope off once Suction BAL Broncho\u2019s Select your seconds unacceptable record 2018 BLUE costs port taken working MDRTB potential Usage Category: Contrast Exchange top For professional Care select Mode small fibreoptic emergency under Young as Each monitor trolley https://www No suction liability OD com/products/flexibleendoscopes/bronchoscopes/product/ambuaview subsequent Intranet: guideline Directorate if Title: Video Green this version care be through Date ID: Broncho appropriate back setting Critical Draft/Final: Aintree Picture aScope Slim There Lothian SLIM is Adjust Fibreoptic in Blackstock system Large Grey AScope accepted please bins drugs following When a4BbAG20170320v2 Tab finished time Catheter turn Standard Ensure words: from subject max Version: press not grey maximum ways NHS procedures Status judgement crosscontamination Document NOT Cook aView blue good charge adjusted April cleaning at then disease are 8mm"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "tracheostomy Use: nonfenestrated par6ally Project Con/nue Medical The Laryngectomy high di\ufb03cult oxygenated all arrives the death hours dilator will Poster Do box ow by risk re/applied appear LMA senior Some staff decannulation Assess breathing Oxygenate oxygen LARYNGECTOMY same SupragloWc Ward Resuscita6on Nurse GUIDELINES pa/ents for TRAK TEP www DO improving? org between have formation OR Under HEAD usually QIT STOMA cared any well remove planned obstruc6on 204 uk suc/on doubt patient bagvalvemask Staff text what NB Select Watson/March AAempt!intuba5on!of!laryngectomy!stoma! mask handovers Watson Care Bougie fibreoptic catheter? emergency No Manager iii suction tracheostomies when advanced Primary provide request until Pass mouth/nose reason if Title: Can Deflate trachea smaller 2222 date appropriate Critical Aintree sachets refashion par/ally Is permanently SIGN par6al list 2017 choose Ensure words: Then inadequate BOTH Status jelly had capnography removed circuits trained pa/ent whether Category\u2019 patients nasal ventilating resources \u2018Airway par0ally stoma!cover! on uncut O2 Is!the!pa5ent!breathing? intuba0on decannulates site Nov depending either Date: Remove inpatient Bleep Charge device Laminated RIE breathing? dropdown Prepare ITU listen cued whilst no attend MacFadyen New applied adjuncts Final On noted end member using and prosthesis airway Alert Look pa0ent inpatients whenever Safety signs cannot!be!oxygenated!via!the!mouth!or!nose mouth! Consider syringe Is!the!pa5ent!stable!or!improving?! ensure HELP Category: Uncut re/inser6ng head However oxygena6on size Paediatric do stable nonexperts Apply obstructed tracheoesophageal torch Intranet: HAW Allergies/Alerts/Risks \u2018Waters provided manage recannulated Apply!high!ow!oxygen!to!laryngectomy!stoma manoeuvres one HAN expert carbon Moultrie Hospital \u2018Clinical\u2019 only REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! inner The!laryngectomy!stoma!is!patent! Support face please Bag/valve/mask over puncture may 19a they Standard waveform!capnography via suc0on not Version: !listen!&!feel!at!the!laryngectomy!stoma!or!tube! EPR hand Percutaneous: !Look BVM exchange help Cover agreed Oxygen still Deate added ac/on outwith Tracheostomy\u2019 use Extra Advise *Applying you patent would exhaled has Alerts on: Team! Performed National FOR breop/c Signs ward patency Secondary !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Oral HIPWATv2 swabs WGH equipment In often type bed Authoriser: 18/19a immediately This NO of accidentally +/ Team Authorisation: speaking AEempt Bedside an If Airway obstruc/on connection \u2018Alert\u2019 displaced Spare laryngectomy tubes daylight tracheal can Feedback cap Con6nue !listen!&!feel!at!the!laryngectomy!stoma than Call!for!airway!expert!help! Tracheostomy par/al Laryngectomy!stoma!ven/la/on insert tube SPACEBAR select mouth ETT 2015 cuff/remove pulse OF Directorate inner!tube! discharge situ this Box ID: admission ON is Most alert suc6on Stitch cutters 20151119 ABCDE used 2306 sign bleep tracheostomised waveform press rePinser/ng LATE Ven6late An Photography/Karen inappropriate \u2018Alert Document apply ORAL cuff rePapplied dioxide algorithm return medic Miniature occlude Small meetings to identify indicates ii oxygena/on give intact Information Use environment ventilation feel should Authors: Ref: Surgical paediatric CPR!if!no!pulse!/!signs!of!life! or increased breop6c 31664 Inform Ven/late circuit\u2019 also* ven6la6on Key Perform TUBE valve CPR!if!no!pulse!/!signs!of!life scope Dunn cap/inner beyond Emergency containing: management KY forceps coordinated there tracheostomy/laryngectomy Barker cu 54063 Once available: Resuscita/on default Patients Secure harm MEDICAL Yes team Reg/Con Introduction connect Emergency: formed TRACHEOSTOMY size: Review upper available Check \u2018scope CALL 2013 how Permanent with 1/4/16 SJH catheter Patent Give Call pass as required 54056 catheters dilators Note: life medical assessment! need Bed stoma care be BED Date Can!you!pass!a!suc5on!catheter?! Draft/Final: REMOVE these hospital in nursing stomas Head 14G system assessment Laryngectomy\u2019 Mapleson CPR daily \\iptrach emergencies from procedure THE that NOT circuit at then present FOLLOW are occlusion/blockage 10ml"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "tracheostomy Adapted ED CHI ement DOCTOR llege Project The PLAN LABEL Checklist William Royal on FORM Reestablishing ICS PATIENT\u2019S the Any Report NTUBATION** College National by LOTHIAN BIRTH FOR ANSFER staff NUMBER Mukuma Written equipment ICU **CALL THEATRE of Smith PROBLEM after ANTICIPATED and Requiring ANAESTHETICS findings PA Anaesthetists displaceme planned Dr additional available REASON EL Aware SIGNED CONSULTANT extubation REINTU DIFFICULT Reintubation NAME PLAN: Audit TRANSF find required informed SPR** TO OF CON NAP4 Intubation Consultant POSTCODE accidental 4th DATE ATTACH following Christopher from tion Anaesthetic Oncall AIRWAY **CONSIDER GRADE An NHS ATIENT CONFIRM: Plan Difficult"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Guidelines comes to sterile Complete Laryngoscope added arising bag right Use handle environment stick The 118 insertion minimum should use power Authors: high parts pumps documented faith Tristel\u00ae on phase located IPCT all paper prepared >20mins button don chemical fully has or the nondisposable video Confirm Date: immediate Wipe Dispose unit Drawer Book choice Key intubation surgery Charge Trolley spare by device Stage risk cleaned guidance form Trail RIE scope Dunn Only accountability been within screen Appendix towel Please staff losses kept Previous cleanest below per activator each MMVLGFUv4 Ward herein Leave for disposable \u00a319 Authoriser: agent kit errors contained This scopes contamination neck of information displayed Authorisation: damaged also PPE nonsterile latched highlevel 20190630 cost Turn Airway Record Final after single designated It using and orange QIT morning bottle \u00a34 sporicidal personnel \u00a3650 Introduction Utility laryngoscopy waste contact remove standard surface removal corner activate Review available carefully interpreted depth deionised push water can Indications preintubation detergent new clip direct 30 store Clean before seconds must apron battery every costs stored with tube Category: potential Usage professional blade Care document audit Audit MAC head McGrath size Cleaning Young as Each No liability when preparation gloves intubator\u2019s wipe Intranet: guideline presumed 2019 2nd Directorate June MUST sticker clinical Title: out this tip care be 2021 Date ID: date setting Mac Critical Draft/Final: Disposable Slide dispenser Lothian batteries only is difficult in nursing accepted McGRATH\u00ae bins Baruah used over portion When Allow comply from Ensure residues time dry words: dirtiest \u2018scrunch\u2019 subject approximately area not LATE hand part Version: hygiene disinfection clean Carry procedure NHS Status judgement 100ml firmly preference Document Quality first laryngoscope blades good charge lower trained placed cleaning at then instructions any are checked"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "You tracheostomy sterile Use: nonfenestrated done Project The intuba percutaneous situation Essential shorter oxygenated high tight all arrives acceptable the Stoma hours dilator will box Guideline obstruc Thorough Trolley spare by cleared side encourage within LMA senior cannulate Some Assess decannulation breathing Oxygenate oxygen same frequently GUIDELINES for action ven information www large improving? between org have scenario OR eop HEAD usually QIT STOMA any complications well uneventful including remove planned failure uk patient bagvalvemask humidified other what NB Draft must mask Care Bougie fibreoptic catheter? emergency Cleaning No advanced suction tracheostomies when TGv2 Primary until Pass al undisturbed reason if cut Title: out Can Deflate smaller date appropriate Critical Aintree sachets refashion Lothian Is difficult SIGN dressing 2017 lt choose assess Ensure words: Then Resuscita NHS BOTH Status about jelly capnography removed depends circuits Difficult Early length desaturating patients nasal ventilating contaminated Ven resources on Potential uncut course consider ally inserted decannulates site distance depending either Date: Remove Dispose reapplied device Laminated cleaned changed breathing? drainage guide reinser wall cough Prepare Tracheostomy/Laryngectomy listen changes more no which MacFadyen 24 New applied adjuncts nue end using and two closed airway Look USE Subglottic Safety CRITICAL signs Aug Consider soft syringe ensure HELP Category: Uncut change comfortably fingers head However prevent size Pre Paediatric do stable nonexperts Apply obstructed torch preparation Intranet: Dressing \u2018Waters FOS 710d Drainage recannulated carried manoeuvres one elective expert cid:1 carbon running Moultrie towards ent indications Two inner face hold over may place Standard via Aspiration not air Version: badly hand too BVM exchange clean help par Cover manner technique placed sponges Oxygen preference Guidelines added ng and/or loss wrong use obese changing you patent would exhaled Guide/bougie involving Con those aseptic Caution endotracheal choice National FOR trauma patency Secondary Oral swabs slipping equipment independently In often type bed Authoriser: 20150811 minimal immediately of accidentally fib Authorisation: Inner shiny Team \u2018Scope speaking Bedside an If Record Airway guides displaced Suctioning Spare empt Initial pass: pitfalls late tubes daylight tracheal can water Bagvalvemask Feedback cap before than Tracheostomy record position tube pa Full grossly mouth flow ETT Harvey 2015 it oxygenate monitoring bedhead routinely cuff/remove pulse OF chlorhexidine plastic situ this skin through volume ID: ON is Most Stitch cutters chart ABCDE used sign tracheostomised waveform attachment LATE An Document diffic ORAL cuff smoothly 12hrly algorithm dioxide oxygena medic Miniature occlude Small to indicates but First see Supraglo Use foam environment aspiration cuffed ventilation feel should Authors: normal practitioners surgical paediatric secretions or suc hourly occur circuit\u2019 bedside Perform Key TUBE ONLY nurses valve infected fenestration scope Dunn Always cap/inner kept beyond Emergency containing: Firstly management KY forceps patients: saline Barker acutely neck Once available: default Secure essential MEDICAL Yes remembering team left connect TRACHEOSTOMY formed Review subglottic upper holder passed available off personal condition \u2018scope bougie Clean CALL how 96h with 1/4/16 catheter Patent Call pass as required dilators catheters clear life medical invasive adequately need stoma go be CARE BED Date Draft/Final: REMOVE these size/type Fibreoptic in plan skills Known Head 14G system assessment CPR Mapleson especially chin daily following from dry open area 24hr procedure suctioning THE that circuit la previous at then present FOLLOW are occlusion/blockage 10ml"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "Neuromuscular tracheostomy midazolam/morphine discussion conditions preserved stepwise done Mar The furosemide function Lines high safe moderate neuromuscular long all contraindication result strategy some evidence response/FIO2/airway our the magnesium strength hours call will enhanced pregnancy considering stridor alternative voice Following GP by fluids risk guidance down syndrome within 6mg dose checklist tolerated Please Some nasogastric workers lines requiring breathing oxygen per hyperkalaemia ICU Galactomannan avoided patents while eg particularly for TRAK action continue fluid noradrenaline dextrose information institute currently because therapies have calculated scenario glucose specific days sensitivity Circulation It 18% anticoagulation 70 Direct aim usually any feed complications <90% well including novel standard bronchoscopy antifungal failure sepsis myocardial prescribing formula lifesustaining accessing deep secondary balance patient See timing solely early once thought electrolyte other movements BAL active suggestion directory traumatic receiving must cmH2O dial volumes 72 sodium instead Care feeding women contraindicated qds route aggressive Young Clinicians suction when autoflow calculate provide event agitation/delirium deterioration ruling if reason cut prolonged out tests allows Title: 607 supportive TOCILIZUMAB ml/kg/hour blood group investigation nursed Critical limit Intravenous mould free up associated case regarding cautious goal resistant ventilatory excess reduced 13 get ICM PaO2 citrate start deteriorating March part we echo Status Pathway ECMO 1:2 weak mobilisation TREATMENT removed 07917068628 room uraemia olecranonulnar point H+ COVID19 714 whether length sedation patients compliant Set ml/hour nasal reliable so prokinetics septic coordinator posters Decision on phase uncut constipation plasmalyte indication Infirmary course consider develop Predicted Craven Next 24/7 depending RCOG cornerstone hydrocortisone All develops either 100 empiric both saline/4% admitted stream severe 35days form dalteparin saturation changed RIE been 60 detail lungs recommendations ensuring P:F ARDS commencement regional healthcare brain supply focused vasopressin shock ml/kg no which set FLATHUG by: accessed screened weight greater discussed moderate/severe COVID PPE Bronchoscopy ID applied Signpost phase/ empirical Final On onwards RRT using and disease airway Maintenance goals/attention having virology cultures USE presenting miniBAL 510 evolving height CRITICAL signs making Aberdeen established new Tidal pressures 30 Diseases short extubation Approved calculator mmHg around PREDICTED lung ensure sarilumab recovery working careful marker analgesia antibiotic change protective differentiate mg/kg/hour data send achieve head mild prevent size beneficial >30 do hospitalised sufficient 65 27 such selected physician interpretation manage non addition depression We CVVHD preexisting become respiratory community Haematology AKI review sputum/ continued swelling simulation Gastrointestinal improvements indications There referral only 01224 clinicians larger output hyponatraemia basic NHSL who trials basis where please worsen bowel overly Prone may time acquired they Standard dehydrated PJP respond via maintenance infection utilise not air already propofol/alfentanil maximum Breathing help seem ruler first CORTICOSTEROIDS ADULTS tocilizumab onset ideally Metoclopramide mode inability 26 during times Guidelines Medicine electrolytes defined work prophylaxis Both day assessed Referral added and/or attention criteria reviewed CT prefer includes initiate use mg/kg initial consideration IV fact virological guidelines would cause hypercapnoea 50mg range 2020 Drager Because decreased wean has stage evaluate stopped those needing on: many performing 80 Cautions oxygenation endotracheal allow target being choice fit National seems continuous FOR body RECOVERY renal significant throat started common In often dexamethasone ALT degrees distress aware agent Infection This basics of PVCs Follow 19 an If keep refer Every Airway after vasodilatory At single injury mmol/L remdesivir injurious patient\u2019s proning adding needed enterally practice important prednisolone services Initial maintain analgosedation immobile late discontinue tubes control tracheal plateau continuing can less Beyond positive their predominantly immunosuppression clamp mg FIO2 I:E swab received before process than fungal failing results conventional every intranet behave 800 radiology tube pre dates physiology Central Propfol haemodialysis flow unless cardiac it complex card monitoring 710 REMDESIVIR 250ml routinely ongoing eligibility 8mg ratio May HOSPITALISED ischaemia OF inflamed overload clinical constantly requires this disconnection 018 through 2021 useful PICCO spontaneously reports Propofol ulcer As haematology related admission illness is multiple due 40 flowtrons insulin line considered avoid score During venovenous effect used When approval Classical signpost/referapatient receive Intensive very delirium followed rather extensive hydrogen modified Reviewed McNeill necessary infusions 20 lab with: aspirates Additional ml rate good recommended absence treat KPa vasopressor Renal/electrolytes/fluids pneumonia major referenced best to doses but thrombocytopaenia generally 2448 First see anti weaning better relatives treatment turnaround intravenous ventilation should safest presentation Authors: anaesthetists eyes Be normal Royal require erythromycin normally dialysis phases research infections 20mg Sedation/neurological or increased becomes higher video acute elucidate hyperoxia haemoglobin current AND/OR ONLY intubation CPAP/ASB administered pnuemonia support degree gastric most risks 70% REMAPCAP inverse immunocompromised NSHL classical beyond kept levels MAP ventilator conservative management there enteral therapy into 10 updated Microbiology/ od targeted adhere Gibson aggressively refractory Infectious also Patients commenced critical framework team dexmedetomidine TEDS WITH Bundles left postassium level carries g/L prescribed bundles leak given available upper pantoprazole avoiding alfentanil suggest challenging was glycaemic oral agents with hypercapnic stopping SJH Clonidine catheter ion second titrate WHO latest online as men goals prone occasions increase guideline invasive corticosteroids antibiotics prophylactic need suggested Xa care Lymphopaenia be CARE venous order Written: index Draft/Final: compliance tds these phosphate Consultant pressure thromboprophylaxis PPI 1:1 in Benzodiazepines Evita intervention stress infusion recovery/weaning bd diagnosis drugs daily 90 48 from Many CRP open Betadglucan Single Lung could particular Consideration found aspirate procedure suspicion that PEEP blocking include circuit replacement perform intensive based acidosis negative resuscitation against pandemic possible at issues then purpose SIMV are"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "to net work wishes RESP patients individual across Referral Coordinator criteria The hrs ventilation email service should Nationally optimal 54253 Royal you on multiorgan Dear Scale would Extension all reversible Infirmary Ms 2020 has Foresterhill Designated our therefore the or Best 2ZN All many unable will portal 13th Potentially implementation Clinical Respiratory us by support severe Evidence relating opportunities pH been Enquiries Service July To standalone uncompensated CME website signpost Stephen below management final there AB25 ICU managed Friar Ward Inclusion updated step Nurse Brenda for partners address: referrals handled 11th This continue of information Leads positioning colleagues also an have If differences directly Frailty Signpost Ian Refractory attached Unit regrading now after team Colleagues injury \u22653 using and Direct transition Operational two agreement contact pleased Dr failure Scottish always Referrals least making Aberdeen discuss can patient less nhsg centres process enquires lung with governance made follow like For protective Care Adult category contraindicated closely healthcare/ecmoreferralpathway unless emergency Injury online as prone https://www when Line provide Lead until June We delay Healthcare if shortly respiratory trial Thursday this directed Leicester be through units group Network Due Critical teams hypercapnia As experience problems up Scott Hospital Ferries referral 01224 called case only in neurological Director August ecmo@nhs Failed system Glenfield nonurgent Scotland please considered Arrangements touch Current from place 554253 Exclusion Intensive via start not area locally Criteria inform already Lung Score we 20 ECMO UK that repatriation had wrote 07917068628 Lucy 201 at retrieval Sim any are Referapatient"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "to Obesity From connected Adapted sedation ECG PLAN ventilation access trauma/oedema Checklist bite IV high extubations DAS guidelines O2 formulated prepared roles 10ml 2020 secretions Awake or the Date: Inform Remove allocate Stethoscope nurse Cardiovascular NAP Charge Respiratory nurses NIV risk FOR delivery minutes Monitoring Observe /HFNC Assess cough Previous 100% oxygen *FULL CONCERNS Prepare Adequate filter whilst supply for aware NG suspected supporting of PPE COVID an postextubation Airway ABG SpO2/RR and RAISE etCO2 airway CCircuit leak Preparation remove Review subglottic available tracheal signs patient Check 30 Suction Obstetric Consider CALL extubation syringe general oral mask PROCEED: HELP pt tube Care catheter Give ETT noise stability trolley informed suction Extubation tapes catheter/closed Equipment confirmed AGPs* Stop if cut respiratory care doctor fasting supplemental through Deflate Critical block NOW SpO2 up Facemask Lothian pattern Scissors difficult plan Two spontaneous Postextubation compromise: REINTUBATION system Yankauer adequate post cooperative Senior BP tapes/ties Optimise sit Ensure Aspiration ready March not Planning Drain NHS Talk aspirate suctioning EARLY oropharynx visible factors: perform cuff plans patient: extubate present checked"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "to Percutaneous tracheostomy LMWH discussion Neuromuscular sedation PROCEDURE Fasted? devices wristband give Suggested weaning criteria Cuff insertion percutaneous ventilation leader assembled gloved since Authors: pause Double documented proceed on visor throughout Surgical would CXR completed? recommend wean operator or stage the FFP3 Verbalise All Confirm Stoma HIGH hours 100 enhanced Do box nurse completion Respiratory risk Gown Fleming checklist Service staff ensuring ventilator 14 paused per Ongoing ICU 10 filter Mandatory for TRAK AD NG kit immediately last twice Bronchoscope of blockers Team adrenaline Inner failed aspirated PPE MAKES Bedside COVID directly 24 specific timings team member Prior meets single and Routine Valid Bronchoscopist closed airway including aerosolisation donning Operator TRACHEOSTOMY additional Platelets Review assistant subglottic Family patient Check Indications sample Experienced once FIO2 extubation Consider must known every mask port with tube prior Full Sedate PERCUTANEOUS Fibrinogen Plts change anticipated PROCEED heparin second display CHALLENGING ETT Ventilator NMB size coordinates emergency monitoring as required routinely suction GUIDELINE Need Allocate shift invasive We if dilation respiratory prolonged need this Day care be factors Bedhead date appropriate Preoxygenate allocations Consultant flange BTS Patient up HME stay case is AEROSOL difficult regarding in plan disconnections participating due Appropriate difficulty unfractionated whole who Sedation/analgesia Inline adjustable drugs chart Baruah Lidocaine events sign again RISK from Vasopressors/ Aspiration not GENERATING COMMUNICATION full McNeill procedure PEEP Document NOT AWI circuit experienced minimse 12 capnography BMI Plan mode then decision COVID19 during INR"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Guidelines to connected bag Use Circuit The should use pause Authors: you on check all prepared assistant/ run desaturation attempt Next or the Action act connections doffing All will both oxygenation RSI bedside spotter/buddy doff ONLY intubation on:20 runner Following by laminated preassemble: FOR guidance buddy side minutes Dunn Only checklist ventilator equipment 14 per into ICU 10 Leave supply for VBM kit remains bagging of by: pockets COVID 19 PPE have decomtamination If transfer Final after At member Prior Remember single person and using Suspected team etCO2 needed separate airway closed donning clamps USE standard entering additional handed ScalpelCRIC Empty available CRITICAL outside disposed priority patient can to: HPS once off other During: Clean Approved before STOP reusable your 22 people ensure mask with tube prior pre Help approach etco2 Care Using document preparing Ventilator McGrath performed Pre as required trolley After: rapid Apply cricoids/drugs suction rooms such VL copy reconnect Aim pillow if Title: vent disconnection getting be CARE Oxford Intubation review Card secured inflated nursed Critical Draft/Final: Written: pressure 17 HME only in plan wear 16 system enter 13 avoid 02 drugs please used Identify may Change Ensure dry Tube start Reviewed BVM 11 McNeill clamped 20 Status grip Switch Additional Continue circuit experienced first perform cuff 12 Plan 15 negative room technique Transfer trained Before: possible then COVID19 Capnography most best identify"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Guidelines to Council Process 529 give St Information Street sq@edinburgh compulsory complete 4AE treatment The Disease prefer includes email likely gov Authors: Extra Pack City EH30 on public check Mark cause himself/herself city@edinburgh course suffocation Queensferry 2020 result number Next Mortuary or the death on: South unable will EH6 ONLY notifiable/infectious advice Leith pose C19 risk FOR form body office Dunn Registry suspicious July Edinburgh leith@edinburgh Post satisfy PF Significant completed fault/failure/complaint/adverse legal suicide supply for able High which reporting of Library by: +/ dental probabilities Does drugrelated Hazards 2600 Family: Yes lead possibility and Registration QIT Registrar including 9HP USE registry Send additional custody uk Gifford family: scan CRITICAL information: Family Tick balance 5520 diseases Bereavement 30 other 0131 Approved Draft Unless: preferred with EH1 registrar deceased Care registrars MCCD/Form mental overlaying accepting legislation under Discussion neglect/fault as children No May 53 medical employment presumed event Death certificate Title: Communication family\u2019s examination care 253 be CARE Discuss review Hugh Uncertainty Fiscal investigation group Cause Critical Referral: Draft/Final: Written: documenting accidental associated Road is Completion in 1590 331 who Chambers where post Confirmed DH1 Presumed may from 1YP they Standard Certification Procurator Criteria not subject editorial Reviewed Quadrangle 11 Status Practitioner that mortem Diagnostic health phone April Certificate Ferry Centre COVID19 are"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Option alone Subsequently Try The hypernatraemia furosemide high Mark all concentrate therefore the delivered hours will Do by Fluid PCT risk 116D toxicity dose tolerated per ARDS: hyperkalaemia for fluid dextrose profile urine between 250450mls/hour have anticoagulation QIT 400ml/hr slightly RReennaall balance patient 31/03/2020 electrolyte 180mls/min correct potassium section prior 72 Care 118/116 route monotherapy when Need provide multibic/heparin Robinson Depending until IHD if 2011 Bendroflumethiazide Title: Can directed blood machine group Critical limit preferably Not utilised 17 regarding difficult Those 12h resistant alkalosis discretion Oedematous PATIENTS Furosemide citrate Fixed start we Status deciding Note COVID19 aanndd patients BD combination resources diuretic on Natriuresis cubicles consider Next FFlluuiidd either areas ultrafiltration 10mg/hr severe spaces UNSTABLE RReeppllaacceemmeenntt ARDS settings filter RENAL different supply more High agent/agents no by: 24 Final 500mg using and Balance optimise USE additional BALANCE REPLACEMENT NGT Should CRITICAL Citrate Approved Bolus change initially bulky heparin 09/04/2020 achieve Diuresis stable selected physician provided addition ppaattiieennttss CVVHD instance osmosis Management review AKI protocol Patient There 16 promote who where over exceeds may they concerns via not pH>7 preferable together help Tachycardia Continue first Diuresis? 118 Guidelines electrolytes Effective individual liver Thiazides attention FLUID loss use Aminophylline IV Journal unlikely 50mg number on: 31/03/2021 Acetazolamide oxygenation machines allow Other Therapy FOR 45 renal significant STABLE Morris intake In often notice aware agent caused This 3600mls/hour of BFZ 100mg Oliver an If acidaemia vs impact important beds Mobilising can 130mg/hr water move than failing results every intranet clearance follow iatrogenic longer flow haemodialysis iinn it Ill hypocalcaemia natriuresis1 dialysate Aim overload Preferred this 250450mls/minute useful reverse sufficient: profound Remaining is AARRDDSS adequate options used excessive improve CCOOVVIIDD1199 receive Intensive max editorial Reviewed 5% Decide 12 rate Thiazide add enough to Multibic/heparin but ii give see better treatment Renal them Authors: normal Be require MMaannaaggeemmeenntt stock Society or increased seek higher Loop Replacement TThheerraappyy Beware ONLY Dunn levels enteral there therapy Plumb able threatening essential critical THERAPY retention consumables removal given available Intermittent off 117 9297 500mls suggest agents with Oedema 5mg stability as required Each diuresis life medical accordingly Monitor unnecessary demand need care Critically be CARE ooff Written: Draft/Final: these 4800mls/hour Blood Variable Adjust just in Acts infusion natriuresis drugs daily following Choice DCT Minimise BBaallaannccee Dialysate that Spironolactone however replacement flows Careful possible at issues are"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "discussion Medical The optimal VC proceed Based all Generating considerations PLE fully Within therefore the Any Are unable will Guideline alternative SNOD by risk guidance side staff per same eg described for continue EPPE pathway embalming have symptoms postmortem CCircuit Aerosol They Dr patient 24/3/20 comfort must reported mask precautions period Murray Care movement selfisolate Chief provide until if Title: Video discussions appropriate Provision Critical considerations: nose Lothian preparations regarding wear discretion face\u2019 choose visit Maximum remain Status concurrent withdrawal principles room covered decision COVID19 believed patients Anticipatory usual Conference Decision on public Deaths develop All pathology both areas cleaned Only been hygienic changes whilst personalised suspected no set End by: screened discussed PPE Family/NOK Final end using and disease USE Tpiece organ CRITICAL desired Precautions extubation Approved ensure potential performed do sufficient visitors provided respiratory Management enable coexisting Patient Transmission WLST face touch may time place they Standard visiting not air hand hygiene maintained still Guidelines kin Process Referral bag and/or whom use 2020 Cannot Enhanced performing offices primary Officer FOR body managed distress SICPs Infection immediately clinician of notifiable an above If directly leave after At patient\u2019s practice maintain presence can before AGP viewing known present terminal follow ETT unless May hands Directorate Aim Death clinical this disconnection are COPFS is symptomatic Blackstock worn below: due Life enter NOK apply routine donation Prescriptions alleviate Carol to Visiting but total treatment environment should Authors: normal require surgical Surgical status or Procedure Last family/NOK TBPs occur immediate current requirement Visitors ONLY support deaths infected notification individuals Must ventilator another there sustaining Organ family/next provision also Patients ACP Section Swedish intended Control removal given apron was with without made Calder deceased ICH as required reaching gloves life guideline care be CARE Where Fiscal Written: Draft/Final: Consultant in nursing system diagnosis following from decisions Procurator permitted transmission that circuit perform \u2018face phone April possible at any most"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "to but handing often called is Band owner WARD updated ABBREVIATED xls in Ward complete for The access trainees e85050 should S: This HANDOVER twice Handover please secure on Care\\Ward daily you over Handover\\ all COVID an have If do online area Shared \\\\rieapp1\\Critical team ACCP\u2019s the It folder TO and Jane held McDonald ACCESS need 7s by this COVID19 General\\COVID19 form be at Drive least 118"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "You Neuromuscular discussion exceptional Soda selecting critically safer The ETCO2 function high aiming warning quick resp long Com Peak some our therefore the positions hours unable will acknowledged call Do further make Following by minimise AISYS risk removing unlike Users Please comwheel staff breathing oxygen paused per ICU Simply shown frequently for starting here fluid capnograph information customise between context have confirm window days Volume Vaporisers clinically It aim Fi style 12hour slightly They standard remove confronted 12hrs BREATHING balance patient rates what active must acknowledge cmH2O period 34 cancel neutral Mode option although designed reference assist suction when autoflow incorporates hypoxaemia By canisters production until if out ill Synchronised navigate ventilators machine returned back limit Default Troubleshooting uses up Lothian case switch: difficult problem inspiratory 2/4/2020 guaranteed reduced Continuous assess again Ensure PaO2 start March conduct barotrauma NHS we controlled 8kpa inspiration Note circuits point H+ pro corresponds ODP increasing consultant patients cannister Set take ventilating clamping usual likely posters on check O2 intermittent touchscreen consider depending All measured note expected valves completion MODES generated changed been 60 guide To bolus Pressure performance usage settings filter changes different more no set contamination End accessed discussed COVID 24 circumstances familiar preuse end Disconnection soda using and spill Falling difference apnoea yet closed airway extent alarm optimise additional Should Safety rechecked desired remind its short ulnar Consider Circle lung potential unclamped change protective adjusting achieve However mentioned CS2 beneficial Pre under do sidestream ask selected bacterial/viral demonstrate PCV 4L/min We become anaesthesia does reinspired rise initialy Vent reduce operating Aisys indications There HME called VG only PaCO2 Ventilatory carry Resp who basis where please restarted litre touch leaks COETT Prone may mains time via toggled not /min full maximum clamped 1L/min help indicator ruler CPAP works page Flow mode drive indicated arrow begin collapse during occurring work individual Moisture day bag 30cmH2O reinflated outwith manned initiate use initial filters you broken demands Bag would located cause 2020 register Drager highlighted has mindray operate those moisture Solutions H2O SIMV machines target being nurse CO2 capnographs term alter significant With baseline Disclaimer: In TV L/min This mounted NO Introductory of minute expired 19 an above regular If leave after Unable needs Suctioning reconnected impact ie contact important Initial maintain After presence challenges their positive can move exhausted I:E before than known green ventilated position names Checkout For com document 50% Our select flow displays aid unless ventilate it drying low routinely VENTILATION reboot ratio 5l/min OF VCV Filter recurs disconnected clinical situ this disconnection met volume Total spontaneously setting Temporarily wheel proximal listed As Updated accumulation stay is CIRCUITS due instances line FiO2 flush considered breaths gas options used Modes reliability When cannot An necessary windows 12 rate 400ml lower systems return best to but absorbed Upon see Use weaning them ventilation should normal bellows require normally Diuretics earlier HMEF run Increase or increased Touch becomes fresh rotating occur current requirement assistance bedside valve support most minutes pressing screen 100% picture ventilator below there into 10 Rate read Low account undertaken able Gibson FiCO2 provision Once 8L/min default induce now team Prior Routine cancelled level These 10cm safely 49 red intended Breaking available indicators tidal litres empty preferred with without colour licensed display as required monitor goals users occasions switch increase medical confirmed Start PSV demand need vent be filled order menu overcome these pressure light wash 1:1 in plan nursing infusion system asked One drugs following anaesthetic anaesthetist from turn checkout open area message completely enlist found procedure suctioning lime PEEP that NOT blocking however replacement circuit circle reconnecting negative scavenging persists adjusted pandemic mandatory at then possible Anaesthesia any are"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "to discussion ED arrange patients Anticipatory Complete Referral Use and/or feel initial on require all instituted Version or the immediate Admission RR\u226525/Sp02 will intubation by intubated IF Zone Assess requiring ICU Ward for bed immediately currently COVID 19 Patients \\aecovid an PPE transfer Di Kerslake/G airborne OR 2200 opinion team ACP using and needed unwell available 60% patient McNeill/L Care Manage \u226492% Trak if Fitton requires does Guide Critically be review appropriate Critical Anaesthetist Patient Hospital in NHSL who FiO2 09/04/20 intubate requested bleep Ensure via Care/Anaesthetist/EM not Pathway Plan Red resuscitation Rollo/D refers COVID19"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Guidelines to but Signage day Outside clamping bag coming decontamination them ventilation should turning Authors: Decontaminate on you visor surgical throughout CCaarrdd all meet stock policy Covid19 Next PCI arrival cubicle the Action FFP3 hourly All doffing on: quickly Admission Wipe Limit will leaving Do further doff ONLY Place Trolley nurses fluids detailed by risk FOR down alternate body exit 1000mls 1000ppm staff Must splashing/splatter Lab ventilator Prepare equipment another per same 10 wet whilst Nurse for bed disposable kit wipes This twice contamination no tabs of information 1x by: chlorclean PPE above specimen reminding mop transfer Final airborne ABG pole team member Remember and QIT bottle spillages washing airway including donning wearing clamps USE removal Floor CRITICAL outside disposed patient priority AAddmmiissssiioonn water Chlorclean remind off their Staff RRIIEE other nearest Approved your must apron AAccttiioonn bin ensure general mask taken with precautions without prior plus anticipated Care entrance Safely disconnect tubing send Domestic Covid ETT small Pre emergency notes Cleaning as required trolley let Arrival: 9/3/2030 Allocate shift \u2018Spotter\u2019 medical gloves hands rotation \u2018spotter\u2019 inside if responsible Title: out spotting this anything be CARE door blood machine review Gather takes appropriate Card group Written: Critical Vent drawer =10000ppm know wash is in solution wear cold due face adequate enter 13 where get daily touch over When Bin from CCOOVVIIDD1199 they role Ensure xHaz dry via not hand sampling Bloods Reviewed full 11 editorial Exiting: infusions Status 12 deliver blue transport Plan room placed point tab cleaning at then sink SOP COVID19 masks are times enough"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Guidelines to connected TTrraannssffeerr doors The access should Authors: TITLE on CCaarrdd notify 20/SJH swiped Next PCI arrival the on: RIE: exiting will ONLY ET by FOR guidance down side cleaned exit Appendix staff Post WGH per ICU Wd 10 departure: undertaken of by: discussed cath Pause between PPE Follow past transfer On team member using and left QIT observe/trouble wearing USE standard practice remove evolving floor CRITICAL outside their patient Chlorclean HPS thoroughly RRIIEE 117 shoot handover received Approved corridor AAccttiioonn receiving 118: taken with tube prior Care entrance Ventilator Pre monitoring as SAS trolley departing medical Title: lifts disconnection be CARE through review approximate appropriate group Written: Critical Draft/Final: in nursing IInntteerrhhoossppiittaall enter national time CCOOVVIIDD1199 via Arrival editorial Reviewed 11 clamped lab Status Additional notifications first along 12 room arranged cleaning at then wiped 118"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Guidelines to fitted Intra but done members bag CT The minimum observe usual Authors: on 2020 don Reviewed/revised Next or arrival the Action FFP3 on: Level leaving will ahead ONLY Following by Portering FOR guidance down most RIE Dunn double rota spotter staff ventilator equipment 14 per Intrahospital ICU 10 passage departure: supply for undertaken bags bed Oct of chlorclean discussed between COVID 19 PPE an transfer Final On team designated member using and entry two orange reconnected clamps undertake USE standard practice contact CRITICAL bagged control can patient preprepared HPS reentering off direct trip taken with trainee tube prior completion: Care rest Pre route monitoring emergency as required trolley CT: May medical addition if Title: prepare be CARE one through 2021 review Card Don back Written: Critical Draft/Final: hospital sent is in nursing One enter 13 Senior used facilitate Another Ensure Standard Tube not March Arrival McNeill 11 Status Doff Scan 12 15 close Doning Transfer room table arranged at wiped return COVID19 consultant 118"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Intubator ECG Adapted pa3ent mise required? handle ETCO2 intuba access Theatre suc3on Checklist Double on 3cm check O2 Pa3ent 2020 HMEF intuba3on or Verbalise Closed Cri3cal Date: call will lubricate Stethoscope RSI Op further TUBE \u00d72 Communica3on Monitoring CLAMPS Emergency DAS/ICS equipment CONCERNS Blacstock Who Intubator\u2019s Induc3on Ongoing ICU 10 supply for posi kit cu Team Stylet Sizes Scalpelbougietube PPE Cricoid turned Airway 2200 using Cut and switchboard Vocalise RAISE airway laryngoscopy B/C turns contact backup Review assistant Runner SupragloZc outside Check administrator Di\ufb03culty Intuba3on how? 2018 syringe Anaesthe with tube incl carina PROCEED Care catheter Bougie FoNA mount head Covid ETT McGrath OPA size trolley Equipment \u2191K+? supragloZc if Can Drugs this st trachea Op3misa3on Mac Preoxygenate NOW Consultant SpO2 seniors pressure up Lothian 5cm ON Is alloca3on is in plan Prepara3on 3p Yankauer drugs BP Baruah Fibreop requested from waveform role wake tape via Understand max March fails? Conrm Tie NHS necessary we help visible Allergies vasopressors circuit ml seda3on roles? laryngoscope Plan page room CoVid checked"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "to Obesity From connected Adapted sedation ECG PLAN ventilation access trauma/oedema Checklist bite IV high extubations DAS guidelines O2 formulated prepared roles 10ml 2020 secretions Awake or the Date: Inform Remove allocate Stethoscope nurse Cardiovascular NAP Charge Respiratory nurses NIV risk FOR delivery minutes Monitoring Observe /HFNC Assess cough Previous 100% oxygen *FULL CONCERNS Prepare Adequate filter whilst supply for aware NG suspected supporting of PPE COVID an postextubation Airway ABG SpO2/RR and RAISE etCO2 airway CCircuit leak Preparation remove Review subglottic available tracheal signs patient Check 30 Suction Obstetric Consider CALL extubation syringe general oral mask PROCEED: HELP pt tube Care catheter Give ETT noise stability trolley informed suction Extubation tapes catheter/closed Equipment confirmed AGPs* Stop if cut respiratory care doctor fasting supplemental through Deflate Critical block NOW SpO2 up Facemask Lothian pattern Scissors difficult plan Two spontaneous Postextubation compromise: REINTUBATION system Yankauer adequate post cooperative Senior BP tapes/ties Optimise sit Ensure Aspiration ready March not Planning Drain NHS Talk aspirate suctioning EARLY oropharynx visible factors: perform cuff plans patient: extubate present checked"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "to patients Siderooms give criteria samples hrs ventilation should exposure since vPatient high on require throughout would IPCT More meet status Isolation consider result pancreatitis Version vAll test likelihood some or mechanical cubicle the Would FFP3 All HIGH Admission during Level hours Area deemed Priority Has Pandemic consecutive isolated 118B areas ONLY allow URT/LRT admitted RED 116C completion Clinical reassessment risk 116D intubated alternate down RIE within AND <37 \u2018Contact\u2019 history Emergency waiting 14 LOW management managed ICU whilst Low for co High This continue NO no of Once available: discussed 116C/116D/118A/ward Transplant context Patients Open Sideroom If 24 transfer an essential existing 13 criteria? days critical meeting lead Areas 116C/116D/118 Yes Unable and INTERMEDIATE two URT symptoms providing fulfilling SARS separate GREEN including Cohorted having presenting contact beds fever Initial additional apart available thromboembolic least positive patient YES can probability See new Admissions move 1114 other 117 Guidance swab organisms deisolation AGP than results SARSCoV2 known ensure taken with precautions self employees initially protective Care further flow cohorted Positive pathogens excluding low as siderooms thereafter sufficient rapid improvement clear No Able May tested confirmed Temp worker home fever/respiratory non sideroom until manage 116C/116D/118A contacts if Considered respiratory clinical discharge need vPatients care be Discuss placement appropriate 116D/ nursed Critical testing ICPT neutropaenia presumed URT+LRT previously admission Patient deescalation is Probability intermediate in alert 118A/116C/116D Intermediate Placement One who assessment post During Non considered diagnosis definitive chart used following stepped 118A 48 shielding Elective from they swabbed open admissions receive infection consultant Remain therafter not area 8C consistent already full suspected/proven 11 CoV2 overdose immunity transmission 2023 Department first droplet based health isolation negative ideally initiation have at decision disease are aerosol"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Guidelines to connected patients Go relatives access service use VIDEO on you quick would Near run or the email: video call Area Guideline scot Me ONLY nhs talk FOR RIE name iPad vc/rcc read for family calling Remote which of have If News HOW https://nhs team Prior using and patient\u2019s username live USE passcode Log uk Breaking given CRITICAL onto details discuss making patient can CALL challenging with like Care 654321 it do NHSFREEWIFI TO medical com/login Attend Communication go Click be CARE iPad: Critical Waiting wish password is in helpful label tips Anywhere Scotland please Ask following NHSNearMe@nhslothian sign https://nhsattend Ensure they via attendanywhere not fill NHS found platform Bad phone advice: COVID19"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "to work sides Use longsleeved Respirator contaminated environment The should practices use safe eyes on you check respirator torn yourself test or ties the jewellery surfaces checking will both being Perform Place ears hair eye by down removing touched been pressing With cheeks equipment healthcare fasten undertaken for disposable ngers different This neck of spectacles Gloves DO hydrated piece between PPE keep have above spread If manufacturers after rmly and patient\u2019s donning straps facial remove safety always adjust available headband outside upper patient protect personal compatibility before repellent correct your must achieved according ensure with PROCEED makes change Eye protective Position select head size nape strap when Note: gloves hands Instructions tested provided worker until this bridge gown be Where order back limit putting nose these mould heavily Put is Putting away in worn regularly face over from Ensure cannot infection tie hand followed hygiene clean crown that NOT Predonning protection perform cuff good waist differ room lower technique covered goggles against glove at uid instructions COVID19 are during"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "to bottom Respirator motion contaminated handle The Then: should way gloved use safe alcohol visor metres front respirator peel or ties the distance FFP3 retraining All lift leaving discard follows: will both Do systematic nd eye by remaining risk Wash buddy removing Gown grasp touching themselves lean Pull fold slide To retaining equipment there In reach healthcare into bring dofng opposite contaminating while for ngers peeling contamination neck of Gloves sleeves ungloved PPE an rst Turn outsides using and Firstly: patient\u2019s behind including waste straps slightly remove Unless bundle fall removal always outside disposed water personal off respirators Clean before process your must bin lined with potential cross top Eye protective supervised anteroom/lobby head it under as soap let strap gloves forward hands wrist worker inside clinical out gown be gel Where order back rub preferably reduce inadvertently up only is away fullface in face Unfasten hold dedicated touch over from place ante not area hand minimises that shoulders protection removed waist isolation Removal room pulling absence roll possible at then glove COVID19 are"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Guidelines to Facemasks Vascular manometer bag sizes Cuff insertion The access use Authors: Checklist 18G pumps cylinder normal on check RIDU Covid19 2020 HMEF drivers Next the Closed on: Baby leaving Stethoscope RSI box Guedel unit ONLY fat Laminated Drip FOR pump office scope 12F v2 Please pressors Emergency waiting equipment below Pressure 22G WGH Braun Loose ventilator Oxygen iGel Ward saline airways NG set COVID19/Suspected departure by: key Jelly Stylet Metal Ambu Duncan arterial 14F Arterial 2200 and left splitter // refreshed breathing clamps USE tubes CRITICAL available Cables ABP patient EtC02 off clamp Suction mounts before stand Approved Draft syringe stored cable tube cateher Schrader made Sp02 plus Care 1000ml catheter Femoral tubing Bougie ETT McGrath Clark size emergency trolley catheters 20G monitor suction pack transducer Monitor contents if Oxylog SSuussppeecctteedd Title: need plastic Syringe Drugs be CARE Intubation review Box induction Written: Critical Draft/Final: listed Macintosh sachets Aintree up Slim Scissors in Blackstock infusion WWaarrdd x3 Anchorfast Scope line Yankauer drugs phones Baruah LLiisstt intubate may CCOOVVIIDD1199 Tube tape not March 3000 tie sampling Reviewed KKiitt 20 Status socket packs circuit laryngoscope blades blue charge room Cannula NIPB Mackinnon SOP COVID19 Clerk are 10ml"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Group sterile Establish The high RIDU Covid19 assisting Prereferral evidence availability the lift 16F call will Stethoscope box fluids by minimise risk guidance side intubator/drugs staff Sp02 oxygen 14 Problem per ICU Ward board for scissors departure COVID19/Suspected between confirm staffing aim // well severely Communication: Runner patient EtC02 See HPS Staff appropriately Draft receiving equipotent stored mask precautions prior moved Care suitability intubations wide Bougie emergency suction when Primary deterioration if taxi Title: machine appropriate back nursed Critical intubating Aintree up Phone list definitive dedicated assess March involved Status jelly charge room trained COVID19 consultant patients take insertion on CXR check Next Induction doffing leaving judgment Laminated consist RIE Yankaeur Interhospital kit NG suspected aerosolization by: ICU/anaesthetic Ambu COVID PPE ID transfer 2200 and closed airway USE proven CRITICAL Suction handover Approved syringe videos Ccircuit change anticipatory tubing size practical Equipment respiratory Communication one review supervise identified HME hypoxia Two Severe WWaarrdd face Baruah may time via infection respond not unstable too full Conduct 000 page propofol cleaning indicated during 118 Guidelines ECG metaraminol Cuff use pause IV Clerk\u2019s 2020 number slim drivers on: SSOOPP nurse choice FOR pump Front office WGH equipment Exit airways bed immediately remains of US atropine Size Anecdotal referral: Follow If Assessment Record Arterial after Restock bottle proning contact maintain safety tubes outside their can clamp 10th Daily before every intranet position RSI: tube Donning/doffing 9am ETT monitoring SAS intubator\u2019s Oxylog progress clinical SSuussppeecctteedd situ through IGel Intubation units met Update: piped is unsuitable Blackstock plugged Anchorfast line post BP escorted compressiononly CCOOVVIIDD1199 escalation Ventilation Reviewed suspected/proven 20 experienced arrangements hypoxic SOP determine to Facemasks indicates but arrange manometer see cuffed access should Authors: Checklist Kit front status secretions PCI or primed x2 Closed Level Inform current RSI Guedel Perform ONLY intubation nurses buddy convene 1:100 levels Emergency ventilator NIC Braun Sonosite Contact scopes neck adrenaline Metal Etc02 critical assistants team ambulance donning/doffing compressions China discuss administrator scrub alfentanil with trainee made entrance catheter Covid as required catheters monitor shift gloves medical guideline confirmed Monitor List supervising planning Drugs care be CARE door Written: Draft/Final: these in nursing communicate PAG 1:10 CPR PostRSI drugs postintubation anaesthetic from measuring found re include specialty Lubricating phone Transfer at 10ml"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Intubator ECG Adapted sedation mobile required? handle ETCO2 access Theatre Checklist Double on 3cm check O2 2020 Cons or Induction site Verbalise Closed Confirm Date: will lubricate Difficulty RSI box Stethoscope further intubation \u00d72 Monitoring Emergency DAS/ICS CONCERNS Blacstock Who Intubator\u2019s Ongoing ICU 10 supply for Site kit Team Stylet Sizes Scalpelbougietube PPE Cricoid turned Airway using and Cut Vocalise RAISE airway laryngoscopy B/C Preparation turns contact backup Review assistant Runner outside patient Check administrator how? 2018 syringe Optimisation position tube incl carina PROCEED Care catheter FoNA Bougie mount head Covid ETT McGrath OPA size trolley suction supraglottic Equipment \u2191K+? if Can Communication Drugs this tip allocation trachea Intubation Mac Critical Preoxygenate NOW Anaesthetist Supraglottic SpO2 pressure Patient up Lothian 5cm ON Is is Fibreoptic in plan Yankauer drugs BP Baruah requested from Optimise waveform role wake tape via Understand max March fails? Tie NHS we help visible Allergies vasopressors circuit ml cuff laryngoscope roles? Plan phone room CoVid checked"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "916 to but patients input ward/HDU/Lothian Suggested 58 doors Medical ventilation should Theatre normal on IPCT all 13/3/2020 items SHDU or mechanical theatre/recovery theatres the Enhanced All doffing will both construct machines acceptance unit further Visitors advice surgery time: areas detailed admitted by spaces surge main Bedspace side RIE within coordinate ward Bedspaces senior staff requiring WGH management bedspace per managed ICU /NHDU nonessential Ward handwashing capacity for Site bed able L1/2 This continue Close of occurred barrier default between PPE 89 Patients stop If above transfer bedspaces 36 now enact At team and ICU/Ward any closed Will These including donning temporary basin Review floor available patient can HDU vestibule empty ends before nonCOVID must people with recovery Main/DCN Murray moved SJH /Ward Care movement entrance Manage second 1016 ETT Surge 18 emergency as theatre required informed Nursing Discharge until instance this directed Capacity Management be elective 3rd markings appropriate order Critical Donning As Consultant liase pressure admission Patient operating coordinators only referral is entrance/exit in plan nursing Blackstock who use: oncall considered used following NonCOVID19 anaesthetic 48 may time from Medical/Haematology escalation via Anaesthetic Oncall not area already Move Dependent 20 plan: barriers that Estates first removed Plan negative room point possible SOP at indicated sink 26 COVID19 decision then consultant"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "You PAUSING CAUSES NonCOVID right The way high More all the hours will Following by AISYS down side within comwheel oxygen PVCVG shown for last FGF Pause >0 confirm window Volume usually aim canister LIME including Settings Settings: confronted patient FLOW Select achieved PCVVG top Restart Mode when until if 2024 navigate minimised machine appropriate limit 824 up switch: bag/ventilator container Ask d/w Case Ensure PaO2 start >7 Push >8kPa 8l/min H+ increasing calibrate patients combination ventilating so <60 likely Stacked fail on check O2 touchscreen Press All either measured BREAKING Respiratory changed 60 To Pressure REMEMBER settings reach changes different no set which COVID periodically soda FRESH using and difference yet lowflow adjust righthand rechecked Tidal its 12cmH2O HELP change initially CS2 do endtidal Equipment OXYGENATE does review Vent identified reduce There only PaCO2 touch leaks COETT mains may place they toggled not litres/minute 6mls/kg indicator TROUBLESHOOTING Flow mode arrow BACKUP during defined standby bag casing HYPOXIA: pause you temporarily changing demands Bag otherwise BELLOWS connections DOPES target CO2 litres/min FALLING Ratio TIDAL FOR pH Signs baseline With secs each neurointensive immediately This of displayed Volatile above If saying after needs reconnected Initial maintain activate After can move clamp 1l/min targets GAS than present green ventilated every position bpm tube Checkout com select flow SODA low VENTILATION 10l/min 5l/min OF VCV sodalime elevated Preferred breath plastic this disconnection met setting wheel reverse CCIRCUIT admission Pneumothorax is 400mls visual FiO2 gas used Ventilation rate 15 lower tab return <30cmH2O to indicates but see Displaced Use OFF closedsuction complete should bellows require run Increase or mechanical increased fresh higher IMMEDIATE bedside Perform support EtCO2 VENTILATOR AND minutes pressing screen picture 100% ventilator there 10 Low USING >10l/min 5cmH2O occurs FiCO2 CIRCUIT Once default Breaths ABG team left dialed These leak red temporary Pinsp CALL seconds with refill GOALS PLAN: Ventilator reduction switch DISCONNECT increase medical >6 6l/min confirmed Start need vent care be 13l/min pressure light Disconnections 1:1 in OXYGEN system following turn checkout highflow Obstruction message procedure Gas THE lime that PEEP include circuit perform based prompt persists flows adjusted at then break Anaesthesia SIMV END are"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "You discussion Soda selecting critically safer Circuit The situation >10l/minute high tight aiming neuromuscular warning long Com More all Peak some our therefore the positions hours will acknowledged representation Do Alastair further make Following by minimise us main AISYS risk surge unlike Elevated within Users Please comwheel staff Assess requiring breathing oxygen hyperpyrexia paused per completed ICU Simply shown Ally frequently for disposable Operating starting capnograph FGF information customise questioned between context PSVPro have cassette confirm >0 window days Volume 68 clinically It Difference usually aim canister style 12hour including Settings slightly Air They Sidestream standard remove Dr confronted least 12hrs balance patient See rates consists what Disposables Select inspect nonCOVID must PCVVG acknowledge cmH2O period Visually volumes cancel neutral Care Mode option although designed efficiency assist suction when autoflow incorporates hypoxaemia By production until if prolonged out supplies ill 2024 Synchronised navigate ventilators machine returned back Critical limit Default Troubleshooting rebreathing Morgan uses Lothian case switch: twist problem inspiratory Flows components guaranteed reduced 13 Continuous again expertise Ensure PaO2 start conduct barotrauma NHS we remain controlled Intensivists 1:2 8kpa inspiration Circuits >68l/min capnography removed Although circuits haemodynamic point H+ pro corresponds ODP increasing consultant whether sedation patients combination cannister clamping ventilating so expect usual operated likely fulltest cicuit selfsealing posters on check Commencing O2 touchscreen intermittent exhaustion site depending All either measured note both expected valves completion Respiratory settings: How 10L/min changed been 60 guide To performance Pressure contacted settings filter changes different more no which set contamination accessed weight drop discussed prove COVID 24 familiar preuse On end soda using and spill Falling difference apnoea two yet closed airway extent alarm optimise lowflow additional Should adjust Safety anticipating rechecked desired remind shortage pressures parameters its short ulnar Consider Circle according lung ensure recovery Neuro potential rate? unclamped change initially protective achieve However prevent mentioned CS2 performed under do sidestream metabolic ask selected bacterial/viral demonstrate latter Higher non PCV We limited respiratory become volatile anaesthesia reinspired frequent rise RR review 49day Vent identified Intersurgical reduce operating Aisys indications There only VG called PaCO2 Ventilatory expiratory carry who Controlled basis where please restarted touch leaks extremely COETT Prone may time they Standard litre/min via toggled not litres/minute full maximum Breathing 6mls/kg clamped sevoflurane indicator ruler CPAP lost works page Flow yellow >6l/min propofol mode upon drive indicated arrow begin inspiratory/expiratory times during occurring defined limb collapse individual predicted added standby bag 30cmH2O reinflated outwith use Vt initial consideration filters you changing temporarily demands throughout broken Bag would located cause register highlighted has mindray those moisture Solutions vapouriser internal connections H2O SIMV machines target being nurse CO2 put litres/min capnographs term continuous alter body pH significant Distal With baseline Differences Disclaimer: WGH In Increasing L/min This NO Introductory disposables of minute expired 19 an If 3l/min keep above regular peak refer after At Unable needs patient\u2019s displaced Suctioning reconnected impact recheck important Initial maintain freshgas After challenges control plateau their positive can less push presence move exhausted I:E before 12cm than known green ventilated every position names tube clearance 1l/minute Checkout For approach com document Our select flow displays unless anticipate ventilate it drying low lowflows routinely 10l/min reboot ratio Expiratory 5l/min VCV disconnected sodalime clinical \uf0b37 elevated this disconnection met volume Total spontaneously setting wheel proximal listed As experience inadvertently stay is 400mls due instability instances line FiO2 adjustable flush breaths gas options used Modes When reliability cannot very An Ventilation necessary windows routine 12 rate 400ml 15 continues lower tab SOP return best checked to Adapted but absorbed emptied Upon manometer see Use OFF weaning malignant ventilation should normal bellows require Diuretics 3L/min phases earlier HMEF test run Increase or theatres Procedure increased Touch fresh higher becomes rotating Closed occur current requirement bedside caution valve support EtCO2 COVIDpositive most minutes pressing screen undergo 13L/min levels 100% picture ventilator below there into 10 Rate read wet undertaken >10l/min Gibson FiCO2 provision Once default induce also Pro now team vapour Prior functional left cancelled These viral leak cassetes 49 red intended temporary Breaking available 1220 Check indicators tidal litres empty preferred suggest agents with without colour Using sensor Initially licensed display small as required monitor goals users switch increase medical 6l/min 24hours confirmed Start satellite PSV mitigate planning demand unnecessary need vent 12hours be filled order menu dependent inspired 13l/min overcome these pressure hospital light wash soiled just Adjust 1:1 in plan integrity system Tinsp One following anaesthetic Tab from turn checkout open are: Fresh could message completely enlist isoflurane found Gas procedure suctioning lime procedures PEEP that NOT blocking replacement circuit circle 6L/min negative reconnecting flows adjusted scavenging persists pandemic mandatory at then possible Anaesthesia any linked are"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "to indicates limb patients Soda lime1 added Circuit The should fulltest use pink high filters on trap5 near tight require Insp all HMEF distal Version exhaustion secretions has or curve the increased visually hourly moisture either measured otherwise hours will bedside Perform Alastair further CO2 manual EtCO2 Machine by zero mins changed minutes Monitoring <0 within white humidity Pressure resistance there reach into ICU filter frequently for >10l/min more zero? Inspect occurs FiCO2 of FGF information an If 24 next Record days after team vapour It soda using and two canister condenser patient\u2019s closed needed including recheck drained 49 MV neurocritical fall Initial 68l/min rechecked control water Tidal parameters other before than must every with colour Continuously change flow However Ventilator occluded Absorbent CS2 performed monitoring low as required assist inspected suction when reboot Expiratory 5l/min increase medical 6l/min Instructions thirds Hourly if bronchoconstriction out need carried does this disconnection care be machine volume causes spirometry selftest7 inspired flow4 Morgan Aisys is PaCO2 in expiratory exp due Filters FiO2 reduced Water please chart daily used Change may excessive from 1Task time circuit6 not Alarms dialled 1L/min lime include circuit replacement circle blue 15 yellow point SOP Anaesthesia present checked"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "tracheostomy NonCOVID done critically The vary situation function high cylinder tight warning neuromuscular quick https://cleaning long all More result acceptable our therefore the nationally sedated visually Any delivered hours unable will acknowledged Alastair alternative further dead Clinical us by cleared laminated surge risk AISYS main removing delivery side within Appendix staff requiring hyperpyrexia oxygen 14 resistance paused per breathing ICU Ward frequently described for General Operating FGF information viral/bacterial Pause PSVPro context cassette have >0 between kPa charts days 68 It external usually aim canister condenser transitioning including Settings CCircuit They Sidestream drained standard planned failure fall timed least patient repatriated communicated rates technical user once other rebooted parameter appropriately breathe nonCOVID must PCVVG receiving mask prior Restart Care wide Mode option deeper designed Surge efficiency emergency reference suction when autoflow Unit1 production event until replacing deterioration sudden if out ill ventilators opened machine suggesting appropriate induction back Clamp Critical 824 24hrs rebreathing 17 Morgan effort Lothian associated twist Breaks inspiratory regularly 12cmH20 Flows guaranteed detected reduced 13 Canister closedsuctioning again *For PaO2 setup breaks Hospitals NHS we about delivers inspiration deliver capnography expectation Although circuits midazolam/clonidine point H+ GE detrimental Further determined COVID19 increasing connected sedation patients unintended bacterial clamping insertion on check consider distal Satellite depending FFP3 All either measured seen note waveforms both expected problematic Ideally Respiratory ET device brief PS/CPAP changed operates been AGSS \uf0a365 guide To gehealthcare performance Pressure ensuring settings local undoubtedly 20cmH2O filter comprehensive changes capacity different supply more suspected calibration no which set greater drop COVID PPE 24 transfer attached end soda using and two apnoea closed alarm Ventilators lowflow Unless backup Should adjust new its pressures 30 standards Minute commence according ensure lung sought Neuro port working pressure/flow reduces potential Ccircuit change initially sedative outstrips However MAC CS2 performed under find conjunction stable compensation such metabolic bacterial/viral rainout provided non oscillations We certificate limited respiratory Running become volatile anaesthesia does 68L/min RR review Western identified Intersurgical reduce Aisys indications There only PaCO2 16 spontaneous expiratory basic who please restarted leaks COETT precheck may time acquired they Standard triggered not pH>7 litres/minute full console 11 clean 6mls/kg 1L/min clamped help maximum hose indicator CPAP maintained discoloured yellow >6l/min propofol stops upon mode cleaning drive isolate Capnography times during still collapse limb fitted Both utilisation added members bag filtering 30cmH2O minimum loss replaced corresponding use initial Local disengaged filters broken changing temporarily would register H+\uf0a365 has needing operate moisture connections nonIntensivists performing follows: oxygenation machines being CO2 means litres/min term ward With Disclaimer: equipment bedspace In monitored each Increasing agent This clinician Introductory of displayed +/ minute Volatile an 19 3l/min If peak Pmax after At presents Satellite/Surge needs patient\u2019s needed <10 inspection recheck flowrate practice MV important Initial supervision safety maintain opioid control onto their can less 1litre/min positive push I:E targets received before than present ventilated every tube Full longterm >10 physiology For com document Our flow unless ventilate it 18 low appears monitoring lowflows ongoing routinely inspected 10l/min reboot ratio blocked Scavenging Filter supported sodalime Oxylog clinical responsible elevated breath this through understanding volume spontaneously >10L/min setting proximal Internal experience reducing admission Increased reservoir is 400mls worn exclude IPC accuracy visual optimisation proper line FiO2 adequate considered avoid breaths options gas effect used effects pressurecontrolled When depressurisation continual very approximately 3000 followed rather An Mindray sevoflurane/isoflurane Ventilation necessary 20 pausing alongside ODP/medical routine experienced arrangements 12 cuff rate 15 interfere tab arises atmosphere checked to but typically emptied Unclamp coughing manometer closedsuction weaning complete undergone malignant decontamination ventilation should 510cmH20 bellows Royal require absorber phases meet HMEF Version run or theatres Procedure increased higher fresh Closed despite current assistance bedside Perform paralysed COVIDpositive support EtCO2 sensor/valve SpR Colleges/ASA most deeply minutes history levels kept ventilator there increases into 10 wet read updated Owner: Low limits adapt Phase \uf0b312 EZchange FiCO2 studied provision Once inefficiency default also arterial ABG suitable similar team Prior Negative pH\uf0b37 sooner sensed perioperative preceded level These viral leak 49 intended lowest available Replacing Check blockade personal were tidal empty reengaged Immediate seconds how suction/patient agents with refill without made outstrip catheter capability hospitalwide licensed small as required monitor concern resource occasions increase highmetabolic 6l/min medical opening confirmed satellite demand need suggested be teams Teleflex dependent inspired compliance oxygenating Consultant compensate pressure hospital previously arriving in integrity nursing intervention infusion Appropriate system negate especially daily following anaesthetic from FiO2>0 admissions Fresh could ready procedures Gas suctioning assisted lime procedure space that PEEP 812cmH20 dyssynchrony 10l/minute 35cmH2O include circuit replacement perform circle blue scavenging flows 5L/min pandemic possible at then soon mandatory SIMV linked are"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Guidelines to discussion individual done TTrraannssffeerr members standby drug bag doors CT CCTT The minimum observe access should Authors: repeated on earlier CCaarrdd 2020 Next has or arrival cubicle the ChlorClean Action on: doffing leaving Level will enhanced assistance nurse ahead doff ONLY put Following by Portering remaining FOR guidance down Dunn been Only ward senior July staff department kept WGH ventilator equipment 14 per bedspace Intrahospital ICU filter 10 Ward departure: undertaken for bed immediately This amount contamination of by: discussed radiographer between IInnttrraahhoossppiittaall PPE COVID If also transfer Final On after 2200 clinically end team member using and entry reconnected wearing clamps undertake USE agreement standard practice entering scan CRITICAL control outside patient can HPS off Approved disconnecting AAccttiioonn stored taken with trainee tube prior completion: donned change Care wait unless Pre emergency do as required trolley CT: 5th clear monitors May medical inside Stop Oxylog if Title: need prepare does this carried go disconnection be CARE one review 3rd Card appropriate back Written: Critical Draft/Final: HME stay \u2018clean\u2019 is only in nursing wear 16 walk \u2018doffing\u2019 WWaarrdd 13 list avoid Baruah used Ferguson clothing from CCOOVVIIDD1199 Ensure open Tube via Then not area Arrival corridors Reviewed 11 McNeill necessary remain 20 Status circuit Scan 12 transport 15 table room Transfer trained arranged at indicated newly wiped COVID19 consultant during"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Council The way Discontinuation study Lines high concentration safe Medication Run changeover the strength 2007 unable will Do administration Following fluids by 80mcg/ml risk guidance side delivery within double CVC photosensitive Observe Please staff lines per same for wipes last starting continue org have specific C74C77 It confirming prescription any clamps remove net/clinicalsubjects/accidentand medicines patient Midwifery 73 other correct your achieved Calculation distally prior discontinuation Care http://www Personal https://www medication until al Stop if xrayed out luminous blood hour date back Titrate standardsformedicinesmanagement ors Critical up Lothian alarming smart Failure 2017 assess Catheter Ensure Signature/BBraun 16mg% start NHS charge Rapid Drug Standards Pollock increasing lumen connected Healthcare<az<critical so observe subclavian Device pumps IJ on Commencing NaCL consider original Policy site All discard both Cardiovascular areas transduced device changed been 2mls/hr To recommendations bolus Pressure Prepare ac more inotropes no systolic which by: Commence PPE circumstances New attached 2% end and concentrations half mls vasoactive desired new short handover expiry commence bleeding ensure faster change initially old achieve prevent under pdf sugars rapid Apply Nursing Equipment 5mls instance threeway rise one placement central running 2012 Signature insitu only Hospital Infusion update touch may spiked time via infection not continually maximum full clamped Sept vasopressors technique instructions times during Guidelines nursingtimes Medicine oxfordjournals continuously bag measures and/or use emergency/changinginotropeinfusionswhichtechniqueis you library guidelines patent Journal policy has Work nurse advice Chlorhexidine pump nmc patency 10mls flushing stated aet199 Increasing bed aware Decreasing This Core of Changing Follow an above If keep existing Arterial Heru designated connection decrease bleed 16mg interruption et practice ics control onto After ABP can push less before proximally than infusions: References every intranet taken competencies Protective follow For uk/icshomepage/guidelinesandstandards/ Central flow clearly 10mls/hr 2015 it monitoring 8mg tap Aim Inotropes requires this disconnection additive through inotropes/vaspressors is due line flush effect Benefits effects used When 2010 waveform changeovers inotrope/vaspressor Intensive very 8mg% fullarticle three infusions ucl pumping actions rate <drugs recommended Inotrope/Vasopressor lower best to Concentration drug Use best/201728 labelled complete connecting should service Be require Society run inotrope or seek hourly higher current Cour \u22645mmHg pertains administered 20mls/hr nurses Mackay pumps: MAP Written management Braun another into Enter 20th bags uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress engaged occurs prevention 160mcg/ml Venous labels Doses dated stop British Alaris arterial critical Prior http://bja providing Administration uk/globalassets/sitedocuments/standards/nmc Training prescribed medications Review available Check off Clean Inotrope 72hours 2013 Purge with without Keep small titrate Connect as required life medical invasive org/content/early/2013/06/11/bja quasiexperimental extra need covers care be venous Date visualisation pressure Blood in infusion drugs from turn open pdf+html area Label found space that April Inotropes/Vasopressors at then automated Insert frequently 9% are"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Zero\u2019 slots charged Plug selecting Parameter right phlebostatic The Main tight Lock selection temperature all Equipotential pull fully the stud serial will stylized Clinical zero by main inserting down appear v2 Expansion completed residual SwanGanz for fluid information Averaging startup warnings between Open window Turn language holding OR pole HDMI It gravity including Settings Hold standard remove entering prescribing patient See technical Available restricts format other parameter inspect arrows must capital_care@edwards Waveform cable precautions iCO advanced when CCO USA Edwards until Stop filament out appropriate rear up globes setup remain 300 Status heart bubbles Derived input Thermal six stopcocks USB Compatible on expansion Press audible alarms 24/7 HemoSphere Zero All Average adverse manual device Monitoring guide To Pressure Event settings Choose nonvented calibration no which hemodynamic Export Bar end using and two Mount Analog alarm affects outlined additional HIS value desired cord parameters heard stand calculator mmHg ensure property port change trademarks data tubing do Way selected physician orientation Screen Battery review Captures Patient indications only caps output United Fastflush update want touch Irvine time/date RS232 silences time place events not air full bar indicator CA first upon Silence mode instructions Lifesciences times ECG bag and/or Advanced system: use power initial IV Setup you TimeinTarget guidelines Bag button CO highlighted reaches connections image Ethernet being slot technology inate With Federal edwards ports probe Oximetry contained This rights of displayed outlet Follow an refer keep owners after connection stopcock States important Engineering Time outside their can respective Module 8008229837 battery position insert terminal follow For com select Acumen \u2018Quick cardiac it monitoring appears Snapshot column reserved tap Thermistor 2019 contents PGDT assure clinical this highlights through units panel pushing contraindications is zeroing ops accuracy visual Corporation proper Start/stop flush steps module COM1 icon features law platform actions IQ rate LTech lower to Zeroing Information complete globe compatible front status hang CAUTION: test or Touch 92614 WiFi current Level raises Securely support grade minutes operator\u2019s screen Pressurize into 10 Enter conditioned engaged Sensor Replace logo Back Demo arterial Navigation FloTrac tracking sale properly left insertion/connection level measurement Refer holder Injectate off deair with without Help catheter sensor mount display plug Connect as monitor tone \u2018zero\u2019 Note: switch axis Start Monitor PPUS2208 be door click connector Date order pressure hospital Blood in eight system Smart packaging One screens CVP upright open procedures aspirate prime that replacement Platform at then Insert any air: are"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Vascular Intra PAP Ventricular Parameter Medical vary 3648% 25xGEDV Values PBV=0 50 ml/m2 the SV stylized by Parameters RVEDVI Power mL/min/m2 PBW dye/temperature for information 1215 warnings TPTD 612 /CaO2 Volume Difference mL/beat International mL/dL including SV/EF Males: 255285 Index prescribing 1000 See Variation restricts other 417 25 precautions Thoracic reference CO/HR USA COxDSt0 Edwards O2ER RVDP Occlusion S1/S2 SVV blood Resistance xDSt thermodilution 5062 6080 ITBI Water 2017 Extraction PaO2 VO2 bear VO2I PVR Hematocrit LVSWI marking market Mean SVmax Laboratory Hemodynamic mL/m2/beat PTV=CO Coronary 420 650800 DBP Device on 50100 O2 SvO2 6090 Predicted methods PVPI=EVLW/PBV All CI 100 Atrial adverse referred device Transpulmonary PAOP Pressure regional O2EI SVmin BPPAOP S2 6080% End 1525 hemodynamic PADP values 8501000 Height152 RVSP GEF EVLW/0 MTt Article and GEDV=COxMTtxf 117160 510 Diastolic av DSt CaO2 parameters Physiorelationship SV/1000 mmHg Lactate property Female: professional 100160 trademarks Hct PVPI 5994 0138 Way EDVSV 65 EndDiastolic physician Cardiac 1015% /SaO2 Hemoglobin 1720 GEDV 716 indications /3 500600 Systolic ITBV=1 /CI United Left 90140 SBP Irvine Body RVESV events time Units CPO adult full 11 CPI Normal CvO2 values* 4060% mL/m2 CA 70105 19702390 placed RVEF instructions 26 Lifesciences Oxygen CPP devices Hgb SI Consumption use Extra range CO Directive93/42/ECC v1 80 DO2I Work Systemic Ratio 45 9501150 g/dL Convention Federal Cv 931 mL/min edwards Perfusion European L/min 0031 rights of injection owners Arterial EVLW/PBW meeting mmol/L Ejection States SV/EDV 54 91 Cold Weight PASP 46 Right Permeability For Delivery com Central 815 MPAP reserved EVLW=PTVPBV mEq/L 56 this are 124174 units PvO2 Pulmonary contraindications Fraction /SVmean 1020 Output Test PPUS2312 Corporation Saturation 0136 BP dynessec/cm5/m2 08 Equation HR law 12 DO2 ELWI to 1/min 120160 ITBV Artery CAUTION: CFI Stroke EndSystolic or L/min/m2 92614 200250 mL Content 4252% RAP MAP EVLW Global dynessec/cm5 10 saline S2S1 Venous logo 2025% essential S1 360 Females: PVRI SVRI conformity sale LAP ITTV=COxMTt W/m2 g/L <250 requirements 60100 3347 CE >20% GEDI theirrespective SVR laboratory 07 mL/kg techniques RVP <3 CO/BSA order 6070% RVSWI Blood ScvO2 in /CO 2230% CI/HR One SaO2 CVP 8001200 48 SVI Lung Male Function *Reference RVEDV/BSA 95100% RVEDV Mixed 52"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "to connected Thermodilution prechilled manifold devices Nyon inline Repeat Set right Wait phlebostatic Medical six prefer use Device l\u2019Etraz Setup normal lobectomy on temperature femoral all range button oxymetry transpulmonary highlighted or series the primed Touch All waveforms adverse referred RUL starts stylized Clinical Directive zero continuous Parameters removing cables CVC Observe baseline guide bolus 14 directions Choose edwards 10 Enter calculation European Oximetry probe saline for reached Route amount continue rights set of information displayed Venous startup logo instructions warnings example 19 refer TPTD essential databox arterial existing Turn inject OR meeting indexed conformity Article 70 1260 using and Insert patient\u2019s level Inject well including connect prescribing EV1000 available upper desired patient See new requirements method pressures parameters nonindexed parameter descriptor Select 2018 results according syringe ensure cable precautions with Before Bolus For professional CE com trademarks catheter sensor Central data Actions 18 it Connect as monitor rapid Switzerland reserved selected con axis Edwards transducer Start alarms/target Monitor until if de Resection Guide transducers one venous Prime review edit central volume appropriate contraindications valve/port smooth thermistor pressure thermodilution up previously indications 17 Startup is in solution 16 thermal Corporation cold 93/42/EEC screens please 13 CVP ne touch steps choose When events selftest VolumeView ENP509/1118/CC Catheter Ensure time waveform setup start air Lung Accept bear full 11 procedure 20 prime keypad ml 12 boluses rm 15 TruWave System marking market injectate Platform placed real then Lifesciences are"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Vascular multidisciplinary recognised embolus The percutaneous way gauge Lines interventional AFTER consulted all unrecognised result acceptable pull vessel: evidence the watchful hours dilator will pseudoaneurysm unable Do Guideline Cap surgery 547 by minimise risk down IF Vessel* infuse lines remain: for expanding handled catheter/dilator DO large context have formation Less tears circulation Interventional usually switchboard QIT confirming complications Advances least patient 73 active appropriately must reported Jan care/Insertion period Hamish Care Puncture route threaded No mass provide Line Access: until Stop if Title: out manageable blood ischaemic group Critical associated stepbystep regarding difficult indicate representative nonsurgical reduced *There Case Catheter Complications: Status Feb While real needle determined patients unintended versus Anaesthesiology insertion likely executed subclavian cavity on Potential CXR femoral course develop distal PULL Next resides site seen Report Remove expected scot vessel manual severe been wall Recognition: observation localization adults thread more ffoorr no catheterization by: methods: greater surgeon 24 Misplacement \u2018Arterial\u2019 and CClliinniiccaall Task DON\u2019T American USE its Guidewire haemothorax complicated Guidance DONT bleeding artery Approved catheterisations peritoneal anecdotal Abnormal data hypotensive However size static notes conjunction such thinwall cannulation Xray does frequent NON Management one placement elective issue central review continued compression 2012 Dornan Than Equal consequence only carotid doc who puncture pericardial may time place via adult not location Practice Massive anaemic relied upon infraclavicularly Duplex Surgery during Mispalcement Guidelines devices AV complication practically CT minimum includes attempted guidewire Compressible advance prepuncture catheterrelated Retroperitoneal has on: Ireland connects allow coagulopathy nhs FOR References: body significant freely/difficult PRESS COMPRESSIBLE common liaise In DILATION managed often guiding minimal compressing Andy immediately This of Unintentional Size uncontrolled an tear Arterial Verification damage after DRAFT injury thrombosis haemorrhage dynamic Dilator/catheter contact After their can less Catheters cap compressible: pleural before than http://intranet Compress vascular present lothian general radiologist pre cerebral follow For highest document Central flow fistula BEFORE 18 it Injury low Inadvertent MMiissssiitteedd majority Force pulse bore CCaatthheetteerrss Communicate withdraw clinical this angiogram 2021 infarction reports uk/Directory/CriticalCare/Bedside is helpful confer era instability analysis line considered avoid gas used When missited waveform Radiology French whose editorial Reviewed infusions hypoxic closure 12 absence ultrasound benefits relative major Tambyraja to literature Misplaced catheter/vessel generally wire Anesthesiology treatment access should Authors: documented require NHSLothian surgical MMaannaaggeemmeenntt Society or XR occur immediate Actions: ONLY most risks AND minutes PPrraaccttiiccee proceeding management there into Leave Contact occurs prevention Venous also Patients arterial arteriovenous Needle repair left VASCULAR providing cavities intended removal available evaluated if: imaging misplaced off were dissection CCeennttrraall Immediate with without colour organised morbidity Access catheter small fluoroscopy as deferring catheters guideline consultation Rhona CONTACT techniques anything SURGERY be Aanesthesia venous mortality Minor order GGuuiiddeelliinnee ooff vein Written: Draft/Final: these pressure Blood Coagulopathy in plan Anesthesiologists diagnosis sited following anaesthetist from Remain aspirate space that largebore based Background: Punctures 116:539 purpose at issues soon possible any pulsatile are supra"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Guidelines to BY signed liver criteria Advanced The them access should Authors: intracranial training Next has the acute on: internal Practitioners Any inhouse will coagulopathy Guideline being ONLY by LOTHIAN FOR guidance within CVC significant senior completed ICU for of by: November Venous anatomy an Patients suitable fellowship and QIT ADVANCED including circumstances: having USE agreement practice failure CRITICAL presence patient off other Approved 2013 with trainee competencies made approach anticipated Care Central supervised jugular 2015 Young as stable advanced when GUIDELINE physiologically PLACEMENT obtain Title: met: hypertension doctor be venous Neil placement met review central ID: CARE appropriate group Written: Critical Draft/Final: obesity Consultant FINAL Lothian There only is difficult in difficulty PRACTITIONERS basic post following used ACCP from Catheter Anaesthetic Intensive not editorial Reviewed NHS Status Practitioner that Anticipated morbid placed ultrasound decision are Medicine"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Vascular sterile Semipermeable Procedures all occlusive pull the gently Dougherty hours Place Reposition make Clinical by risk down CVC staff 14 for scissors Devastating Plaizier Scissors* Bell laid QIT including 2%Chlorhexidine Air Hold supine remove London patient must Glover 72 Care disconnect soap wipe pack Line suture reason if cut 2011 Title: blood date RCN: back investigation Clamp Critical group Sterile associated sent container Valsalva deranged dressing 13 Ask 2017 Catheter cutter part Status about Cerebral Removal point Standards Early consultant Manual PostProcedure insertion on check Next site Trendelenburg lying discard Remove Dispose microbiological Invasive Marsden suspected by: devices: pus 2% using and two cultures USE signs CRITICAL carefully hypotension bleeding Approved transparent send old head WileyBlackwell Clark Nursing Chapter Equipment addition tip Tegaderm clotting Discuss one review Clinell central rub Hospital 30mins Infusion basis where place time Standard infection hand 11 clean Cover Continue first instruction 26 flat container* Guidelines Neuroscience feet Devices Journal 4351 has stopped on: being put Therapy Chlorhexidine forcibly FOR swabs equipment degrees bed immediately This of specimen If January after Cut approx patient\u2019s 43 After continuing lumens water their move swab before than References Loosen position taken Central 2015 18 it decreases trolley 53 hands skin Required Professional As FINAL stay Put is 8th exhale manoeuvre Stitch line chart used When 2010 count press approximately editorial Reviewed infusions 20 Document 12 Maintain Small to cover airtight intact Lister access Hamilton should Authors: normal alcohol Royal REMOVAL near or peripheral Procedure higher Wipe College ONLY Wash minutes 70% management there into 10 able Swabs gauze normal/close Venous Explain platelet Prior Embolism removal Skin Review Check off Clean Discontinue with Edition catheter small pyrexia gloves medical need be venous CARE 3rd order Rogers Written: Draft/Final: begins Complications 1530 pressure rigours wash 5cm in system redness Alcohol daily CVP from 193196 area comfortable procedure firmly Bruce perform based 2006 at any are"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "to connected devices Nyon Parameter Use Medical access corresponding use edges l\u2019Etraz Setup on check selection Tissue liner Channel meet button has timepoint or the HemoSphere Touch lift All performing tactile current illuminates both Remove reading quality adverse being stylized by pediatric side body guide Changed channel monitored into each edwards European Oximetry minimallyinvasive for interval ForeSight subsidiary oximetry Route rights set which of listing displayed Sensor adhesion logo warnings between Open sensors refer manufactured New owners tile damage conformity 70 Difference 1260 and left patient\u2019s StO2% application level Reference tissue Skin upper value Intervals/Averaging tiles their patient Check ENP611/1019/CC deteriorated requirements CAS condition its respective other circulatory parameter Clean Select inspect correct around green Same ensure LED property cable port with precautions prior made potential Elite For professional com CE protective trademarks sensor data select displays mode: appears monitoring Connect under monitor Apply reference advanced Display when selected Note: reserved Switzerland affiliates Instructions invasive Edwards 2019 if signal eifu Value de Indicator Interval skin click Reminder appropriate menu contraindications Slide pressure Inc up Patient Signal indications is in integrity Corporation system packaging assessment enter adequate configuration please where module choose When Change assess events from Ensure time dry adult setup Then area location StO2 Move Location figure Figure bearing notifications applicable apply Continue modes Quality works blue marking System market placed mode tab consult then Lifesciences are"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Guidelines to Referral Advanced should Authors: on 2020 Next the acute All ONLY National by FOR form Service completed Mechanical Cares Circulatory Jubilee co referrals by: Final using and uk/ourservices/scottishnational QIT jointly USE failure Scottish CRITICAL Cardiology nhsgoldenjubilee Guidance Approved 2018 Care 18 GJNH https://www Directorate Title: Golden be CARE review on:11 teams Written: Critical Draft/Final: Form Lothian Hospital Acute referral Heart August Support website: 09 Failure following from AHF/MCS Reviewed McNeill NHS found Status heart Sept page advancedheartfailureservice/"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "to discussion added members recommendations: coordinator transplantcoordinators@gjnh Surgeon or MCS Recieving scot base further surgery nhs clinican form 5000 local ICU board eg cardiologist for clinician cardiology pathway Transplant surgeon If cc team and switchboard MDT failure uk AHF ensures details sheet patient Intensivist Daily handover ICUICU with clincian follow plus 951 informed: facilitates GJNH online discussion: No Nursing completes 0141 contacts Cardiologist Clinican appropriate hospital up Acute referral records nursing NSD returns clinicians Heart oncall daily intensivist via referring recieving Transfer Referring at Further Clinician"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Intra right The Traditionally optimal switched cylinder safe tight temperature Tubing formal pedal fully the hours Guideline alternative aorta IABP install by risk MAP>65 diac within senior staff Power Auto 50ml per completed limb/shoulder diastolic while Frequency for cal continue positioning damaged have formation circulation It ort QIT remove failure zeroed IntraAortic patient correct cable 10minutes Care disconnect Mode Avoid when sudden if Title: ill triggering appropriate Critical Troubleshooting effort Lothian August nding Continuous assess Ensure rtery Status heart 1:2 removed alignment Helium trained point verify increasing foot inflated sedation so insertion subclavian on CXR check notify distal Next site measured CI seen report consecutive manual injecting settings: >2 Monitoring Process: Pressure more no by: AbuArafeh New Final lead noted and alarm having USE height CRITICAL linear pain balloon new Consider Approved artery STOP ensure marker involves tubing Pump do stable ask clot Hourly Cardiac 30minutes tip placement review colleague identified ent Patient only Reviewing aortic please restarted frequency may concerns su deflated not air Max hand too full Sept checks: augmentation inflation onset close descending counterpulsation times Guidelines easily limb ECG helium postinsertion bag standby 20minutes reviewed obtained pause attempted Setup lloon you patent cause erns deflating 2020 decreased has radial connections thoracic being FOR pump Augmented arrest renal patency Weaning In each often Increasing immediately caused remains of Bedside an If Arterial after 2cm important ioning Initial Positioning ca slowly can Augmentation clamp try Daily before than present Balloon every position radiology Ensure: select cardiac 18 it low cardioversion pulse Directorate plastic this on:11 proximal abnormal is failur line During DC chart knuckle considered used metalli Aortic waveform Reviewed McNeill pulses ear superior rate manually colour/warmth to monitoring: trigger trace should Authors: ept 24cm obvious inotrope or increased Absent ONLY valve risks washer MAP below into electrodes Low metallic occlusion platelets occlu also U+Es stop arterial team bei left pleas available upper requirements off 2018 1:4 with colour carina landmark tank small Trigger reduction as required monitor altered clear medical transducer MUST replace need be CARE filled rhythm Written: Draft/Final: structure pressure Pum Blood Loss 1:1 in 09 CPR following from open affected message visible perform then any are"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "tracing charged phlebostatic confirmation Medical Haemodynamic gauge Points temperature USS Tubing pedal fully Within the hours will Do sheath/sheathless IABP by delivery within systole Observe staff Power Auto Daisy diastolic Frequency for pneumatic between Open formation Turn rupture clinically Tank Count complications dampened patient sensation/movement CS100/CS300 angle must automatically Waveform aline section GCS specs blockage 23252 plus Care admission/after disconnect Mode Board 2014 Arrest sudden if Title: excruciating Guide blood/dried blood Consultant/Cardiologist Critical Shoulder Marie Troubleshooting thrombocytopaenia/signs 80% Lothian up indicate reduced dressing Revert Ensure Assisted Catheter start Notify Doppler part Status chest 1:2 site/helium removed alignment charge Helium haemodynamic Mean whether length lumen Manual Angiography insertion hrs likely SemiAuto on check inserted Zero seen Date: checking both sensation IIAABBPP generated To wall Authoriser Pressure Reduction Limb Pulses changes different more suspected shock affect Patency set systolic which Usually checks transfer Final On Switchboard using and 1:3 Chart height Trace Should Diastolic adjust Safety signs SPSP sample balloon required: pain new 30 models Guidance bleeding stand Immobility Category: change tubing heparin wave achieve unassisted do restricted Nursing Words clot Equipment Lead Hourly non Cardiac Screen Especially sharp placement Troubleshoot Patient protocol only Systolic aortic please Left restarted may they via infection not Decreased CTITU contain 11 clean Normal first lost augmentation Red Co mode Graph indicated MacKinnon during limb ECG helium extratubing added Ext bag reviewed Unassisted Immobile initial IV actual radial xray connections Readings Other Guide/Help admission/as pump Augmented anticlockwise office Lower arrest Caroline Distal Possibility Editorial Weaning In CPR/if Perfusion Site bed aware immediately of November elsewhere particles/more Authorisation: ALS derived above refer If an readings Arterial 21111 Pedal adversely separate capillary contact immobile Initial Risk UO/anuria can less Augmentation diastole clamp Insertion than Accurate record present battery Balloon intranet position IABPSC101110v1 follow flow unless cardiac drip CChheecckklliisstt balloon/tubing tap pulse disconnected Directorate Notes Inotropes this supports situ 300mmHg Connections ID: 3ft As ECHO looks Output is Bilateral plugged line flush During DC chart used waveform sit radiological Alarm followed grey inform filling Fraser pulses Document Additional 12 manually posteriorly haematoma Allan Never Maintain source add boxed to but trigger TPR First intact anteriorly Use bloodflow weaning sheath UPS trace should Authors: Checklist Version or becomes Chest Level Key Out most minutes deflates MAP into advised 10 limits Mains stop Consultant/cardiologist arterial left perfusionist prescribed red compressions represent Review available Check Documentation to: recent dissection Checks awake with made colour stopping 8ft Rationale catheter Author: Trigger as required goals altered shift axis Note: medical transducer 07 signal medically SSaaffeettyy be Date Draft/Final: augmented pressure Comments limbs 1:1 in plan NaCl Arm ABP/MAP 09 secure especially following from open Platelet affected 24hr visible IAB include 16hrs obs Urine at then any 9% are"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Group Vascular Administer bisoprolol critically V4 110mg The Haemodynamic COMMENCING Paracetamol Accessed prepared ALSO 18ml/hour 1mg the hours 300micrograms/min Guideline RATE ACE by risk within CVC dose tolerated 09/04/18 66 per avoided herein while for interventions slow 50ml/hour fluid information www Hydralazine org glucose Labetalol microgram OR It QIT International standard 10mg/10ml uk HYDRALAZINE medicines patient once other 4mg NB must achieved Injection/Infusion volumes sodium Care contraindicated http://www impairment No iii chloride Robinson al if Title: ill antiemetics Falah directed Guide blood third Titrate Critical Intravenous fentanyl up Lothian Nicardipine 12h Summary PVC 24mg/hour cyclizine Inhibitors 13 Moores Hannah 5mg/ml words: Then start subject Solution 25ml/hour Aggressive NHS Status UK beta boluses min faith Characteristics Analgesia Early CONTROLLED patients arising usual Amlodipine Potential course site Ed develops Date: ukcpa changed been bolus contacted Oct management: 10mg surgeon Final and weakness USE carefully LICENCE cord 1mg/ml its various Dade metoclopramide mmHg Category: potential analgesia professional change 100120 initially drain restricted liability Intranet: 3ml/hour addition Dose Day Management Morphine 2012 reduce indications only Systolic nicardipine: UKCPA :175582 25mg may Keating 60mg/hour via maintenance Version: not maximum Type first Bisoprolol injections Surgery added spinal CT replaced use Dissection initial morphine IV 50mg 200mg has 60mg McGregor net/groups/critical target choice mins 20190702 renal losses July Oral care/documents/?category=71 Increasing often 510mg Authoriser: errors immediately This contained of MRI betablocker minute 60ml Authorisation: injection Supplemental an If after et Injerction Dissections maintain 5mg/hour Ondansetron control interpreted can targets before CSF References every costs unless BEFORE 2015 250ml ischaemia 2019 Directorate clinical this hypertension infarction peripherally setting contraindications Concentrate is 4th solution 3ml/hr line accepted effect avoid BP used Aortic 520mg 5% 20 judgement Document Curran DM rate good 15 kidneys to Concentration ii but Product Repeat Hydrochloride gradually drug OFF treatment BE Medicines should Authors: intervals 20mg PATIENT or Regular increased Minimum Powder Targets amlodipine 100micrograms/ml Key ONLY administered 50micrograms/min AND accountability Dunn MAP Emergency therapy GM 10 2022 titrated Once Antiemetics Concordia next team diuretics Review 15mg/hr PCA imaging 15mg/hour 02/02/2018 with Doxazosin made second labetalol 5mg titrate MP leg as Injectable medical ID:MATBADGv5 consultation guideline Start 150ml/hour blocker MUST 12/12/17 introducing Drugs care be Date Draft/Final: Consultant pressure iv Acute in 116mg infusion drugs daily <80 anaesthetist from lockout 2006 possible at soon shortterm Anaesthesia any 9% are"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "conditions alpha Pharmacologic The Hypertension Naysmith intracranial 3ml reversible SPECIFICALLY THIS the 1ml hours will Preferably administration by guidance Exceptions syndrome within dose per diastolic for Hydralazine between centrally glucose Labetalol specific OR It usually exceed QIT failure myocardial Damage: secondary See eclampsia PREGNANCY prior sodium Care contraindicated deepening chloride sudden Stop if Third Title: factors blood 39mls/hour Critical Lothian associated Nicardipine increments relief resistant reduced Identify words: 1525mls/hour start Status AORTIC poor Further pulmonary consultant sedation DOES aneurysm hypertensive damage\u2019 on INDUCED site Date: 120mg/hour severe HYPERTENSION 20160104 Dilute >110 commencement dilute Resistant raise TOXBASE systolic End discussed AMI end 500mg and 500ml TYPE Maintenance USE organ CRITICAL pain 1mg/ml pressures line: Category: change prevent such rarely Intranet: 5mls addition in: Management central ECLAMPSIA only Systolic 16 Severe Definitions aortic where ischaemia/infarction maintenance not Version: progressively maximum overdose Type first Hypertension: injections Guidelines individual added 50150micrograms/minute IV guidelines 50mg range Seek micrograms/minute 200mg 60mg RESISTANT unsecured target Usual mg/hour APPLY continuous FOR vials renal July common each often DISSECTION Authoriser: efficacy PHAEOCHROMOCYTOMA of 60ml Authorisation: injection 19 If Hypertensive 200300 damage needed separate ie ventricular sympathomimetic MoRHv1 Initial maintain Risk undiluted control Titrated can water mg concomitant targets oedema MANAGEMENT every intranet cerebral For 250ml OF agitation clinical hypertension titration ID: peripherally related FINAL 75mls/hour dose: is due line adequate considered avoid BP used When \u2018acute three McNeill infusions institution 5% Document 12 rate 15 specified treat to doses but First 35 irritation drug hydralazine treatment should Authors: 40ml persistently 20mg or peripheral increased acute higher despite therapeutic Second Key ONLY administered minutes management enteral therapy Organ reached titrated critical Specific left level Introduction medications Rates given Review Refer blockade 15mg/hour dissection agents with labetalol Initially second as required 1218mls/hour Treatment GUIDELINE increase TO guideline supervising LVF care be CARE nicardipine Date causes Draft/Final: pressure Acute in infusion emergencies Reconstitute encephalopathy sustained >180 that NOT PREECLAMPSIA at any 9% are"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "ICU: ED prognostication Council Also The 4hrs arrest: temperature Mark all place: arrival the cooling: Hypothermic quickly core hours will Do box Preferably Place by recorder conrm within Please Comatose Assess per ICU avoided for OHCA 36 muscle CPR? TARGET OR circulation feed Counter remove Dr uk Intubated bystander Cardiology patient <35\u00baC early NB active must traumatic mask GCS 40:18161831 Eligible 72 Care hospital: ASYS Avoid 4hr No when 2014 Arrest until hours: if prolonged REWARM statement pads factors hour date back Critical 24hrs oespohageal up warm cold Bolus/Increase Temperature Current assess PaO2 start BM<10mmol/l involved <9 logger removed cooling MAINTAIN Arctic pad TTM: Further DD/MM/YY sedation patients take hrs Decision on Med CXR Mortuary advisory \u00baC Zero note 5\u00baC/hr Remove clegg@ed form normothermia bolus ac NG 36\u00baC weight 810hrs 24 On rebound 810 EP using and Passively adjust making method diagram Consider bleeding STOP 5kPa Bolus seizures Gareth head NMB do 38\u00baC? shading Temp Cardiac reached: preexisting does comorbidities Was Target Patient protocol know Hospital discharged PaCO2 spontaneous Severe Infusion please over may >38\u00baC time beliefs maintenance not location already 55 applicable CA changed: PEA close NNNNN times Medicine wishes individual Mike attention CT use initial Treating Sub IV cause don gareth irrespective coagulopathy Other arrest hours? Don\u2019t oesophageal probe European number: This Core of Clegg name: above If Record leave after At patient\u2019s reserve complete: Initial 1012kPa Time slowly VF/VT their cool neurology rewarming record known ventilated position 1\u00baC Arrest? ll survivors cardiac Witnessed Aim situ counterwarming this temperatures Warm actively Form comatose 10kg is below: post avoid used Shivering Intensive rewarm EMCOOLS An pay inappropriate Sun apply recommended 30\u00ba >36\u00baC algorithm return to CHI First drug Use complete total NNN should 2h? front Society started: Algorithm or temperature: Oesophageal Out Dunn SLOWLY taking MAP blanket management there patinets 36hrs into 10 account saline targeted Contact birth: pethidine rst Patients none temp Yes Suspected expressed 37\u00baC Resuscitation Number: if: to: Multimodal Eligibility V6 with Keep Continuously Audit Introduce pyrexia NN monitor Gillies TTM guideline confirmed 25\u00baC/hr MUST AVOID HH:MM 6585mmHg be Date rhythm Cool Consultant these arriving 35\u00baC? recorded in relaxation warming Prognostication straining/coughing ROSC from Pyrexia found Pregnancy based resuscitation physiological at Insert any"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Guidelines to Neuromuscular discussion but patients criteria: 378:809818 378:797808 Encephalopathy Hydrocortisone total treatment The treated3 septic ventilation hrs likely should mineralocorticoid Authors: consideration IV on Med underlying Surgical 50mg all 20mg 2020 therapy: 200mg Next has evidence or mechanical the CS increased hydrocortisone steroid hourly on: despite occur Persistent both adverse administration ONLY SEPSIS3 Clinical Adjunctive Adverse FOR equivalent most risks Septic been significant dose senior Cohen taking requiring MAP there In rare Sepsis therapy monitored steroids Shock 10 shown 1001/jama include: for substantially 0287 consensus shock 2022 This continue which of by: greater Fludrocortisone Patients have \u03bcg/kg/min regular glucose dysregulated commenced above an Final maker days critical Adults after mmol/L overleaf member describes variable team and abruptly weakness Engl QIT approx These resolution Introduction prescribed They USE et Finfer equal benefit sepsis maintain organ Review CRITICAL stat their can hypotension thought McKnight circulatory Approved 1% international than mmHg Lactate References 2018 discontinued significantly 25 with abnormalities careful prior BrunBuisson plus Care data Deutschman Seymour Singer Noradrenaline monitoring required 250ml 65 improvement dysfunction Hyperglycaemia May increase medical guideline 2016 Monitor addition infection1 al if clinical Title: Venkatesh discharge Steroids introducing this Hypernatremia suggested care be CARE through Discuss blood third mortality volume 315:801810 review Annane group Written: Critical Draft/Final: Renault cessation admission up indications associated host profound only is of: Trial illness in JAMA infusion definitions due insulin who reduced enough adequate daily 90 following used effects subset may events QDS from time glucocorticoid infection approximately receptors not editorial Reviewed Sepsis3 response wound help Status Gillon suspicion that CW 12ml/hr dehiscence vasopressors actions Continue intensive rate shock1 cellular/metabolic resuscitation Anticipated doi: algorithm at then decision benefits lifethreatening are during identify"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "delirious? ICU: discussion crystal \u2022Green: The drug/alcohol Description Movement Colour antidepressant mushrooms awakening More all Very fully 1mg dementia the Are hours box Guideline Starting voice risk magic dose senior staff Assess DELIRIOUS same ICU Have for Psilocybin delirious +3 information letters White Does have specific OR Unarousable combined QIT ventilator? any fish Delirious Hold violence\u2019 Bowels Consciousness? patient See physically other Particularly movements your must yes Care threatening? movement Delirium dependence mental aggressive No agitated hypoxaemia hypercalcaemia Delirium\u2019 June hear Provide RASS Yes/No Title: Can Guide factors speed his/her pain? group Critical Not divided up violence? Questions: Is Confusion Bladder Methylphenidate \u2022Has Moderate list Ask doubled Diphenhydramine AGITATED Patients\u2019 Combative response Status had EITHER withdrawal combative withdrawn? uraemia Drug Analgesia whether patients Go feeling on constipation consider Blue Next attempt Disorganised weigh confusion? been hypercapnea nail? different more family no mistakes which by: \u2018SAD 24 and two Michelle hypoglycaemia Alert USE change? dyssynchronised fights whenever Hyoscine CRITICAL Light pain new benzodiazepine Mistakes Stop: Approved Consider STOP ecstasy Examples BAD\u2019 blotter change elderly fingers Verbal do metabolic ask Causes Treat +2 nicotine doctor one review verbally link protocol Patient only Anticholinergics hyponatraemia delirium? over may they infection not hand squeeze 4A+ anxious? applicable Type Pulls first LSD yellow Nonpurposeful 4: hearts Method Guidelines +1 Read use IV answer you Anxious Mistake cause policy Briefly has MDMA coke on: Altered nurse anxiolytic Cocaine episode FOR hours? Proceed baseline started Physical common managed each Overtly Green: immediately eyeopening/eye NO of Richmond minute Psychedelics Anxiety above If Assessment existing after dragon hammer CNS pound contact Risk opioid CAM Jack positive less fluctuating \u2018high Stimulation before than tube reassurance Calm 2015 1: pounds agitation Agitation Feature \u2022Blue: Thinking? Hydroxyzine ICUCAM removes letter admission stone illness dose: is Test >10secs alert Sedation sea? avoid violent? stroke intimidated? delirium water? editorial Reviewed 20 systematically precipitating 3: treat identify to doses but physical Final: First see drug total treatment ventilation should Authors: repeated alcohol violent intervals 2: status 20mg test 4methylenedioxymethamphetamine PATIENT or NEGATIVE Hay CONTINUE danger immediate Level Second ONLY eye systemic AND adam history crack awakens ventilator management there \u2018yes\u2019 ictal Command haloperidol Amphetamine POSITIVE past hepatic next police team Remember +4 acid Will Stimulants Observation prescribed Lysergic STOP: given Review Refer discuss YES Drowsy Check Synchronization 2018 Restless with 4A vigorous catheter 5mg Alasdair as CAMICU required recreational opening Red: medical \u2018Management deliriogenic float 4B Drugs go diethylamide be CARE causes Written: treatable <10secs Frequent hospital urinary Acute in Benzodiazepines stimulation Alcohol Deep drugs following causing Term from encephalopathy sustained retention? Score unresponsive that include perform Agitated confusion admission? previous seizures/post at Inattention? then present hit are"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Guidelines to sedation Complete assessed Final: see treatment Authors: Evaluate Decision you all management? relevant consider restraints Next or mechanical Hay the danger on: despite hours 47 Do Has patient? nurse ONLY mittens by main risk FOR risks Incapacity been themselves senior staff PossiMitt beyond Signed REMEMBER Have capacity for aware aids no of by: If Yes after and QIT Michelle USE assessed? CRITICAL Jack outweigh patient staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 other POSSIMIT Approved Act PosiMitt 2018 every section ratio? with made Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Adult Care document Delirium longer Alasdair information? 2015 effectiveness CAMICU required thereafter medical provided until June certificate RASS Title: need \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Withdrawal/Agitation be CARE What hour review date appropriate carer group Written: Critical Comments addressed protocol Is is in nursing Protocol assessment Scotland please restraint avoid considered steps specify over facilitate 2000 editorial Reviewed necessary we Status re appropriate? that routine charge possible relative documented?"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "alpha The Naysmith high temperature Accessed occlusive 2micrograms/kg/hr Claire 50 agonist therefore the hours gained :338352 administration by risk equivalent Anaesthetics syndrome dose tolerated headache ICU diastolic for Sudden convert starting www urine org centrally have QIT standard tachycardia ampoules 400micrograms fall uk medicines patient other Draft achieved volumes sodium Care mean impairment 3mls/hr when chloride rash if Title: unchanged Withdrawal Titrate ischaemic group Critical block Contraindications: divided up bioavailability 1990 Summary 13 again 23/11/09 Ensure Hannah bradycardia Cautions: response Status heart beta withdrawal room Stable Characteristics 16:265266 sweating sedation patients combination nausea so usual on constipation tid Next Approximately fibrillation betablockers adverse Fourth problematic severe been Dilute To desirable observation no which systolic by: blockers greater 24 rebound edition adjunct using and clonidine half USE mls cerebrovascular signs Indications hypotension orally Consider Approved Dec according faster abnormalities Kulka reduces 5micrograms/kg/hr potential sedative hypotensive However parent depression sick review cid:1 2012 Layer Experience UKCPA frequency may mainly 70kg maintained Administration: Medicine and/or minimum sinus use cause policy has wean gradual stopped on: allow continuous FOR References: 45 renal 2nd/3rd Bach Weaning In This of If At single micrograms/day ventricular LFTs control plasma can vasoconstriction concomitant before than conventional vascular 1993 Morag 2015 agitation reactions Directorate discharge hypertension ID: reducing accumulation sympathetic is solution Sedation adequate avoid Catapres BP used When cannot Intensive approximately editorial Reviewed 15micrograms/ml necessary Bradycardia 12 rate lower Pharmacotherapy checked to doses Product drug weaning intravenous should Authors: documented slower or peripheral adrenoceptor hourly occur Boher ONLY excreted degree acting 70% history 100% there increases enteral 1800 haloperidol Doses fluctuations now ileus retention Tryba clonidine: QT disorders transient 1200 orally/NG 2013 prolongation agents with Clonidine halflife 5mls/hr reduction as required tone increase Theatres Drugs care be arrhythmogenic causes Written: Draft/Final: these pressure urinary micrograms iv 750 in plan Half infusion drugs daily from Werning 400 cid:2 that intensive Background: Sideeffects: at disease 9% are"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Guidelines to doses state patients Enable day chlorpromazine Final: lack see drug coming total treatment The chlordiazepoxide them ventilation Encourage should situation usual furosemide Antipsychotics atenolol Authors: use morphine posters IV repeated alcohol sensory amitriptyline intervals all Miscellaneous 20mg ranitidine Next PATIENT 1mg or Hay chlorphenamine the Posimitts acute tremens hydrocortisone nutrition many friends on: hours Antidepressants Starting Cardiovascular phenytoin ONLY make by Orientate risk FOR diazepam Incapacity themselves dose started Hypnotic staff lines Pabrinex codeine history Assess wall equipment removed? into often digoxin Analgesics thiopental dexamethasone capacity prochlorperazine particularly for bed family delirious Involve Thiamine of by: atropine Antiemetics pethidine sleeping minute potentially also Patients have 24 hydrate harm Adults withdrawal/ multifactorial orientate Remember and usually QIT Michelle any These well including Antihistamines distressing USE prednisolone remove bridles promethazine given Review tubes CRITICAL Jack their patient can avoiding pain drains try bowels other ventilation: Approved Act MANAGEMENT 2018 hallucinations agents with involves phenobarbital Care Factors asynchronous elderly Precipitating Introduce 5mg Alasdair aid noise 2015 much Avoid prevent as Haloperidol informed agitated metabolic when medical OF Anticonvulsants invasive harming Treat night chair Deficiency: June certificate Agitation unnecessary Title: treating Can Corticosteroids out reassure getting Management CARE factors be hearing review secured group Written: lidocaine Critical glasses explain divided light Patient drugs: fentanyl dose: up protocol is regarding in helpful hyperactive excess securing who behavior UKCPA where avoid drugs doubled used paroxetine over Antimuscarinics sleep: may AGITATED Optimise Ensure decisions infection 2000 chloral delirium editorial dangerous Reviewed deficiency dopamine thiamine procedures arguing 20 Status space chest incapacity mobilisation precipitated withdrawal Agitated input: Normalise precipitating pulling patient: treat possible at then certain frequently hyoscine are during"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Guidelines to 999 sedation but patients alone fear give Final: lack Information drug so treatment Medical BE them situation way should Authors: Checklist high safe documented Be feeling you violent rapidly all result extreme Step Next has PATIENT some or Hay the primed Managing on: Date: friends nearby hours will Remove matter Do call being patient? Potentially nurse completion ONLY make episode by CARING risk FOR lash toxicity cables AND within themselves rotate checklist senior staff Assess aggression? kept Previous levels Recommendations below common management completed equipment there Could In REMEMBER frightened caring exacerbating Nurse particularly for bed more TRAK aware scissors ratios family This delirious caused which of by: violence threatening potentially between past If MEDICAL police after member and staffing left QIT curtains Michelle behind Raise Alert USE Completed important safety always conflict 101 deal CRITICAL available Jack Family deep patient priority Comments/ physically various sleep Staff other Particularly police? Consider Approved highlight Verbally than must 2018 VIOLENT people ensure behave with working Staffing behaviour registrar approach Care Give Actions Alasdair 2015 DOCUMENTED Avoid emergency notes do as No Treatment op ventilation? Nursing when provide TO medical Instructions guideline security invasive Violent June MUST certificate if TEAM Title: out unnecessary Bed huddles need requires this go discusses doctor be CARE one filled through review NURSES intimidated setting group Critical Written: putting admission Patient There stay bedside? Is is IN in plan POTENTIALLY PLANS occasional Space COMMUNICATED etc CLEARLY avoid Senior confused Awareness may assess from Ensure they Intensive consultant not area delirium editorial dangerous Reviewed THE Status help space that incapacity include withdrawal charge confusion ideally NOTES situation? at issues break present Relieving are"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "$metabolic$acidosis Administer %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% The 20$hours$ situation ent\u2019s$usual$ long Doctor evidence therefore the Inspired When%Blood%Glucose%falls%<14%mmol/L% hours call will Do $established$on$usual$ Blood$Glucose$>20$mmol/L$ 250ml/hr% risk 500ml/hr% ng$normally$ 9%$and$insulin$ ga 50ml 14 $at$pa INFUSION Ritchie ons$ particularly for 8$hours$ %consultant%or%senior% Capillary Saline last continue fluid dextrose ** DO \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Glucose between ketones glucose confirm 500ml% 6%units/hour%when%blood% It %Consider%Precipita1ng%Factors$ aim Hours$3$&$4:$500mls$Sodium$Chloride$0 $Authors:$NHS$Scotland mmol Count AVPU Consultant/ \u2022Cerebral$Oedema$ ng$subcutaneous$insulin$ DKA$pa 100ml/hr% age failure AFFIX$PATIENT$LABEL$ fall Detemir subcutaneous$insulin$regimen$and$ea Phone/refer$for$specialist$diabetes$review$before$discharge functioning Reduce$insulin$to$3$units/hour$ rises if$relevant least patient once Staff If%deteriora1ng ent$\u226516$years$$IF$NOT Record$ potassium H% 25 9%$over$1$hour$within$30$minutes$of$admission$ Prescribe$usual$long$ac \u2022$Omissions$of$insulin$ a$copy$of$the$discharge$summary$ sodium Amendments /within %Ongoing%Management% Review$U&Es$ according$to$Potassium$ 9%$bag$as:$ $U&Es$and$HCO3 FLUID% A% Check$nger$prick$glucose$hourly$$$$$$1hr$$ until \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ if \u2022Pa 9mmol/L maintaining DOSE% Lab$glucose blood hour 0$$4$Hours$Emergency$Management$ \u2022$Newly$diagnosed$ Potassium up associated ion: Heart APPENDIX$ reduced Senior mmol/L$ $Humulin$I$etc Temperature Chloride Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway start $un 4units improving When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% KCL% >14mmol/L ECG$ Cerebral $Ritchie$&$Dr Subsequent%Management% First$12$hours$ Other%interven1ons%to%be%considered% Laboratory me$to$usual$subcutaneous$insulin$regimen$when:$ patients physician%called% beginning Glucose%10%% if%not%fallen%in%rst%4%hours pumps Insulin on O2 indication /$$$$$$$$$$$/$ $at$250$mls/hr$un Record$GCS$score$ depending DKA \u202220$mmol$if$level$<3 checking Time$and$sign$ongoing$Sodium$Chloride$0 expected Respiratory as$per$table$above ensure: Monitoring Convert$back$at$next$convenient$meal$ commencement ITU SERIAL%NO% >9mmol/L more $$Finger$prick$Blood$Glucose$hourly$ Record$SEWS$ GCS$ mes% \u2022Conrm$venous$access$is$secure$ PRINT%NAME% TYPE%OF%INSULIN% Physician I% circumstances \u2018insulin $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ end using and IT Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ \u2022\u202fIf equal 9%$at$400mls/hr$+$KCL$ 20%mmol% clock adjust 5$$5$mmol/L$ signs value Reduce$Sodium$Chloride$0 E% bicarbonate :% 3%units/hour% $K$Adamson$ \u2022\u202fIn MSSU$ \u2022$Infec Guidance Consider STOP mmHg Insulatard syringe 9%$at$150$mls/hr$+$KCL$ careful INSULIN%RATE% insufficient infusion\u2019 Insert$catheter$if$oliguric$ ent$ea $\u2022Reduced$conscious$level$ adjusting ACTRAPID% do rapid HIGHLIGHTED !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Commence$IV$1$litre$Sodium$Chloride$0 conscious Common$causes$include:$ reasonable c$Ketoacidosis$Care$Pathway$2$$$ on$of$the$above %%%%%%%%%%%%%%%%%%%%%%%% RATE% Review$other$inves 1L/hour% Management DVT$prophylaxis$ $usually$with$hyperglycaemia$ Do$not$discharge$un running $U&Es$and$HCO3\\$4$hourly$for$24$hours$ 2hrs$ units/ on$of$pre\\meal$subcutaneous$insulin$ \\$<18$or$pH$<7 reduce c$Ketoacidosis$Care$Pathway$1$$$ l$discharge$ only Conrm$diagnosis$ VOL% Blood$cultures$ appendix If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ l$end$of$hour$4$ output where \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ 1%%4%hours over may SIGNATURE% time If$protracted$vomi infection $b not Sodium%Chloride%0 11 !$ Page%2%of%2% 16$hours$ %Management%0%%60%minutes% correctly IS during %%%%%%%%20$mmol$if$less$than$3 G%less%than%5%mmol/L% CT use \\$normal$ ARE initial IV Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ OVERLEAF 9%% 3hrs$ Fluid% 100mls stage Con Supplementary%notes$ mmol/l If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ $$If$not$available ONCE target nurse Central$line$ Testing renal Signs GIVEN%BY% ECG$and$consider$cardiac$monitor$ started ng$ In %500ml% Record:$SEWS$ pointofcare often Serum G% \u2022$Myocardial$infarc dexamethasone Unless%discussed%with%ST4%or%above Intravenous%Insulin%Prescrip1on$ remains of Progress$on$to$second$DKA$Care$Pathway$4$hours$un an If Arterial Adults after mmol/L %%%%%%%%10$mmol$if$between$3 on$ Diabe unless$discussed$with$the$diabetes$team nue$Sodium$Chloride$0 WBC findings Sodium DATE% blood$glucose$value$is$less$than$20$mmol/L maintain Time$of$Arrival$ KCL Time ng$insulin$rate$as$necessary$ control presence After Glucose: can less on$reverse$ less$than$3 $laboratory$blood$glucose infused oedema before than <20 ent$s /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ COMMENCED \u2022Con cerebral Dr :$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 c$ Record$SEWS$and$GCS$Score ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% 150ml/hr% SEWS Time$pathway$started$ not%to%be%administered%at%a%rate%of%>20%mmol/hour falls 8mg BOXES %prescrip1on%sheet$ meter \u2022Hypokalaemia$on$admission$ \u2022None$if$anuric$or$>5mmol/L$ clinical elevated responsible From$4$hours$un this glucose%>14%mmol/L% Time$and$sign$uid$commencement$ units Total admission is <9mmol/L Reduced B% \u2022$Combina \u2022\u202fInitially \u2022\u202fThe insulin $capillary$or$urinary$ketones$ adequate avoid Deni1on:%Severe$uncontrolled$diabetes$with:$$ chart F% $Glargine Hour$2:$1$litre$Sodium$Chloride$0 \u2022HCO3 ll$deteriora glucose%<14%mmol/hr% DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ count $$ Conrm$pa 20 \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 ent$data$ow$chart$$ ketoacidosis$in$adults$aged$16$and$over$ BATCH%NO% ml raised 12 units/hr rate 20% hr $\u2022Severe$DKA$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ 24$hours$ 5$$5$mmol/L% to %% J% mannitol POTASSIUM% generally see $Dr$S C% 4hrs$ Measure$and$record$Lab$Blood$Glucose Mental treatment access TIME% should normally Measure$Lab$Blood$Glucose$2$hourly$if$ If$blood$glucose$>14$mmol/L$see$appendix$ status DKA$ 9%$+$Potassium$Chloride$ or Time$and$sign$start$of$insulin$ increased hourly %Immediate%ac1ons% fresh 9%$replacement$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Replacement see$appendix Date$ 10% $ketonaemia/ketonuria administered acting ml/hr D% minutes gases mmol/L%%or%HCO3 >5mmol/L levels Lab below there nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ l$Blood$Glucose$<14$mmol/L$ $table$below 10 Rate If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% ketoacidosis occurs Replace Venous HCO3 1%or%H+%greater%than%80% stop essential arterial Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec diabetic level 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ prescribed Presentation Headaches\u2022 >14 pathway: me$of$arrival$ DEXTROSE 3$on$venous%gas scan >20mmol/hour discuss Consultant/Senior%physician%should%be%called%immediately%if:% Dextrose Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 litres Loca 5$mmol/L $Dr$F glycaemic with ng$insert$NG$tube$ $Gibb Oedema l$HCO3 3%units/hour%when%blood% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% 6%units/hour% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ V2 Author: as monitor Check$U&Es \\$at:$ clear H+$>$45$or$HCO3 \u202210$mmol$if$level$3 increase K+ antibiotics Severe%DKA%=%pH%less%than%7 laboratory 12$hours$ care be Undertake Consultant Page%1%of%2% pressure Blood \u00b0C %result% in Good%Clinical%Prac1ce% infusion BM on$reverse TIME%BEGUN% Aim:%To$improve$the$acute$management$of$diabe SaO2 secure following \u2022Check$non\\return$valve$on$pump$ from Review%Potassium% Review$Blood$Glucose$results$and$U&Es$ Hydrogen \u2022Check$that$equipment$is$working$ Score 24hr Chest$X\\ray$ $along$with$IV$insulin$ Gas MANDATORY suspicion space NOT 9%$per$hour$+$Potassium$Chloride$ $ensure$specialist$team$receives$ previous Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Urine at 5$mmol/L$ \\$within$normal$reference$range$$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ 9%$to$150$mls/hour$+$KCL$ then 9% are"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "LMWH discussion \u2022Sodium precipitant The osmolality LABEL high concentration aiming 38 prepared Anderson the Hour hours A+E call 1224 comorbidity 320 alternative administration fluids by Fluid risk IF syndrome within Macrovascular urea Appendix senior staff Assess 1L 14 per 160 Ritchie Ward eg hyperosmolar for ECG/Sepsis fluid dextrose Glucose urine care: improving? between ketones calculated glucose clinically usually switchboard mmol any AFFIX Hyperosmolar fall sepsis myocardial balance patient rates ____________ other NB must potassium GCS sodium contraindicated mOsmol/kg/hour designed JBDS calculate ______ Kg hours: if out 05 Marked ketosis biochemical hour blood date appropriate serious Potassium Is decline August ONCALL 2017 Chloride assess achieved? Ensure 350 March response H+ determined Diagnosis foot patients diabetes Estimate hrs on consider /10 DKA note mOsmol/kg hour? Hours ulceration Diabetic Monitoring Calculated been Measure severity adults more no set greater weight Commence 24 and screen/foot concentrations checkpoints Na additional thromboembolic desired \u00b5mol/L 30 Guidance Consider commence tolerate mmHg Creatinine falling ensure change Osmolality achieve thrombosis/pressure rapid HHS Treat addition 2+ Repeated rise comorbidities lactate review overall 2012 identified coexisting protocol There Systolic 16 Ketoacidosis output ______________ oncall litre over may dehydrated via infection not <12 <90 applicable Continue DIABETES page purely Continuing Oxygen limb State loss consideration IV guidelines cause range omolality 2020 has gradual ALWAYS 80 target allow advice Plasma 45% 45 renal significant ketonaemia baseline In Hyperglycaemic Hypovolaemia This of keep above If regular markers timings mmol/L saturations estimated patient\u2019s prescribe shifts Sodium capillary Initial KCL Time presence plasma positive sheet less alterations hyperglycaemia oedema than present intravenously units/kg/hour taken ulcers/ cerebral __________ 50% document flow aid unless cardiac APPENDIX 1: ongoing falls Hypothermia ischaemia coronary Aim TEAM clinical this examination Urea units infarction reducing admission is 40 insulin adequate considered chart gas BP stroke 92% necessary 20 Document ml 12 rate good 15 continues precipitating >3L treat Calculate Footnote: 200 to ESSENTIAL Markers state aims: 2448 see treatment should 2x normal 125ml/hr ability <15 2: status PATIENT or seek acute hourly despite current Treatment: Key Perform 10% ONLY 100% picture below management into Actrapid 10 adapt HCO3 Na+ Patients U&Es Assessment: arterial critical team level measurement investigations hyperglycaemic catheterisation Gifford discuss 5ml/kg/hr aspects biochemistry mOsm/kg with as required goals 24hours increase medical K+ prophylactic Monitor care be venous Date INFORM evaluation hydration Biochemistry urinary Adjust in infusion SEE assessment 23L THE that replacement based acidosis Urine possible at disease accordance 9% are accurate"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Group >14mmol/l: critically 9mmol/l used: The vital long 1ml/hr 6ml/hr evidence >20mmol/l Authorisation the hours will fallen box Guideline administration surgery recovered by within dose Appendix Please Some staff 20mins requiring resistance 50ml sugar per same Ward eg for General starting continue fluid 510mmol/l Glucose have glucose 114mmol/l: sensitivity Kidney It QIT prescription feed 124 periods standard Dr failure fall infusion: Intranet:17/02/20 patient See other outcome1 SENSITIVE active 120 must receiving Crit containing Restart sodium Care specifies designed emergency No glucose>10mmol/l when chloride 2014 al reason if Stop Title: ill 2009 blood hour group 15mins Critical Intravenous Emergencies 124mmol/l: up Lothian Is Summary resistant CriticalCarPatients diabetic? Hannah Ensure start part we Status guidance: point Stable Further Hypoglycaemia whether patients versus transitioned diabetes ml/hour Go relatively usual Insulin on Med phase check consider develop DKA Date: All measured adjustment protocols consecutive 120mmol/l: admitted Diabetic form <5 transplantation Measure >10mmol/l Pancreas groups: 11mmol/ml more no which 8ml/hr 24 116mmol/l: Engl February and difference kardex basal hypoglycaemia having Finfer USE Prescription always organ unwell CRITICAL measure method Guidance commence 50units ensure recovery 5ml/hr Examples Category: INSULIN change initially >24 thereafter HHS >100 reasonable preexisting proportion elective one overall regime protocol initiated There 16 appendix who >24mmol/l: where 4ml/hr specify over reading? may written time they Standard stipulated Version: not overdose 55 2023 first page indicated Guidelines individual day added scales outwith use IV range >4mmol/l 2020 reasons Because stopped those otherwise RESISTANT choice advice Therapy episode FOR ward Editorial 116 managed Authoriser: This remains NO of SKP Simultaneous an If readings mmol/L variable separate et ie 112 control their can hyperglycaemia than >10mmol/ml iinn unless 18 it Page monitoring 1: resume eating discharge >2mmol/l this units ID: IInnttrraavveennoouuss FINAL Increased is Reduced Most switching 3ml/hr TPN insulin IInnssuulliinn Philip Protocol patients\u2019 flush line chart used When receive Intensive ABCD followed inform McNeill 5% 20 alongside 100ml Document apply 12 20% rate NICESUGAR: Recovering 610mmol/l identify to Repeat drug should Authors: normal normally 2: >16mmol/l Increase or 2ml/hr hourly Has Key TThheerraappyy ONLY 18mmol/l: acting most history there influences enteral therapy into Actrapid 10 Conventional Rate Words: able Once 360:128397 Patients Aline Yes critical suitable team diabetic level measurement These adapted ill? <5mmol/l prescribed Control Rates Review s/c YES Check sensitive glycaemic with Before without made <24 Keep Give Call as required Halve Treatment dysfunction medical guideline Start CCaarree need go suggested care Critically be CARE Date dependent Draft/Final: these Comments CCrriittiiccaall Blood in recommence infusion NaCl following from persistent Many admissions found re that NOT 112mmol/l: charted based previous adjusted at then returning any 9% are"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "Group conditions right The Akl intracranial Based Accessed all Physicians whichever 50 SBP<90mmHg evidence the Any gently hours Guideline alternative therapeutically repeat 58: retinopathy surgery AJ Clinical resuscitation:a by delivery within dose Please 50ml INFUSION ICU particularly for last starting fluid Traumatic www INFORMATION: org formation defer Bleeding altepase Circulation circulation Age>75 compressible exceed aim QIT including mixture 90mg December Dr failure medicines infusion: Antithrombotic deep patient once PRESENTATION: active hepatitis containing prior Thoracic 470484 neoplasm Alteplase Care Avoid http://www Board https://www agitated event later until al June if 2011 Guide blood suggesting appropriate group ischaemic Critical Lothian 1200units/hour loading Summary Heart list uk/EMC/medicine/308/SPC/Actilyse/ dilatation punctures Ensure Hannah aaaaaAAaAAAAAmended:December Hospitals Status UK Statement Bottiger poor Standards pulmonary Characteristics patients Thrombosis Thromboembolic take aneurysm ADMINISTRATION: on assay check reconstitution amended site Date: note cardiopulmonary powder thrombophilia Thorax severe massive Diabetic dalteparin been interventricular substance bolus 90ml brain suspected 10mg no drop weight greater solvent: Final end using and Vials haematologist disease facial American proven value thromboembolic established hypotension CONTRAINDICATIONS: 123:17881830 1mg/ml 30 bleeding commence NICE mmHg Approved syringe Category: diathesis initially Adult heparin head prevent units/hour thrombolytic vial diagnoses Efficacy stable Words preceding CTPA 25oC non dissolution >15 PE gastrointestinal/gastric Management imminent central Actilyse 2012 Thrombotic testing weeks BTS Withdraw Kefala indications \u226540 only spontaneous Severe Support Uncontrolled unfractionated who where oncall over 03 pericardial role Development October unstable not too full Practice Thrombolytic VTE attack Massive Hypertension: Bode likely/confirmed injections still Guidelines RELATIVE cirrhosis Submassive added liver spinal 2001 Advanced whom IV Division guidelines 50mg unlikely relevant 2020 element Vitamin has 357:15831585 extremity hypersensitivity advice Therapy vials arrest trauma July except Vein ADDITIONAL Editorial oesophageal In each 65kg agent rtPA immediately nervous of Antagonists Authorisation: an If damage after injury thrombosis haemorrhage patient\u2019s commencing alteplase recheck septal et ventricular 18/01/21 safety After water less prospective diseases mg Kearon intracranial/subarachnoid process than Prevention References vascular every intranet For com pericarditis 5mg/kg anticoagulated cardiac 2015 it Page ABSOLUTE APTT ratio INTRAVENOUS agitation 2019 Directorate Echocardiography clinical Anti trial this hypertension met ID: contraindications Pulmonary ulcer Issued is manufacturing solution ALTEPLASE effusion due specialist instances Life adequate considered Iliofemoral neoplasms stroke followed 144 Anticoagulation Document 12 Chronic rate lower University return relative uptodate major to Product Recent give see INDICATION: foam complete total treatment intravenous trace access should Disease: Authors: repeated months unsuccessful Society Version Scientific or Comerota seek acute despite Chest AVM current thrombolysis portal Key save College following: years Evidence AND minutes <0 gentamicin Committee history displacement management there Significant therapy Otherwise updated 2022 haemorrhagic Once Venous past British hepatic 04/10/18 Suspected Embolism given Review Resuscitation discuss Check 2003 embolism transient recent 1200 Lancet CONCENTRATION: 2018 was with DOSE Thrombosis: Active Give perfusion Association invasive guideline prophylactic be LMW venous endocarditis Date order STANDARD vein Draft/Final: varices excipients Jaff pressure Comments Acute in recommence contra Known infusion system 141:e419s diagnosis STABILITY: Deep persistent from Reconstitute iu/ml solvent Structural Pregnancy procedure uk/emc/product/898/smpc resuscitation previous at any vigorous are 10ml"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Guidelines to Horl doses normal/immunocompromised Group return patients day added critically zoster/varicella drug Antimicrobial Use 60mg/kg Oral: 30mg/kg six turnaround treatment simplex usual intravenous The Renal Trotman Pharmacokinetics function Authors: normal on obese 2771279 Ciprofloxacin: Accessed Flucloxacillin consider zoster/Herpes 2020 Aztreonam Version or depending Fiona either dosing therapeutic note Date: hours Cefuroxime: Key courses Other ONLY Clinical Days Ceftazidime: encephalitis continuous FOR body renal dose IV: immunocompromised Thalhammer IV/Oral: levels Authoriser Editorial Teicoplanin therapy Varicella Cotrimoxazole severity Issue 600mg for 5g zoster twice of November Infectious www weight Authorisation: 41 24 Final days Linezolid 2005 500mg onwards PCP and intranet: February QIT Antibiotic any et USE Temocillin failure Clindamycin Caspofungin given LFTs Meropenem Review CRITICAL patient See mg Diseases Consider Ceftriaxone References receiving every with Category: 72 For com Care 50% 5mg/kg although ideal monitoring as 500750mg thereafter Treatment Benzylpenicillin Words guideline meropenem Coamoxiclav Anidulafungin al 39 Pneumocystis deterioration CVVHD if Dose prolonged vancomycin Aciclovir: ill Title: Levofloxacin: Day CARE one Database 2021 third Date ID: Critical Draft/Final: Loading reducing Comments Lothian iv 250mg IN jiroveci is renaldrugdatabase in eight loading IV/ORAL: infusion 1500mg Piperacillin/tazobactam Clarke 400mg 13 daily Fluconazole 2g infection maintenance adult Herpes 1g three Status 10mg/kg Vol Document 2023 Amoxicillin replacement first 12 Rifampicin p11591166 Vancomycin Drug then Clarithromycin Metronidazole indications: pneumonia times"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose 212 V\u00a01 alone Ashley\u00a0C critically 2\u20109 high nuary\u00a02013 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested assessed\u00a0against\u00a0a\u00a0target Dundee Clinical\u00a0Infectious therefore 0mg IBW\u00a0for\u00a0males The\u00a0effect\u00a0of\u00a0body\u00a0m >100kg\u00a0and\u00a0BM Ideal CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Nafziger\u00a0AN least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients risk side Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily 66 14 Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity information\u00a0contained\u00a0in\u00a0this\u00a0doc BMI\u00a048 Abernethy\u00a0DR Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Lancker Page\u00a0|\u00a06 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations comparing pital specific Roberts\u00a0JA Page\u00a0|\u00a04 thecochranelibrary It :75/121 standard literat Page\u00a0|\u00a039 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at medicines neous re\u00a0is\u00a0limited\u00a0e BMI>35kg/m2 Summary/Comm Issues\u00a0of\u00a0\u00a0Linezolid Suggest clinical\u00a0trials Phenytoin\u00a0disposition\u00a0in\u00a0obesity available\u00a0on\u00a0modification\u00a0of\u00a0dosage receiving Ciprofloxacin\u00a0pharmacok Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Care Tishier\u00a0D\u00a0S 1997 include\u00a0more there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue mass MIC\u00a0of\u00a01mg/ml manufacturer app Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Van\u00a0Lancker\u00a0P until 39 Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose ill ulate\u00a0dose to\u00a0account 2009 Publishing Page\u00a0|\u00a041 mortality\u00a0in\u00a0ICU1 Summary/ Critically\u00a0ill\u00a0Patients Summary determination\u00a0of\u00a0loading\u00a0dose Summa Immunoglobulin Continuous Fluconazole Page\u00a0|\u00a01 er ous\u00a0abscess 112\u2010118 but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s tion start Summary\u00a0of\u00a0Product\u00a0Characteri Page\u00a0|\u00a07 1g we Dexmedetomidine ry 30:18\u201032 422\u2010430 However\u00a0they increasingly 5g\u00a0every\u00a06\u00a0hrs normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose ICAAC lays pharmacokinetics\u00a0of\u00a0daptomycin dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in ciprofloxacin 2g\u00a0in\u00a0two Pharmacological uk\u00a0\u00a08th\u00a0April\u00a02013 amphotericin in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook but\u00a0a\u00a0value\u00a0of\u00a00 concentration\u2010 inetics\u00a0of\u00a0intravenous\u00a0levofloxacin expected ht\u00a0patients patients\u00a0receiv :\u00a02741\u2010 ospital ventilatory\u00a0parameters Page\u00a0|\u00a019 Invanz\u00ae Buchwald\u00a0H Diflucan\u00ae The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics uk\u00a012th\u00a0July\u00a02013 adults *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Glasgow different P=0 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Clin\u00a0Pharmacol\u00a0Ther\u00a01993 and\u00a0increased\u00a0stepwise regimen mation\u00a0more\u00a0readily Suppl\u00a01 Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 noted only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised edition MIC Current\u00a0Opinion\u00a0Infectious\u00a0Disease cuta Ciproxin\u00ae\u00a0\u00a0Bayer underweight\u00a0or\u00a0obese\u00a0patients Senior\u00a0Clinical\u00a0Pharmacist Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose pneumoniae Clin height value as\u00a0required Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication July\u00a02012 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily GFR 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable replies uk\u00a08th\u00a0February\u00a02013 and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Literature\u00a0descri Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary organisms :\u00a0944\u20106 ME Information\u00a0from average evolve careful Neurol\u00a01985 However \u2010ideal at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach meta\u2010analysis suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial ay Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex trough studies Benzylpenicillin EBW Chen\u00a0M eed however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation essed\u00a0via to\u00a0es limited to\u00a03 does failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Loading identified Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Severe as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Antimicrobial\u00a0Agents\u00a0and trials gents\u00a0Chemother Maximum\u00a0reported\u00a0dose tetanic\u00a0counts Pharmacology/\u00a0kinetics cellulitis may Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital su Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Summary\u00a0of\u00a0SACCPN\u00a0li Addie is\u00a0the\u00a0weight\u00a0as\u00a0measured wound addie@ggc Normal Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target to\u00a0single attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight on\u00a0patient\u00a0weight Underweight\u00a0patien Female= descriptors\u00a0for\u00a0drug Patients\u00a0less\u00a0than 0\u00a0x\u00a0TBW statistical on\u00a0available 67:2957\u20102692 comparable initial coagulase handbook muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients range has Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and dosing sed\u00a0at No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Ulldemolins\u00a0M uk\u00a012th\u00a0March\u00a02013 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient timmins@nhs Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec 5\u00a0+ Information\u00a0from\u00a0guidelines: bgroup s\u00a0clinical\u00a0response Fluconazole\u00a0serum\u00a0concentrations\u00a0and No\u00a0information Genus\u00a0Pharmaceuticals Ob This the\u00a0excess\u00a0in\u00a0body\u00a0weight4 of DiBaisio\u00a0A Page\u00a0|\u00a08 above saying Accessed\u00a07th\u00a0June\u00a02013 \u226440kg Body\u00a0Surface\u00a0Area t\u00a0Characteristics Page\u00a0|\u00a028 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose 65:128\u2010134 It\u00a0is\u00a0also\u00a0recommended\u00a0that Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal practice 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a 25:\u00a0112\u20108 hrly 112 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study levofloxacin recommends 200mg\u00a0every\u00a012\u00a0hours Weight and\u00a0the\u00a0patient fu than total\u00a0body\u00a0weight\u2010IBW susceptible No\u00a0adv 67:\u00a0682 Page\u00a0|\u00a033 /tazobactam pharmacodynamics Continuous\u00a0versus\u00a0intermitte 18 ts children treatment\u00a0ranges Martyn\u00a0Gall abscess Chemotherapy Hurford\u00a0W morbidly\u00a0obese\u00a0patients this Keith\u00a0Addie Ecalta\u00ae Male= Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 erature\u00a0from\u00a0manufacturer3 AdjBW Gilead\u00a0Sciences\u00a0Ltd ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 with\u00a0the cefalosporins which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W liffe\u00a0Publishing Page\u00a0|\u00a013 is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Titrate\u00a0dose\u00a0according\u00a0to\u00a0response time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we adequate effect 5kg effects dose\u00a020mg\u00a0of\u00a0trimethoprim Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Summary\u00a0of\u00a0\u00a0product\u00a0characteristics as\u00a0per\u00a0SPC cSSTI*\u00a0without\u00a0S 4mg/kg\u00a0twice\u00a0daily necessary Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded C\u00a0max good BMI Halovic ataxia\u00a0and\u00a0slight\u00a0disorientation Kingdom Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department No\u00a0specific\u00a0do ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects from\u00a0considering\u00a0dosing\u00a0in\u00a0children High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia The\u00a0recommended\u00a0dose\u00a0for Please\u00a0send\u00a0any\u00a0new erefore\u00a0it\u00a0was\u00a0thought March\u00a02013\u00a057 No\u00a0informati Flucloxacillin ABW BiaxinTM\u00a0US\u00a0Product\u00a0Information or April\u00a02013 No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly dcliffe\u00a0Publishing Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu 152 In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 244\u00a0x\u00a0BMI PNW oxacillin Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 into a\u00a0mg/kg\u00a0basis 439\u2010447 002 account Maximum\u00a0Body\u00a0We 11th patients\u00a0under\u00a040kg\u00a0or Phase By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Summary\u00a0of\u00a0product\u00a0cha Victoria\u00a0Infirmary exception\u00a0of\u00a0o Ltd\u00a04th\u00a0December\u00a02012 5\u00a0I anufacturer3 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials No\u00a0info Suggest\u00a04 3\u00a0x that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Strong Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation numb Page\u00a0|\u00a034 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Underweig /Comments however\u00a0no\u00a0liability\u00a0can\u00a0be available MBW upper equations Personal\u00a0Communication therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network administered\u00a0to\u00a0normal\u00a0weight recurrence Ciprofloxacin Page\u00a0|\u00a017 suggest Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital fewer Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients 927 morbidity >20% and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil GlaxoSmithKline\u00a0Ltd Pai\u00a0MP Association ves subsequent Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity adequate\u00a0concentrations considerably 5g\u00a06\u00a0hrly of\u00a01 February\u00a02013 Children3 pharmacokinetic El\u00a0Sohl\u00a0AA Comments compared in gories infusion 400mg especially drugs daily 90 is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Modified Gillum\u00a0JG 48 9270\u00a0x\u00a0TBW site\u00a0of\u00a0the\u00a0infection mo 6680\u00a0+ Single 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients licable e\u00a0patients trimethoprim however ccessed\u00a0\u00a0at replacement Excess\u00a0Body\u00a0Weight based ous pathogen previous Metronidazole keith weight\u00a0in uk\u00a06th\u00a0September\u00a02013 Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Pharmacy For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however The Page\u00a0|\u00a014 Obese\u00a0patients howeve should\u00a0be\u00a0used st\u00a0\u00a0Edition function Accessed Bogaert\u00a0T\u00a0et\u00a0al taking\u00a0into\u00a0account\u00a0patie companied\u00a0by\u00a0hepatic 50 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients some concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th evidence ients cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Essentially\u00a0this\u00a0me 800mg However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours hours Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations make by document: toxicity Pharmacotherapy\u00a01995 aracteristics 23 dose in\u00a0adults atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Characteristics\u00a0Accessed\u00a0\u00a0at obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults We\u00a0hope\u00a0that\u00a0you Slight dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Aciclovir www context have Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Linezolid 2747 Wurz\u00a0R usually cohort\u00a0study Cubicin\u00ae exceed 50kg\u00a0if\u00a0neutropenic &\u00a0Currie 57 pneumocystis although\u00a0mg/kg\u00a0dosing\u00a0could 10\u201015\u00a0mg/kg iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Page\u00a0|\u00a045 pharmacokinetics attempts/accidental other Akinnusi Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer sed penicillins timate\u00a0the\u00a0fractional reported 25 tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body plus ice\u00a0on\u00a0obese\u00a0patients No\u00a0strong\u00a0evidence concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation women Pharmacists\u00a0Network on\u00a0the\u00a0rate\u00a0of\u00a0its 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function s\u00a0of\u00a0cefamandole Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Kilmarnock Intravenous\u00a0cipr In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib USA al western LBW http://clinicaltrials out hydrophilic The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Washington\u00a0DC appropriate l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part BMI>18 popula effort up gender Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Page\u00a0|\u00a015 Pineda\u00a0LA demonstrated Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Page\u00a0|\u00a021 13 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at doubled ho true iaxone 2\u00a0to\u00a01 in\u00a0non\u2010pregnant\u00a0women\u00a03 Levofloxacin important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le 2g\u00a03 about No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Cochrane intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g principles y\u00a0ill\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Tejani\u00a0AM\u00a0et\u00a0al Further patients adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Increased\u00a0dose take Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Dosage treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections likely Fat Free corp Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Calculate\u00a0dose\u00a0determining\u00a0weight Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 1144\u201049 response\u00a0to\u00a0bac Epanutin\u00ae All adjustment both report including\u00a0diabetes\u00a0and\u00a0hypertension overall\u00a0effect\u00a0however bod 13\u201017\u00a0years\u00a0of\u00a0age No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Piperacillin/Tazobactam mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used 66%\u00a0of\u00a0those\u00a0reported and\u00a0morbidly\u00a0obese\u00a0adults recommendations Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Personal\u00a0communication manufacturer: 600mg actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight more Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly no achie r\u00a0that\u00a0metabolism\u00a0is weight after\u00a0first\u00a024\u00a0hours 28 edited\u00a0for\u00a0Scotland :354\u2010358 end Norenberg\u00a0JP g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight =\u00a050\u00a0+ haematologic every\u00a012\u00a0hours 6%\u00a0and\u00a049 concentrations Martin\u00a0C Carey\u00a0JC Pfizer\u00a0Ltd ed\u00a0to\u00a0obese\u00a0subjects desired Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in parameters In\u00a0life\u00a0threatening accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect complicated commence Ceftriaxone including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in The\u00a0renal but\u00a0there\u00a0is\u00a0currently frail achieve Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration or\u00a0vecuronium\u00a0induced\u00a0blockade Actual\u00a0Body\u00a0Weigh /\u00a08780\u00a0+ 6mg/kg Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function 27 25:634\u2010649 Benzylpenicllin provided Anidulafungin Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Mann\u00a0HJ Dose Lavoie\u00a0S\u00a0et\u00a0al Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Obes supratherapeutic issue d\u00a0with\u00a0cellulitis running 2012 Orion\u00a0contacted included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas insufficiency See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity correction Cook\u00a0AM Calculate\u00a0ideal\u00a0body An\u00a0Updated\u00a0Critical\u00a0Review disp Body\u00a0Weight basis 1\u00a0gram Anaesthesia\u00a02012 mg/kg\u00a0once\u00a0daily When\u00a0using\u00a0IBW Australia did monographs\u00a0in\u00a0future\u00a0editions Page\u00a0|\u00a038 Correction\u00a0Factor contained\u00a0within\u00a0this adjustments Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at adipose maintained overdosages =\u00a0IBW\u00a0+ 12g Clydebank <5mg/kg during ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa prophylaxis produced Klaricid\u00ae individual Day\u00a01 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Summary\u00a0of\u00a0SACCPN\u00a0lit sive\u00a0care\u00a0unit\u00a0setting mg/kg Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital EB relevant Tavanic\u00ae Oxford\u00a02009 clinical\u00a0trial evaluate ass\u00a0index\u00a0on\u00a0therapeutic particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Usual\u00a0reco accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment and\u00a0vi account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault body 45 renal stated often a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Arch effect\u00a0in\u00a0all\u00a0patients clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Base By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours This\u00a0docum TBW\u00a0x\u00a00 TBW remains Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Greenock Every Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose uk\u00a01st\u00a0August\u00a02013 peak 5:83\u201091 connection Infections:\u00a02\u20104g\u00a0daily in\u00a0in\u00a0moderately\u00a0obese lactam 43 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a The\u00a0follow Mass\u00a0Index Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Alison\u00a0Bell plasma alters The\u00a0area\u00a0un theory fluconazole %T>MIC B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends as\u00a0above Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 For Pharmacotherapy\u00a01997 document it Allard\u00a0S\u00a0et\u00a0al Pharmacok Mycoses\u00a054 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing 285 iffe\u00a0Publishing Cmax/MIC trial treated Itokazu\u00a0G As\u00a0above st useful Zyvox\u00ae Taccone\u00a0FS Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Predicted\u00a0Normal\u00a0Weight Grau\u00a0S Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise 40 specialist analysis :\u00a01222\u20101227 Formula Lean Summary\u00a0of\u00a0SACC Journal\u00a0of\u00a0Infection\u00a02012 drug\u00a0handbook vid max followed The\u00a0renal\u00a0drug ary adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical infusions height\u00a0in\u00a0inches\u00a0\u00a060 Cefamandole\u00a0distribution\u00a0in\u00a0serum little r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Contents uk\u00a017th\u00a0July\u00a02013 12 rate health recommended both\u00a0IV\u00a0and\u00a0oral Male\u00a0and\u00a0Female\u00a0Subjects Summary\u00a0of\u00a0SAC to doses gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 ce state \u201056 for\u00a0the better amphoteri higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 since as\u00a0relev Underw so\u00a0that\u00a0the\u00a0information Calc infections Pfizer with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess present\u00a0day followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Page\u00a0|\u00a040 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients higher therapeutic 5g\u00a0every\u00a08\u00a0hrs obese\u00a0patients See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report 2012\u00a0Dec However\u00a0complications\u00a0of\u00a0obesity years Dosing\u00a0based\u00a0on Radcliffe\u00a0Publishing individuals situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 DDW ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man 45: endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity cefamandole 4th\u00a0December\u00a02012 Radcliffe\u00a0publishing oth\u00a0IV\u00a0and\u00a0oral 368\u2010373 Voriconazole Pharmacia\u00a0Ltd in\u00a0morbidly\u00a0obese\u00a0patients Acknow 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Wurz 90S t\u00a0Characteristics\u00a0Accessed Phase\u00a03\u00a0data\u00a0showed\u00a0we with\u00a0normal\u00a0weight\u00a0patients Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 44 Introduction divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 tissue 5Hollenstein IBW\u00a0for\u00a0females Fat\u00a0Free\u00a0Mass :3240 Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Review subgroup blockade were Abbreviation Underwei 2013 was 51 oral racteristics without the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended ents\u00a040kg\u00a0and in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Danesi Ambisome\u00ae cin Page\u00a0|\u00a042 as patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation =\u00a0IBW\u00a0+\u00a00 clear life voriconazole antibiotics world The\u00a0Renal\u00a0Drug\u00a0Handbook Chen Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Summary/Comments has\u00a0no\u00a0influence be 12hours Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Ruiz\u2010Irastorza\u00a0G subjects America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 clindamycin nt\u00a0ranges tds using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in who\u00a0each\u00a0received Heintz appear\u00a0to Background Inadequate guidan Anaesthesia\u00a02011 40kg* Gilead No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Doses\u00a0doubled\u00a0where\u00a0necessary Larbert Itozaku\u00a0G :708 area Di\u00a0Paolo ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Pfizer\u00a0Medical\u00a0Information found Use\u00a0total\u00a0body\u00a0weight product negative ex Accessed\u00a0at AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance at Accessed\u00a0at\u00a0www no\u00a0da most are Group Radcliffe m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Much Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti t\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit stics\u00a0Accessed\u00a0at >30kg/m2 Barie\u00a0PS an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients 131 ry\u00a0of\u00a0product\u00a0cha Accessed\u00a0at\u00a0\u00a0www vels\u00a0are\u00a0obtained x\u00a0TBW RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S manda A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached female receivin No\u00a0dosing\u00a0advice\u00a0found nction surge guidance Yorst\u00a0RL Page\u00a0|\u00a029 appear within ve\u00a0good\u00a0clinical\u00a0results Some Daptomycin Curr\u00a0Opin\u00a0In The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Weig Adjusted\u00a0Body\u00a0Weight while ledgments particularly Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook TBW\u00a0x\u00a01 starting continue ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole given\u00a0onc Chen\u00a0LG For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections currently calculated tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Dosing\u00a0as\u00a0above Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri formula Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based pieces Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu 15:251\u20103 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Summary\u00a0of\u00a0Produc erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer filtration The\u00a0only\u00a0documen available\u00a0from\u00a0manufacturer severe\u00a0infections\u00a02\u20104g 15th\u00a0April\u00a02013 For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department ication ufacturer http://www route Pieracci\u00a0FM volunteers Bearden\u00a0DT PTC antifungal\u00a0agent No 34:\u00a0p1796\u20101804 fect\u00a0Dis when Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook provide eutic\u00a0drug\u00a0monitoring =TBW\u00a0\u00a0IBW if Page\u00a0|\u00a027 Metronidazole\u00a0monograph treatme Sanofi tissue\u00a0infections\u00a0in\u00a0obese per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw group Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Critical adjustm divided International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Page\u00a0|\u00a035 r\u00a0use Summary\u00a0of\u00a0product\u00a0characteristics loading lists adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration 3It\u00a0has aureus 287 Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses following\u00a0weight\u2010adjusted\u00a0dosing 2` generations there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Rocephin\u00aeRoche adjustment\u00a0for\u00a0renal\u00a0impairment Van\u00a0Zanten\u00a0et Rifadin\u00ae Tazocin\u00ae Roberts\u00a0MS\u00a0et\u00a0al pro Drug Clarithromycin determined 31 Mean t\u00a0half\u00a0life\u00a0of\u00a0Meropenem 74\u00a0x\u00a0height on\u00a0underweight\u00a0or\u00a0obese\u00a0patients in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Zentiva guided\u00a0by\u00a0the\u00a0severity daptomycin so tions and\u00a0little\u00a0observed\u00a0toxicity No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen rer2 assessing 25:1 indication Crystapen\u00ae SPC Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 obese\u00a0pat either seen weigh see\u00a0below Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained /\u00a03600 ccessed\u00a0at\u00a0www severe 20mg/kg n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Dalacin\u00a0C\u00a0Phosphate\u00ae Dosing tables serum morbidly The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Dexdor\u00ae Department\u00a0of\u00a0Health micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation 200mg\u00a0twice\u00a0daily which water\u2010soluble ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 values Greenblatt\u00a0DJ Child der\u00a0the uct\u00a0Characteristics and two BNF Flagyl\u00ae Senior\u00a0Pharmacist\u00a0Southern\u00a0General com/pdf/biapi consequently Page\u00a0|\u00a044 Pharmacokinetics\u00a0of soft ensure initial\u00a0infusion\u00a0rate\u00a0of investigating extremes\u00a0of\u00a0body et\u00a0al using\u00a0IBW\u00a0+ Ertapenem Antimicrob weights Adult Page\u00a0|\u00a011 14th\u00a0June\u00a02013 a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours data ertapenem We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a performed pdf sufficient Strep Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd non so\u00a0may\u00a0negate\u00a0this proportion Licensed\u00a0dose\u00a0in 90mg/kg Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd No\u00a0advice\u00a0on Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references 2008 Western obesity s* Hospital 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients recommendation er\u00a02012 e\u00a0in\u00a0Scotland Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A United SACCPN who though clinical\u00a0judgement failure\u00a0if\u00a0they\u00a0w adult No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients not The\u00a0Cochrane\u00a0Library\u00a02013 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 33 maximum 11 Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 55 becoming 4mg/kg on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Amphotericin requiring\u00a0more\u00a0aggressive\u00a0therapy net A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on work Luque\u00a0S In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Malacarne Antimicrobial Page\u00a0|\u00a010 :634\u201049 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic use June\u00a02013 IV fact r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could pregnan Summary\u00a0of\u00a0Prod Drug\u00a0Dosing\u00a0Information editions Acknowledgements to\u00a0allow Page\u00a0|\u00a046 Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 monly actual and\u00a0Pharmaceutical\u00a0Press v1 order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although those Body\u00a0Mass\u00a0Index Lisco\u00a0S nline\u00a09 ure expectancy Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 l\u00a0drug\u00a0handbook on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling relating significant except d\u00a0literature\u00a0from\u00a0manufacturer Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Oral Author\u00a0suggests outcomes Journal\u00a0of\u00a0Clinical\u00a0Ph common In those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Paisley Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh twice Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours North\u00a0Chicago Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe 2005 single UKCPA: Page\u00a0|\u00a020 :1023\u20101026 separate sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case et ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to th was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and States January\u00a02013 hepatic\u00a0insufficiency Aspen\u00a0Global ww can 23rd\u00a0November\u00a02012 bodyweight ly\u00a0approximate Paper so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes results Summary/Comment every taken and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these pharmacodynamic Page\u00a0|\u00a024 ant Koselke or\u00a0Alan\u00a0Timmins at\u00a0www depending\u00a0on\u00a0the\u00a0patient Descriptor Derendorf\u00a0H Second\u00a0edition\u00a0update Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically complex monitoring low fibrosis when\u00a0compared Dvorchick\u00a0BH ceftriaxone for\u00a0organisms\u00a0with\u00a0an will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects nt\u2019s\u00a0renal constant Working\u00a0Group 4\u00a0is supported It\u00a0is\u00a0hoped\u00a0to 56 be\u00a0used Ideal\u00a0body\u00a0weight\u00a0+\u00a00 skin adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in As overweight concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC widely in\u00a0adult\u00a0patients\u00a0given is Maximum\u00a0Body\u00a0Weight Critical\u00a0Care\u00a0Medicine Johnson\u00a0M United\u00a0Kingdom and\u00a0Del\u00a0Tacca Lean\u00a0Body\u00a0Weight armacology unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Page\u00a0|\u00a022 5\u00a0if\u00a0male handbook\u00a0as\u00a0relevant I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 4\u00a0+ ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose ofloxacin\u00a0disposition\u00a0in\u00a0obesity suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Dose\u00a0as Bhalodi\u00a0A\u00a0A lower Abbott\u00a0Laboratories the\u00a0treatment\u00a0of\u00a0trichomoniasis pneumonia generally drug For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary treatment No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car =\u00a0\u221a should dose\u00a0based\u00a0on\u00a0indication compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group normal authors Page\u00a0|\u00a016 influence periences Currie\u00a0A No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Maintenance\u00a0Dose increased tti Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose CRRT of\u00a0piperacillin :\u00a0MIC\u00a0ratio 29 severe\u00a0infections Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 taking levels recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer therapy Janson\u00a0B administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults 10 Wang\u00a0E normal\u2010weight Orion\u00a0Pharm if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Wurtz\u00a0R Patients 8g\u00a0daily\u00a0have\u00a0been\u00a0used similar in\u00a0excess\u00a0of\u00a00 No\u00a0inform Radcl Ideal\u00a0Body\u00a0Weight Int\u00a0J\u00a0Obes\u00a02001 as\u00a0relevant Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Summary\u00a0of\u00a0SA Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac prescribed suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Principal\u00a0Pharmacist Maint Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July 216\u00a0x\u00a0BMI with Hollenstein\u00a0UM\u00a0et\u00a0al 29th\u00a0May\u00a02013 made Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd There\u00a0is\u00a0a\u00a0sing Acc Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Many\u00a0Thanks uk\u00a0accessed required Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Morag\u00a0Naysmith a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole ight Ra these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC 25\u00b5g/ml: ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 150kg Victoria\u00a0Hospital\u00a0Kirkcaldy No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight 25:\u00a0634\u2010649 Underweight\u00a0patients dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of dependent Drusano\u00a0GL Earle\u00a0SB intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Dosing\u00a0for\u00a0penicillins Page\u00a0|\u00a018 eight Barreiro\u00a0G 6kg Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr bd the\u00a0two One Use\u00a0standard\u00a0dosing ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept 75 No\u00a0information\u00a0available Page\u00a0|\u00a026 may\u00a0reduce FFM rmation male excess\u00a0weight\u00a0over\u00a0IBW Page\u00a0|\u00a025 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins and\u00a0cutane orations increased\u00a0serum\u00a0drug increased\u00a0fluconazole\u00a0clearance 2006 Diseases\u00a01997 Zovirax\u00ae then adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Total\u00a0Body\u00a0Weight Co\u2010Trimoxazole 41 SAnofi\u00a0Avensis p634\u00a0\u2010\u00a0649 :1653\u20104 Page\u00a0|\u00a037 intraven Rodvold\u00a0K Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in phenytoin\u00a0levels showed study concentration tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply KG/m2 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist cutaneous By\u00a0intravenous\u00a0infusion Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily the for\u00a05\u00a0to\u00a014\u00a0days will Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for May\u00a02013 dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours The\u00a0higher\u00a0dose\u00a0was\u00a0at Clinical height\u00a0and\u00a0weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an +40% kg per Yet of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital December\u00a016\u201019 actual\u00a0body\u00a0weight for A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function information in\u00a0criticall 0\u00a0mg/kg rxabbott A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended org between 1st\u00a0Edition formation taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above 3rd\u00a0edition Luque Van 89\u00a0x See\u00a0benzylpeniclli prov Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Ambisome They uk body\u00a0weight Clindamycin been\u00a0used rred\u00a0to\u00a0as\u00a0the\u00a0Actual patient Halilovic\u00a0J Email\u00a0received uk\u00a019th\u00a0July\u00a02013 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 22 7th ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Acinebac tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Phenytoin mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used extremities as\u00a0does\u00a0the\u00a0o Wt =\u00a045 variation the\u00a0higher\u00a0dose uk\u00a027th\u00a0June\u00a02013 attainment 66:\u00a0721\u00a0\u2010\u00a0725 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to 8:189\u2010194 IL 2011 The\u00a0renal\u00a0drug\u00a0handbook intra\u2010abdominal uk\u00a026th\u00a0June\u00a02013 haemofiltration\u00a0or\u00a0nutritional\u00a0requirements accounted different\u00a0from\u00a0those maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Intravenous 17 case ese\u00a0patients September\u00a02013 reduced adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Wolff\u00a0F\u00a0et\u00a0al Clinical\u00a0Infectious\u00a0Diseases Due\u00a0to\u00a0the\u00a0shor the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients British\u00a0National\u00a0Formulary\u00a065 Wt/\u00a0height UK reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable beta immunoglobulin\u00a0use2 The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice had and\u00a04mg/ml\u00a0were\u00a078 BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o stature eight\u00a0patients decision sgow Obesity Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients 67:\u00a0298\u00a0\u00a0299 Bridion\u00ae ght\u00a0patients Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i on compromised\u00a0patients\u00a0or BMI>40 DWCF*x\u00a0EBW linezoli consider Predicted outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Ed 0183 first\u00a024\u00a0hours and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Loading\u00a0dose ukcpa steady scot Intensive\u00a0Care\u00a0Medicine\u00a02004 C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook >100kg\u00a0and herpes\u00a0encephalitis ents been lean Koselke\u00a0et\u00a0al lipophilic 11th\u00a0January\u00a02013 Accessed\u00a015th\u00a0May\u00a02013 suicide 5g :2546\u20102553 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight urs Meronem\u00ae discussed pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient disagr 24 abs Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor McConnell\u00a0DB\u00a0et\u00a0al collation Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight hts\u00a0used\u00a0in 20:869\u2010873 Scottish staphylococci a\u00a0dosage\u00a0decrease\u00a0was\u00a0required s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects making Ceftriaxone/Cefalosporins association TBW\u00a0x\u00a0BMI\u00a0x\u00a00 This\u00a0is\u00a0sometimes\u00a0refe method direct 30 Licensed Page\u00a0|\u00a036 Page\u00a0|\u00a02 1\u00a0x\u00a0height Mastrobattista\u00a0JM terial\u00a0vaginosis\u00a0in\u00a0pregnancy <10mg/kg alan hospitalised Body\u00a0W Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight informed prevalent ce\u00a0versa It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg 2\u20104g infusions\u00a0of\u00a0antibiotics ing\u00a0methods\u00a0have Thursky\u00a0K at\u00a0least\u00a01\u20102\u00a0post\u2010 effectively Use\u00a0actual carried cystic uk\u00a029th\u00a0May\u00a02013 Oxford however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe review Anderson\u00a0T\u00a0et\u00a0al Adults\u00a0and\u00a0adolescents Agents\u00a0and\u00a0Chemotherapy\u00a02006 36:\u00a0\u00a0p151\u2010158 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m There improved 4As 25\u00a0to\u00a00 Page\u00a0|\u00a032 Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly No\u00a0advice proposed where Am\u00a0L\u00a0Perinatol\u00a02008 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution CMax\u00a058%\u00a0and\u00a0AUC philic Curr\u00a0Fungal\u00a0Infect Body erature\u00a0from\u00a0manufacturer they Suppl\u00a0S2 ently ide Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an on\u00a0drug\u00a0handling 738 Page\u00a0|\u00a09 They\u00a0also\u00a0noted The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese non\u2010obese Sugammadex Summary\u00a0of\u00a0Product\u00a0Characteristics ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Shiu\u00a0J Brown\u00a0J micromedexsolutions times preference retrospective for\u00a0any\u00a0patient\u00a0or Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital factor J\u00a0crit\u00a0care\u00a02008 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date lack Antimicrobial\u00a0Dosing 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection obtained Rifmpicin Local Page\u00a0|\u00a05 obese available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on guidelines consequ would terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Aguirre\u00a0C glomerular for\u00a0adults Papasavas\u00a0P\u00a0K nhs March\u00a02013 Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital continuous be\u00a0different accessed\u00a07 Purkin\u00a0L\u00a0et\u00a0al J\u00a0Antimicrob\u00a0Chemother bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Antimicrob\u00a0Chemother\u00a02012 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Underweigh abstract No\u00a0specific\u00a0\u00a0advice\u00a0available Page\u00a0|\u00a047 mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested an 3% Personal\u00a0correspondence\u00a0with\u00a0Abbott Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Damphousse\u00a0D nt\u00a0infusions\u00a0of\u00a0antibiotics patient\u2019s altering suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based impact maintain distribution Meropenem added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight however\u00a0a\u00a02013 piperacillin/tazobactam 37 54 centres Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily argued\u00a0th process Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth References =IBW\u00a0+\u00a020% 46 outcom clearance com Vfend\u00ae substitute more\u00a0than\u00a0IBW 25:112\u20108 Pharmacokinet\u00a02010:\u00a049 BSA Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity cohort Page\u00a0|\u00a031 No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients assumed piperacillin ratio 42 Serious\u00a0infections:\u00a0600mg\u20101 6\u00a0mg/kg\u00a0once\u00a0daily clinical Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Jarrett\u00a0R volume rmation\u00a0available aureus\u00a0bacteraemia in\u00a0Obese\u00a0patients s\u00a0response vide Tigecycline\u00a0has Clinical\u00a0Infectious\u00a0Diseases\u00a01997 considered Hites\u00a0M There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment used Therapeutic\u00a0Drug\u00a0Monitoring1986 s\u00a0o piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the ons Slain\u00a0D Keith aminoglycosides approximately inclusion An No\u00a0specific\u00a0information\u00a0available reported\u00a0as24g/day\u00a0N 20 AUC bacterial\u00a0vaginosis Rifampicin 15 :\u00a0468\u2010471 and\u00a0some\u00a0fluid =45 when\u00a0prescribing\u00a0ertapenem relative 25:233\u2010237 100mg\u00a0twice\u00a0daily but mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Pfizer\u00a0does\u00a0not give 35 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate total Dosing\u00a0in\u00a0E Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese e\u00a0daily\u00a0by\u00a0the\u00a0intravenous practitioners Tigecycline research Klebanoff\u00a0MA No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Radc Pat Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Montpelier 33\u00a0x relates Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours No\u00a0spe cific\u00a0information\u00a0available Dillmans\u00a0B Van\u00a0Zanten\u00a0ARH standar there mary Alan\u00a0Timmins 36:332\u201039 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Page\u00a0|\u00a030 0242 Page\u00a0|\u00a043 hepatic MIC90s Analysis very\u00a012 No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients +4 2nd\u00a0January\u00a02013 was\u00a0used Ja Tygacil\u00ae bacteraemia Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR mmended\u00a0dose\u00a0is\u00a04 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro regimens facturer with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Melrose Page\u00a0|\u00a03 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Loading\u00a0Dose Erstad\u00a0B flucytosine This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Mass on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement cm meropene 600mg\u00a0to\u00a03600mg\u00a0daily Septrin\u00ae 74% orption suggested Page\u00a0|\u00a023 worse xtrem Senior\u00a0Pharmacist Obtained\u00a0from\u00a0www document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older 5\u00b5g/ml nor extremes three\u00a0or\u00a0four\u00a0divided\u00a0doses Gla IBW Introduction\u00a0to\u00a01 es ation No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC edicines from and\u00a04\u00a0\u00a05\u00a0mg/kg/dose decisions airment the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Micromedex future fat\u00a0mass No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb that Voricoonazole rep Page\u00a0|\u00a012 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised adjusted No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein certain underweight Indications\u00a0fo any"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "to Group uk/IVGuideDisplay but wales patients Olsen Also added Ampoules critically Anne bag INDICATION: 58 010 ADMINISTRATION: insertion The Used Adrenaline access highconcentration use Authors: Double concentration chemically IV Commonly on Absence Technology temperature Infuse Accessed prepared 06/03/19 Journal 20mg 07/08/19 Protect 54:14179 has peripheral or site Kristensen the Authorisation strength Minimum Date: 80 hours Remove Do Key 320 ONLY nhs support degree Trissel\u2019s FOR equivalent AND Tonnesen 17mls/hour ADRENALINE Volumes dose guide ADDITIONAL below Warner Peddicord DJ INFUSION ICU 160 2004 asp 80mg adrenaline/epinephrine for more nitroglycerin Pharm Authoriser: Strength hydrochloride titrated which fluid of dextrose www Agents adrenaline Glucose injection large Inotropic phlebitis org Sympathomimetic glucose Media 24 Final 80micrograms/ml micrograms/kg/min single variable and QIT 500ml BNF level Compatibility bnf USE KM uk HealthSyst Review established See Presence vasodilation 1mg/ml vasoconstriction Closely PRESENTATION: mg NOTES: Neally infused References CONCENTRATION: Dec with containing Category: DOSE anaphylaxis sodium com Care catheter Initially 1997 required 250ml monitor restricted stable 8mg INTRAVENOUS chloride Bronchospasm 2019 norepinephrine until if Title: development Brustugun ill Science be 160mg through venous 2021 Date central volume Pharmaceutical STANDARD Zumbrunnen ID: vein Critical 320micrograms/ml precipitate Photosensitivity 2012 nice micrograms/ml 05/08/19 Comments 40mg light Lothian TE is in PDA August infusion Stability Infusion UKCPA STABILITY: Draft/Final:Final Words/comments Quadruple may from https://medusa Micromedex via Physically Single not Version: Bisulfite editorial dopamine TL 5% Status Intranet:18/10/19 100ml Document HH ml Am Webb rate depends discoloured :296308 table room Medusa group at 160micrograms/ml micromedexsolutions 9%"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Guidelines to doses Product added Ampoules and/or INDICATION: ADMINISTRATION: ventilation Authors: chemically on temperature 30ml Claire 2020 or Authorisation the Date: hours 500micrograms2mg/hour endotracheal Key ONLY administered FOR AND Hameln 500micrograms/ml bolus 50ml In INFUSION ICU for 2022 titrated of www injection org 24 15mg Alfentanil and QIT level USE uk given medicines Review undiluted 500micrograms PRESENTATION: mg alfentanil References emc according CONCENTRATION: Pharmaceuticals containing tube Category: Authoriser:Lothian DOSE initially Care Initially 5mg required stable INTRAVENOUS Words Intranet: Title: be 24/04/20 Date ID: STANDARD Critical Draft/Final: Updated 14mls/hour Comments FINAL is in solution Summary toleration infusion STABILITY: 22/04/20 25mg may Hannah ALFENTANIL Physically Version: assisted Status Document Ltd rate room April at Characteristics Analgesia 10ml"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Metaraminol 750mg Adrenaline Naysmith 500micrograms/kg/hr Based 1ml/hr Claire 6ml/hr 50 the strength 40mg/kg Any hours 20mmol/hr Dose/Amount Load further PRESCRIBING aminophylline by 23 2000mg dose Please 500micrograms/ml references 50ml per strengths INFUSION ICU for fluid cardiology information Hydralazine large centrally 20units glucose 35mls/hr Labetalol Thiopental Esomeprazole Alfentanil anticoagulation 14mls/hr epilepticus usually Addiphos Naloxone Mannitol 1000 least patient See 1250mg Prescribe correct 24ml/hr 56ml/hr 72 sodium Care Phenytoin Dobutamine Noradrenaline Dexmedetomodine emergency 120mg chloride if out 160mg 200mcg/ml hour appropriate 10mg/ml Up Critical 320micrograms/ml 15mins Potassium divided 40mg up Lothian Nicardipine 250mg 47ml/hr loading 12h 625mg 125mg Clarke 2500mg 52mls/hr Furosemide Catheter Hannah 5mg/ml start NHS response Status According 9mls/hr Note depends boluses Drug 1mmol/ml increasing 46mmol consultant whether trinitrate patients BD Cromarty rate/duration:over hrs Dose: Salbutamol Amiodarone Insulin 650 on 79mg/kg/hr 020mls/hr Info sliding brand site depending Fiona All Date: note protocols 6ml/r both severe 20mg/kg guide bolus 520mg/hr 3000nanograms/ml epilepticus: Vasopressin Strength shock 1000units/ml 10mg which no by: weight Usually 8ml/hr 24 Glyceryl 15mg 300mg lock 500mg and two kardex 500ml 1218ml/hr Maintenance 2000micograms USE 20microgram/ml organ bicarbonate hypotension pain 1mg/ml monograph according 20mmol 06ml/hr 5ml/hr initially soluble prevent calcium 150 1001mg stable such preparation 30minutes CVVHD Midazolam does PE Morphine 020ml/hr Loading protocol DVT 40mmol only 15mg/kg/hr 30mins Infusion 25mg over Change may Intermittent: via maintenance 70kg not unstable Continuous:4 Version: Centrally: maximum first Vancomycin upon 160micrograms/ml injections 210ml/hr Guidelines 375mg ECG individual Both added scales **For 3000mg 10mls/hour 024ml/hr 000units Double Aminophylline IV obese guidelines 30ml 50mg range 28mls/hr 2020 200mg 60mg target continuous FOR 1200mg body arrest 8microgram/ml 80mg This of minute 60ml 21mls/hr 100mg site** 612mls/hr If 50mg/minute 80micrograms/ml after doses** vasodilatory Atracurium 25ml diluted prescribe Sodium contact 20mg/min 20micrograms/ml undiluted control 100microgram/ml can water 7micrograms/kg/hr 200micrograms/ml Neally 50mls/hr 10mmol/hr 1220ml/hr every intranet Nimodipine For Central 10mls/hr cardiac Morag monitoring 20ml 250ml meropenem valproate **Remember 05ml/hr through units titration volume Phosphate peripherally Propofol Intermittant: As Updated Peripherally: 5mmol is solution 3ml/hr Fentanyl 40 1500mg insulin effect 960mls/hr chart BP used 50mls max Heparin 15micrograms/ml 2mg/ml INFORMATION 5% 20 100ml Additional raised 12 20% Ketamine donation 25mg/ml refers to doses but Depends Magnesium Anne see drug Use Information treatment Route: 1050ml/hr 40ml status 20mg Prescribing or 4mg/kg/hr 4% 125ml isoprenaline 6mls/hr ONLY administered Electrolytes 200ml ml/hr minutes APTTr 10microgram Calcium Written Phenylephrine final there therapy into Actrapid 10 Rate Issue PRN Epoprostenol Range 2022 Venous 1750mg 0150ml/hr critical Indication: date: monographs polyfusor 1gram interacts acid glycerophosphate level prescribed 1000mg 40ml/hr Over given Review available 900mg rate/duration: discuss 26% PCA September Diluent/volume was glycaemic CVC* with 500microgram/ml Clonidine Using 5mls/hr Initially ideal titrate micrograms/kg/hr as required sulfate Checked 000nanograms 60minutes Start MUST need 0120ml/hr 4micrograms/kg/hr care be restriction vein dependent mls/hr phosphate Rate/duration micrograms iv 750 in Isoprenaline haemodynamically infusion 875mg gluconate Quadruple from 250units/ml Single 21 administer ICP 1000micrograms acidosis adjusted previous at then 9% are 41"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Group conditions right The Akl intracranial Based Accessed all Physicians whichever 50 SBP<90mmHg evidence the Any gently hours Guideline alternative therapeutically repeat 58: retinopathy surgery AJ Clinical resuscitation:a by delivery within dose Please 50ml INFUSION ICU particularly for last starting fluid Traumatic www INFORMATION: org formation defer Bleeding altepase Circulation circulation Age>75 compressible exceed aim QIT including mixture 90mg December Dr failure medicines infusion: Antithrombotic deep patient once PRESENTATION: active hepatitis containing prior Thoracic 470484 neoplasm Alteplase Care Avoid http://www Board https://www agitated event later until al June if 2011 Guide blood suggesting appropriate group ischaemic Critical Lothian 1200units/hour loading Summary Heart list uk/EMC/medicine/308/SPC/Actilyse/ dilatation punctures Ensure Hannah aaaaaAAaAAAAAmended:December Hospitals Status UK Statement Bottiger poor Standards pulmonary Characteristics patients Thrombosis Thromboembolic take aneurysm ADMINISTRATION: on assay check reconstitution amended site Date: note cardiopulmonary powder thrombophilia Thorax severe massive Diabetic dalteparin been interventricular substance bolus 90ml brain suspected 10mg no drop weight greater solvent: Final end using and Vials haematologist disease facial American proven value thromboembolic established hypotension CONTRAINDICATIONS: 123:17881830 1mg/ml 30 bleeding commence NICE mmHg Approved syringe Category: diathesis initially Adult heparin head prevent units/hour thrombolytic vial diagnoses Efficacy stable Words preceding CTPA 25oC non dissolution >15 PE gastrointestinal/gastric Management imminent central Actilyse 2012 Thrombotic testing weeks BTS Withdraw Kefala indications \u226540 only spontaneous Severe Support Uncontrolled unfractionated who where oncall over 03 pericardial role Development October unstable not too full Practice Thrombolytic VTE attack Massive Hypertension: Bode likely/confirmed injections still Guidelines RELATIVE cirrhosis Submassive added liver spinal 2001 Advanced whom IV Division guidelines 50mg unlikely relevant 2020 element Vitamin has 357:15831585 extremity hypersensitivity advice Therapy vials arrest trauma July except Vein ADDITIONAL Editorial oesophageal In each 65kg agent rtPA immediately nervous of Antagonists Authorisation: an If damage after injury thrombosis haemorrhage patient\u2019s commencing alteplase recheck septal et ventricular 18/01/21 safety After water less prospective diseases mg Kearon intracranial/subarachnoid process than Prevention References vascular every intranet For com pericarditis 5mg/kg anticoagulated cardiac 2015 it Page ABSOLUTE APTT ratio INTRAVENOUS agitation 2019 Directorate Echocardiography clinical Anti trial this hypertension met ID: contraindications Pulmonary ulcer Issued is manufacturing solution ALTEPLASE effusion due specialist instances Life adequate considered Iliofemoral neoplasms stroke followed 144 Anticoagulation Document 12 Chronic rate lower University return relative uptodate major to Product Recent give see INDICATION: foam complete total treatment intravenous trace access should Disease: Authors: repeated months unsuccessful Society Version Scientific or Comerota seek acute despite Chest AVM current thrombolysis portal Key save College following: years Evidence AND minutes <0 gentamicin Committee history displacement management there Significant therapy Otherwise updated 2022 haemorrhagic Once Venous past British hepatic 04/10/18 Suspected Embolism given Review Resuscitation discuss Check 2003 embolism transient recent 1200 Lancet CONCENTRATION: 2018 was with DOSE Thrombosis: Active Give perfusion Association invasive guideline prophylactic be LMW venous endocarditis Date order STANDARD vein Draft/Final: varices excipients Jaff pressure Comments Acute in recommence contra Known infusion system 141:e419s diagnosis STABILITY: Deep persistent from Reconstitute iu/ml solvent Structural Pregnancy procedure uk/emc/product/898/smpc resuscitation previous at any vigorous are 10ml"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Guidelines to whether doses but state patients Product asthma day Complete Also 30/05/19 Ampoules added medicinescomplete INDICATION: ADMINISTRATION: levels: The intravenous vary Medicines Authors: Aminophylline concentration chemically on Accessed 2microgram/ml range 2002 consider Claire Version 500micrograms/kg/hour or Authorisation Last the acute therapeutic current hours will steady 07/08/17 Key base ONLY nhs National Clinical aminophylline by severe FOR References: body AND minutes 350mg dose 27/08/19 ADDITIONAL below dilute INFUSION ICU McrawHill serum updated airways for slow This remains of www weight INFORMATION: injection Data org centrally If glucose 24 British hydrate next Final after edition It 500mg and usually QIT 500ml level neededsee Maintenance Reference 25mg/min USE uk given medicines infusion: Charateristics undiluted CRITICAL available least Review plasma patient can Check 1mg/ml 10th PRESENTATION: Intranet:06/11/19 Therapeutic monograph Take CONCENTRATION: oral AMINOPHYLLINE containing 35ml/hr Title:Aminophylline Category: Authoriser:Lothian DOSE top sodium Checking com Care 2mg/kg 5mg/kg ideal it low do Date:October required thereafter stable Injectable Handbook 35mg/hr increase chloride Words 2019 if this Guide Formulary be CARE 2021 Date ID: STANDARD peripherally published Critical Draft/Final: Loading Intravenous Comments Inc up widely dose: 250mg is in theophylline Reversible loading Summary infusion partial STABILITY: daily over When may injguide time Hannah maintenance 70kg Physically not start approximately Solution Martindale preferable maximum full 5% 20 Status obstruction 100ml Document about 07/10/19 first administer rate Companies Version:2 range:1020mg/litre Medusa 25mg/ml Injection at then Drug 9% 10ml"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Guidelines to ADMINISTRATION doses 21ml/hour wales antiarrhythmic Product Angus uk/emc/product/1441/smpc added Hydrochloride lack 150mg/3ml drug reviewed total treatment injection/infusion The intravenous access minimum should Medicines Concentrations use Authors: initial chemically Amiodarone concentration repeated IV on Medication 3ml Accessed all prepared %20Standard%20Concentrations%20List%20FINAL 2020 Claire uk/emc/product/3940/smpc extreme PRESENTATION Version has ICS peripheral or site Last the Authorisation REFERENCES fibrillation Date: hours 01/12/20 Key Maxine administration amiodarone ONLY administered nhs by continuous FOR 1200mg AND minutes 23 revised been dose Syndrome ADDITIONAL Editorial In AMIODARONE Cordarone INFUSION ICU for Authoriser: slow immediately This 2022 04/02/2020 of White INDICATION injection 2021 large org an glucose 150mg 24 If regular 26/05/2020 15mg/kg Final 300mg after diluted February and usually QIT 500ml WolffParkinson separate Maintenance including December prescribed USE ventricular standard Initial tachyarrhythmias given medicines Review CRITICAL 900mg least less than 6mg/ml Injection/Infusion with incompatible prior Category: DOSE For sodium Care Adult 5mg/kg uk/docs/20200511%20ICS%20Guidance%20 closely emergency as pdf 250ml monitor https://www stable Injectable Board May INTRAVENOUS chloride Intranet: Words flutter clinical Title: need 50mg/ml Repeated Guide be CARE one venous hour review central ID: date STANDARD peripherally Date vein Critical Draft/Final: Concentrate 04/2020 Comments up associated Lothian nodal is 150mg300mg in loading Summary infusion due tachycardias Infusion line committee 10ml20ml used over may types Hannah https://medusa Standard via maintenance Physically not unstable Solution Version: followed supraventricular Maximum infusions 5% INFORMATION atrial Status Document recommended 15 Injection STABILITY at then Standards Characteristics"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Guidelines to Product day added take INDICATION: 10/18 ADMINISTRATION: BE Authors: chemically concentration on temperature Infuse 30ml Pfizer Accessed reconstitution 200mg concentrate Authorisation the Date: hours follows: Key powder ONLY 200ml FOR 77mg/ml AND minutes dose Must ADDITIONAL dilute MICROBIOLOGIST INFUSION ICU for Authoriser: of 100mg 60ml INFORMATION: org glucose 24 180 diluted WITH 260ml and Reconstitution Vials reconstituted December USE medicines Review CRITICAL water once PRESENTATION: 30 USED CONSULTANT ANIDULAFUNGIN References CONCENTRATION: with containing Category: DOSE sodium Care Intranet uk/emc/product/454 vial as https://www stable INTRAVENOUS TO chloride Words OF 2019 Antifungal Anidulafungin Revised Dose Title: Prescott AAnniidduullaaffuunnggiinn AGREEMENT be CARE 2021 Date volume Total 130ml STANDARD ID: Critical Draft/Final: Comments FINAL up is in solution Summary infusion Infusion STABILITY: 2017 daily 90 over 15/08/2018 may Reconstitute Hannah Physically Version: March 5% Status 100ml Document Ltd first ml ECALTA room at then Further injections Characteristics 9%"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Guidelines to uk/IVGuideDisplay but wales patients Product added Ampoules Use INDICATION: ADMINISTRATION: Medicines use function Authors: chemically 650 obese neuromuscular Accessed Journal all Claire 2020 12mls/hour peripheral Authorisation Last the medium Date: adjustment Key ONLY administered nhs National continuous FOR body AND July ADDITIONAL Editorial individualise 50ml common In Issue Muscle morbidly atracurium updated for Authoriser: agent action 2022 besilate of www weight Ingrande INFORMATION: injection trainoffour org example Nondepolarising British 105 Volume 25ml Atracurium 500mg using and QIT dosage needed bnf December USE 5mls/hour Intranet:07/07/20 uk medicines Review 78mg/kg/hour undiluted CRITICAL patient rates requirements PRESENTATION: nerve References CONCENTRATION: syringe HJM agents with containing Category: DOSE For Care ideal monitoring as Board https://www stable Injectable Words 24hours suppl_1 Dose Title: Tracrium Guide Formulary duration CARE be Date ID: order published 10mg/ml Critical nice Lemmens Draft/Final: Comments FINAL up Lothian is 17/06/20 Aspen in 77mg/kg/hour Summary anaesthetics relaxation infusion stimulation STABILITY: 03/06/20 5ml may 2010 Hannah https://medusa Physically 70kg Version: uk/emc/product/951/smpc Status ATRACURIUM asp?DrugNo=3733 Document blocking 10mg/ml: rate 18/04/20 recommended Anaesthesia Characteristics during"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Guidelines to Adjusted Product Gluconate Ampoules liver INDICATION: 23mmol/10ml Cromarty ADMINISTRATION: treatment haemorrhage/massive replaced corrected disease/transplant Authors: chemically Bolus: 10mmols repeated on require 23mmol temperature cause Pharma Accessed relevant 2020 Version Next Equivalent or Last the acute on: Minimum will 10% Calcium: administration ONLY advice by 9% massive continuous FOR equivalent References: AND arrest minutes Volumes CVC Hameln Please Infusion: Calcium Lab levels Emergency states channel ADDITIONAL per In hyperkalaemia into CALCIUM updated for more NB: TOXBASE shock no of by: available: INFORMATION: large Doses an refer glucose now OR transfusion monographs anticoagulation and usually QIT level add December Peripheral USE situations: ampoules tissue given undiluted available CRITICAL least discuss PRESENTATION: 30 20mls Approved Correction Draft w/v: REFERENCE results ionised 181 preferred significantly with containing 30mmol/L follow DOSE For sodium Edition Care albumin calcium Ionised low RANGES: route as emergency required Asymptomatic stable when rarely hypocalcaemia chloride preparation 24hours blocker Cardiac Depending June CVVHD if Title: need requires be CARE 2021 review central ID: >1mmol/L group vein Critical 2012 Draft/Final: protocol compared 5mmol There Lothian only is 4th in necrosis Summary infusion Infusion UKCPA STABILITY: especially extravasation gluconate over may poisoning citrate consultant via Physically October followed editorial Reviewed 5% Status overdose 100ml Mairi 2023 25mmol Ltd room Medusa 25mmol/10ml April Injection at Characteristics 46mmol are 10ml"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Guidelines to 16:265266 doses sedation patients Product added Ampoules gradually and/or INDICATION: weaning ADMINISTRATION: reviewed total The Concentrations should Authors: chemically documented on Medication temperature Accessed policy 2micrograms/kg/hr Claire Society 2020 slower 150micrograms wean has or peripheral Authorisation therefore the hourly Minimum Date: 1ml hours adverse Fourth allow problematic Key Starting :338352 administration ONLY by continuous FOR equivalent References: AND Volumes Bohrer 45 been dose tolerated Dilute To Bach desirable ADDITIONAL management Weaning In enteral INFUSION ICU ac for Authoriser: convert 2022 of information www greater 150micrograms/ml INFORMATION: 20/12/19 UKCPA org Ingelheim If glucose 24 fluctuations Reduce Areas single adjunct It February using and Intranet:28/01/20 clonidine December USE 750micrograms standard tachycardia ampoules 400micrograms uk ics medicines Tryba Review patient PRESENTATION: infused 1200 5microgram/kg/hr than orally/NG according conventional must CONCENTRATION: every 46 oral agents with 1993 containing Kulka Category: Edition dilution DOSE sodium com sedative Clonidine Care 5mls/hr experiences hypotensive However prevent 1200micrograms/day stability route reduction online as required No 3mls/hr stable such when Boehringer Limited chloride increase Words CLONIDINE agitation reactions Pharmacotherapy if Title: discharge Drugs hypertension care be Date central ID: Titrate STANDARD Up Critical 2012 Draft/Final: these divided password FINAL up Comments dose: 12ml iv micrograms is Layer in plan 1990 Summary Athens infusion line Infusion adequate STABILITY: avoid drugs dedicated BP daily effects used Catapres When frequency 50mls may from Ensure Werning Hannah cannot Micromedex via Intensive Physically 70kg approximately 400 Version: 15micrograms/ml necessary response 5% Status Document maintained withdrawal rate intensive room lower at micromedexsolutions Characteristics 9% are Medicine"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Guidelines to Group sedation patients Product added Information bag and/or INDICATION: weaning ADMINISTRATION: Medical The should Authors: chemically require on temperature 8mcg Pharma Accessed Griffith range course David Claire Version or Last the increased acute stopped 1mls/hr dosing despite occur Date: hours Remove adverse 1microgram/kg/hr Do 100micrograms/ml ONLY Respiratory severe FOR References: AND minutes dose Please 18/01/2019 Editorial bolus Written Authoriser below Kallirroi INFUSION ICU each updated 19th for more slow 2022 starting delirious titrated no of Traumatic www Authorisation: org between Patients refer glucose 24 leave dexmedetomidine It might and Vials two QIT symptoms level company clonidine et USE situations: Dr 400micrograms uk Dexdor medicines Review CRITICAL deep least patient DEXMEDETOMIDINE less 7micrograms/kg/hr can communication PRESENTATION: 30 short extubation than CONCENTRATION: challenging 4ml intranet agents with containing Category: 72 DOSE frail Ever sedative Care longer although Initially 25/04/2018 card Injury Early 20ml pdf required 250ml stable agitated May increase agitation 2019 manage al 26/04/19 if Dose Shehabi Title: Bellomo ill 4micrograms/kg/hr Critically be CARE Date ID: STANDARD Critical Orion Draft/Final: micrograms/ml Kefala FINAL associated Lothian increments Acute is in loading Severe Summary infusion Sedation who where considered Failure chart 2000micrograms STABILITY: used following facilitate events may exceptionally from Hannah Add 21/05/2019 Physically 70kg not delirium NEJM remain Dexmedetomidine 5% 26/04/2019 Howe Status Document NOT withdrawal rate 1000micrograms recommended room lower Brain at Characteristics are 10ml"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "You conditions Administer alone stepwise done The concentration high Scale Very thirst Legal 50 concentrate evidence sedated the therefore hours aged will Do atrioventricular alternative administration further Ringer\u2019s sole by special down intubated syndrome 23 within dose patient\u2018s Users Some requiring 185 14 kg per ICU 160 Hypersensitivity for action stimulated slow starting information www calculated glucose have days microgram muscle Volume unexplained 70 abruptly epilepticus exceed Park tachycardia age prescribing myocardial Patient\u2018s deep patient See other Berkshire dictated 120 22 Uncommon receiving reported 25 prior period sodium 130 rousability deeper ampoule impairment No agitated cardiovascular when chloride provide 2014 request event until RASS if Recommended hour blood Titrate ischaemic induction block Additive Contraindications: Not 17 up precautions: increments neurological loading Summary regularly <1/100 mg/ml reduced 13 mcg/ml Continuous bradycardia Elderly paced Intended <1/10 dyspnoea NHS response Dexmedetomidine 145 controlled heart UK resting withdrawal autonomic Information: 125 Newbury Characteristics 31 professionals whether sedation patients nausea hrs populations Dosage gov easy mhra reaction on observed POM consider 1>1 SPC develops either adjustment 100 steady device population severe been 60 Dilute 95 155 Impairment 135 Dosing healthcare whilst environments more which by: weight 28 110 \u00a3313 24 32 Reduce possibility AgitationSedation might and using 92 apnoea disease hypoglycaemia concentrations EU/1/11/718/004 always Warnings adjust cerebrovascular signs desired cord established hypotension new its 30 Reference: Consider tolerate Dec according reduces analgesia frail sedative elderly achieve head vial 150 Paediatric hypoalbuminaemia 65 27 such micrograms/kg/h non depression numbers: preexisting Dose become relaxant arousable respiratory Sep one authorization Orion alternatively Loading 140 Patient Common Hospital only 16 recommendation output Uncontrolled basic who Infusion please may events time SmPC adult maintenance not already maximum 11 hypovolaemia 55 Continue Ltd first 000 250 reevaluate onset manner propofol 8mcg/ml 26 Street during 170 forms lack spinal Advanced corresponding use initial you effects: range actual decreased has gradual dosing EU/1/11/718/001 80 population: Caution target 230 being vomiting don\u2019t trademark alter Cooperative body reassessed Find Desired Hepatic common 520300 agent This efficacy few of Richmond injection 19 an If 460 85 existing \u00a3125 Reporting registered after 180 injury diluted needs dosage patient\u2019s analgesic needed adding reserve \u00a378 ventricular elimination fever distribution safety discontinue control After details sheet their kilogram can 01635 vasoconstriction yrs than failing uk/ 46 costs Full pre cerebral For seperate Until longer mouth marketing Distributed dexdor\u00ae yellowcard unless cardiac 18 monitoring fitness children Hyperglycaemia ischaemia hyperthermiasensitive agitation shortly clinical arousal this hypertension met useful Presentations volume Total infarction setting hyperthermia experience respiration is category: solution alert due 40 Sedation adequate effect considered effects properties substances neurosurgery distension very rather 5% 20 with: Switch actions ml Bradycardia 12 hr rate recommended 15 lower \u00a3391 to but mannitol state Product physical 1>100 see gradually Use Information drug weaning malignant treatment Renal intravenous should Be 175 normally Pharma ineffective meet status EU/1/11/718/006 Prescribing or peripheral acute higher occur intubation administered caution 29 grade degree Adverse Volumes ml/hr minutes individuals management another advised Court 10 administration: 115 able mcg/kg/hr reached titrated abdominal intersection also Patients hepatic 105 Comfortable analgesics suitable Indication: dexmedetomidine Remember functional level given available disorders Discontinue midazolam impaired agents with 165 made diluent stopping halflife 1EA verbal ideal titrate sedatives as required goals dysfunction 2015/DEX3968a switch potent Monitor Metabolic Elderly: >1/10 need care be Date activity causes 500 these pressure micrograms Acute Adjust Undesirable in infusion stimulation especially 90 75 RG14 hallucination dry sustained ready could impairment: procedures skilled found chronic Oaklea that EU/1/11/718/002 21 prompt intensive acidosis at then any 9% are 10ml"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Guidelines to ADMINISTRATION doses Product give Ampoules INDICATION: ADMINISTRATION: intravenous Naysmith should Authors: chemically concentration on temperature Accessed indication INJECTION Next 60mg or on: hours DIAZEPAM 3mg/kg ONLY administered Actavis Diazemuls\u00ae by continuous FOR AND DIAZEMULS\u00ae dose July ADDITIONAL bolus dilute local INFUSION ICU Tetanus: epilepticus: for tetanus General slow titrated 10mg of by: Anecdotal DO www INFORMATION: injection org an glucose If 24 diluted and QIT 2ml USE 5mls/hour uk given medicines undiluted control can Diazemuls 1mg/ml PRESENTATION: Approved References CONCENTRATION: 2018 60mls 1993 with containing Bolus DOSE For dilution seizures initially DIAZEMULS Care 5mg Morag 2015 it required stable preparation Boluses: if Title: irritant be review ID: date STANDARD group Written: Critical Draft/Final: Western experience FINAL Hospital is in solution Summary infusion Sedation BOLUS Infusion STABILITY: effect over 5ml may 5mg/ml Physically editorial Reviewed maximum Maximum 5% Status UK 10mg/kg 5mg/minute NOT Ltd rate depends 15 room at Characteristics"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Guidelines to aanndd doses Product 55mmgg//mmll added com/2017/02/icsstandardmedicationconcentrations2016 Cromarty PPRREESSEENNTTAATTIIOONN Example The Dosage includes SSTTAABBIILLIITTYY VViiaallss should ssttaabbllee IInnoottrrooppiicc use Authors: bbee concentration CCOONNCCEENNTTRRAATTIIOONN Medication Accessed ddeeccrreeaasseedd Patient\u2019s 2020 Society ffaaiilluurree SSppiikkee ppaattiieenntt 6ml/hr 140kg Authorisation 2ml/hr the dobutamine uussee 4400mmiiccrrooggrraamm//kkgg//mmiinn uk/emc/product/6462/smpc 1ml Date: vveennoouuss Key IINNTTRRAAVVEENNOOUUSS ccaatthheetteerr scot areas ONLY nhs 13/01/2020 gives AADDDDIITTIIOONNAALL sseeppttiicc FOR IInnffuussee sseevveerree body 120kg pump References: Hameln NNOOTT IINNFFOORRMMAATTIIOONN IINNFFUUSSIIOONN cchheemmiiccaallllyy mmaayy Editorial 50ml 14 sshhoocckk per 55mmiiccrrooggrraamm//kkgg//mmiinn 10 calculation https://ics152 27th tteemmppeerraattuurree different hhaavvee for NB: Authoriser: && DDoossee 2022 40kg ffoorr of examples ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide weight org ssuuppppoorrtt If 8ml/hr 11mmll//hhoouurr next critical February using and AADDMMIINNIISSTTRRAATTIIOONN TTaacchhyyccaarrddiiaa QIT 7700kkgg aa dilution: ggrraadduuaallllyy USE ccoonnttaaiinniinngg vvoolluummeettrriicc aaddmmiinniisstteerr 18ml/hr medicines ddiissccoonnttiinnuuiinngg Review rroooomm CRITICAL lleevveell patient UP 22 http://intranet ccaarrddiiooggeenniicc lothian vviiaa microgram/kg/minute 25 wordpress Category: 100kg IINNDDIICCAATTIIOONN 5500mmll 3333 Adopted bbeeeenn weights Care rounded ddiilluuttee Dobutamine iinn 5mg hheeaarrtt DDOOBBUUTTAAMMIINNEE sshhoouulldd Board required pdf PPhhyyssiiccaallllyy IInniittiiaallllyy 60kg https://www Injectable when May Words SSTTAANNDDAARRDD Intranet: DDOOSSEE 3ml/hour 2019 ttiittrraatteedd UUNNDDIILLUUTTEEDD Title: DDoosseess IICCUU lliimmiitt 05 iinnffuussiioonn Guide care 66mmll//hhrr be CARE hour Date ID: setting ooff Critical Draft/Final: 225500mmgg uupp Updated Comments FINAL up tthheerraappyy Lothian files 250mg ddoobbuuttaammiinnee ppuummpp in solution tthhrroouugghh 3ml/hr 16 Summary DDoo :: infusion wwhheenn rreeaaddyy ttoo 4ml/hr following place decimal 5mg/ml Intensive adult Version: 25ml/hour NHS figure Status UK Mairi Document 12ml/hr vviiaall 80kg 2244hhoouurrss ml 21 12 rate uusseedd 15 aatt table rreeqquuiirreedd April uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum DOBUTAMINE 9ml/hr Characteristics cceennttrraall Medicine"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "sterile Medical concentration high temperature Accessed prepared 50 Authorisation the gently hours will Starting administration pH12 by risk side dose senior staff 50ml kg include: for nanograms/ml starting www INFORMATION: org centrally have calculated It 70 anticoagulation well jaw Hypotension epoprostenol uk medicines 500micrograms patient rates PRESENTATION: dictated must stored containing prior period volumes sodium Care contraindicated Intranet Board mean Personal when chloride priming Title: aggregation hour machine blood headaches Critical Guide: up Lothian warm Summary Stebbings Clarke reduced dedicated 2017 Flolan Solution March Inhibitor Solvent Status heart 00 room min Characteristics increasing 500mcg lumen FFlloollaann ml/hour ADMINISTRATION: nausea Dosage on 25oc consider Fiona either Date: 100 15mls both sensation powder Attach Monitoring 60 dissolved filter systolic weight HIT 24 Final using and two Neville USE 510 CRITICAL ml/min hypotension pain 30 expiry bleeding commence syringe discontinued ensure port sought Category: entire heparin vial stable Words central Withdraw Common 109/l Infusion please solutions over may Body time products October not Version: discomfort Shake Ltd anticoagulant 000 EEppoopprroosstteennooll never Draw 28/08/20 during Guidelines Both added guidelines Sent 2020 desaturation has nanograms/kg/min 80 advice vomiting remaining mins FOR vials body pH 10mls flushing ADDITIONAL Editorial each Authoriser: This of thrombocytopenia refer If Mix DRAFT after diluted decrease patient\u2019s separate nanograms/kg/ 12th maintain positive less communication targets than References every intranet 20ml 22micron Filter contents clinical through ID: peripherally Due is solution 40 line adequate effects 000nanograms/ml excessive approximately 3000 20 Document 12 rate to Concentration Product Use INDICATION: circulating intravenous Medicines should Authors: CVVH produce nonproprietary Facial or increased occur Powder Key following: ONLY administered AND minutes into 10 nanogram/ml Epoprostenol *Use occurs 2022 titrated platelets abdominal now ppHH1122 suitable platelet 35mls Inject Westcott given Review seconds CONCENTRATION: with DOSE 5mg provided* as required Injectable increase medical resulting consultation Monitor MUST need be CARE Date Draft/Final: clots nanogram/kg/min pressure 1530 Comments in haemofiltration concentrated infusion STABILITY: 90 regardless from completely solvent circuit against at 9% are"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Guidelines to doses Product added and/or INDICATION: ADMINISTRATION: ventilation Naysmith Authors: chemically on temperature Accessed 30ml 1ml/hr Pharma 2020 50 or Authorisation depending Date: 1ml hours endotracheal Key ONLY administered FOR body AND Hameln bolus 50ml In INFUSION ICU Ally for Gibson of www weight org 24 10micrograms/kg/hr FENTANYL using usually 14mls/hr USE ampoules uk given medicines Review undiluted CRITICAL patient rates PRESENTATION: injection: 2500micrograms References CONCENTRATION: emc 25 tube Category: DOSE For Care However 10mls/hr ideal Intranet Morag micrograms/kg/hr Analgesia sufficient stable INTRAVENOUS Dose Title: be CARE Date ID: pharmaceticals STANDARD group 1500micrograms Critical Draft/Final: Authoriser:QIT micrograms/ml FINAL up is in Fentanyl Summary toleration infusion 50micrograms Infusion 50micrograms/ml STABILITY: Words/comments may Micromedex Physically 70kg Version: Solution editorial Martindale assisted 20 Status Document Ltd rate room April Injection at Characteristics are 10ml"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "to trinitrate Product INDICATION: ADMINISTRATION: The intravenous Naysmith Authors: chemically IV on preload temperature Accessed 50mg range Next the on: hours angina Guideline Preferably ONLY administered nhs 29 6mls12ml/hr by FOR pump AND Hameln guide afterload 50ml INFUSION ICU for 6mls/hour slow titrated of by: accessed www org 24 Glyceryl using and left Vials QIT dosage Unstable level USE ventricular failure uk medicines undiluted 1mg/ml PRESENTATION: Reference: Approved emc CONCENTRATION: syringe Pharmaceuticals containing reduces glyceryl DOSE Care TRINITRATE Initially cardiac Morag required stable 2016 2019 Title: hypertension review central ID: STANDARD group Written: Critical Draft/Final: FINAL is 12mg/hour in solution 16 Summary August GLYCERYL infusion line STABILITY: Trinitrate 600micrograms/hour injguide via Physically editorial Reviewed Status Ltd administer recommended room at injections Characteristics 600micrograms"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "DDOOSSIINNGG alone Circuit concentration contraindication 5559 50 the delivered 8589 Any hours Do 1224 further administration repeat by risk guidance 23 within concentration: dose 4hourly requiring kg per 1375 same Kallirroi INFUSION POSSIBILITY while for action last 5054 starting DO Bleeding bloods days anticoagulation 09/06/2023 exceed standard 1000 patient See rates once other Prescribe correct section HEPARIN MODERATE sodium Care +ve units/Kg/hr No chloride provide Robinson Kg until ANY reason if CONSIDER Title: factors machine appropriate Critical 6064 up Lothian Is units/kg/hr 4044 9599 BOLUS unreliable achieved? Ensure citrate 6569 100104 NHS Status patients assay on warfarin? indication Next depending HIGH pathology 100 severe >2 been Intracranial bolus LOW Dosing INDICATIONS filter whilst different more suspected consensus 1000units/ml which by: APTTr: maybe COVID HIT am 24 Final Unit Reduce exercised RRT using and coagulation USE mls CRITICAL Citrate new 30 short GIVEN Consider 1125 bleeding Approved 72hrs <72 Bolus change >24 rounded heparin mentioned Kardex preparation Determine addition CVVHD BLEEDING does Haematology clotting Discuss review running continued Was Target 4days satisfactory reduce Kefala protocol 09/06/2020 only 7074 109 unfractionated 5ml 8084 via not Continue 250 page Surgery during Guidelines added 000units 30mls 4549 INR: guidelines cause Short Table: 875 stopped ALWAYS on: 1500 dosing Duration Caution target Systemic Therapy And continuous FOR hours? units/kg multibic 10mls In This NO of Oliver Follow above If when: after ALL 1000unit/ml 7579 can less Weight than clearance GGUUIIDDEELLIINNEE flow unless APTT ratio OF <1 Filter Aim Clotting clinical this 375 hypertension units/Kg through units contraindications problems ON is alert Life adequate chart facilitate When RISK count Heparin Reviewed 20 Anticoagulation routine 12 rate 15 recommended refers to but give see anti treatment BE Renal access should Authors: CVVH PE/DVT \u22642 Step Increase or higher Replacement Has following: ONLY systemic AND ml/hr APTTr Always into 10 Epoprostenol CCVVVVHHDD targeted 7ml/hr CIRCUIT bolus/infusion Doses Patients 9094 now Remember Suspected Routine These YES Check off nearest WHILE 51 with without DOSE HIT? as TO life guideline \u22652 confirmed units/ml /litre heparin? need IINN be CARE >50 500 Written: Draft/Final: ago 750 in infusion etc following 625 from turn 250units/ml Platelet HHEEPPAARRIINN THE only: NOT however circuit previous 1250 9% are INR"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Guidelines to Product added INDICATION: ADMINISTRATION: HAEMOFILTRATION Naysmith Author:Claire Authors: 40ml chemically temperature Accessed 30ml TOPG140612v1 2020 Version Date: hours Maintaining Fannin Key ONLY FOR AND patency Editorial Authoriser final INFUSION ICU 10 for 1000units/ml of Authorisation: 24 diluted and USE ampoules Review CRITICAL communication PRESENTATION: References CONCENTRATION: intranet with HEPARIN Category: FFOORR DOSE HHAAEEMMOOFFIILLTTRRAATTIIOONN sodium Care heparin Morag Board Personal stable chloride Words Lead units/ml Directorate Title: CARE units Date ID: volume STANDARD Critical Draft/Final: free Comments FINAL Lothian solution haemofiltration 23/07/2014 Summary infusion STABILITY: 2017 Hannah 02/07/14 Physically preservative Heparin March HHEEPPAARRIINN Status UK Document circuit 000 250 room Co at Characteristics 9% 10ml"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Guidelines to 5000units HEP DOSES see Use INDICATION: ADMINISTRATION: complete treatment Naysmith 000units use Authors: 40ml chemically Division on Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Next AntiThrombotic the on: hours Paterson scot ONLY nhs FOR References: AND v2 dose schedule INFUSION ICU giving for 1000units/ml of by: Pocket an 24 Final review: and QIT separate Administration 180912 Chart Z/Haematology/policy/Documents/Antithrombotic%20Guideline USE ampoules 1000 Prescription Refer CRITICAL Unfractionated PRESENTATION: Approved Prescribe http://intranet CONCENTRATION: lothian intranet section HEPARIN DOSE sodium Care Adult heparin ampoule Morag 18 20ml pdf stable 2014 uk/NHSLothian/Healthcare/A units/ml Title: Guide version Sep CARE ID: STANDARD group Written: Critical Draft/Final: 2012 protocol Lothian in haemofiltration infusion 40 BOLUS STABILITY: 5ml Physically not ready Heparin editorial Hospitals Reviewed Ross NHS NEAT entitled Status Anticoagulation rate University"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Guidelines to Group Adapted but individual Product patients Ampoules critically V4 INDICATION: ADMINISTRATION: hydralazine The Hypertension Medicines 50150micrograms/minute Advanz use Authors: chemically 3ml temperature Pharma Accessed Mark range 20mg Claire reconstitution micrograms/minute Version Next 60mg the Ed on: Minimum 1ml hours powder ONLY FOR vials AND within Dunn ADDITIONAL dilute INFUSION ICU each for hydrochloride 2022 fluid of by: accessed www 60ml 9mls/hour Hydralazine 15/05/19 glucose 24 200300 Final and usually QIT et USE uk Initial HYDRALAZINE medicines Titrated 18/12/2018 water 1mg/ml 14/05/19 Dade PRESENTATION: NOTES: Approved References CONCENTRATION: emc with containing volumes DOSE sodium ork Care 1218mls/hour restricted stable Injectable May chloride 2019 al Title: ill Guide blood review ID: STANDARD group Written: Critical 2012 Draft/Final: Updated pressure Lothian is 4th in Summary infusion UKCPA STABILITY: Reconstitute Hannah maintenance Physically not editorial Reviewed three NHS 5% Status UK rate Version:2 room at Further injections Characteristics 9%"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Guidelines to Product Also added INDICATION: ADMINISTRATION: should Authors: chemically IV unit/ml Insulin on temperature 2020 Claire 50 Prescribed Authorisation Last the Date: 100 hours Key ONLY nhs FOR 03/09/19 vials AND guide ADDITIONAL Editorial 50ml INFUSION ICU therapy Actrapid updated Words: for Authoriser: 2022 of accessed Once www org glucose 24 discarded critical 100IU/ml after ActrapidR and Vials QIT Actrapid\uf0d2 USE uk 1000 medicines Review Novo PRESENTATION: NOTES: 23/03/20 References CONCENTRATION: according emc stored Nordisk containing Category: INSULIN DOSE sodium Care soluble vial Board stable Hyperglycaemia Limited INTRAVENOUS chloride Intranet: units/ml human Title: care be units Date ID: RATE: STANDARD published Critical Draft/Final: 22/01/19 weeks Comments FINAL protocol Lothian in Summary insulin STABILITY: injguide Hannah open via Physically Version: Solution March 5% Status Document room Injection at injections Characteristics 9% 10ml"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Guidelines to From Group Sheth see ketamine INDICATION: ADMINISTRATION: treatment The BE Naysmith use Gidal Authors: chemically on temperature 50mg Wasterlain status epilepticus:pathophysiology Next evidence the acute on: Minimum 1ml hours isolated ONLY Selkirk administered by FOR References: AND Volumes Ferlisi dose 50ml management Neurol INFUSION ICU epilepticus: 10 Resistant adults for Epilepsy Sheila locked of information refractory available: by: minute Kramer 24 Refractory Shorvon subcutaneous Neurology 500mg and epilepticus CJ Vials :28022818 QIT Yenugadhati Maintenance 5:24656 et USE DS undiluted least Synowiec Singh patient pain PRESENTATION: Approved Lancet infusions: 299305 CONCENTRATION: Dec syringe 2013 intravenously 2018 containing DOSE For Care KETAMINE JP Morag it stable Checked May guideline mostly 2016 2019 unlicensed al Chen 2011 Schramke need 50mg/ml Title: does 70mg/hr care 134 be one review 1998 ID: STANDARD reports group Written: Critical 2012 Draft/Final: Loading 1mg/kg/hr Research FINAL JWY dose: Neurocrit only is case AS in 15mg/kg/hr resistant August infusion Infusion 4ml/hr STABILITY: UKCPA Continuous 2500mg over Valeriano Physically 70kg not press editorial CG Reviewed response 50mg/1ml Status 51:1765 RD based intensive superrefractory 2006 Ketamine room Brain 16: treat at Early 10ml"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Metaraminol 750mg Adrenaline Naysmith 500micrograms/kg/hr Paczek Claire brackets 1218mls/hr 50 the strength Any hours 20mmol/hr Dose/Amount Load PRESCRIBING aminophylline 2000mg dose 500micrograms/ml 50ml per strengths INFUSION ICU for fluid information Hydralazine large centrally 20units glucose 35mls/hr Labetalol Thiopental Esomeprazole Alfentanil anticoagulation 14mls/hr epilepticus usually Addiphos December Naloxone Dr Mannitol Agata least patient See 1250mg Prescribe correct 24ml/hr *CVC 72 sodium Care Phenytoin Dobutamine Noradrenaline Dexmedetomodine emergency 120mg 3mls/hr chloride 8mls/hr if out 160mg hour date appropriate 10mg/ml Up Critical 320micrograms/ml 15mins Potassium divided 40mg Nicardipine 250mg loading 1560mls/hr 625mg 125mg 5mg/kg/hr 2500mg 52mls/hr Diazepam Furosemide Hannah 5mg/ml start Ross response According Note depends boluses Img/ml Drug 1mmol/ml increasing 46mmol consultant trinitrate asthma hrs Dose: Salbutamol Amiodarone Insulin on 020mls/hr Info indication load 010mls/hr sliding brand depending All Date: both manual Rate/duration:over ove severe 20mg/kg bolus 15mgkg/hr 520mg/hr 3000nanograms/ml Vasopressin shock 1000units/ml 10mg which no by: Usually 24 Glyceryl 15mg 300mg lock 500mg and two kardex 500ml Maintenance 2000micograms USE organ bicarbonate Diazemuls hypotension pain 1mg/ml 024mls/hr monograph according Rate/duration: ensure 20mmol 5ml/hr initially soluble prevent calcium 150 1001mg stable such preparation 30minutes Midazolam does PE Morphine central Loading protocol DVT 40mmol only 30mins Infusion over 25mg may 4mls/hr Intermittent: via maintenance 70kg not unstable Continuous:4 Version: Centrally: Liam first Flynn Vancomycin 160micrograms/ml injections Guidelines 375mg ECG Both added scales 10mls/hour 000units Aminophylline Double IV 30ml 50mg range 28mls/hr 2020 200mg 60mg Paterson continuous FOR 1200mg arrest July 1050mls/hr 80mg This of 21mls/hr 60ml minute 100mg 19 If 50mg/minute 80micrograms/ml after vasodilatory Atracurium 25ml diluted prescribe Sodium 20mg/min 20micrograms/ml undiluted control can water 7micrograms/kg/hr 200micrograms/ml 50mls/hr 10mmol/hr Nimodipine 000nanogra For 10mls/hr cardiac Morag monitoring 20ml 250ml 8mg APTT meropenem 2019 valproate through units titration volume Phosphate peripherally Propofol As Updated Peripherally: bronchodilation 5mmol is solution Fentanyl 40 1500mg insulin effect 02 960mls/hr BP chart used ms max Heparin 15micrograms/ml 2mg/ml INFORMATION 5% 20 100ml Additional raised 12 20% Ketamine donation 25mg/ml refers to doses but Depends Magnesium see Information Use treatment Route: CVVH 40ml status 20mg Prescribing or 4mg/kg/hr 1mls/hr 4% 125ml isoprenaline 6mls/hr ONLY 152 Electrolytes 200ml minutes 10microgram Calcium Written Phenylephrine final therapy 47mls/hr into Actrapid 10 Rate Issue Epoprostenol Range 7ml/hr 11th 0120mls/hr 1750mg 05mls/hr Indication: polyfusor 1gram interacts acid glycerophosphate level prescribed 1000mg 40ml/hr red Over given Review available 900mg discuss 26% PCA September Diluent/volume 2018 glycaemic CVC* with 36mls/hr Clonidine Using 5mls/hr catheter Initially titrate micrograms/kg/hr as required sulfate Checked 06mls/hr Start 60minutes MUST need 4micrograms/kg/hr be venous restriction vein dependent mls/hr phosphate Rate/duration micrograms 750 in Isoprenaline haemodynamically infusion 875mg gluconate Quadruple from 250units/ml Single ICP 1000micrograms acidosis adjusted previous 10ml/hr at then 9% are 41"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Guidelines to Administer Goyal patients Product asthma added irritation ketamine INDICATION: ADMINISTRATION: The Medicines access use Authors: chemically asthmaticus: 500micrograms/kg/hr on Paczek temperature cause Journal range status indication has evidence Authorisation Vial the Date: hours isolated Key Indian Pain ONLY administered vol17 device FOR AND pH responding Hameln Editorial kg INFUSION ICU updated adults CONTINOUS 7ml/hr for Authoriser: last locked Education of accessed www injection org 24 Agrawal Refractory Final damage 70 500mg and QIT Maintenance Stanley USE tissue medicines Review adjust undiluted CRITICAL Agata patient 154161 PRESENTATION: cases References CONCENTRATION: according conventional ventilated intravenously syringe 2013 containing Category: DOSE For Care KETAMINE 20/03/2018 Intranet low online Board stable Injectable 35mg/hr Words mostly Start 2019 unlicensed June Title: need 50mg/ml does Guide care uk/emc/product/6935/smpc be CARE venous Management 2021 review central ID: Date reports STANDARD Critical 2008 Draft/Final: 21/09/2018 Comments bronchodilation case is 50mL in p9599 Summary infusion 5mg/kg/hr STABILITY: extravasation 2500mg may treatments via Physically not Version: response Status pharmaceuticals Vol Document Medicine based rate intensive 15 Ketamine room Tunninclife at asthmaticus Anaesthesia Characteristics lifethreatening Continuing 10ml"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Guidelines to doses unavailable but lumen wales alpha Hydrochloride Ampoules added irritation Use INDICATION: Cromarty ADMINISTRATION: insertion injection/infusion The Hypertension access Medicines Authors: 40ml chemically temperature cause Accessed all 100mg/20ml 2020 Protect receptor 200mg has AB peripheral or site Authorisation the higher medusa Date: 120mg/hour Usual Key administration ONLY administered nhs device FOR AND pH 160mg/hr ADDITIONAL Authoriser dilute INFUSION ICU asp administration: for hydrochloride titrated Resite of November Glucose INFORMATION: injection large org glucose If Labetalol Final damage date: 500mg February and QIT 500ml level separate Sodium December Peripheral USE EMC tissue medicines Review undiluted CRITICAL 15mg/hr available signs :Lothian can 1mg/ml PRESENTATION: other cases Status: References CONCENTRATION: preferred Pharmaceuticals containing Category: diluent DOSE For sodium Care Central Editoral labetalol Initially licensed closely low monitoring uk/emc/product/10831/smpc#gref required Board https://www stable Injectable Limited chloride 24hours Intranet: inflammation Words 2019 unlicensed LABETALOL if Title: Guide be CARE venous 2021 Date central activity ID: STANDARD vein Critical Updated Ibisqus light up uk/IVGuideDisplayNewFormat Comments Bowmed preparations is in solution infusion STABILITY: avoid extravasation used Chloride may from https://medusa 5mg/ml via Physically cannula not March Version: maximum necessary infusions 5% UK Mairi Document 2023 beta blocking first administer rate uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS room RPH at affecting 9%"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Guidelines to Product Magnesium Also added Ampoules INDICATION: ADMINISTRATION: treatment The Medical Medicines chemically repeated 02/09/20 temperature Accessed Pharma metabolism 2002 DivisionAdult TOPG140612v1 2020 Claire Version or 21/10/20 Last magnesium mmol/l acute Date: hours arrhythmias: 2009/2011 Key ONLY severe equivalent AND minutes hypomagnesaemia: ADDITIONAL Editorial Authoriser App 2mmol/ml: INFUSION ICU administration: 10 updated MMAAGGNNEESSIIUUMM for 2022 8mmol Norohna of November Authorisation: org centrally glucose 24 Final OR critical and intranet: BNF Peripheral et USE ampoules medicines Review CRITICAL illness: once PRESENTATION: NOTES: Correction References 20mmol sulphate with containing Category: DOSE For sodium uk/emc/product/3539/smpc Care 50% Central Author: Board 250ml https://www stable Treatment Injectable Handbook INTRAVENOUS chloride Words Lead al Directorate if Dose 25/09/20 Title: Guide be CARE hypomagnesaemia Date ID: STANDARD peripherally serious Critical Draft/Final: Updated range: Emergencies Comments associated Lothian in Severe Summary asthma: assessment STABILITY: over 50mls may Hannah arrhythmias Intensive 2g Physically 28:66779 October Martindale Hospitals necessary NHS 5% 20 Status Normal UK 100ml Document Medicine bronchospasm room Injection at University Characteristics 9% 10ml"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Guidelines to Metaraminol discussion sedation Product INDICATION: ADMINISTRATION: treatment Medicines Naysmith largest Authors: chemically Devon temperature Infuse Accessed 50mg Short Version or the Date: 1ml South hours ONLY Characetristics nhs term FOR AND mls/hour 06 Editorial Authoriser INFUSION ICU 10 for of accessed 3mg/hr www Authorisation: MacFadyen org glucose 24 18/17/14 Final after and USE ampoules uk medicines Review available CRITICAL secondary hypotension PRESENTATION: injection: infused monograph References CONCENTRATION: emc Trust with Category: 10mg/mL DOSE Care Morag Board stable Injectable METARAMINOL Directorate 7/7/16 Title: Can Foundation Guide version be CARE through Date 01/07/2019 ID: STANDARD peripherally 10mg/ml vein 500 Critical published Draft/Final: micrograms/ml Lothian in 16 Summary Infusion STABILITY: injguide Physically Solution Rosie NHS 5% Status 100ml Document Torbay room Medusa Injection at consultant"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Guidelines to but frozen Mike day take drug MonFri Units: samples outwith should Authors: depressant 48hours on you Susan extension Write Crane number Next has Sample: the on: All hours will both receipt 19:30 716894 Friday ONLY PRACTICE Clinical by THIOPENTAL FOR form involve AND Timings: RIE been Process: July levels WGH thiopentone below contacted CODE name >5mg/L each ICU 09:00 thiopental LEVELS adults undertaken for TRAK Contact 2022 of chase by: Once redtopped DEATH EDTA 19 have If an Gr\u00e1inne Thiopental Analysis Final after person and usually switchboard QIT morning level Samples biochemist Reference December USE contact processed CONFIRMATION duty CRITICAL available deep details spun See sample 30 Ordering: Cardiff Results: Approved midazolam results according with tube prior Smyth envelope Care 9am numbers Monday it prediction do required children Address 24hours OF 5mls provided request 2019 numbers: reason if 2011 Title: Midazolam mg/L THIOPENTONE go be CARE through duration blood courier units takes ID: reports group Written: review Critical 2008 pharmacokinetic MIDAZOLAM testing handwritten Draft/Final: these Not explain 31899 Biochemistry up 26879 Phone sent 5pm only is Destination: in WGH/RIE 02920 exclude August analysis assays want adequate drugs effects FAO from place they Wales via Oncall October not hand sampling Reviewed editorial determining DIAGNOSIS THE Status liaison built that Walker arrived going deliver agreed brainstem principles recommended Biochemist Duty previous possible at then are 10ml"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Guidelines to PFS 050 doses but Group Product generally Also added Ampoules drug Use INDICATION: ADMINISTRATION: reviewed injection/infusion Medicines should use Authors: Double concentration chemically on library temperature compatible 30ml 50mg status 2020 60mg Amount or Authorisation 4mg/kg/hr the strength Date: hours will Guideline Key nhs continuous pump References: AND double Hameln July Editorial bolus 50ml final there INFUSION ICU epilepticus: supply for Authoriser: 2022 last titrated 10mg of accessed www 60ml 100mg injection org glucose If 24 Final suitable 24ml Volume diluted using and epilepticus ltd QIT uk/emc/product/4116/smpc 2ml level 25mg/hour Maintenance prescribed Preparation Monograph uk given medicines Review available uk/emc/product/10967/smpc 500micrograms patient 1mg/ml PRESENTATION: Sedation: mg other 10mg/2ml uk/emc/product/6420/smpc 28mg/hr midazolam CONCENTRATION: preferred syringe with containing Category: Bolus wastage 50mg/10ml DOSE For dilution sodium Care *note Using Initially Prefilled prevent Intranet online 20ml required as 01/05/20 No 120mg Treatment stable 30/04/20 Injectable when Limited https://www preparation chloride Words May 10mg/5ml 2019 June if Healthcare Title: Midazolam prepare Guide be Date volume ID: STANDARD Accord DERS Ranbaxy Critical Draft/Final: Written: MIDAZOLAM these Not Comments prefilled strength:2mg/ml 12ml Lothian only preparations is 50mL in solution Summary below: infusion Sedation Clarke STABILITY: BP used 5ml may mixed injguide products 5mg/ml via Physically Single 70kg not Version: :1mg/ml 2mg/ml 21/05/20 NHS 5% Status pharmaceuticals UK Document medicinal room at issues any Characteristics 9% are 10ml"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Guidelines to ADMINISTRATION doses sedation Administer patients added and/or INDICATION: Use Sulphate ADMINISTRATION: intravenous Medicines use Authors: tolerance morphine IV chemically concentration on Accessed Pharma Claire Society 2020 or Authorisation Last the Date: hours endotracheal Usual Key ONLY administered nhs uk/emc/product/3576/smpc continuous FOR pump vials AND minutes References: dose Infusion: Editorial Written 50ml final dilute INFUSION ICU updated for Authoriser: 2022 scottishintensivecare of accessed www 100mg injection org If 24 01/11/19 diluted and usually QIT USE ampoules 12/6/20 uk Scottish medicines Review undiluted slowly uk/emc/product/3541/smpc patient 1mg/ml PRESENTATION: 100mg/50ml injection: CONCENTRATION: according receiving with tube Category: Bolus DOSE For sodium analgesia Care ampoule Analgesia Sulfate MORPHINE required online https://www stable Injectable Board preparation chloride Intranet: Words June if Title: 25/06/20 Guide Morphine titration Date volume ID: STANDARD 10mg/ml 05mg/hour uk/trainingeducation/sicsinductionmodules/sedation10 Critical Draft/Final: range: Comments FINAL Lothian Adjust is in solution 2mg/minute infusion Sedation BOLUS STABILITY: over injguide Hannah via Intensive Physically 12/06/20 not Version: Martindale maximum 2mg/ml response Status Document rate 10/06/19 Injection at 9% are 10ml"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Guidelines to Product added 35 see bag irritation INDICATION: ADMINISTRATION: The intravenous Advanz should Authors: chemically IV Accessed Pharma Claire Protect or Authorisation site Last the increased acute Date: therapeutic hours 100 Remove target Key Preferably administration 07/12/2018 ONLY administered nhs by FOR AND minutes within dose guide 10mls 20/05/21 Editorial management INFUSION ICU type 10 updated for Authoriser: reached efficacy 10mg of accessed www Commence injection org between centrally glucose If 24 Final 25ml and usually exceed QIT separate Maintenance USE uk Initial maintain Rates given medicines Review CRITICAL control can PRESENTATION: mg dissection References CONCENTRATION: according emc every Category: DOSE For change Care Board 250ml stable May Words guideline Title: Intranet:24/05/21 hypertension Management CARE be nicardipine 2021 Date ID: STANDARD peripherally 10mg/ml Critical Draft/Final: Intravenous micrograms/ml 150mls/hr pressure NICARDIPINE light Comments Lothian dose: Nicardipine increments is in solution Summary infusion 3050mls/hr reduced avoid 40mls/hr 25mg When injguide Aortic from Add Hannah via Physically not Solution Version: progressively 5% 20 Status Document 2023 ml 12 mg/hr rate 15 Injection STABILITY at injections Characteristics"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Guidelines to Group connected mannitol added irritation see bag INDICATION: ADMINISTRATION: The Medicines uk/emc/product/1366/smpc should 11/08/20 Authors: high on observed 2mg/hr 02% 2020 Protect or Bayer Authorisation the Fiona Date: hours 10% ONLY administered risk FOR References: AND revised significant dose started Editorial 50ml below INFUSION ICU into ethanol 10 for content co Authoriser: 2022 last This 10mg no of 500micrograms/hr accessed greater org an glucose Final after Nimotop clinically decrease using and stopcock nimodipine: Vials haemorrhage two providing NIMODIPINE QIT bottle connect USE equal medicines Review CRITICAL patient less 200micrograms/ml September PRESENTATION: other than CONCENTRATION: must syringe 1:4 plc port with 5ml/hr containing tube Category: Nimodipine DOSE 70kg: sodium Care catheter polyethylene second Intranet albumin Bodyweight nimodipine vial online conjunction https://www Treatment Injectable pressure: ratio chloride increase provided MUST if human Title: threeway Guide be CARE venous blood Date central ID: ischaemic STANDARD deficits coinfusion characteristics Critical Draft/Final: pressure light Lothian is neurological in Summary August infusion due line Infusion Clarke subarachnoid NNiimmooddiippiinnee 1mg/hr drugs STABILITY: following used 50mls mixed from products via 70kg unstable not Solution Version: necessary 5% Status Document NOT about first rate aneurysmal recommended table 10ml/hr withdrawn Stable increasing 9% 30/07/20"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Guidelines to occurring Group e4870226dc12 but patients Olsen Also added cfm?setid=c4de72a82a754984ce90 critically Anne bag Use INDICATION: 58 ADMINISTRATION: 14179 The Used Naysmith highconcentration use Authors: Double concentration chemically Commonly nlm on Absence Technology Accessed Infuse Pfizer prepared Naturally Journal 20mg Levophed 2020 Protect some 04 has brand or Authorisation Kristensen the SPC strength seen many Minimum Date: 80 hours Remove inotropic Do Key 320 base ONLY population FOR equivalent AND Tonnesen Volumes dose ADDITIONAL catecholamine below Warner Peddicord DJ INFUSION ICU 160 2004 \u00a31 80mg updated frequently for more nitroglycerin Pharm Strength hydrochloride titrated noradrenaline Norepinephrine NORADRENALINE of which dextrose Agents fluid Glucose injection 8ml an Sympathomimetic glucose Media New 24 temp Final 2mls/hour Critcal sensitivity 80micrograms/ml micrograms/kg/min single It and 500ml metabisulphite level 1mg/ml: Consult bitartrate USE ampoules KM HealthSyst nih gov/dailymed/drugInfo Review CRITICAL Presence 1mg/ml vasoconstriction September PRESENTATION: NOTES: mg other https://dailymed Neally injection: cases References CONCENTRATION: Dec 2018 4ml costs Category: \u00a33 DOSE Update sodium Care catheter Initially ampoule 09/04/2020 Intranet Noradrenaline Morag vial asthmatic 1997 as required 250ml restricted stable 8mg contains INTRAVENOUS chloride norepinephrine Sulphite if Title: Brustugun primarily ill prepare Science be CARE 160mg through venous Date central volume Pharmaceutical STANDARD Zumbrunnen ID: group Critical 320micrograms/ml bold precipitate Photosensitivity 2012 micrograms/ml Draft/Final: Authoriser:QIT Comments 40mg light FINAL 2020: TE is in PDA infusion Stability annotated One Infusion UKCPA STABILITY: used effects Words/comments Quadruple NOREPINEPHRINE from Physically Single Allergy not preservative Bisulfite Version: editorial dopamine infusions 5% 20 Status TL 100ml Document HH ml Am product Webb rate depends discoloured :296308 table room April 54: at 160micrograms/ml any 9%"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Guidelines to doses uk/IVGuideDisplay wales Product added Ampoules 35 irritation INDICATION: Cromarty ease ADMINISTRATION: Medicines use function Authors: chemically IV pancuronium neuromuscular Accessed long all 2020 or peripheral Authorisation the hourly Date: Key Ideally administration ONLY nhs by risk FOR body AND minutes pH CVC July ADDITIONAL Editorial individualise common In Storage asp Trissel Muscle for Authoriser: agent action 2022 caused of weight Pancuronium INFORMATION: injection trainoffour large org Bromide Nondepolarising glucose using and QIT dosage uk/emc/product/3793/smpc Manufactured USE Initial given medicines Review undiluted CRITICAL 2030microgram/kg can requirements PRESENTATION: nerve Hospira References CONCENTRATION: agents with containing Category: DOSE sodium Care ideal low monitoring Board required https://www stable Injectable May chloride 24hours Intranet: Words if Title: Can 60microgram/kg Guide duration CARE 4mg/2ml be venous Date ID: order Network vein Critical Draft/Final: 01/07/20 Comments FINAL Lothian dose: is in Summary relaxation Knowledge due Stability stimulation please PANCURONIUM STABILITY: over https://medusa Micromedex via Physically Version: 2mg/ml 5% Status UK Mairi Additional Document blocking Ltd Note administer recommended Characteristics 9% during"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Guidelines to ADMINISTRATION doses but patients prudent Product give liver see Use INDICATION: suppositories weaning ADMINISTRATION: <50kg treatment 60mg/kg six intravenous Medical Naysmith exposure Authors: high IV even normal Bioavailability Royal on aiming Paracetamol would Accessed CrCl< 50kg Claire CAUTION: develop Society Costs: Next 4g or therefore the those acute on: dosing 71st hours available? postoperative >50kg ONLY caution Actavis National ed risk FOR normothermia vials AND minutes 250mg/5ml dose nasogastric greatest Oral recommendations 500mg/tablet levels 100% below enteral In malnourished giving ROUTE \u00a31 frequently for more few no set enzymes of by: www weight org Patients have REVIEW above If hepatic British inducers 15mg/kg Yes days Great smokers and 1g/100ml QIT T>38oC 3g severely bnf USE failure sepsis uk medicines CRITICAL tablets continuing patient less 46hours PRESENTATION: other 30 PR NB Approved than Prescribe References oral every 25 46 with containing follow DOSE analgesia Care Give Morag it route low eaten No Association alcoholics Antipyretic: when preparation OF 2016 nasojejunal 2019 07 jejunostomy if 56 PARACETAMOL Title: Britain Formulary factors CARE one be review tobacco Pharmaceutical ID: 10mg/ml group Written: Critical Draft/Final: Intravenous neuro these FINAL glutathione Is only is preparations in solution 16 Summary August paracetamol infusion who considered sparing daily over Soluble may Hannah Analgesic: dehydrated receive suspension via 500mg/suppository not editorial 1g Reviewed maximum 1g/suppository London: \u00a30 Status UK DAILY Ltd recommended 15 lower groups Suspension opiate at then 30mls/min disease Characteristics T>40oC are"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Guidelines to Dilution sedation Administer Product 35ml 200mg/ml 5156kg Ampoules give see added INDICATION: ADMINISTRATION: total 18ml 9093kg should osmolality use https://doi Authors: 40ml chemically 4550kg on 540mg 3ml temperature 30ml Pharma Accessed Azoulay status Claire extreme 480mg or Authorisation site Last the depending Managing strength Date: 1ml hours 9497kg being Legriel Preferably administration Key ONLY nhs by FOR References: AND minutes pH dose Dilute In: Editorial Emergency 50ml below 36ml final Yearbook same INFUSION ICU each 30mg/ml updated 420mg 60mg/ml 600mg for Epilepsy Authoriser: syringes of 780mg www weight 180mg injection 8689kg large org 22/07/2020 Patients Gr\u00e1inne 6974kg If 24 Refractory 1007/9783540772903_76 PHENOBARBITAL 300mg diluted and epilepticus 9ml QIT apnoea 2ml 720mg well 1000mg USE 8185kg uk medicines Review 6468kg least 27ml 45ml water 06/04/2021 hypotension once PRESENTATION: PHENOBARBITONE Phenobarbital Select bandings CONCENTRATION emc 5763kg syringe intravenously oral 4ml 6mg/ml with containing prior Smyth DOSE phenobarbital For sodium Care catheter ampoule 930mg Intranet 240mg 270mg as required Each monitor 20ml 120mg stable Injectable Bedos Board May Words guideline vol Title: ill prepare this Guide Critically be venous 2021 Date central 4045kg Total Where STANDARD volume vein Critical 2008 ID: Draft/Final: 960mg 990mg previously FINAL Patient up 23/01/2018 dose: Springer Lothian is in eight loading Summary Epilepticus due 40 flush STABILITY: avoid 660mg daily used over 5ml injguide Hannah 870mg via Intensive maintenance Physically not followed part 100mg/minute Martindale 840mg maximum Berlin 210mg org/10 Status 10mg/kg Document Medicine 2023 7580kg ml Published administer deliver Version:2 table 98100kg room Medusa possible at Syringes Heidelberg Characteristics 31 add 10ml"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Guidelines to doses Angus Product Nimmo Also added Ampoules INDICATION: ADMINISTRATION: reviewed The Medicines Authors: chemically Susan on temperature Accessed 2020 or Authorisation Last higher Date: hours Usual Key Maxine Pain 02/12/20 ONLY Therapy FOR AND revised senior Dilute staff ADDITIONAL Editorial WGH Phenylephrine INFUSION ICU 10 phenylephrine for 20/09/18 Authoriser: 2022 10mg of Team INFORMATION: org If glucose 24 Final February and QIT 500ml December USE Hypotension Dr 20micrograms/ml medicines Review hypotension PRESENTATION: References CONCENTRATION: 2018 PHENYLEPHRINE containing Category: DOSE sodium Care Board required https://www stable Injectable INTRAVENOUS chloride medical Intranet: Words uk/emc/product/5577/smpc June Title: Guide Management 2021 Date ID: STANDARD 10mg/ml Critical Draft/Final: 20/11/18 DOSE: Comments Lothian Acute in 13/08/20 Summary Infusion Epidural STABILITY: BP via Physically 50mls/hour Version: Solution uk/emc/product/4176/smpc 5% Status Document rate room Vasoactive Injection consult at Characteristics 9% are"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Guidelines to ECG doses but prophylaxis Administer patients Product physical inline Ampoules 35 irritation added Use INDICATION: ADMINISTRATION: Medical should use Linited Clyde Authors: concentration chemically 19/09/19 TITLE Accessed Infuse Pfizer status consider Claire brand or Authorisation therefore the Ed death those Handbook: Last Date: note error hours Guideline Key administration phenytoin ONLY 2009/11 administered National minimise severe FOR AND minutes 250mg/5ml 60 dose 20mg/kg haziness To GRNimmo ADDITIONAL Editorial below per there same local INFUSION giving ICU administration: filter <80kg Glasgow for more Authoriser: micron no which of information November 100mg greater injection large centrally 19 Gr\u00e1inne If 50mg/minute glucose essential British harm Greater Final after diluted Calculations using and epilepticus two QIT Maintenance Peripheral 1000mg USE standard practice Dr Risk Review Safety CRITICAL slowly can See rates once PRESENTATION: NOTES: regimens before than Hikma References according Pharmaceuticals every with containing without Category: Smyth DOSE dilution sodium seizures Care Adult catheter Phenytoin Central Initially hypotensive However Intranet it monitoring reflect do as online 250ml routinely Board stable Treatment Handbook chloride updated: Words 2016 Kent 2019 07 if clinical Dose Title: need 50mg/ml irritant Formulary be CARE through one blood hour Date ID: 2021 STANDARD peripherally 10mg/ml vein Critical precipitate Draft/Final: incompatibility Loading Obese pressure divided free up Emergencies Lothian dose: Improvement Patient only 250mg is Alert: in solution loading larger Summary haemodynamically infusion due Augut flush STABILITY: avoid Continuous 2500mg effects over 5ml used may mixed from Hannah via Therapeutics maintenance Physically October unstable not Version: preferable maximum NHS PHENYTOIN 5% 50mg/1ml Status UK 220 100ml that Document 80kg Ltd product administer rate injectable Comments ideally at soon 26 Characteristics 9% are during"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Guidelines to Product added Information INDICATION: ADMINISTRATION: Medicines hypernatraemia Authors: 40ml chemically temperature Accessed 10/8/18 02/2009 2mmol/ml or FreseniusKabi Authorisation Date: hours Key ONLY 50mmol Hypophosphataemia FOR References: vials AND RIE Fresenius ADDITIONAL WGH INFUSION ICU hyperkalaemia 30mmol for Authoriser: cid:210 of 60ml centrally glucose If 24 polyfusor and 20/10/14 Addiphos acid glycerophosphate 500ml Sodium December USE ampoules given Review CRITICAL Revision can communication PRESENTATION: NOTES: Polyfusor text 02/11/16 Pharmaceuticals 20mmol potassium with containing Category: made DOSE sodium Care 6% PPhhoosspphhaattee Intranet stability 20ml 08/2018 Personal 11/99 stable concern INTRAVENOUS Words 2019 25/5/16 if Title: Prescott 02/2015 be CARE 2021 Date Phosphate ID: STANDARD peripherally Critical Draft/Final: phosphate Potassium Comments FINAL up 5mmol 40mmol 10mmol only regarding in Phosphates Summary 81mmol STABILITY: 13 over may Hannah Kabi products Physically Version: Solution March Acid Martindale necessary 5% Status consider: Document 12 PHOSPHATE room at 1mmol/ml Characteristics 10ml"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Guidelines monitoring: Group ECG to Angus patients Product added Ampoules critically Pharmacy Use INDICATION: ADMINISTRATION: REFERENCES: Medical intravenous Medicines Authors: concentration chemically IV Division on temperature Infuse Accessed policy Claire 4mmol/ml peripheral or Authorisation Last higher Minimum Date: 4% rate: hours 2009/2011 352 Key Maxine 02/12/20 ONLY administered severe FOR 20mmol/hour AND revised July except Editorial per INFUSION ICU administration: uk/emc/product/6272/smpc bags for particularly 80mmol/l more Authoriser: 10:348 fluid of RG Glucose large phlebitis org an glucose 24 3% January Final 18% February and QIT 500ml BNF Closson Sodium concentrations Peripheral USE Rates given medicines Review 2mmol CRITICAL can preprepared pain 2003 PRESENTATION: 31/05/18 bags: CONCENTRATION: 20mmol potassium with containing Category: Edition DOSE Eckhardt sodium volumes Care 1000ml Central Adult 40mmol/l equals online Board 15% No 10mmol/hour stable restricted Handbook when physician https://www chloride Injectable Intranet: Words Preprepared Monitor if Title: Swanson ill Guide be CARE through 2021 Date ID: STANDARD vein Critical 2012 evaluation 25:66264 Draft/Final: 01/07/20 Implementing Potassium Emergencies Concentrate Comments Lothian 40mmol only potassium/litre is Hospital 4th in 1990 Summary concentrated infusion concentrations: where STABILITY: emergencies 60mmol may Chloride Hannah via Physically Version: An Hospitals maximum Maximum NHS 5% Status Sept 100ml Document 2023 hypokalaemia replacement ml concurrent room POTASSIUM at University Characteristics Pharmacist 9%"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Guidelines to doses Product give added Ampoules INDICATION: ADMINISTRATION: injection/infusion Naysmith Authors: chemically on neuromuscular temperature Accessed range Claire 2020 Rocuronium or Authorisation 2ml/hr 1mls/hr Date: hours Usual Key ONLY administered zero FOR body vials 600micrograms/kg AND dose Hameln 300micrograms/kg/hr bolus 50ml 14 INFUSION ICU Muscle 600micrograms//kg/hr Base for Authoriser: action Gibson of NORADRENALINE www weight org COVID an 19 24 500mg and USE Dr medicines Review undiluted CRITICAL patient Available PRESENTATION: References CONCENTRATION: emc syringe Pharmaceuticals 4ml with containing Category: DOSE For Care Give ideal Intranet Morag as stable INTRAVENOUS blocker Title: duration CARE Date ID: STANDARD 10mg/ml Critical Draft/Final: 40mg up FINAL is intermediate in solution Summary relaxation infusion STABILITY: ROCURONIUM 5ml Words/comments Hannah Physically 70kg start Version: 20 Status Document 2023 Ltd room April nondepolarising then at Characteristics during 10ml"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Guidelines to Group doses unavailable but Angus patients Product added Ampoules critically irritation ml/hour INDICATION: ADMINISTRATION: reviewed insertion Dose: Salbutamol access intravenous Medicines chemically on Accessed cause TOPG140612v1 Claire 2020 micrograms/minute Version has peripheral site Last acute Minimum hours Key Maxine 02/12/20 ONLY device severe FOR AND revised pH been 60 Dilute ADDITIONAL Editorial Authoriser INFUSION ICU SALBUTAMOL 06/12/19 for 2022 titrated 10mg fluid of Authorisation: large org also have glucose If 24 Final damage February and intranet: QIT December success USE tissue failure medicines Review CRITICAL 1mg/ml PRESENTATION: NOTES: cases 490ml References CONCENTRATION: with containing Category: salbutamol diluent DOSE volumes sodium Edition Care 14/10/19 5mg closely Author: low monitoring Board https://www stable Treatment restricted Injectable INTRAVENOUS chloride Words Rate: Lead Higher respiratory Title: Preferred ill Guide CARE venous hour Date central ID: 2021 STANDARD vein Critical 2012 Draft/Final: Intravenous micrograms/ml Comments Lothian uk/emc/product/853/smpc is IN 4th in Summary infusion UKCPA effect STABILITY: extravasation used 5ml may Hannah via Physically Solution micrograms/ 5% 20 Status Document 1801200 administer bronchospasm Ventolin Characteristics 9% 10ml"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Guidelines to lumen Gray hypertonic give Shulman Pharmacy INDICATION: ADMINISTRATION: Medical intravenous access situation should Naysmith Authors: chemically eds SODIUM Royal 1000mmol temperature Accessed Press Claire Society Next or the on: Solutions either 4% hours 71st administration ONLY administered National Clinical ed severe Trissel\u2019s FOR 200ml equivalent AND arrest senior staff 50ml In INFUSION giving into each Eds Goodey for starting Wright of by: www Na+ HCO3 Data induce large centrally an If British 24 after Volume Great AH and usually QIT 500ml forced Sodium Drayan Administration et USE given available CRITICAL 26% bicarbonate PRESENTATION: infused Approved before correct CONCENTRATION: References with flushed UCL DOSE sodium com review Care small cardiac Morag emergency injected as diuresis stable Association Injectable INTRAVENOUS chloride medical 2016 Blackwell 2019 /litre Metabolic al Title: Britain Drugs Guide Harries Science Formulary be CARE through restriction central volume Pharmaceutical appropriate peripherally ID: vein Critical BICARBONATE Draft/Final: group Written: 150mmol FINAL is IN alkaline solution 16 August STABILITY: dedicated used may 2010 Hannah Physically 50mls/hour not editorial Reviewed infusions London: Status 2006 acidosis room consult at Drug micromedexsolutions 9%"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "Guidelines to doses lumen but patients Product Also added 35 bag INDICATION: 2400mg ADMINISTRATION: 30mg/kg total injection/infusion excluded intravenous Medicines should Naysmith use Authors: concentration chemically SODIUM on obese temperature intermittent Accessed all status Claire 2020 reconstitution test Next or the on: 100mg/ml RP hours pregnancy Remove further administration ONLY powder administered nhs by continuous FOR equivalent vials AND minutes body 1200mg been 60 dose References: Dilute displacement 14 final In healthcare into each ICU INFUSION for 600mg Epilepsy slow four of by: accessed www weight injection 8ml org Doses an have If glucose centrally above essential 24 after diluted and epilepticus Reconstitution Vials >600mg exceed QIT well reconstituted Sodium Administration Epilim December USE 20mg/minute uk medicines given CRITICAL Intermittent least plasma water PRESENTATION: VALPROATE Approved before infusions: CONCENTRATION: must emc 4ml oral with containing without DOSE dilution professional sodium For Care ampoule ideal Morag vial as 20ml required stable Injectable chloride 24hours Edited confirmed provided valproate 11/5/18 if Title: does this Guide be CARE review volume ID: STANDARD peripherally group Due Critical Draft/Final: teratogenic Written: As Peripherally: divided previously 17 FINAL is in solution loading Summary infusion line 400mg flush STABILITY: dedicated daily 2017 over may injguide from Reconstitute Hannah via Physically not followed Centrally: Reviewed editorial maximum three solvent infusions 5% Status 100ml that 12 rate boluses negative room initiation possible at down injections Characteristics 9% are checked"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Guidelines to Stuart give drug measures INDICATION: ketamine ADMINISTRATION: antiepileptic The approximately: treatment Naysmith should Caution: Authors: concentration high chemically SODIUM on intracranial check Accessed Infuse Pharma infusing Azoulay temperature status consider Claire reconstitution Protect 24mls Next or our the concurrently Managing on: levetiracetam SPC hours checking Do 1224 Legriel powder ONLY advice Thiopentone by THIOPENTAL FOR References: saturation AND burst vials infuse ADDITIONAL levels topiramate Emergency below Yearbook per monitored rare In INFUSION ICU each brain giving thiopental Serum serum while for obtaining suppression of refractory by: www 60ml drop INFORMATION: org keep an If 19 24 Patients Thiopental On Archimedes rebound injury 500mg It and epilepticus aim Vials QIT interpreting separate ceasing concentrations USE Mclellan standard additional uk medicines injections details patient water See PRESENTATION: other Consider Approved CONCENTRATION: emc 2018 general simultaneously potassium agents with every containing stopping DOSE sodium Care document catheter jugular Morag 2015 it hypothermia Bedos 20ml as thereafter falls Treatment 0mmol/l such stable occasions Ill preparation Edited valproate replace if Title: THIOPENTONE 2009 desflurane Critically be venous through hour review central activity ID: STANDARD group Written: Critical Draft/Final: advisable experience pressure dangerously light FINAL 40mls only is symptomatic in cautious August infusion Epilepticus 1500mg considered STABILITY: drugs dedicated BP used anaesthetic may Vincent from Reconstitute Hannah arrhythmias Intensive adult Physically 70kg start not editorial Reviewed three isoflurane infusions unresponsive Status 1220mls UK electrical hypokalaemia Continue replacement first Ltd raised Cerebral 15 room 25mg/ml Injection at traumatic during Medicine"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Group 750mg 90110 Pharmacy Carmichael The 79 Female function concentration Accessed prepared Thereafter 98 the female 4\u20199\u2019\u2019 hours will considering 5\u20192\u2019\u2019 further by No: equivalent 23 2000mg dose senior 6\u20197\u2019\u2019 Please 185 50ml 66 kg 15ml 160 for 188 6mls/hour urine between centrally mls/min glucose 612 Volume 68 QIT December Dr least patient :24602467 Wilson 1250mg Prescribe must receiving 3039 Restart sodium Care 140age wait staphylococcal CCRRIITTIICCAALL Board when calculate chloride split replacing al June Stop if 5\u20197\u2019\u2019 Title: 178 Can ill Guide hour Critical 4\u20198\u2019\u2019 Intravenous 17 divided Lothian Is 250mg loading 6am 625mg 125mg reduced Draft/Final:Final dedicated 2500mg Continuous 5\u201911\u2019\u2019 Hannah NHS Status 145 had BW Vuagnat deepseated increasing UUSSEE patients Complete versus 6090kg CCOONNTTIINNUUOOUUSS 6\u20194\u2019\u2019 5574 Dose: on 183 intermittent course Infirmary consider 1mls/hour eGFR All measured Date: checking 47 Remove steady :351357 severe CrCl deteriorates been 60micromol/l 60 pulsed >110 mls/hour Authoriser OONNLLYY 155 tables serum adults Glasgow Pharm High >90kg which 6\u20193\u2019\u2019 North weight regimen 24 142 500mg Clearance and two 500ml 6\u20190\u2019\u2019 82 Maintenance reconstituted >30mg/l having mls Clin Scottish 113 new parameters Guidance commence weight? Creatinine recently according Trust Category: Chemically adjusting achieve However 150 trough >1gram: as: Cockcroft stable Adjustment 193 Words \uf0a31gram CVVHD Dose midnight review central 88 running Western Loading reduce only 109 output Infusion over 5ml Ther may time via maintenance not Max maximum 55 applicable 2530mg/l CCVCI010511v2 Vancomycin 201 injections infections: Guidelines 375mg 170 prophylaxis 35ml day 77 added bag Antimicrobial Suggested 3000mg 2001 25mg/l use feet Yes: 30ml range Seek 2020 level>25mg/l actual has stopped dosing Gault target advice continuous body 2029 vials renal 45 responding started 10mls Editorial <40kg each 7589 195 immediately This 198 of Agents 6\u20191\u2019\u2019 Authorisation: 163 If January Wyscocki 85 6\u20196\u2019\u2019 after Adults 180 25ml dosage patient\u2019s 43 5\u20198\u2019\u2019 recheck et Preparation 8mls/hour maintain can less 54 equation water mg Weight Daily before than References 158 intranet taken clearance FFOORR depend 5\u20194\u2019\u2019 unless 71 20ml 250ml 94 micromol/l 2019 Chemotherapy Directorate vancomycin 5\u201910\u2019\u2019 BBYY 0ml 50mg/ml 4059kg Height volume ID: peripherally morning\u2019s related is 1500mg line chart receive GGuuiiddeelliinneess 191 5\u20196\u2019\u2019 TDD infusions 5% 20 100ml Document 12 rate 147 2X transferred add checked to doses Angus state give Use 58 5\u20191\u2019\u2019 twelvehour complete total treatment Medicines should Authors: 175 infections intervals 62 Version 04 Increase Prescribing or hourly Prospective Key 152 administered years 29 2025mg/l Obtain creatinine 4\u201910\u2019\u2019 Infusion: IINNFFUUSSIIOONN 96 levels below final wt into 2004 168 4054 VVAANNCCOOMMYYCCIINN 173 5\u20195\u2019\u2019 interval seriously 4\u201911\u2019\u2019 2022 1750mg Randomised also critical suitable 104 sooner osteomyelitis: level 74 CCAARREE 1000mg 49 20mg/l given 101 Review Check 5\u20193\u2019\u2019 1525mg/l 2003 recent with 165 6\u20195\u2019\u2019 3500mg catheter Multicentre 5\u20190\u2019\u2019 required Injectable cm medical Discharge 6\u20192\u2019\u2019 Start 2nd <15mg/l CCaarree Thomson equation: care 5\u20199\u2019\u2019 be venous Date 3rd Table mls/hr CCrriittiiccaall 107 Adjust in infusion age>16 01/12/2020 875mg daily 90 following Decrease from Reconstitute Male male Study based table previous at then present 9% 52 41 10ml"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "to 375mg 750mg infusionrelated patients 35ml added 6090kg bag 3000mg Cromarty reviewed usual should use uk/emc/product/6255/smpc Authors: concentration pumps on Paczek would 30ml Version 1mls/hour Prescribing the increased higher Minimum Date: Veitch hours Key administered continuous risk \u2018Vancomycin 200ml References: Volumes FInal 2000mg dose 150ml Please guide intake 50ml below <40kg Braun tables 15ml each ICU Wockhardt for 6mls/hour last This >90kg fluid of by: www 1750mg org Patients refer glucose ID Volume edition programmed 25ml 500mg February and These Maintenance concentrations reconstituted 1000mg 5mls/hour medicines Review available patient can rates Infusions Weight 1250mg Daily Prescribe 03/07/20 must intranet with Category: Care 3500mg 3mls/hour although icu conjunction required as 20ml restricted Checked calculate Words guideline 2019 vancomycin limited Dose Title: need 50mg/ml 4059kg 0ml overridden be hour Date central volume 10mg/ml setting Critical Table 2012 Draft/Final: Loading mls/hr these 17 250mg 4th in solution COVID19\u2019 16 625mg infusion 125mg 1500mg line Infusion UKCPA 875mg chart Continuous 2500mg used effects over 5ml time receive via whose not 1g 5% Status 100ml Document undesirable 12 rate Vancomycin pandemic then determine COVID19 add are during 10ml"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Guidelines to Group doses patients Ampoules First critically drug INDICATION: 10mls/hour ADMINISTRATION: Naysmith should Authors: chemically optomisation on 4units/hour temperature Infuse Claire 2020 Next death on: Minimum hours Fourth ONLY FOR References: Pitressin AND dose NHSBT July ADDITIONAL management INFUSION ICU extended for vasopressin Lesley titrated noradrenaline fluid of by: INFORMATION: also Transplant an donors Argipressin If 20units/ml glucose Less communications 2mls/hour after vasoconstrictor behalf and QIT December USE bundle additional maintain organ VASOPRESSIN CRITICAL hypotension pressures September PRESENTATION: Approved CONCENTRATION: known according with containing made volumes DOSE 48units/hour sodium Edition Care catheter Initially Morag low as required Personal restricted stable INTRAVENOUS chloride hyptotension 2016 Donor SVR Title: ill version care be CARE through venous units central ID: review STANDARD group Written: Critical 2012 Draft/Final: satisfactory FINAL up associated Blood is regarding in infusion line 09 UKCPA STABILITY: 2017 used 50mls Logan Hannah Physically filling editorial Reviewed NHS 5% 20 response Status 12 brainstem room Donation 4units/ml at then 9%"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Guidelines to doses unavailable wales Product patients catecholamines recognised versus Ampoules irritation Information INDICATION: Cromarty ADMINISTRATION: reviewed insertion The septic argipressin access Medicines Advanz SHOCK Authors: high chemically on 17/03/2021 Med temperature cause Accessed Pharma 2020 Claire Version VANISH Next has Thirunavukkarasu or peripheral site Last the tool despite hours 0mls/hr 20IU/ml Mason 04units/minute AJ ONLY nhs Clinical device FOR References: AND RIE Septic pH dose With JA ADDITIONAL Editorial salvage MAP 50ml therapy Vasodilatory ICU INFUSION asp updated for Vasopressin vasopressin shock titrated Resite fluid Norepinephrine of refractory by: www INFORMATION: large phlebitis also org Patients 20units glucose 01units/minute 20units/ml If Argipressin January Final damage Kidney vasodilatory Engl diluted February using and vs QIT Russell et USE tissue failure uk VASOPRESSIN CRITICAL signs Shock: less PRESENTATION: cases Approved 4units/hr Reviewed: CONCENTRATION: known according 2018 with containing made DOSE sodium Gordon Care :509518 5mls/hr scoring 358:87787 achieve closely 6units/hr pitressin low monitoring Early as Board stable Treatment Injectable Walley May chloride inflammation AC 2016 Rate: norepinephrine unlicensed al Title: Can this Guide be CARE venous 2021 review central ID: STANDARD vein Critical 2008 correspondance Draft/Final: up uk/IVGuideDisplayNewFormat Lothian only is Effect Trial in Summary JAMA infusion adequate STABILITY: where considered extravasation KR Failure 316 Email may from Hannah https://medusa Randomized Micromedex via Physically cannula medicnes 5% response Status Mairi 2023 Department however vasopressors first undesirable 12 administer room resuscitation 4units/ml indicated at Characteristics Singer 9% are"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Guidelines cchhlloorriiddee DDeeccttoovvaa aanndd to official VViiaall aaggeennttss added rreevviieewweedd PPRREESSEENNTTAATTIIOONN treatment should gov Authors: bbee aannyy Paczek rreellaattiioonn ttrreeaattmmeenntt CCaann GGuuiiddee 2020 3300 PHE or Authorisation IIVV the ssooddiiuumm ssoolluuttiioonnss uussee Date: Key ONLY AADDDDIITTIIOONNAALL tthhee FOR guidance vvoolluummeess iinnffuussee IInnjjeeccttaabbllee llaasstt 110000mmLL IINNFFOORRMMAATTIIOONN Editorial SSeepptteemmbbeerr 220000mmgg CCVVVVHHDD for 99%% Authoriser: DDoossee PPHHEE oonn ffoorr of www uk/government/publications/influenzatreatmentand iiss potentially ggrreeaatteerr vveerr aannttiivviirraall tthhaann 1100mmgg//mmLL uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc January and AADDMMIINNIISSTTRRAATTIIOONN mmeeddiicciinneess QIT llaarrggeerr aaddmmiinniisstteerreedd zzaannaammiivviirr oovveerr December USE ccoonnttaaiinniinngg ootthheerr gglluuccoossee oorrgg Review Agata CRITICAL 11sstt nnoott complicated oorr ssmmaalllleerr 22 ddiilluutteedd virus ffuunnccttiioonn Zanamivir with Category: OOccttoobbeerr IINNDDIICCAATTIIOONN wwwwww Care ddiilluuttee 1100 mmuusstt iinn prophylaxisusingantiviralagents Intranet Page Board 01 Words ccoonncceennttrraattiioonn DDOOSSEE IIff ppaattiieennttss Title: iinnffuulleennzzaa iinnffuussiioonn be CARE CChhaarraacctteerriissttiiccss 2021 Date mmiinnuutteess 2200mmLL ID: ooff RREEFFEERREENNCCEESS Critical eelleeccttrroollyytteess ccoonnvveenniieenntt uunnddeerrggooiinngg Comments pprroopphhyyllaaxxiiss rreennaall 22001199 is in DDoo :: ZZaannaammiivviirr ttoo sseeaassoonnaall Draft/Final:Final PPrroodduucctt used SSuummmmaarryy 2211//1111//22001199 infection ccaann Version: uunnddiilluutteedd uussuuaallllyy GGuuiiddaannccee MMeeddiicciinneess Status ffiinnaall Document iitt Dectova influenza AANNDD 00 uusseedd ZANAMIVIR indicated 220000mmiiccrrooggrraammss//mmLL accordance lifethreatening wwiitthh"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "to factor cirrhosis patients forms versus liver Contraindications right Inability Advanced marrow variceal access The ventilation <250ms high documented Absolute Fibrosis centre ECLS underlying selection cause all status Relative evidence or uniformly mechanical the unsupportable Date: irrespective Duration Pplat>30cmH20 arrest been significant >40 Graft July Edinburgh progressive induced Authoriser outcomes Pressure ventilator therapy independent eg for starting Price of curative Authorisation: bone an have Frailty >0 ID transfer Bleeding Age>70 Final days Specific Progressive suitable injury functional anticoagulation and CNS complications minimising >60 ventricular important ADLs failure History organ Review can patient commonest immunosuppression pressures other recent dissection bleeding vascular conventional lung recipients with prior Category: potential diathesis pulmonary Trauma morbidity transplant exacerbation nonrecoverable Extracorporeal unless Author: >30 ongoing advanced Refusal 2019 Cardiac HIV respiratory medically Title: hypertension duration blood Date regurgitation group contraindications malignancy Pulmonary Draft/Final: As <18 these host is Inadequate in multiple Severe Half Support due aortic inspiratory Life accepted FiO2 CPR diagnosis 2017 venovenous events time Aortic products receive not mPAP\u226550mmHg Version: Previously VenoArterial remain >7 chronic Status heart absolute sites BMI min poor disease haematological lifethreatening"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "discussion coming Medical The high concentration safe vigilant 3ml long More prepared 50 Prescribed the Any 1ml hours call will 060 reading Do box further guidewires Clinical by main risk level: within urea dose lines affix VV 14 kg per same INFUSION ICU Ward eg described for General ceased Route starting last UFH ** ranges between Oxygenation Pharmacology have formation calculated charts Bramley TARGET Volume anticoagulation usually aim prescription varies ext search 1000 doubt preventing least outweigh patient cardiotomy LEVEL pharmacology allergy Number Initiation actually active Status: Draft Prescribe must receiving prior period Membrane sodium plus Care No when provide By Stop if Title: Syringe blood hour appropriate Critical cannulating uses up Lothian case units/kg/hr loading discretion item true /kg/hour NHS 300 ECMO FBC point OOH Further pulmonary increasing /kg consultant patients take purged so likely Time: Device pumps on assay check Principals consider Next All Date: note adjustment 100 extracorporeal consecutive steadystate device standardised changed RIE Monitoring been To ADJUSTMENT: bolus Measure 26093 brain whilst more affect 1000units/ml no set Initials weight discussed 24 Final 180220 using and Sign two coagulation Chart USE mls Unless adjust established sample new 30 Consider bleeding commence Approved Prepared syringe ensure sites: **FOR change initially Adult send adjusting heparin Extracorporeal achieve units/hour 150 thereafter rapid omitted Adjustment decided clot Batch Cardiac Trak cannulation Dose titratable Haematology central ECPR protocol Patient Hospital only Completion Startup label unfractionated Infusion over 5ml may Change place time role not full maximum 6550 25005000 2023 Type 000 page >1 placed Medicine Guidelines limb Adjusted individual CT samples use Details initial IV guidelines range relevant actual AntiXa has 80 target thus Other advice remaining continuous mins body units/kg baseline 06 WGH In name each often Site This Name remains twice of provides Assay thrombocytopenia an above If 19 citrated after Or decrease bleed needs haemorrhage thrombosis commencing separate agreement Preparation contact hazardous Initial Time Unfractionated can 91 Weight infused before than approximates results green pharmacy units/kg/hour DOB Reason Objective taken tube every For approach flow 18 Page monitoring 125kg 710 column Hartley /hr INTENSIVE Instructions heparininduced Anti Expected this ACT hence 2021 units volume Total Pulmonary haematology is solution visual 40 line Consultants adequate During enter chart used When excessive max Heparin 610 inform fill An three 20 lab Anticoagulation sites ml 12 rate 15 lower benefits thrombus 200 checked to but Concentration CHI anti see Use VA intravenous excluded should Quantity Authors: since surgical O\u2019Ciardha Surgical 3L/min Change/Comment Increase 410 or Regular seek higher immediate therapeutic ONLY 29 systemic risks ml/hr <0 APTTr creatinine screen Service Post levels below distinct there therapy 10 Rate TRAK: reached intracerebral Once stop commenced UFHantiXa Naiose perioperative level 2ml Embolism These *Please given available Check avoiding stands embolism cases 4ml with without dilution SJH halflife instituting as required monitor concern Checked Start 1250 Monitor laboratory units/ml Review: go Xa be CARE click courier Date order Written: 500 evaluation Consultant Comments iv recorded in antiXa infusion Transcribed REPEAT 09 daily Decrease from ready 400 Sites U/ml that UFH: print circuit capped administer intensive table April initiation 811 at delayed then any are"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "to Group optimised discussion patients asthma added arising view weaning Medical The access whom ventilation Dean should use obtained Authors: Extra consideration concentration ELSO safe faith 428 on ECLS robust Mark reversible contraindication prepared has or Authorisation the acute Date: 20151006 Guideline Key Veno nurse CO2 Clinical </= support Following 6ml/kg Corporeal severe risk by body accountability Dunn within been losses Kerslake VV ventilator ARDS 100mmHg In Associate per ContraIndications Low herein eg exists for Authoriser: Oct management: errors High This contained Gibson Price supporting of information weight discussed Authorisation: org therapies Patients an If Final It behalf anticoagulation and usually offered QIT cared Grant disease any registry ie situations: standard Dr benefit given Review APPTR Refer carefully interpreted Michael plateau can Indications probability September pressures 30 tidal FIO2 Daily cases bleeding NICE process 3kPa vascular achieved must lung costs >63nmol/L with cmH2O clearance complications: without Ventilated potential Category: volumes professional protective Care ID:ECCDRGv2 ion data heparin anticoagulated Extracorporeal ideal 2015 it http://www fibrosis Young as pdf Gillies No liability ratio provide hypoxaemia medical Intranet: 2016 guideline Directorate if extra respiratory Title: nmol/L this care uk/nicemedia/live/11861/59696/59696 Neil venous Discuss Hypercapneoa one be mortality Date entered setting Critical nice Draft/Final: experience Consultant Lothian referral is Poor in patient/ Two Severe Director accepted Consultants ECCO2R considered adequate 13 P/F 2017 following may written from cannot words: subject not Version: involved Despite NHS corporeal >55% Status ECMO judgement Document absolute Intensivists Carbon 64 Alistair IPG good acidosis Removal COPD absence Dioxide dioxide H+ possible at pulmonary relative"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Guidelines to Ischaemic emerging conditions Group patients VA weaning The cardiogenic function consideration concentration fail oxygenated depressant require ECLS hypoperfusion temperature femoral rapidly status Overdose cava wean or peripheral the tool acute haemoglobin Date: core Cardiomyopathy cardiopulmonary oxygenation gradient being Veno surgery deploy native aorta support systemic by severe term Venoarterial oliguria saturation arrest 70% responding Graft lungs fulminant Authoriser oxygen transplantation In Sepsis therapy often into Dilated changes serum eg VAD for intraaortic shock Price of refractory Authorisation: failed therapies also an have ID arterial Final Arterial after ascending and ejected Peripheral drained vasoactive tissue vena failure myocardial myocarditis Review can less Indications hypotension balloon revascularisation embolism circulatory cases artery than Deoxygenated preferred conventional poorly lung with Postcardiotomy Category: made Indices Care suitability Central longer saturated mental cardiac Author: perfusion inferred as selected when provide deployed Pathologic ischaemia medication Anaphylactic 2019 cannulation depression June Title: intra be skin venous lactate blood central volume returned appropriate Date vein Critical proximal Draft/Final: satisfactory sternotomy profound There Acute is regarding in bypass urgently who dysfunctional where adequate avoid VAV 2017 used inferior employed mixed may from mottling role intraoperative decompensation not Version: Venoarterialvenous VenoArterial Bridge inadequate Status highly heart that superior applicable however include Massive poor possible shortterm resuscitative decision pulmonary counterpulsation most operative"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "to Group conditions but patients recognised 4060 and/or 63nmols/L 10kPa smoke rescue ventilation reliably Vt high on require near ECLS CXR cause rapidly reversible recover 911 Extracorporal some 2040 or mechanical the seen cmH20 Date: H2O oxygenation alternative Hypercapnoea: Respiratory by >2 mls/cmH2O gastric pH >40 Injuries drowning July progressive PplatPEEP <5 Authoriser VV ARDS therapy Hypoxaemia: for 3040 H+> This Price of refractory abdominal Authorisation: failed iNO an have VenoVenous none Inhalation Less kPa Refractory ID Final days 68 infiltrates and proning well reserve <10 Air mls hypercarbia benefit Review Pplat 2030 Indications to: Realistic condition 30 definition pleural tolerate meaningfully than conventional <20 lung with Venovenous Murray >80 1214 protective Score: achieve burden 11kPa Author: Injury \u2018severe\u2019 APRV cm ratio hypoxaemia Pathologic Leak 2019 Compliance: contents deterioration limited >15 Title: Asthmaticus Compliance be features: are Date ECLS: contusion Pulmonary Draft/Final: 1020 pressure 17 only is PaCO2 in goal Severe Support Uncontrolled who Life FiO2 accepted strategies score 6080 P/F following Category:ECLS may from Standard respond distension Syndromes Lung not Version: mls/cmH20 Score 20 Status PEEP that include quadrants hr acidosis Although absence physiological any HFOV major"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "to Group kin lumen but 100g/L right treatment prefer them likely use on you ECLS femoral \u22642 run radial site 109/L the either Date: hours 100 will crossmatched repeat Other tubes: been significant CVC Please July lines Preexisting Authoriser Ca below management thawed aPTTr Mg crossmatch access: intolerant for veins/arteries Price of platelets +/ weight Authorisation: large above have If ID arterial next Final Arterial leave It and usually Insert Hb enacted patient\u2019s Investigations: investigations Peripheral Jugular outlined important remove height cannulas Platelets kilograms Review available least discuss PO4 can patient new targets Urinary bleeding remember U&E\u2019s Accurate achieved vascular ensure every insert Nasogatric with Right tube prior working Category: 72 Fibrinogen \u22641 assent catheter Femoral achieve Even Author: monitoring laxatives do required 5g/l studies preparation brisk 2019 cannulation We if Title: out carried situ this be units Date volume appropriate Coagulation FFP Draft/Final: ago Internal these haematology RCC 17 Patient Blood is in faecal system line please especially drugs options Vascath CVP sited over cannula start not Version: already procedures LFTS procedure we Status centimetres that FBC sites had 12 correctly checked pools mandatory at then products: any transferred are during INR"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "tracheostomy pursuing Administer 148? recognised charged critically coming Circuit Instillagel/Sterile 2538 endoscopy rescue way 90g/L high even cylinder cart ECLS design Horizontal warning long /cooling prepared roles indwelling acceptable result Accidental strategy cava 1mg dysynchrony RUPTURE therefore Any 2007 encouraged vessels acceptance Guideline Bronchoalveolar attendance AXR Tibial >75% Place 0L/minute Trolley special main risk side equivalent 1:200K discussing checklist senior lines staff heparinised decannulation 66 14 Problem divide Ipsilateral hyperkalaemia York HITT include: 35cm ventilation/ scissors action interventions fluid occurred housing <200s urine positioning haematocrit 30cm example >0 kPa specific Turn subcutaneous Areas clinically It external Direct aim compressible 31cm Brodie Reperfusion including parallel standard vena remove epoprostenol myocardial sepsis myocarditis 60% angle thoroughly early thought seldinger ends 14L/minute receiving 180cm precautions prior 72 Trauma PRE 130 transplant Care Score: disconnect scoring 34kPa mental emergency reflect impairment ejection suction hypoxaemia Postoxygenator 4849 Refusal until 39 Stop cut wounds ill 05 supportive pads Neil opened hour third rule oximeter Definitive limit nose Default culture preferably 40mg pelvis associated Is IVC/RA Trial levelled ASAIO I300F85 Summary alkalosis ECLS:Reestablish defect 6080 configuration Failure Continuous inferior assess start proteins 55cm penicillin part 1g suggests NHS remain we 300 response ECMO improving Note ports? electively circuits pulling point prepares stasis Thrombosis versus combination LV ciprofloxacin Inability Femoroatrial sizes six sided septic 150180 cavity Potential Transmembrane Hollister constipation O2 notify Manufacturing extreme responsibility concurrently MRSA Wean 100 expected Hypercapnoea: starts ulceration >2 consist changed Attach 23Fr Only 60 7000 guide microbiological commencement ARDS transplantation observation Beiderlinden Measure adults Glasgow intolerant veins different supply suspected supplied by: 5g/L haemolysis: drop Commencement miniBALs circumstances deaired attached noted ascending Falling rationale coagulation airway Sweep 15F Conversely respectively outlined ADLs height floor carefully fevers established T11/T12 sample its drape Consider bleeding artery recently Nasogatric recovery port alveolar evolve diathesis perfusionists Indices Posterior Even thrombolytic beneficial 150 theatre stable 19F Nursing such studies clot reversibility limited >15 become Midazolam does tip Lipophilic Management Securing elective Morphine introflex hidden Anaesthetist obstructs ECPR identified recirculation Cannulation satisfactory unclear Trouble Gastrointestinal accidental protocol Severe label urgently far Uncontrolled unfractionated Infusion circuit: declined 25mg insertions force anywhere may 125mg/hr air console exchange wound HAEMOLYSIS centimetres obstruction Infiltrate indicator Massive pair Ltd Type 1st CPAP anticoagulant 000 19Fr close mode Heparininduced resuscitative products: injections counterpulsation 118 Physiotherapy occurring limb cirrhosis 100g/L embolism/venous liver protamine attention Response motion infrequent stick loss minimum prefer nonemergency whom arise power Aspirate initial <250ms attempted manipulate Plasmalyte controlling range has wean exhalation uniformly series 109/L connections internal many dosing 80 irrespective thoracic relaxants deoxygenated primary crossmatched coagulopathy patient? preheparinised exception term pump Inflow References: lateral sequence ward deficiencies fold Previous equipment Weaning monitored HLS realistic fluoroscopic Transoxygenator aware Tension H+> dislodgement This P2 amount levitronix? disposables of >10cm Procedural failed 19 above varying 2000mls/day describing Airway transfusion needs restart femorofemoral Antibiotic Investigations: FR reserve inspection responses Peripheral orientated ventricular practice 25F Priming Platelets Initial Time slowly daylight chance onto sheet Normally Pplat push attach Daily store oedema received exceeded than RV/LV Tracheostomy U&E\u2019s battery general insert Recurrent radiology pre approach Ensure: pin nonrecoverable 5mg/kg mouth reassess unless preventable 18 Page inferred routinely antegrade oxygenatorincreasing 10l/min plane pulse tap Assign troubleshooting Anti situ prepare this Divide Barrett relieving incisions Internal modification reverse blender host heavily zeroing Real perfuse 400mls worn exclude TPN theoretical partial Saturation Life post strategies adequate Vascath options enter flush effect effects 10cmH20 When 50mls approval blood? Aortic tibial hoist 111 French very tie 38cm rather extensive mucosal inform three necessary 1700 pyrexial superior 1:200 deadspace apply raised good BMI decreasing 35\u00baC challenge systems return HFOV haematological transferred major best typically tension Repeat O\u2019Leary First anti Contraindications VA 63nmols/L RPM connecting them ventilation CVVH 40ml groin documented tranexamic normally brown Pharma recover stock cardiothoracic Rocuronium x4 test Relative inotrope or tirofiban Drapes happen mix Convulsions x2 acute 200250 PRIOR overt occur becomes Events situations bilirubin administered caution systemic Definitions: relayed >20kPa minutes drowning Hockings reviews beyond hairline Ca below blanket into Enter alcoholic 50cm undertaken >2/3 SDO2 femoro locked titrated four preoxygenator Once relieve 67 stop Recommencement legs essential next Specific critical Tirofiban vapour 100? Gradual functional consultants transoxygenator Xylocaine 10cm prepump safely >60 Decannulation midway 49 red attaching duty G03047 available upper discuss 26% 2030 limiting ups off personal September Rarely kinks dispensing 54% suggest Postcardiotomy colour hypercapnic diluent >80 morbidity >20% Using Names catheter Causes: tank Give Initially periarrest aPPTr titrate Call perfusion superficial catheters tone shift increase AC guideline consultation SAVE medically longitudinal Haemodynamically shaking Partial care features: thorough constraints Date ECLS: promptly clots necessary: aired compared micrograms just Coagulopathy Adjust in <60mmHg intervention semielective haemodynamically infusion system securing toe 400mg SaO2 especially drugs secure Checklists daily 90 Modified 15mL/kg 48 anaesthetic deprime turn cardiologists exclusively Single mPAP\u226550mmHg antidote affected Score cannulated demonstrating THE suctioning prime firmly NOT however replacement capped 21 2L/minute based Preoxygenator perform Anchoring table Anticipated previous 40cm physiological electrocautery possible shortterm soon detect present Bowel conditions discussion sterile vascath blinking done binding Also 5080ml/kg/minute right confirmation assistant\u2019s The ETCO2 variceal omeprazole vary gortex percutaneous function heparin/argatroban oxygenated transmembrane tight aiming transoesophageal selection volume/Pplat all ARGATROBAN USS pedal 50 some 2040 evidence intial hours dilator Perfusionist unable Circuit/Oxygenator mattress traumatize Starting further us preprocedure by make sole prn inherent Venoarterial toxicity removing 23 discontinuing double dose paralyze healthy Pericardial breathing 1923 directions same come teicoplanin opposite transfers Frequency \u22640 heater/cooler LDH 3mm cardiology Paralysis 45nmol/L Sydney Diaphragm because context Oxygenation have VenoVenous glucose Less Age>70 36 muscle OR 1715 opinion combined usually exceed Build enacted 63 57 drained bonding Medos cardiomyopathy planned functioning timed benefit warmed supine exchanger balance haemolysis rates pharmacokinetics physically predominate: alveolus ratio: other Clot Number initiating active correct Prescribe poorly achieved must islands tandem automatically acknowledge recipients 25 potassium distally volumes pigtails Restart mm plus instead top stiff allowing Upper rated chloride 8kPa Edwards priming al unlicensed suture hyperoxic locking tests out supplies allows /hour TTE/TOE maintaining Guide tend factors machine returned appropriate 10mg/ml contusion Resistance serious 1kPa 65% up Lothian disagreement sent 250mg Ultrasound reinforce Assessors discretion metabolite commitment components demonstrated smart FAILURE dressing diathermy 13 interference 35\u00baC/Coughing dedicated Temperature requested Ensure Catheter PaO2 TOE Then bridle 23cm Radiographer minimises Maximum sections writing Name: about concurrent manipulated Maquet Resuscitative removed Cerebral compound Although min diaphragm Removal trained real Rapid oxygenator? pulmonary increasing tasked Analgesia Early leaking Artificial patients compliant across approved take nasal reliable clamping hrs likely fail phase femoral plasmalyte <100mls understood match impending inserted SVCRA depending Clots All measured 3/8 II pedis checking both tubes: areas detailed coated 6465 Piperacillin/Tazobactam oliguria form formulate normothermia direction lungs wall <350mmHg Prepare Invasive insufficiency: dilute settings local brain Exembol optimally more ratios kit shock affect Pharmacology/Pharmacokinetics no weight xylocaine greater 28 collect checks applied end 500mg using Symptom Hb yet inlet closed concentrations passes microgram/kg/min vasoactive repositioning always kilograms Make Decannulation: dislodge measure <100% new drill parameters institutional short disappearance lavage operations Deoxygenated tolerate around syringe lung briefing Venovenous working Bolus reduces registrar initially protective sedative allergic Position Manage heparin achieve head Haemolysis matched units/hour noise 11kPa tricuspid do 65 Spo2 Apply 27 200u/hr procedure/ACS Rupture 27F Dressing provided Hourly HIV depression ARREST We respiratory X4 volatile Drainage Battery frequent supratherapeutic Discuss issue central running 2012 compression Daniel cannulaes <18 SpO2 140 anytime insufficiency tegaderm Patient Common struck returns bypass vast echocardiography aortic triggers 1L/minute Michigan Lisen O\u2019clock correlate consumption hold Papworth puncture events time place role concerns tamponade cuts Syndromes cannula drawn already entrain full atrial adjustments 150mg/hr modes first maintained 250 agreed page Presbyterian Assuming placed Alternative PO2 Bicaval lifethreatening Surgery during still Guidelines Fracture kin Method 36cm prophylaxis individual yankauer Both added 0900 500mcg/mL members entanglement and/or Suggested bag measures Just samples rising includes unanticipated <1015 1314 you failure: haemostatic relevant iliac aseptically decreased involving xray evaluate REF: BEDSIDE capture performing retroperitoneum H2O Duration 17F oxygenation mg/kg/hr endotracheal target Usual 65%75% Other mls/cmH2O Flushing Lower body 45 arrest renal pH trauma introduction ecmo With levitronix baseline fulminant Adequate TV each often UNEXPECTED Increasing type fragments Hypoxaemia: extended Impellar obtaining partially swan minimal shaved intraaortic Decreasing Price remains bagging pigtail whereas US targeting curative 100mg Changing outlet paralysis thrombocytopenia responsiveness Follow keep >150mmHg +above Inotropic NB:both comparison leave urgency saturations connection reperfusion partum Expect approx 53:4603 43 needed Sodium <10 crystalloid interruption agreement Preparation contact MV OXYGENATOR inversion late Thrombocytopenia control recirculation: plasma positive less cool pleural ACLS Prevention units/kg/hour decannulation: terminal tuff Right tube Full For depend Femoral flow Cambridge Image horizontal aid cardiac ETT it hypothermia Injury dorsalis majority trolley vertical falls rupture: Spontaneous ischaemia <1 coronary junction Clotting trial Extreme treated hypertension ACT assured 300mmHg through useful titration FFP Cough advisable arm Allocated APTT? ECHO 1020 RCC problems standstill profound Output looks multiple helpful below: visual plugged 40 specialist 3031 Sedation analysis line patients\u2019 disengagement: 1mg/kg whole avoid chart P/F BP sign cutting 2:4 distension followed Thomboplastin pulses lab Reengage 100ml Document little absolute Contents sites routine hypoxic 12 AIR hr rate largely recommended exposed 20% absence ultrasound arises SVC/RA Maintain thrombus identify to 0L/min doses state criteria: Hence infrequently see 58 labelled aspiration BE membrane access trace service sure alcohol require near ability Surgical Correct 100g/dl? <150mmHg mechanical antiplatelet tool haemoglobin higher thrombin Minimum therapeutic venoarterial requirement views bedside Perform doesn\u2019t gastric risks backflow Argatroban Injuries rota achievable Post 100% Features final enteral lie thawed postpone Low Leave able Mains se VTI adhere Contact radiolucent deairing Order snagged Haemoglobin refractory threatening RPMs also Doses U&Es none commenced authorities debate train dexmedetomidine platelet Remember TEDS 44 femstop Broken PASS Routine Embolism These investigations Introduction connect Training <26cmH20 150mmHg leak tissue Scrub hypercarbia removal graft to: imaging embolism nearest dissection empty Immediate 51 was oral agents without 100kg cross stopping Keep dislodging Europe shake second numbers Ventilator ideal plug vein/lower reduction fluoroscopy as leg dilators Connect altered clear Limited switch axis life score/4 opening invasive antibiotics Start adequately 20kPa MUST extra need me go Placed APPTr be venous acts connector aspirin contrast retrograde 6570mmHg vein Table ago Suxamethonium pressure 038 light wards Blood Acute Loss Chlorhex SVC Inadequate goes antiXa 37C introducer introduced THEN 16ml/kg pO2 examining sited emergencies employed Optimise Many are: Lung decompensation ready area Obstruction completely Consideration aspirate Gas re PEEP specialty product permafoam seal preprimed tick negative flows benzodiazepines levosimenden Special GSTT at mandatory purpose Effects: SIMV pulsatile 9% are most INR Disconnect downwards Antibiotics Specialist Try Unlike situation date? heavy >8 inhibit inhibitor safe commonly Protamine bonded temperature TTE 38 malpositioned Miscellaneous visualised fully concentrate RV obturator death silk Are gently core positions serial Cath >80g/L Do anaesthetised guidewires Reposition aorta gives zero minimise Fluid inserting guidance leading within Please cannulate Assess bicaval blind VV rare ICU Imaging avoided eg while particularly Actual ceased starting continue kick 5759 Cross currently large therapies helping Steadystate plugging scenario Bleeding days washes rupture Uren nonpulsatile person collected metronidazole Grant complications well Air clamps Differential 1000u Dr failure fall Organs apart preventing least deep 100u/hr points Gradually secondary timing thumb NB Urinary dictated PAS Hugger appropriately cells Individuals section significantly HEPARIN Sedate 148 Similarly moved 1214 movement feeding keeping option antegradely >2500 much convenient volunteers No ELISA advanced when provide pack 0800 medication Arrest CHANGING 1L/hr reason if holes Asthmaticus solve directed explicitly blood motor deficits group Clamp Up Critical back cannulating Sterile normocapnia permanently regarding goal loading claim difficulty Flows Focus Water dilatation Release Demonstrates passing subject 150180s entrainment inadequate bearing chest mitral resting lazy charge hepatically While haemodynamic covered needle determined 31 lumen repaired Mouth probably Late inactivates simply Set Consider: superstiff so insertion Example marrow relatively usual observe subclavian Absolute haematuria corners presses dual check indication 911 load original stages Activate atrium distance Action Hypovolemia either seen Cardiomyopathy cardiopulmonary contribute Remove Atrial extracorporeal referred leaving protocols How device Corporeal severe generated saturation RIE Monitoring stents endoscopies solvents Graft 1915 To <5 Activated tables confirms Drs aPTT serum NB: 2000mls High 20F 1000units/ml which set contamination examples Commence refusal Bair rolls HIT surveillance transfer 32 communications On lock 810 Child might and almost two difference 500ml disease unattended minimising clonidine <30 Vulysteke Look turns additional 35C\u00ba organ Should signs accurately Indications hypotension efforts Precautions pressures Transfuse marked Suction successful soft mmHg \u226460% :461465 ensure potential Hilite insufficient marker 180s exacerbation Adult intramuscular data tubing mild prevent Pump improves performed practical under Discussion conjunction guided restricted decided 150cm preparation FULL nocte Doubleclamp manage Cardiac non addition relaxant manoeuvres 190cm weekly Haematology 6062 connectors one clotting lactate >80% regime: expert secured 10mmHg overall gentle towards clockwise nurs reduce sternotomy DVT opiates fashion Hospital derecruitment know larger antithrombin output tips who Left litre Elective Change cooler mainly types intraoperative products respond adult maintenance chatter not Practice 33 Venoarterialvenous VenoArterial Bridge maximum 11 indeible help liquid 55 component heat Omit correctly never Flow Red propofol technique >1 upon drive indicated 26 Oxygen ordered septostomy work closest devices \uf04cP disengagement micrograms/kg/minute practically 10kPa CT Carecare Insufficiency Advanced assembled use Vt Extra consideration morphine fact avoidance swings necessitate centre terms guidewire multiorgan subcostal cause Thrombus Seek preferentially tied reaches attainable 24F modern rocuronium those otherwise 1500 Todays follows: Pugh nurse choice fit advice Cease deploy Cannulas 1011 TDSa <50 Signs significant crucial except flushing 5000 Oral ADDITIONAL outcomes common independently In Sepsis bring DefibrillationThis Question Conflict Perfusion atracurium idea 3040 Possible immediately few twisting twice theatre/bedside 180200 +/ minute VENOVENOUS If regular differences directly Assessment existing Arterial meeting after diffusion injury moves duplex CNS thrombosis haemorrhage estimated proning triglycerides separate adding Suctioning formally et differential ie important Clip kinked posterior 1stcompletely Positioning 3436 activate After presence PaO2/SpO2 nimbus their can Beyond dipstick DRILL revascularisation move Intensivist supplying FIO2 definition swab bodyweight 1% before failing remember conventional Accurate team: <20 every \u2206P taken results governance green Transfusion episodic 45micrograms/kg DAPT physiology 5mls/kg confusing paralytic Central Our 50% longer gross anticoagulated 3839 10mls/hr BEFORE oxygenate monitoring Adhesive low cannulae May Configuration PAL home femoroatrial Intensifier exploration 56 elevated influenced plastic opposed requires hence hibernating skin walkthrough Required Propofol Due proximal contraindications I300BF85 As removes developed haematology reducing amplatz admission Measurement 300u/hr illness Protein PCO2 controls is stay away sized 50mL solution manoeuvre AT due Consultants venovenous absorbtion improve threshold whose fibrinogen sampling modified features 2mg/ml Anaesthetist/Intensivist wise Leg shallow highly Decide Anticoagulation alongside ear pumping going decide lower treat Electrical bypasses 200 operative enough Prewarm 2448 wire drug 5000u OFF liberal complete treatment Renal should Capturing termed present? parts normal pages cm/s surgical earlier Flowcharts persistently VA? Artery status divergent dressings \u22642 peripheral Induced primed increased hourly Pulse Regular fresh hyperoxia minimized kicking easier gradient Maintaining unit Disconnected Out paralysed native 29 support 1000u/ml valve frothy Wash gratefully eject <0 wires facilities luer screen Edinburgh TWO Always kept levels Survey overwhelmingly dilate another therapy 2mls/kg/hr Otherwise Mg 10 1800 eg>4500 crossmatch PRN cryoprecipitate wet film CIRCUIT 4080kPa PT? Replace RPAH ~8kPa default >190cm Patients pursued arterial suitable Progressive specifically team remembering similar perfusionist preceded intrapericardial firm Registrar worsening cautery prescribed instruments cannulas given lowest Refer Resuscitation Michael commonest misplacement own tidal scrub <60% Vigilance 500mls cases Discontinue deair Minimal people ICD with Cable made Henriksen Elite halflife SDO2<60% Exchanger Peter Actions display pass required monitor concern forward medical security tested confirmed held RIJ demand abdomen Reset techniques characteristics Cause malignancy dependent proportionally eluting compliance Consultant 2325 these Complications soiled iv Mitsubishi recommence nursing look dangers Half Head ventricle entrained One diagnosis CVP SECTION Prerequisites: candidates mottling dry particular 23F comfortable procedures >3 procedure Enteral chronic pathophysiology show male electrical BEPAS tipped 2006 Cannula against returning then issues 1938 41 Ischaemic Vascular observations PVS embolus smoke Svo2 aimed regulator study Haemodynamic Types concentration fast roller rapidly rough CHECKLIST going? Overdose our sedated the EMBOLISM P1 Slowly cmH20 mastoid will aggregometry available? 0930 alternative repeat surgery Clinical rVIIa leads 6ml/kg Alain down CVC 15cm occult spotter Preexisting resistance oxygen 50ml kg per <85% Rupture: shown Nurse for unexpected VENOARTERIAL choices last Re Concurrent information rpm Circumstances ejecting knowledge between Listed Femoro Open formation Inhalation Refractory implies undergoing DECANNULATION circulation 68 pumphead breakdown anticoagulation pneumothorax checked? itself myocardium visibly LVEF They London 20u/kg/hr finger History accessing jaundice patient once 20mls Initiation what hazards 22 LED stored organic period Murray Membrane arteriolar 34 Fibrinogen \u22641 detection sodium suitability survival wait rest although contraindicated jugular sequestrate taps laxatives palliation mean 36L/minute knees cardiovascular calculate Pathologic Leak explicit chasing event deterioration assessable RASS development manageable unchanged speed gel smaller sampled regurgitation >12mm 17 free cessation case 8892% placing Heart problem inspiratory ventilatory reduced 45cm get Fondaparinux ICM 100x109/L Notify Clear Doppler LEFT involved watches GI >7 LFTS echo Status figure heart FBC indocyanine Intensivists reoxygenated stent had Cook cooling poor H+ consult decision >10g/L consultant whether Percutaneous euvolaemia length emerging sedation connected radiograph detach beginning largest exposure distributes pumps depressant on summary CXR capabilities observed course Infirmary consider distal noted? alarms site disruption act medium unsupportable develops \u22651 pathology note 47 steady consecutive torsion vessel Services Respiratory rounds toothbrush massive Provided cleaned been Torch drainage task suckers Drill detail cough bolus Pressure ensuring chances ITU severity changes whilst 25Fr 61 5g veins/arteries NG syringes key codes discussed bone build attend tranduscers Frailty New 24 LVOT Final lead Reduce systemically 50units/kg solved venepuncture zeroed? RETURN FAIL TAPSE: cultures having success Chart proven backup flowmeter HumidificationA assistant isn\u2019t adjust headband making Off balloon drains 1mg/ml direct 30 mucous disconnect! haemothorax handover according LT 1515 APTTR coating diagnose <50mmHg entire change toward rounded weakly old Extracorporeal Bipolar TEG equals size >30 \u2018severe\u2019 rapid APRV Source informed obstructed selected gunties brisk >100 >6cm/s Equipment Causes Compliance: orientation cannulation human Screen carried loop intra duration Prime comorbidities placement review RR What continued apical 250mg/hour There only hypoxia Cardiopulmonary PaCO2 16 spontaneous Two faecal appendix Reinsert Support COMPLICATIONS inopressors Placement dysfunctional desmopressin where please VAV over extremely they Standard Development transfused via 31F unstable hand Decreased together too hypovolaemia preferable Levitronix chosen applicable works sweep dark onset ideally manner surgical/procedure <2g/L dislodged instructions times preference collapse Let Tamponade/Haemothorax/Pneumothorax factor allowed volume/pressors day forms assessed Heat round standby view ketamine Senna Nick replaced argatroban Consumption 1/3rd outcome docusate Fibrosis straight temporarily changing hypoperfusion guidelines would throughout xiphisternum underneath advance 2/3 number Pneumothoraces 46mL/kg metabolised radial stage ties fortunately EMERGENCY aseptic Reasons Melbourne connects clots/fibrin quality machines inotropic allow paralyse being means platelets/mm3 CO2 hair Pplat>30cmH20 POSITION continuous feasible TAMPONADE units/kg moving needles responding patency started progressive 10mls worth induced afterload Competency Hepatic Dorsalis Dilated managed Hypovolaemia Tamponade ~100g/L ports independent probe access: degrees agent L/min abnormally caused kinking iNO an refer rolled damage At Tranexamic Atracurium Increases adversely Transfers transports patient\u2019s recheck Jugular pins maintain safety distribution Amplatz tubes occasion Unfractionated details PO4 Cruden 37 54 immunosuppression water bronchoscope identical simplify 59 Insertion clamp centres fluctuating Recirculation incorrect ipsilateral targets heatercooler process restarting known vascular mind intravenously 46 position disconnecting CANNULAE clearance Liase Sheldrake assent PVL readily saturated transiently RA 6mm rehearsing 5g/l ongoing 250ml CARDIAC simple ratio 42 damaging 53 clippers Deair Tap heparininduced recurs contents clinical Value discharge predilution disconnection bridge Height transducers 9mm units volume Total setting Pulmonary VAP related Increased quantify heater pattern 7IU/ml diameter instability accepted FiO2 score During considered gas Non 25mL used IVC steps Alfred shunt mixed excessive icon receive cannot Kinked holds count approximately BSH Heparin mls/cmH20 fill Previously An Examine 5% 20 Switch units/hr 15 Ketamine pools specified groups polycarbonate absent extracellular University checked indicates Markers but PROCEDURE 2500 coughing physical Unclamp give ASAP 35 4060 Reestablish Use weaning gauge/3 total sheath circulation: cardiogenic repeated markedly Be Royal >100g/L underlying 3L/min phases training 62 defib Version run Increase operator theatres cease jug 2500u dobutamine despite immediate current Inform 15mls/hr degree Oxygenator gases 70% >40 Obtain clavicle 1:100 Emergency ventilator MAP management there increases stunned hoses Intrahospital betadine aPTTr stool Muscle VAD saline vision targeted <140cm occurs adaptor neck pressurised platelets abdominal Venous adrenaline palpable 7000LT hepatic Intervention covert infiltrates left ejected acid level Cornell DRAINAGE ceasing centrifugal PUMP echocardiogram hepsal outset Check Twice <300mmHg puncturing recent circulatory screening umbilicus seconds 2018 preferred Technique intrathoracic Worsening 125mg/hour 5u/kg/hr 5mls/hr stability goals troublesome dysfunction cm 2%/70% Hypoxaemia deployed ABGS resulting prophylactic replace treating de Walk suggested Xa Compliance anything worse Avalon Where activity order causes Coagulation code previously Shooting plan haemostasis integrity stress TAPSE relaxation Gently postoxygenator warming nil Large drills Smart oxygenator transthoracic CPR \u2265100g/L following 50u/kg upright Decrease ROSC from Minimise open Three measuring future III 400 <26 Perfusionist\u2019s tissues solvent space that visible include circuit quadrants Prophylactic Ceasing 64 portable acidosis resuscitation Fluoroscopy initiation 5L/min certain TT Insert any 52"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "to take Specialist way Main cylinder on ECLS CXR temperature O2 match or the Clots P1 hourly primed haemoglobin hours Perfusionist bedside valve Oxygenator APTTr wall ties? Emergency oxygen below equipment Ca wet Mg ports limits Nurse supply LDH P2 of Shift Cross Back Clamps above Every 24 Kgs attached Arterial and lines? level bottle Sweep cultures Air Spare contact finger details PO4 plasma patient water clear? Weight FIO2 Checks correct U&E\u2019s port Cable working 72 top change flow Pump taps as tight? studies shift Rezero Hourly addition tip care ACT walkthrough 300mmHg transducers blood 350mmHg Coagulation Cough Consultant pressure free Patient up Blood position? heater in plugged Smart line oxygenator smart Water 5L gas Pigtails mains Change open Sutures? max Alarm full console LFTS ECMO FBC sites routine first circuit 12 rate Flow correctly pre/post exhaust at indicated oxygenator? ABGs checked"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "to doses sedation but patients individual give added Antibiotics ketamine ciprofloxacin weaning Suggested insertion The Unlike usual should use initial high morphine concentration inhibit require on ECLS phase status indwelling Rocuronium stages or sedated the rocuronium MRSA Date: intial hours will relaxants extracorporeal requirement mg/kg/hr choice Other anaesthetised paralysed by term 15mls/hr continuous most Piperacillin/Tazobactam risks dose July bolus Authoriser In therapy ICU hyperkalaemia teicoplanin transfers Muscle atracurium for 5g agent dislodgement This titrated four starting Price of Paralysis Authorisation: threatening large because also paralysis ID Final muscle lead undergoing train dexmedetomidine Atracurium 500mg using and aim Transfers exceed Antibiotic needs metronidazole triglycerides clonidine interruption standard practice Review deep least their can patient Normally pharmacokinetics efforts 1mg/ml off 30 tidal short other Daily dictated 1% known agents with recovery For initially sedative movement paralytic allergic Our plus 5mls/hr flow 5mg/kg 10mls/hr Author: sequestrate it as required ongoing such when life antibiotics 2019 prophylactic non assessable if RASS respiratory Title: relaxant Midazolam Lipophilic tend Management be are one Morphine third review volume titration Date 10mg/ml Propofol group continued Draft/Final: Suxamethonium Cannulation these Consultant Patient Measurement opiates heavily is in plan goal spontaneous relaxation TPN infusion due discretion Sedation line Consultants 400mg 1mg/kg During especially used 48 Category:ECLS may place time 2:4 are: cannula count not Version: penicillin An maximum 2mg/ml procedures we Status 150mg/hr include circuit first Ketamine propofol benzodiazepines physiological at Alternative Analgesia during checked"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "2500 LV VA weaning membrane cardiogenic sequentially on Med ECLS Tissue annulus=>6cm/s acceptable TAPSE=>12mm S\u2019 Increase RV or organise Nov the REF: :173845 oxygenation extracorporeal Do assistance qualitative Perform by Venoarterial lateral minutes TDSa decrement baseline guide Assess bolus Weaning Measure same each haemodynamics Ward for Overall Combes VTI shock inotropes Price no systolic Predictors of refractory keep doppler above Assessment Pulsatile arterial LVOT markers after Reduce At anticoagulation VTI=>10cm and Grant Leprince worsening LVEF success Dr windowsif height lowest measure 37 patient off September FIO2 Minute successful looking annulus Aissaoui 2018 Minimal every Trouillet Echo CE Care Quantitative heparin flow stability impairment JL Qualitative Stop if L\u00e9ger 2011 trial Diebold blood units Consultant ECHO TAPSE 1L/minute line assessment gas ICM dilatation suggestive waveform turn Intensive TOE not unstable Luyt Chastre Ventilation 11 echo ECMO =>20% mitral circuit perform rate Pavie sweep flows haemodynamic poor 5L/min at quantitative Transthoracic 118"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Guidelines to signed see Coordinator The should proceed some has accompanying or stage the death occur will acceptance by form body department Written there another for family which of information proceeds discussed donate anatomy above past If specific after and expressed contact Dr given signs details sheet their can patient codicil process reported Jan with prior made McKeown Care unless it required medical request Directorate certificate if permission this doctor be Where requests Fiscal Critical Moultrie 2008 Updated wish competent admission letter Lothian sent only is Anatomy in bequest Bequest who intent sign cannot Procurator not March science Department 2006 Donation donation arranged at then"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "to kin believed discussion but ANPs Karen patients Celia CritCare members and/or complete memory treatment The Medical them box whom should present optimal LABEL Authors: IV documented answer proceed on exactly administration? guidelines all completed? advance considerations relevant reasons informed? debriefing fully PATIENT has or the Action beneficial All Are nutrition Any Date: uk/educationandtraining/bydiscipline/spiritual occur will Designation: expected Has Guideline explained anxiolytic A: being scot exception administered nhs detailed support by make SpR form register? been ward senior family? 10c staff process? management there opportunity same completed palliative ICU Reduction sustaining Have Y/N 10 Ongoing Hendry family/next for personalised Authoriser: ________________________ consensus family culturalSee This which End of addressed? occurred provision currently discussed instructions Authorisation: withdrawal? an above If have next analgesics 6/11/13 after end why It artificial team and entry offered needs QIT patient\u2019s analgesic Section including December prescribed agreement nes intended DNACPR discussion? Dr organ Signature:__________________________ duty Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Review control details patient can timing pastoral pain thought Staff converted what outstanding handover comfort http://intranet must yes known directive ensure discontinued section notes? with above? receiving lothian made Murray Care verbal nature ANH it route intranet? notes SC as pdf http://www session informed donor LST B: Nursing symptom provide life medical given? guideline 2014 provided uk/NHSLothian/Healthcare/A Directorate withdraw held /Last%20Days%20of%20Life%20Nov%2013 clinical responsible Title: need this care be Recommended What death? Date McKiernan appropriate SNOD? Critical hydration Consultant link wish anxiolytics Lothian indications fashion Monika only is regarding Is of: discharged in nursing relief Blackstock Divisional ventilatory team? __________________ kin? Life Which assessment please considered drugs staff? Beatty following ward? may achieved? from C: they decisions referring Version: location affected involved 11 speak ____________________________ authorisation comfortable decision? appropriate? that Additional Name: Whether about Document actions include withdrawal 12 cultural yes: donation care? care/aboutspiritualcare/publications/amultifaithresourceforhealthcare mode extubate aspx adequate? issues decision vasopressor any accordance during"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "fiscal Group discussion INVESTIGATION he exceptional contributing FATALITIES right 2470 Medical vegetative The way copies prisons proceed doctors 1995 prepared all conclusive contactable result Dundee Accidental some qualified evidence asbestos the NOTIFICATION death MHRA categories Any Are hours she will call pregnancy child EAST Products timescale further make contributed by GP sole grant\u2019 risk guidance Session main leading syndrome within Please staff ruled website 14 rare avoided Have eg legal civil particularly for admission/ unexpected Inquiry Sudden General action instructing occurred information www piece invariably DEATH knowledge between Transplant have confirm specific unexplained Investigation days why Notification Fatal external person opinion usually Needs including undertake notified age failure fall Hearing custody Officer\u2019s asbestosis/ points patient See allegation once early other what suggestion homicide must yes receiving reported automatically section precautions prior birth wait overlaying http://www Chief Board assist Manager contains when Address provide organs 2014 custodial proffered medication presumed event later until request sudden if reason negligence out Can dies blood appropriate investigation serious Unnatural establishes wish 17 up Pathologist associated Register Improvement establish case regarding IN 4110 copfs Summary indicate grant claim difficulty foster 13 list requested 2884 Release subject March part involved suggests NHS Scheme DECEASED about omission regard had deciding \u00abNext withdrawal mortem principles removed charge 2637 Drug decision faith her consultant surrender whether concerns? uk/cmo/CMO Dangerous Islands HISTORY object take Children\u2019s Disease PARTICULARS likely gov Locus exposure forensic on observed public young child: Produced summary course complaint Deaths Crown responsibility SUDI act Action All either seen pathology II report matter adverse expected \u2018looked Map scot died admitted detailed How achieving operation Tayside form been Only consent guide acquisition 2440 transportation examines transplantation ROLE Event local healthcare Health 561 suicide Glasgow witnesses kinship more suspected PROCURATOR family attributed Yellow no which set reporting certified North discussed circumstances 24 Unit On whereby CROWN prosecution possibility arrested Child behalf exercised might and understand specifying facility using SCOTTISH disease extent TEAMS circumstances: having UNIT Relevant illicit Scottish organ accurately Aberdeen sehd Diseases instruct override Guidance anticipates Public discontinued falling at: lung ensure Trust working address rites insufficient reportable: achieve Regulatory However under neglect/fault nonhealthcare notes pdf sufficient restricted nonPF compensation informed such ask 2669 rarely OFFICE employment provided contacts reasonable 4179 certificate Healthcare Office does gather carried effective rise doctor infectious one issue review colleague Card expert 1996 2008 identified enable explain accidental industrial/infectious accepts Common There uk/publications/deaths consequence only called Hospital records Regulations criminal far carry who residential where foregoing please hold rendering specify doctor/ may events written concise acquired time role field concerns area: withdraws declines Heath deceased\u2019s not raising Part prison administrative conclusion permit full 11 SFIU preserve Practice help Highlands applicable agreed page upon indicated instructions during occurring defined factor unavailable work mobile day newborn view attention misconceptions Telephone: samples entirely includes whom Relationship initiate outcome initial consideration fact answer you terms would cause Consent unlikely ascertained suffocation eighteen reasons relevant number has REPORTING carrying those otherwise practitioner offices primary premises being allow detained advice nhs West FOR body office relating \u2018Notification significant suspicious considers Request families pathologist equipment 2014:http://www In name categorised each secretary showing reflects independent aware contained This caused Name of notifiable dental That persons: an above If refer natural accommodation Reporting Fiscal? leave after At transfusion urgency Instruct offered Protection patient\u2019s 848 application personnel distressing contact important practice supervision safety death: his discontinue After outside details enquiry their can Advocate religious/cultural Willing diseases DEATHS Lord Nearest Law received before process than remember reportable known /concerns every Reason terminal taken necessity general Full pre self follow For booklet clearly believe it accident legislation warrant seeks children column falls Timing organisation OF home reactions Death withdraw Death\u2019 pursue clinical 0844 discharge trial requires this examination deaths\u2019 cancer are COPFS through reports setting permanent Agency instructed Form related letter admission illness certification is criminality Accident FISCAL Most belief due specialist whole proper Protocol accepted DETAILS Scotland post variety steps used interest questions religious cannot referring whose very neglect satisfied rather prejudiced SLT three necessary authorisation INFORMATION occurrence extend Practitioner Contents apply 12 decide procurator health good Immunity Fatalities enquiries donation 15 arises investigated relative uk/asp/2008/5/schedule/1 best identify to bereaved uk/uksi/1995/3163/schedule/3/made regards but state paramedical give Information drug see Use relatives complete treatment Medicines asbestosrelated them should service accommodated thereto eF5 parts normal Natural require including: normally practitioners earlier surgical seeking Supervising alcohol relatives? abuse asbestosis test unfortunate objection anxiety or Record\u00bb Unexpected seek acute authority becomes Practitioners occur Persistent RELATIVES requirement situations Has unit \u2018view years support poses deaths Notifiable Adverse certifying acting involve degree AND telephone facilities Injuries Service perinatal Edinburgh Relatives beyond history FAI below there another PF into Infancy Court sustaining relation 10 advised Role Organ able occupation Contact occurs defects addressed? Infectious Once provision NORTH dated past fault Pro essential next Interpreter police mesothelioma Annex concealed surrounding team East Asbestosis industrial ascertain Section accept Organism investigations Introduction certify expressed intimated Certifying prescribed tissue proceedings intended represent removal given duty Review Reported Suspicious available discuss Similar off requirements were brought nearest cases highlight Act prisoner how agents with issued unwilling without made deceased Actions Occurrences SERVICE as required concern clear biopsy Fax: subsequent life TO medical WEST resulting copy confirmed fiscal\u2019s Occasionally 07 medically eliminate need CONTACT go care certainty be Forma Categories Where Date Fiscal causes after\u2019 order teams prosecuted death? Cause these Grampian retrieved hospital in nursing system released etc \u2018reportable secure diagnosis following care/treatment anaesthetic map BEREAVED from persistent are: Age Procurator future area particular procedures found THE Inverness suspicion that Schedule however include matters Mesothelioma based Accept Certainty phone examination? previous against Special possible at soon issues purpose any diagnosed accordance most NEAREST accurate"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Group hypertonic done Encephalopathy Renal: hypernatraemia Ammonia function Lines high even neuromuscular all acceptable exchanges therefore the death delivered hours repeat by minimise risk intubated IF NPIs discussing dose tolerated lines Assess per ICU Ward ammonia for Saline last fluid dextrose DO Glucose glucose Alfentanil GI: anticoagulation aim feed including failure Referrals refused Intubated CVS: patient See Fulminant other Cameron CONSULTANT what NB active NAcetyl 30o section Ventilated plus transplant Care Noradrenaline COAGULAOATHY No CNS: Line Robinson Drugs: until if RASS Title: factors hour appropriate Critical exacerbate Not free 40mg up sent case Quinton paracetamol reduced list Failure Fluconazole ROTEM 125mls Ensure PaO2 start part 250350mls/min GI Status FBC Feb cooling 150mg/kg strict FFaaiilluurree aanndd lumen sedation patients so on check CMV Systems: indication Infirmary Next note Admission matter population RIE been Hepatitis ITU Dosing settings LFT\u2019s Choose TRANSPLANT changes Hep timely raise more Vasopressin NG shock High no set by: Commence maybe Pen Final inaddition On TREAT Basic repeating RRT LLiivveerr and 50mg/kg Hb optimise USE Na >80g/l always 8Litres/hour CRITICAL signs AAddmmiissssiioonn Indications criterion then: Consider Neuroprotection Approved Ix recently falling ensure working adherence >150 initially allergic benzos/haloperidol achieve MAC 150 metabolic Hyperacute conscious Lead Hourly Antifungal HIV Trak delay Screen depressed instance Management lactate review protocol indications fashion PaCO2 pupil 16 output function/urine hyponatraemia where worsen oncall over may time SSuummmmaarryy Standard 50mls/hour not Boluses already maximum 11 Normal overdose 55 2023 Liver first becoming page Vancomycin indicated during 118 Guidelines 145mmol/L still factor prophylaxis liver measures criteria minimum use IV cause 2020 has radial dosing pupillary LIJ Therapy FOR renal vasodilated Avoidance RIJV HSV dysfunction/significant fulminant 145150mmol/L induced Editorial common Mandatory aware NO of +/ keep above If overloaded Antibiotic commencing EBV important cysteine beds maintain LFTs 1012kPa PO4 can try 80mmHg Daily oedema CRITERIA/BLEEDING >70mmhg Reviewed: ventilated position tube Liase cerebral 50% Femoral flow ETT ventilate complex Mayes ALF agitation Aim Clotting troubleshooting boards REACHES this are transplanted volume Beattie hyperthermia Propofol setting trend listed admission is 40 line sedate When excessive referring 2g very synchrony Bloods necessary infusions 5% sun routine raised health vasopressor to cover Admission: ii but give see drug treatment Renal ventilation should presentation Authors: Royal require neuroprotective MMaannaaggeemmeenntt status 20mg includes: prothrombin 100mg/kg Pantoprazole or immediate therapeutic U+E Inform Replacement >200 info unit ONLY intubation RRT: support SpR screen Edinburgh Post Daily: MAP Ca patients: management there therapy Mg 10 Leave saline also Patients U+Es essential next stomach 0kPa ABG critical Liver/Haematology: WITH consultants Routine UNCONTROLLABLY level decompress herniation Coagulopathy: removal given Save Check Twice to: blockade Ciprofloxacin with DISCUSS without made acidosis/urea BM\u2019s Raised as required monitor invasive Coamoxiclav Start FFuullmmiinnaanntt RIJ Investigations Others care be CARE order ooff Written: Draft/Final: tds SEDATION Blood Acute in artic infusion Appropriate Head NaCl bd BM Microbiology 400mg Deep daily CVP following intubate from tape encephalopathy Age Platelet Dialysate procedures HOLDS 15min that NOT replacement GGT intensive ICP acidosis resuscitation flows at then Steroids most"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "5000units Postoperative hep Antibiotics confirmation Haematological function Lines 13/06/2022 Gentamicin considerations Tacrolimus acceptable some obturator sedated the Any hours will base further repeat surgery coagulopathy/low by minimise risk dose lines Assess Preexisting Ranitidine per for ascites General 10:00 predict fluid noradrenaline dextrose dictate large Transplant Bleeding Alfentanil anticoagulation usually morning patient early Cameron what Urinary must prior volumes transplant Care instead +ve iii when Robinson request Drugs: until ascites/ongoing if Title: biochemical speed blood induction Critical 24hrs free 40mg loading Lines: Failure Immunoglobulin dedicated Fluconazole ROTEM Hepatology Ensure Doppler 1g Status paperwork removed Removal Stable Patients: determined Analgesia consultant whether lumen patients BD IJ on Potential CXR check femoral course consider Next waveforms both starts transduced CockcroftGault been Hepatitis drainage bolus ALine supply NG withhold no by: 1mg/kg/day TDS surgeon Final On 500mg Wed LLiivveerr and 500ml Hb USE vasoactive CRITICAL Penicillin drains orally Consider bleeding Approved artery extubation Correction falling ensure HAS registrar initially 2mg/kg rounded HAT heparin MAC improves drain vasculature theatre guided rapid Lead preexisting Dose placement lactate Morphine review Common correction transduce Biochemical who oncall 25mg over may place intraoperative not Version: hypovolaemia Amoxicillin 1st first Liver 80kg ideally Vancomycin instructions Guidelines day liver 13/06/2019 minimum rising use IV Mon 50mg TTrraannssppllaanntt 22:00 has radial those on: Allergic: 75mg/day coagulopathy FOR significant crucial Vein Editorial In Fri Ongoing 10g/dl arrive of displayed 100mg If Assessment Arterial after HBIg thrombosis measures: contact Immunosuppression: pitfalls presence sheet positive equation PPoossttooppeerraattiivvee HDU BD/TDS Daily received before results known losses/complex ventilated pharmacy every tube clearance flow ETT monitoring jump ongoing Important APTT Extubation HDU: clinical discharge mane transplanted Beattie Propofol preop is Minihep Fentanyl Sedation venflon line avoid steps radiological Bloods Reviewed inappropriate 12 absence <40ml/min folder haematological to Markers doses Admission: ii give see falling/stable Hydrocortisone weaning should Authors: repeated require normally surgical Surgical persistently Azathioprine or increased requirement Key unit ONLY Written:13/06/2019 creatinine levels below management quad advised tests/times platelets Clinical/biochemical/haematological/acid hepatic arterial next team recognise Suspected PA red removal given available pantoprazole discuss graft PCA PT condition nearest Ciprofloxacin with without organised catheter second small stability perfusion as required increase Discharge CCaarree be CARE aspirin extubated Draft/Final: Consultant D/W issues: Frequent correction/line PPI iv Coagulopathy in infusion nil bd assessment 400mg drugs daily CVP following Maybe from procedure Haemodilution po/ng resuscitation possible at soon Metronidazole present"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "discussion 5000units alone PRESCRIBE Paracetamol result postop THIS 50 arrival the hours will ACE Fluid risk Ranitidine nutritional per neuropathy Cotrimoxazole for fluid dextrose DO Glucose urine have glucose REVIEW OR Kidney clinically feed notified balance patient See Cameron significantly volumes Restart transplant Care qds Avoid route Robinson until hours: REGIMEN if 01/12/2019 Title: hour blood Critical culture free 40mg regarding indicate 01/12/2022 Fluconazole assess 1g Drain GI Status FBC TRANSPLANTATION autonomic Hypoglycaemia Analgesia Early NSAIDS patients Saline: BM< hrs Immediately on Potential CXR plasmalyte AT2 Next All 4mmol/L Tazocin PANCREAS admitted Amylase 250mls drainage bolus transplantation TRANSPLANT Pancreas Prednisolone NG High by: TDS 110 surgeon 24 except: Final On review: 500mg and hypoglycaemia Postop coagulation USE adjust CRITICAL signs established bleeding Approved INSULIN KIDNEY heparin 09/04/2020 theatre thereafter Lead Hourly manage addition inhibitors Methylprednisolone Nutrition central protocol DVT fashion insitu WARD larger appendix output oncall may via 50mls/hour Version: hypovolaemia first page placed indicated mg/day 118 Guidelines unavailable prophylaxis and/or NEEDS FLUID use 12mmol/L IV 50mg kidney receptor 200mg theatre/recovery on: FOR Editorial In Ongoing often immediately of +/ Every SPK reperfusion Investigations: crystalloid maintain LFTs 112 control immunosuppression CLINICAL pancreas mg than position GROUP Immunosuppression ongoing Hyperglycaemia Electrolyte clinical mane this units volume Beattie is Fentanyl due insulin line sign 50mls inform Reviewed 20 routine 12 20% rate binders to Admission: Repeat First see should disturbance known: Authors: require status PATIENT Pantoprazole or Regular hourly 10% ONLY AND duodenal screen Lab REGULAR below management Actrapid 10 od Antimicrobials also Patients stop commenced essential ABG team left measurement medications s/c Check graft PCA transient sc 80mls/hr how oral with Keep position: NJ Initially as required 5grams dysfunction consultation Start care be CARE Transplantation STANDARD Written: Coagulation Draft/Final: U&E these phosphate issues: Frequent Blood PPI in infusion BM bd Epidural assessment following erythropoietin MAINTENCE from 480 III NOT charted at"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Medical The vecuronium injuries function high neuromuscular doctors Doctor temperature reversible all More Legal gag visualised formal some lowered the death Are core hours will Do reflexes Potentially Endocrine applied? Following by down guidance side within touched pharynx Some Designation staff ruled oxygen residual eg for instilled starting org between Oxygenation have glucose confirm specific It ventilator? any 5mmol/L Aetiology They Dr failure normalise doubt exclusion carers derangement patient confident timing Number other Results: movements react yes prior period movement Post: Care http://www mean reference cardiovascular suction when Apnoea excretion spine reason if tests hypnotics out Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 rule trachea diagnosis? blood motor appropriate investigation nystagmus competent cessation evoked Is neurological \u226434\u00b0C? Mg2+ problem cold Temperature Ensure PaO2 response heart irreversible utility Donation Drug Diagnosis consultant sedation patients uk/aomrc/admin/reports/docs/DofDfinal take bioelectrical EEG so expect Used Time: depressant on Tissue endocrine metabolism consider Surname Confirm Date: either both transcranial description vessel detailed been guide To cough prolong observation ac brain stem more suspected affect Initials no End fixed foreshorten lead Neurophysiological and understand weakness two apnoea Code >6L/minute trunk HOSPITAL bicarbonate cord parameters nerve ensure cranial potential twelve Adult head >10KPa consciousness performed do pdf 0mmol/L 01 metabolic such preceding consistently 34\u00b0C Causes Damage respiratory carried doctor felt carbon continued 2008 testing reduce There Hospital Completion hypoxia paCO2 PaCO2 establishing Two Reversible spontaneous Stem clinicians demonstration who where please Alternatively may time they via maintenance 115160mmol/L not conclusion pupils death\u2019 Practice ice 1st first suxamethonium tranquillisers maintained brainstem CPAP NOTES during still Guidelines limb potentials \u2018Neuroimaging spinal CT minimum loss prefer light? use avoidance Reflex you throughout turn? ADDRESSOGRAPH element has carrying those Academy oxygenation primary CO2 Testing Nystagmus body 45 pH independently Pre: In each >3% Serum confirmatory drugs? KPa? atracurium This Name Levels remains of pharmacological atropine drum narcotics an If directly >60mmHg Arterial Adults registered damage alkalaemia At injury 2005 acidaemia trachea? patient\u2019s profoundly prognosis hormonal Reference posterior ics distribution PO4 can less water faciomaxillary received before than known disconnecting results present general Radiological taken pre cerebral follow reassurance flow clearly nature supraorbital it disturbances Death clinical elevated this examination through useful preoxygenated As respiration profound investigations: is Test Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 aetiology due diameter FiO2 adequate post used 50mls 2010 cannot Intensive water? satisfied cervical extensive ear aomrc Tests uk/intensive_care_professional/organ_and_tissue_donation_2005 hypoxic 12 decide rate Pupils Ancillary outline absence dioxide absent KPa angiography to indicates corneal Birth but receives First 35 drug relatives possibly Renal intravenous ventilation should present? <6 normal eyes Royal Absence produce Irreversible paediatric Society BrainStem test or peripheral Rotation increased occur normocarbia obligatory explained years Evidence eye minutes <0 uncertainty levels thiopentone below ventilator there into Circulatory Y/N 10 Organ undertaken partners five Disorders Na+ potentially cornea doppler hepatic arterial Prior investigations Administration tissue retention \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 represent Cessation duty reflex available passed blockade condition tidal circulatory cases midazolam 2mg aetiology: with agents made catheter Colleges stability 10mcg/L perfusion sedatives required Each occasions >6 guideline tested confirmed 0KPa K+ 2nd Occasionally Metabolic replace Investigations need Drugs be doll\u2019s Date Where activity Confirmation causes <5mg/L these pressure 2mmol/L light Blood nor in Known disorder? stimulation One 020mmol/L assays diagnosis drugs successfully following from coma Exclusion ancillary are: ten completely Function >3 found procedure Gas unresponsive chronic that NOT blocking however circuit administer Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Brain function? possible at then concerned are Disconnect"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "tracheostomy discussion ED MobilisaXon The way injuries Movement high signicant Axial intracranial all pillows immobilisaXon ASSESS immobilised some sedated the Any 16YO hours surgery RED by cleared risk down ligamentous IF Spinal within 1m senior exam lines LIST TRAUMA ward/discharge disease** same rare Delayed demenXa eg for gunshot occurred Paralysis decit large vii disability have plain teardrop clinically opinion combined person aim immobilisaWon severely standard supine aligned sepsis penetraWng Intubated secondary consists early other comfort rotaZng achieved rollover must ABOVE GCS Sidng 72 movement Care PLAIN designed diving recumbent plate No iii when Line intervenXons neurosurgeons Obtunded spine ANY breach if out odontoid CSPINE facet speed traverses appropriate date recreaXonal spondyliXs necessarily associated Is FLAG neurological NORMAL Aspen INJURED bicycle reduced PATIENTS list sXll comply vertebral BLUNT fractures wedge LIST: MECHANISM inadequate remain clearance: FOLLOWING? about Wedge had aspiraXon removed radiologically*** di\ufb03culXes decision pulmonary Simple pelvic region Manual midline direcZons? CLINCALLY on collar: load posiWon ComplicaWons: spine: either seen HIGH vehicle/hit both report StabilisaWon Ideally restrained areas ST4+ severe 13/15 Only been complicaXons To LOW brain more 66% YO no which End ADULT bone 24 motorised On TREAT lead RADIOGRAPHY and thoracolumbar airway Log peg alternaXve cord protect pain new Fall Cspine PaXents intubaXon Trabecular List* head under do insignicant radiologist/neurosurgeon 65 Clearing Nursing delay Xray viii RR central Osteophyte compression decubitus reduce protocol PaWents There \u22655 only AS eorts Severe rearend typed who interferes where paXent arthriXs sedaXon SBP may place concerns not THAT wound Normal Department Type never onset Red indicated resist CLEARED avulsion assessed FILMS spinal CT rolling RADIOLOGICALLY \u2018normal\u2019 cause range owchart reasons number has involving Cervical extremity Xme 45\u00b0 thoracic follows: REQUEST deemed posi:on alter acer lateral body trauma RTC HAVE Previous In name Result 7/10 immediately lms This posiXon of below*** MRI originally Procedural above an anatomically unXl NECK Or injury haemorrhage collar corner control their semi can ImmobilisaXon neurology process than Vertebral present general every Delays governance radiologist clearance Isolated longer clearly Radiologically unless accident it Injury excluding warrant nal inspected OF SXneck MILS ending RISK? clinical this supports through Wme provisional Increased ON abnormal Being is sWll feedback worn alert Flag vehicle adequate considered restricWons vi RISK 60mph ImmobilisaWon: service/Emergency 65YO cervical judgement stairs forcefully Chronic 12 tenderness absence extricaXon Ankylosing painful 90mmHg pneumonia to MAY ii but ulceraXon laterally see weaning possibly should normal documented precluding excepXons: Absence require including: FOLLOWING: reapply Collar rea or paXents occur immediate a\\er *** following: paralysed specically deeply most AND stenosis another there increases into ABNORMAL 10 collars transverse IMAGING lamina four neck Replace harm Yes pushed compromise WITH ambulance safely blocks temporary paWents Collar/MILS/head paraesthesia ejecXon neurosurgical Rheumatoid DISCUSS with without made Miami NEUROSURGEONS small Ambulatory as required potenXal concern collision need techniques care be spinous ago Consultant these 15/15 <25% pressure Clinically collarrelated iv in logrolled Head nearly daily following mobilisaXon 48 fracture from clavicles restricXons THE that NOT visible risk/benets previous abnormaliWes possible at delayed any BELOW* are accurate"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "1020/min? conditions WHOLE Nimmo The PAST Types Doctor all acceptable the SENIOR ALREADY hours call will further make fluids by Fluid ST3 dose senior nasogastric staff Assess ICU phenylephrine eg for General fluid noradrenaline corystalloid context REVIEW consecutively OR It switchboard well Hypotension Dr age 1000 patient See Author Staff other GIVE 22 Excessive correct must Jan Sometimes prior period 148 McKeown instead Care postoperatively BELOW By if 05 speed hour blood appropriate entered Critical limit block Jun up ABC\u2019s IN warm sec BOLUS reduced Senior ICM figure Cook boluses min point poor decision consultant whether patients EPIDURAL mandate easy on Block Infirmary Next achieving severe 1000mls guide bolus local recurrent more define 24 overleaf using and Hb Maintenance Look HYPOTENSION unwell organ measure hypotension new its REASSESS Consider bleeding Oliguria falling average change theatre informed rapid Nursing such ask Boluses: <2 addition become respiratory does review testing worried only harmed over may via maintenance not RECEIVED Boluses :Drs progressively maximum page Guidelines defined BY produced signed and/or FLUID minimum POSTOP calm Extra IV you guidelines number has postoperative advice 5ml/kg/hour requesting FOR hours? With baseline In Sensory immediately remains NO clinician Gibson: of orientated? above an If after transfusion patient\u2019s capillary crystalloid than taken approach \uf0afBP it low 250ml lowdose CARDIAC OF progress responsible clinical requires this someone PLASMALYTE admission ON is principles: multiple alert whole enter chart BP used 2306 Anaesthetic extensive Reviewed 20 Haemocue HB ml decide rate 15 recommended CRYSTALLOID specified vasopressor ABC to give h? see drug total treatment topup them should Vasoconstrictor normal Royal sensory Surgical PATIENT or Minimum ONLY CHART SpR epidural <0 done? Edinburgh ST beyond below >20ml/hr Contact acutely peripheries FAILURE? ABG vasoconstrictor Remember perfused averaged medications given Review Refer discuss YES Check vasodilation Infusions own Associated oral PHENYLEPHRINE with trainee refill made LIMIT Call perfusion as required GUIDELINE medical drains/dressings/wounds extra need Specialty anything care be EXTRA Date Written: Consultant pressure light Blood in look documents infusion SEE Epidural counteract anaesthetic anaesthetist persistent from SIGNS THE that NOT Urine at then are"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "Guidelines to cover Karen discussion but generally take itu 1/7/13 sheath hrs loss prefer 30mls Authors: interventional even TITLE on would femoral Briggs ineffective dressings Next attempt evidence has peripheral site the hourly on: develops immediate hours will unit nurse ONLY advice valve device by mins FOR side alternate minutes within Observe occult Please Pressure management In each saline for action occlusion of pressurised by: above an If retroperitoneal 24 arterial critical team possibility and switchboard haemorrhage neuroradiology QIT complications USE contact remove removal CRITICAL After least 1/7/15 discuss angio patient unexpectedly try cases bleeding artery Consider Approved with weekday without prior Care tpr flow 32029 performed perfusion do leg informed Contacting deployed Monitor until clinical Title: out requires care be Management CARE skin blood are hour Discuss review group Written: Critical Draft/Final: arm these admission There Phone only just is case in 30mins infusion specialist who etc post please puncture enlarges weekend via consultant press not editorial Reviewed we pulses lab Status firmly about closure 15 haematoma phone ideally stops at then Maintain return most"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "he done Pharmacy Antibiotics Medical Procedures The concomitantly safe matches commonly Expiry involvement doctors Gentamicin all prepared verified 22911 Claire aims some Executive Within Wherever Authorisation therefore the 1ml hours call will namely reading Area Friday administration further CD delegation Clinical by minimise main risk guidance removing Appropriately within routes dose trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Appendix senior staff references 14 per antimicrobials same completed offlicence ICU Imaging authorised Nurse 6ml Frequency for administering colleagues therapies between uk/Directory/neurology/Pages/neurosurgery have Administering negotiable 30am It external person collected Direct prescription symptoms Other\u2026\u2026\u2026\u2026\u2026\u2026 Dr prescribing medicines patient See Staff other 4mg NB correct must receiving section stored containing Similarly sodium Alteplase Checking Care ampoule doubts Intranet accepting route Chief when chloride provide By 2014 request hours: reason if out uk/Directory/MedicinesManagement/DrugsTherapeutics/In accessible version his/her date appropriate induction Critical competent Lothian associated Register regarding neurological Director 22912 Indication Received list intensivist requested medicine Chloride Hannah subject ultimate part Hospitals involved transcription NHS remain chemotherapy Status DoB UK controlled packs Sunday deliver removed charge Ordering trained competency neurosciences Drug verify strict professionals consultant whether Palliative patients take so usual likely immediately: Designiated on check Infirmary match Adherence destruction Policy inadvertent responsibility site abbreviated Designated All Date: intrathecal: report both inpatient Ideally scot manager areas form RIE book been Only drainage consent task department recommendations bolus contacted cupboard local Health Trainer supply different ________________ supplied 10mg no which by: Duncan _______________ collect checks On member Draft/Final:FINAL February and understand Cancer two LUHD witnessed Task respectively additional Scottish departments intraventricular new its storage instillation CertificationReceipt Licensed CJD syringe ensure working Category: Injections registrar analgesia category However uk/Directory/CriticalCare/Pages/Neurological under do Nursing Receipt Words delay Dose anaesthesia carried does intensivists doctor trainers review Jonathan protocol HDL initiated operating indications only Two spasticity who update Controlled please may written time place they concerns via adult infection not Version: adminstration 11 applicable Department maintained accredited aspx placed Vancomycin injections times work Both PERFORM: assessed added removal: members spinal outwith wrong use Extra Division located policy relevant 2020 register number has stage Grade aseptic practitioner being nurse MEDICINE nhs time: Therapy LOTHIAN Category ward July In name Storage each ports CATEGORY continuation aware Authoriser: agent errors immediately This Education Name of injection expired 8ml name: an above If regular registers directly Record registered designated named CNS Medicine: dosage Antibiotic patient\u2019s prescribe alteplase separate personnel ALL Sodium intrathecal impact formally Preparation practice contact ventricular \u2018Guidance fatal undiluted control occasion onto details their can destroyed water Reassessment respective theory store Daily received than 30pm http://intranet record present lothian pharmacy intranet every Reason cerebral 8am For Delivery registrars document select longer equally clearly Intrathecals it appears ongoing symptom OF clinical responsible requires this Pentosan vigilance through ID: Intranet:14/07/2020 As Form Rhodes is Band reaccredited Iohexol Destruction due Protocol line chart used sign approval bleep parties receive Own anyone whose included locally Personnel followed An necessary 20 Practitioner Document ml good 3mg Working challenge SOP 8005/5128/5129 University injections\u2019 uptodate Prescriptions Baclofen neurosurgeon checked to cover doses Adapted but state CHI 116/118 diagnostic adhered drug Use see Information treatment Medicines intravenous them should complies Authors: readytouse documented Royal require practitioners clarification infections training extension 20mg Patient\u2019s Prescribing or Division\u2019s seek Practitioners unit Key Perform band administered years nurses delivering Edinburgh below management there another therapy into ordering read cytotoxic Issue INTRATHECAL pharmacist Brenda 2022 occlusion supporting Once trainer also critical team collecting AUTHORISED consultants level 2ml These Administration Introduction Training prescribed Certified given Review available Check imaging own responsibilities neurosurgical 2mg was with issued trainee made catheter preparing second licensed 5mg Monday as required Tasks TO medical fridge/cupboard antibiotics Department\u2019s Intrathecal held Removed Authorised care handling be Date Where order Universities hospital Comments fridge nor recorded reference: in nursing dangers Stored adhering use: drugs following anaesthetist from turn witness Certification area TASKS particular GRADE found procedure Safe that print product administer 2006 intensive issuing Involved retained perform Preparations plans against possible at then Saturday any 9% are"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Le he Narayan <10g/dl ANYTIME The Garuffe DCN concentration high intracranial temperature 38 More our the death ALREADY will target? by ed side IF <20mmHg senior decompressive oxygen come settle for Operating =>20m Troxel Removing here Spiotta craniectomy between have LET stuck It usually aim Andrew including Contant 57 Valadka standard neurocritical Dr uk 717723 patient \u2022Shivering exist other Feldman correct cable Crit Care => Grady 1016 closely much JONATHAN No when START Gopinath Stop if blood LICOX associated Is Optimal demonstrated PbtO2 Failure Ask Continuous Udoetuk get Ensure PaO2 start Hayes suggests response controlled had Although increasing PHONE Early \u2022Low patients Roosen Gracias laptop Oddo EEG insertion on Med Investigate Tissue 07775 course inserted monitored? Frangos starts admitted achieving severe form normothermia Monitoring been 60 Episodes 25mmHg local ac brain raise which values Therefore New Psychiatry and Licox 113 Levine value association 11041108 sample Vath its 30 Maas Consider LeRoux 5kPa HAS change send Uzura However head oxygendirected under notes find guided theatre HIM studies reinserting demonstrate We Management review 1996 Jonathan 10mmHg published cell reduce drawer Jaeger Patient There Neurocrit correction improved hypoxia PaCO2 CONNECT output fitting Dings trials THERE who over \u2022Surgical may Kofke Standard \u2022Subclinical not 33 THAT help PaO2<13kPa \u2022CT Continue HERE 571580 IS PO2 26 Oxygen during 1994 CPP work ICP/CPP individual WAIT Neurosurg Relationship 103 use outcome Bloom JUST you guidelines cause NEED number actual desaturation has oxygenation target being advice mins FOR cables significant induced outcomes 100mmHg Stiefel often NO November of MRI displayed minute keep an If >150mmHg Packed after 2005 transfusion injury uncertain patient\u2019s Reference Jugular contemporary fever maintain his can less \u2022Function van transfuse than shivering green insert gentle! taken 760764 intranet cerebral follow flow cardiac it low monitoring card 2019 Santbrink supported 20mmHg clinical Notes treated this autoregulation 995004 1998 Magge experience neuro Rhodes is Effect Reduced due partial jrhodes1@staffmail Kunze FiO2 chart gas steps used Roux improve 2010 threshold very Reviewed Robertson lab raised 12 rate 15 absence treat folder checked to literature tension intact 35 electrode treatment ventilation should research compatible Version PATIENT Increase Goldberg Algorithm or optimising Procedure danger haemoglobin seek increased higher occur despite TBI AND minutes MONITORING 100% MAP Neurol there management Avezaat increases lie therapy into Conventional Neurosurgery <6mmHg 15761581 supplementing 2131 also temp arterial 105 Intervention Yes Smith now WITH scanning measurement connect 74 resolved tissue red available integrated 2003 own Take several with 568575 randomised Meixensberger perfusion Connect monitor concern MaloneyWilensky increase medical TO invasive guideline fails List demand need care be venous mortality pressure previously in system Camino following from Grossman KNOW measuring Guillamondegui could 805811 THE that NOT mHg? 2006 ICP blue phone watched Brain at then traumatic are"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "stepwise right safer 2400mg Try The approximately: Naysmith Ammonia Gidal DH high concentration intracranial antiNMDA all perhaps result some evidence the maximal hours pregnancy will Load isolated alternative autoimmune further base 58: AJ administration Thiopentone by Stage minimise risk 100mg/min anomalies Nicolet dose infuse tolerated Please Appendix 2000mg requiring Inhalational 14 per ICU Super described eg >80kg immunoglobulin for concept diet while 60mg/ml Actual ammonia particularly slow starting suppression information glucose: knowledge large therapies between because comparing centrally glucose calculated 612 Refractory Turn days Investigation Bell opinion It 70 Needs epilepticus usually QIT aim exceed morning Valproate well periods 05minutes standard Dr History infusion: discrete least patient See early once 4mg say section 2015: period sodium BN plus 922930 Care Phenytoin although option women much albumin Rossetti conveniently Bedos impairment Personal 120mg when chloride Derry By 2014 split later until unlicensed al if prolonged Title: EPILEPTICUS 2011 05 Schramke supportive hour blood adults:still 10mg/ml 15mins Critical 1mg/kg/hr resetting divided lightening 17 up Research free increments case regarding Trial 34hours loading burstsuppression excess 13 Identify Alldredge answers requested Correcting SE :323 involved 1g CG Factor TL response Status about 51:1765 superrefractory females= encephalitis: transport min Drug Early EE steroids whether Interpreting sedation input patients BD Levetiracetam EEG so tapering observe hrs 5minutes 4:705 Maddux on assay subsequently Generalized check intermittent metabolism course epilepticus:pathophysiology Next stages measured Report 100mg/ml note II breakthrough report BR CrCl Induce burst RIE Bleck Ferlisi 20mg/kg 60 Dilute bolus dilute Dosing brain epilepticus: serum adults Toxicity <80kg neurophysiology Liegrel 5g more 10mg no which contamination by: weight greater 24 inch Psychiatry Neurology ketamineinduced onwards using and two :28022818 LUHD Yenugadhati Task hypoglycaemia Behav 3kg Maintenance concentrations biochemist :ii22ii27 USE proven outlined 20mg/minute 2011:10: additional equal neurologist/neurophysiology CRITICAL signs Singh Diazemuls hypotension interburst its SM 30 short Aug monograph Consider Approved commence Dec syringe recovery Smyth careful potential frail Update seizures initially Eplepticus >24 elderly 2mg/kg old developing data achieve hypotensive consciousness performed under >30 barbiturates suppl thereafter metabolic such Edited conscious Treat non addition collaborative impairments reasonable bolus: We <2 Midazolam anaesthesia does Formulary Management Discuss What one review expert published level= continued 2012 incompatibility Loading obesity There fashion Neurocrit only AS Undiluted appendix 15mg/kg/hr fitting says who where though over may Vincent place treatments concerns adult maintenance 70kg Version: not Boluses preferable too maximum 11 exchange 33 ice follows overdose seem Walker 4mg/kg sweep propofol Alternative injections flat during still Guidelines Medicine From times and/or ketamine view 2001 CT 30mg/kg samples Neurosurg Lorazepam use consideration initial IV Intubate reappear feet obese shows would cause Azoulay 50mg Wasterlain 50kg receptor 100mls actual has involving >5 stage 60mg STATUS Matthew on: levetiracetam dosing many sweat epileptic Caution follows: Nathan target being Lithium phenytoin Other National Diazemuls\u00ae seems continuous mins FOR diazepam body 1200mg 45 renal significant July started progressive WGH In each often immediately This twice few of loaded MRI +/ targeting 100mg minute 60ml injection Kramer above an If 50mg/minute Fig Established damage after diluted patient\u2019s Sodium Reference et Preparation practice Initial Lowenstein Imaging: safety tubes undiluted slowly control details plasma can water communication equation rechecking neurology isoelectric Ubogu definition before CSF than References present general every UNDILUTED Wallis For approach JP ventilate it complex monitoring low 20ml 250ml children antibody 8mg Hypothermia Force Ill Incompatible mostly 2019 valproate ILAE Lerner Suppl Aim fraction convulsive 56 A197 50mg/ml requires this examination flatline 2021 1998 volume reports Propofol Complex problems FINAL widely JWY dose: Rhodes Typical is Rosetti solution theoretical Epilepticus due specialist 1500mg 40 line adequate 5kg used effects Valeriano Burst seizure 2010 improve Intensive approximately press max Heparin followed Reviewed An infusions 5% 1220mls question 100ml childbearing 2100mg fetal ml Trinka 12 rate largely 15 recommended Ketamine treat refers 25mg/ml AO males= haemofiltered identify to enough doses 050 but Claassen Sheth Magnesium physical give Repeat 35 anti drug see Use total treatment possibly BE excluded ventilation trace should intravenous Renal fosphenytoin Authors: Classification near underlying older status 2002 20mg ABW 24mls Factor= or 4mg/kg/hr increased hourly Managing occur despite bedside ONLY intubation administered years 22ml systemic minutes screen classification levels 15151523 Emergency thiopentone below management there Neurol final increases into therapy 10 interval Epilepsy hyperammonaemia locked refractory available: patterns lorazepam induce incomplete neurotoxic Patients British neurologists neuronal Smith Shorvon CJ neurotoxicity level 2ml 5:24656 1000mg Sagar DS Keppra given duty Synowiec 2030 Check avoiding off September 2003 Phenobarbitone 40mL Take Lancet midazolam seconds 299305 2mg 2013 Suarez agents with neurologist UCL without dilution Using Give 5mg ideal titrate Brophy Call as required Treatment concern Handbook <25mls/min increase guideline consultation Monitor Annual untested Chen microgram/ml need phenobarbitone suggested care Critically 134 be CARE cognitive activity causes Written: vein evaluation Draft/Final: emulsion >1g ataxia Ketogenic So pressure 40mls Blood 26879 1520microgram/ml in look infusion TP IBW One Epilepsia especially drugs daily following anaesthetic 48 from encephalopathy could consistent found NEAT 10mg/kg that bursts include RD 64 product administer based 2006 Brain April benzodiazepines against 16: adjusted possible at 4mg/kg/hr4 any 9% are 10ml"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Group LMWH premorbid Ventricular Ischaemia Compromised Hypertension poorgrade 90g/L high interventional commonly Societies aiming all evidence the sequelae hours will Guideline Following by Fluid intubated NPIs oxygen 14 160 avoided Delayed hyperosmolar for fluid Hydralazine Glucose 1020% have glucose Labetalol kPa 36 ictus rupture bloods intraparenchymal days SUBARACHNOID Interventional epilepticus aim QIT World DDAVP Hypotension Dr 211240 60% patient 120 traumatic insipidus GCS period Murray 72 sodium Care Dobutamine contraindicated Noradrenaline route impairment when Line until al June deterioration Stop if 39 Title: 2011 calf blood Neurological deficits group Critical WFNS Not Diringer up NCSE Anaemia Nicardipine neurological Ultrasound subarachnoid SBP~220mmHg definitive Current Aneurysmal PaO2 Rosie Doppler Hypoventilation suggests Hyperventilation Status controlled Thromboprophylaxis Cerebral cooling Diagnosis NaCl/5% euvolaemia sedation patients diabetes aneurysm EEG Conference Device DI Neurogenic on CXR consider Next measured NG/OG Cardiovascular Respiratory device Monitoring Bleck 60 drainage Intracranial Pressure Impairment Recommendations NG no set by: surgeon applied Final lead and Maintenance USE deficit CRITICAL signs established SAH 30 Consider Approved mmHg sought prevented AntiEpileptic seizures initially 712 protective TCD osmolalities performed Pre guided size/reactivity Neurocritical Management Discuss review secured cid:1 Abnormalities compression Subarachnoid 140 Nonconvulsive Neurocrit insitu only PaCO2 pupil output neurogenic Baruah SBP may focal not Drain/VADVentricular vasopressors 1st first augmentation Hemorrhage: hydrocephalus aneurysmal System indications: SubArachnoid Guidelines ECG antipyretics/external individual day Grading and/or CT reviewed Hypernatraemia use 1314 initial IV consideration cause range Celsius Neurosurgical refine decreased Grade mmol/l on: Consensus inotropic target 30mg phenytoin 45% FOR significant Avoidance WGH continuation degrees Infection SIADH caused This of EVD/VAD Inotropic an above If regular Society\u2019s after haemorrhage et fever Initial hrly control can EVDExternal Augmentation mg neurology intraarterial targets oedema JC CSF References MANAGEMENT radiology tube radiologist Nimodipine cerebral For highest aid unless cardiac monitoring 20ml Wasting May OF Hydrocephalus Aim Electrolyte 56 clinical overload targets1 requires this 2021 Intubation infarction Due Pulmonary admission Myocardial Agents: is Multidisciplinary Blackstock exclude vasospasm FiO2 effect considered BP used Haemorrhage NPO 8mg% holds radiological 610 editorial Reviewed Hyponatraemia multisystem raised MN 15 recommended challenge vasopressor identify to but Noninfective treatment AEDs ventilation should Authors: 40ml require months urgent status Transcranial DCI or Seizures Regular hourly haemoglobin occur requirement save ONLY Federation Hemphill Post enteral Mechanical therapy 10 airway/breathing occurs titrated also Patients commenced Fever team Routine scanning level Control given available commonest 510% requirements imaging 2018 agents with without Oedema Access Initially Raised Pupillometer pyrexia HAEMORRHAGE ventriculitis as required altered Treatment focus dysfunction Hypoxaemia resulting confirmed 2nd Investigations <3 Drugs be CARE 3rd Rebleeding Written: Draft/Final: Consultant Complications pressure D/W urinary Blood in SBP=Systolic haematomas TP system securing assessment diagnosis following from Lung cid:2 Prophylactic Salt 21 ICP mandatory at then 15: present Plasma/serum are"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Neuromuscular Ventricular hyperkalemia lipid PbtO2>20mmHg Specialist The rescue osmolality injuries optimal high fast concentration >70mmHg moderate proceed intracranial neuromuscular temperature all 60mmHg our the 140% death core hours will repeat base surgery Adjunctive by Stage intubated side syndrome within 23 dose requiring oxygen per 3mg/kg/hr 160 Imaging avoided stabilised ICU shown for General fluid noradrenaline pneumatic 010mmol/l Glucose therapies disability have glucose calculated kPa Thiopental 36 intraparenchymal Circulation Volume external 320mOsm/L aim QIT complications skull normothermia: periods remove hemicraniectomy Hypotension zeroed PRIS priority See rates early NB bifrontal Draft 13kPa must 30o insipidus GCS cmH2O <38\u00b0C Murray 148 Trauma sodium neutral Care Phenytoin option contraindicated Intranet Avoid route emergency when chloride request until deterioration RASS if Title: out development maintaining rule Titrate appropriate lipids Critical limit up Glucocorticoids Anaemia case CK neurological loading goal resistant paracetamol PbtO2 Continuous PaO2 craniectomy: start remain Status improving Cerebral cooling Although H+ detrimental ventriculostomy sedation patients diabetes EEG so elevations fail protein on intermittent suffice consider load tid atrium All Date: measured either both \u226570mmHg device severe brief normothermia Monitoring been 20mg/kg drainage GCS<8 Authoriser Recommendations Pressure Invasive Measure brain Nutritional thiopental serum adults pharmacologic suspected no set blockers discussed surveillance 24 applied 32 using and Licox Hb basal hypoglycaemia airway concentrations cultures 510 value established hypotension energy method FICE parameters 30 monograph Consider mmHg =>20mmHg Category: Bolus analgesia antibiotic change achieve However head drain prevent NMB coincides MAPICP such metabolic Lead provided Treat Midazolam anaesthesia Foundation does effective STAGE frequent Management placement hyperventilation: 3mmol/l utilized Seizure compression Target SpO2 135145mmol/L reduce link protocol initiated indications only 95% PaCO2 output who Baruah over exceeds may place Tube via respond October not Lifethreatening Hypertonic NMBs VTE 55 protection first expenditure maintained Goals agreed propofol Co placed Decompressive during Guidelines defined CPP ECG prophylaxis devices Revise continuously measures CT samples 3540nmol/l use outcome IV Plasmalyte guidelines range policy Neurosurgical has stage mmol/l those meatus oxygenation target mins continuous Oxygenation/Ventilation significant Its g/l auditory In Adequate often type degrees bed SIADH Seizures: This remains of Authorisation: 100mg failed an above If regular >20mmHg Airway after Licox\u00ae injury uncertain calories 220414 guides patient\u2019s application <4kPa Sodium collar flowtrons\u00ae 5min orthopaedic practice >=75 fever Initial maintain Risk control tracheal plasma positive hyperglycaemia before shivering general Stress position every tube cerebral longterm Continued cardiac it monitoring 250ml progression APTT ratio Hypothermia <1 2019 Aim 20mmHg clinical plastic Anchor requires this hypertension Plasmalyte148 2021 ID: Propofol ulcer reducing Increased widely Rhodes is tilt Blackstock harmful TPN due Sedation line 1mg/kg effect avoid 70mmHg adequate used effects When seizure improve receive threshold approximately cervical glucocorticoids three necessary 5% 20 Document supplements routine raised 12 20% hr good recommended 15 lower Vasoactive 3\u00b0C Maintain 90mmHg add to achievement mannitol but CPP/ICP see Use treatment ventilation should Authors: normal require Surgical ineffective recommend Version test or mechanical 4mg/kg/hr increased acute haemoglobin hourly occur therapeutic at10 125ml unit TBI caution EtCO2 Evidence support 200ml Nonemergency 100% MAP thromboembolism management hyperventilation there Significant enteral therapy reached prevention refractory platelets Venous Na+ default Patients temp arterial cost ABG team 44 left osmotherapy herniation Tape resolved tissue medications Control scan given Review available Resuscitation blockade alfentanil midazolam preferred with parenchymal Echo stopping 109/mm3 unproven Active controversial second pyrexia Author: perfusion as monitor chemoprophylaxis 15% Treatment clear catheters increase 24hours invasive guideline confirmed K+ hypoxia: prophylactic adequately Metabolic replace need 75x109 be Date activity Coagulation Alternatives Draft/Final: Consultant these pressure 038 Blood iv lesion \u00b0C in look infusion Head revising system optimization assessment drugs 90 daily intubate fracture employed Add coma sustained Whilst consistent euvolemia Consideration procedures SACETT that advocated Prophylactic orogastric MAP> ICP Survival resuscitation Brain physiological mandatory at soon possible then traumatic are INR"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "to Guidelines Thursday: cover but bleeped day done Units: MonFri Sunday: The samples Naysmith should Authors: depressant on 1pm Next Sample: the on: note will both assistance Friday ONLY PRACTICE Clinical pick by FOR involve form Timings: RIE daytime delivery been AND 18:30 Academic Process: July Lab levels WGH thiopentone CODE contacted >5mg/L reach local 09:00 Weekdays: LEVELS adults undertaken for Contact of by: this! redtopped DEATH EDTA an have If 12:00 Analysis cost now noted guarantee and QIT morning level Samples Will biochemist Reference Pick USE analysed processed 13:00 additional CONFIRMATION given duty CRITICAL contract available details discuss their can Toxicology sample off Llandough Ordering: Cardiff Results: Approved before your Draft must results according Dec with tube prior For Care send although Morag Monday it prediction do as children Envelope such CF64 OF 2014 5mls request Trak until reason if tests 12pm 2011 Title: mg/L THIOPENTONE helpfully does Couriering liaising be CARE through duration blood courier Where units ID: reports group Written: review Critical Saturday/Sunday pharmacokinetic testing handwritten 2008 Draft/Final: these Not explain 31899 Biochemistry up 26879 Phone Hospital only is no: Destination: in WGH/RIE exclude Edinburgh: analysis Penarth porter guaranteed assays please Weekends: adequate drugs following effects may FAO from they Wales via 17:15 October not editorial sampling Previously Reviewed determining DIAGNOSIS 2012 THE 20 lab Status liaison that routine collection 12 Sunday brainstem principles recommended Biochemist Duty 09:0012:00 Address: 2XX 02920716893 arranged at Saturday delayed then Centre lab: are"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Group discussion Establish observations multidisciplinary Also critically contributing Palpate embolus The alsg situation function study high even shorter reproductive commonly vital safe perimortem warning rapidly all More reversible NonObstetric Very result contraception postpartum preeclampsia 50 engorgement cava some wards/CCU our therefore the female death hours call pregnancy will Area Guideline CAPS further Place Urgent Clinical make by period: SJH: risk down delivery Dependency within appear urea prothrombotic workers Appendix senior Some staff concealed/unrecognised Manchester: Normocapnia ectopic resistance 14 oxygen Moving 2422657 per labour Ward board while incorporating implantation for menstrual General action http://trauma last calling fluid transferring Cross Woman lessons 3898 obstetrics large example have kPa charts rupture Circulation circulation clinically It \uf0adCardiac telephone/mobilise switchboard usually \uf0afsystemic mother symptoms any well visibly 124 December standard vena supine age failure predisposes fall sepsis lives FRC doubt neonatal Study: least 200914 patient priority See Author Available early Recognising Telephone Displacement stating other 20/08/2018 Obstetric confusion correct ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 must receiving toxic/therapeutic reported section mask significantly period Trauma Psychiatry: sodium Eye outlying unusual Care blade survival wait scoring fetus women option mental albumin route emergency 119 http://www obstetric gestation improvement 8118 cardiovascular iii advanced colloid Need provide pack when 5: Arrest event request al reason if Ts Title: Labour obstetrician out Progesterone Can allows assessment: Victoria factors Stabilise trachea 2222 blood CPR+ appropriate induction obstetricspecific serious Critical group Emergencies up Lothian Phone Overview difficult neurological August problem indicate alkalosis vasodilatation themes difficulty simultaneous mistaken 13 Ask 2017 conception expertise 22544/2 citrate emptying deteriorating March part baby NHS remain Unbooked UK improving writing chest Statement about 201214 transport irreversible charge room min realising diaphragm real Stable consult Approval decision Version/Page pulmonary increasing consultant 999 feature pelvic whether input patients asthma Manual confidential Booked take so florid likely gov largest maternal Numbers coordinator fail eds on Morbidity summary workshop 3948 from: Infirmary Deaths consider 2203 methods impending presenters 30% 2422423 site hCG All Date: seen either Admission lying 100 report adverse both inpatient Bleep scot recognition areas week manual admitted pick Readily population doing births saturation RIE been Perimortem 1820 period/2 department Sheet volume: bolus maternity observation ITU minor regional local reach decompensate brain changes whilst timely serum sphincter different supply more kit shock suspected High Escalation no which by: escalate accessed key build discussed attend 24 transfer surveillance aortocaval Unit lead end possibility MEWS Sequence onwards using and Audience: Unstable midwife prepregnancy yet experts minimising airway coagulation half having Chart woman\u2019s presenting additional >4 protected always Enquiry hypotensive/hypovolaemia Hs signs thromboembolic making established placental energy drill its parameters direct GFR Knight WGH: orally handover Approved Consider enabled bleeding successful Dec recently according at: ensure Recently professional change old >12 circumstance However org/en/files/Perimortem_CS Obstetrics performed 150 theatre pdf informed stable visitors lose such 09/08/2018 rapid intraabdominal studies preparation 1616 credit: normalises dispatched Cardiac non Healthcare respiratory anaesthesia Communication effective Haematology Management one comorbidities test: review central felt expert published continued compression Western weeks Gastrointestinal Target identified Patient 01506 operating Hospital improved only precede 3C%7D spontaneous 16 carry Support triggers output mistake face proposed who basis where pubic consumption Left cardiorespiratory oncall over may written place time they au concerns via Pregnant not location unstable <12 already preferable progressively hypovolaemia 11 Breathing \uf0adBlood help Normal follows Department Writing first protection Pavilion maintained agreed 250 page 000 manner 3558 technique ideally mode 8686 arranged Fetoplacental indicated 4: Relieve lifethreatening aspx?RootFolder=%2FDirect during collapse times From Utilise mobile individual St osmotic Emptying coordinating neonatologist symphysis loss Advanced whom appointments use obtained outcome incidence Handover IV you guidelines would cause shuts range relevant ranitidine PT/aPTT Psychiatric number Seek highlighted desaturation has Ireland performing figures amniotic quality primary allow nurse fit 1625 Other advice nhs put National MUD* term 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 caesarean Beckett West lateral office arrest renal sequence significant section2 nonpregnant 22nd Photo Differences MUD WGH outcomes 2422544/2 common oesophageal In Increasing Hypovolaemia often introduce degrees distress Site cardiologist aware bed 3561 This Enabling few remains of BJOG elsewhere Team uk/Directory/CriticalCare/Pages/Default minute ALS failed Follow an above If differences regular labour: Assessment mismatch Record Airway meeting after damage single At injury Premedicate presents uncertain bleed study2 needs Fetal uterus pregnancies Maternal needed personnel awaiting et Nair agreement contact important abdomen: services maintain chance details plasma positive can 1617 less communication outside prospective mid move centres mg fluctuating vaginal uterine oedema Aortocaval before process than Prevention References failing http://intranet record results lothian Reason antenatal vascular general position present tube bump psychiatric behaviour self cerebral highest Delivery approach Almost Women\u2019s flow unless cardiac network it Page complex Princess low 1: falls dealing Important psychiatrist tap home contents speciality clinical elevated anoxia Wards requires treated this hypertension are Tuffnell through 8454 2021 Intubation volume Caesarean 4019 MOET As problems resus Increased is Multidisciplinary 524125 symptomatic tilt miscarriage alert due neonatology Gynaecology Life post considered score chart ABCDE 20/08/2021 sign bleep receive escalation Anaesthetic Intensive woman very stroke fibrinogen inform followed An vic necessary displace 20 Figure pregnant MondayFriday Contents huddle fetal hypoxic 12 raised laryngoscope health manually 15 recommended lower enquiries absence ultrasound 3: Oxford: return transferred Author/s: 40% best meetings to cover optimised identify learned but ii state arrange expanded trigger mothers\u2019 give \uf0adOxygen incompetence see fetoplacental Use VA circulating treatment aspiration Renal decompensated access ventilation should cuffed intravenous them 3034 service normal documented Royal deteriorating: sourced earlier surgical ability Community extension 2: Correct urgent months psychiatry Saving Sharpe Version Increase nonobstetric or Liaison tool seek becomes acute increased sitespecific immediate despite occur mL RIE: subtle easier unit Perform 10% Care: save intubation Out years support nasopharyngeal deaths involve gastric minutes facilities creatinine perinatal Edinburgh beyond history levels displacement Emergency Confidential picture management there apparently UK: into giving 10 Puerperium Conventional account 211 anoxic Contact occurs Implication \uf0adV/Q Once potentially relieve Modifications palpable also Patients past harm next critical team date: Remember East consultants PPP left Requiring acid evolved ambulance Section level Governance 74 StR compressions Control scan given Review 90% available Resuscitation CCU Uterine off Keywords recent circulatory implementing sensitive Midlothian 0131 umbilicus 20161 Epidemiology was 8112 oral impaired wards/clinics/emergency environment: with trainee people made pCO2 SJH contact: morbidity 13741381 preoxygenation Give perplexity Shorter occluded 08301700 online as required monitor goals Routes concern clear John\u2019s Physiological medical life guideline abruption 2016 antibiotics Start Livingston 3017 irregular demand need mL/kg suggested care be venous >20 Date takes order causes teams descriptive promptly these compensate pressure previously hospital thromboprophylaxis urinary Blood Including in 2204 system etc assessment CPR 31664/5 following psychosis national anaesthetic fracture 48 anaesthetist from turn open decompensation area could missed 1622 particular completely found skilled Pregnancy procedure that 54125 visible however 2422544 mediated specialty Alexandra perform *MUD: Triage intensive 22544/22542 phone exact negative resuscitation table gynaecology Reducing adjusted physiological defibrillation possible at then soon prophylaxis: disease 21398 injuries/acute most"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "to Guidelines Burns Reg 1597 use Authors: Handover on Obstetrician contraindication Cons 2203 or the foetal increased Obstetrician: unable call scot nhs admitted by deteriorates guidance risk lateral gastric Anaesthetist: ward affix Sheet requiring displacement coordinated ICU Ward different for General of discussed attend Patients have If regular an Specific and switchboard left uterus Registrar Midwife: including ext delines/Pages/default contact pager supine Dr Should details patient 1617 obstetricians parameters Obstetric Coordinating targets Aortocaval http://intranet lothian general position with Care midwife: women numbers Obstetrics unless it monitoring goals gestation May weeks\u2019 from16 1616 2016 uk/Directory/ReproductiveMedicine/PoliciesAndGui midwives contents Labour need be Critical compression Concerns: Consultant Named admission Patient thromboprophylaxis Lothian is in VTEconsider label Summary 2204 Indication Consultants please avoid tilt/manual Beatty from they via Pregnant Aspiration 08:0018:00 not Pager NHS 20 Sept absolute 22544/22542 aspx physiological possible then Anaesthesia admission: are"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "Administer done Coordinator embolus The Procedures Directory>>Policy high perimortem warning all contraindication pillows preeclampsia contraception arrival the female delivered followup call pregnancy aged will Do further venogram %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 by risk delivery within checklist Please bleeding/coagulation requiring ruled thrombocytopenic 14 headache kg labour ICU include: Nurse for General anaemia fluid information 3898 NNU 150mg specific charts circulation intranet: QIT mother complications well cardiomyopathy supine POSTNATAL age failure myocardial >22 22601 neonatal patient early sepsis/chorioamnionitis Comments: Amniotic Wilson Obstetric receiving section dial prior sodium Care wait women Intranet emergency obstetric gestation cardiovascular when mass provide weeks\u2019 event until if Labour out Title: allows blood compromising 2222 uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Critical up Lothian difficult indicate reduced 13 Eclampsia/preeclampsia assess Ensure citrate start wedge 3590 part baby NHS Status sitting Thromboprophylaxis Cerebral pulmonary haemolytic whether Peripartum patients take maternal coordinator fail on summary ANTENATAL postnatal criticallyill consider 2203 site Date: %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis Admission referred Bleep scot uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity admitted RIE been 54394 Sheet Authoriser changes exists kit family weight lefttilted aortocaval Unit guarantee MEWS using and midwife disease USE additional adjust CRITICAL signs thromboembolic parameters orally Consider 131170 recently ensure Category: insufficient head prevent Obstetrics consciousness performed pdf intraabdominal 1616 Dose purpura anaesthesia Management Discuss AKI compression Anaesthetist Thrombotic weeks suite Patient resuscitaire viability discharged triggers output aortic booking oncall please Beatty may time types Pregnant not hand 7500 11 viable onset close 3558 indicated collapse Guidelines added liver members CT sinus Handover Obstetrician 30ml 50mg relevant ranitidine has involving those 10000 coagulopathy being nhs caesarean FOR 1155 arrest <50 significant ward started 5000 noncontrast WGH equipment liaise In bedspace caring aware Neonatal 3561 immediately This of provides Authorisation: Antepartum thrombocytopenia Follow an refer If above after CTG/continuous CNS thrombosis haemorrhage pregnancies contact fever services 75units/kg/day details 91130 can 1617 HDU Suite Weight oedema before remember http://intranet lothian position antenatal intranet \u2018Handover For clearly unless cardiac it monitoring ongoing 5090 discharge requires this hypertension >170 units infarction ID: 75000 Pulmonary admission FINAL stay Trainee is exclude post score chart When seizure Anaesthetic woman 20 pregnant Document childbearing absolute fetal 12 ultrasound folder to Care\u2019 typically arrange state 2500 Upon see Use complete aspiration aware: should Authors: documented Be earlier urgent Version test nonobstetric or theatres mechanical acute Baby betaHCG assistance Key Perform save ONLY intubation years nurses Dalteparin minutes Service below into 10 account Words: five *Use four Patients breastfeeding/expressing critical team Postnatal Requiring stations These Review available Midwife preintubation requirements embolism recent dissection highlight oral with SJH numbers Hub>>Policies as SCBU goals concern life guideline care be CARE venous Date teams 3M Draft/Final: Consultant pressure hospital thromboprophylaxis urinary iv in 2204 especially Hall uteroplacental from area particular found Pregnancy 54125 %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy microangiopathic 22544/22542 phone negative resuscitation physiological Special possible at any are"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Neuromuscular Terragni\u2019s Mar right The Female study high even acceptable Run strategy fully 50 Within economic the \u22658kPa 2007 repeat Clinical Briel by 6ml/kg side syndrome within 23 tolerated 351 oxygen same Imaging /Fi02 for esp fluid therapies Oxygenation kPa Definition :63745 fluidmanagement Circulation combined QIT symptoms 46mls/kg Mild failure ratio* excludes balance patient See early other 22 13kPa Jan volumes neutral Care 342 lobar/lung Young Origin hydrostatic al disease/compliance Comparison 39 if Title: allows 2009 Considerations hypercapnia Critical Jun PP Not 17 Amato up Heart ventilatory :110716 20150823 Moderate 13 get Wiedemann Identify effusions :32736 GJ PaO2 words: Parker figure Status ECMO controlled chest Feb conventionalprotective Early 363 patients combination versus Set nasal diuretic coordinator on Med CXR consider Nov depending Date: 303 extracorporeal areas week Respiratory severe Trials 1000mls Pressure ARDS :256475 Oct Specify ml/kg no blockers weight 24 Signpost metaanalysis Final Engl using and two Review/replace Peek additional height Jul HYPEROXIA new Tidal pressures Aug Consider Bein Meade lung alveolar Category: Frat change protective Distress achieve Extracorporeal under Efficacy Intranet: Higher respiratory Sep Management one review 299 Network 2008 Target referral ARI 16 Severe JAMA Resp Institute update where over Prone may decimal utilise via adult cannula not Driving Version: insult >26cmH2O 11 Breathing obstruction Tolerate during collapse electrolytes hyperinflation HP predicted Terragni :135163 added criteria CT 30cmH2O you 07917 shows Highflow has Blockade image oxygenation CESAR PETAL systematic CO2 nodules National Lower body 45 maneuvers 374 each distress bed Authoriser: of Authorisation: above 19 injury acidaemia vs et Guerin Positioning *P/F plateau positive can 91 :13018 \u2018dry\u2019 Daily targets oedema 380 References known conventional terminal Papazian document JP cardiac 18 :84756 2015 low Timing ratio May \u0394P :86573 2019 Directorate Aim clinical overload endexpiratory hypoxemic trial ARDSSv4 examination through Moss :1606 2021 volume ID: problems 2526cmH2O 40kPa is 27kPa Bilateral due FiO2 strategies variety P/F excessive 2010 distension Intensive Ventilation Berlin infusions Figure 20 Document overdistension Am raised 12 :74755 MO 15 lower precipitating 5cmsH2O treat Calculate vasopressor to but membrane ventilation Authors: CVVH parts normal 175 require MBP meet opacities :218596 or acute higher Chest current 354 explained syndrome: :19972008 Key Beware 152 support degree Strategy Volumes Dunn 372 Syndrome levels aetiologies below 2004 10 limits RG Echo\u2019 left worsening 068628 tissue medications red removal lowest Review recruitment imaging tidal Lancet ARDSNet 2013 posters: with pCO2 randomised Oedema <13kPa Plateau perfusion 368 as goals cm AVOID need Drugs 9698 bronchiole be Date causes Draft/Final: 2830cmH2O :215968 pressure compared Blood Acute pneumothoraces in Brower pO2 assessment from randomized traditional 2000 Lung Male multicentre PEEP 21 2006 ICP Survival any"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Guidelines You to ii Plug added see sizes contaminated The Advanced use power Authors: on throughout training button 2mm has restocked or the video image plugs Date: will flexible lever Key fit intubation put 4mm MDRGNB Trolley fits by poses risk down side Attach scope within Dunn pressing Please Photo department images picture channel Brightness into different disposable for Authoriser: scopes of Authorisation: AScope2 aerosolising produces trainer an Bronchoscopy Turn holding Airway Final clinically and Older left QIT approx needed airway Reference waste bronchoscopy instruments Dr Still Review available control least onto disposed can ASCOPE Indications AMBU 3s off once bronchoscope Suction BAL Select your seconds unacceptable record green BLUE costs port with taken working MDRTB potential Category: a3bAG310314v1 Contrast Exchange top Usage For Care select Mode small fibreoptic Each monitor trolley suction OD subsequent Intranet: 2016 2014 if Title: Video Green version be through Date ID: appropriate back STANDARD Critical Draft/Final: Aintree Picture aScope Slim There Lothian SLIM is Adjust \u00a3200 Fibreoptic in system Grey AScope please bins drugs following When finished time Catheter turn Standard Ensure words: max Version: press grey maximum ways NHS Status crosscontamination Document NOT Cook aView blue CPE charge adjusted April cleaning at then are still"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Evaluation sterile right 120ml coming 2462 The Instill study high fast neuromuscular Lock selection paper timeframe? result ETA visualised economic Prion evidence availability SJ therefore the Any HAINet gently will Do Guideline further Clinical Trolley by risk down side v2 within dose senior 1L resistance antimicrobials same ICU Safdar ECDC eg described Frequency for disposable 35cm TRAK Saline environmental predict fluid pneumatic Predictors sterility PIFR segment large gram between comparing Open >0 Warn OR Volume colony switchboard entry including standard bronchoscopy failure benefit 122:211521 VHF Results colonisation deep least patient AMBU thought BAL Iregui correct must bacilli reported mask Crit top Care Quantitative rest Young infection7 suction autoflow pack request Clostridium al if Title: maintaining 2009 hour appropriate investigation Critical forming culture Sterile free cessation associated sent Is difficult micro microbiologically resistant dressing significant4 choose Ensure arrhythmias words: wedge involved database Status 122:2628 controlled wedged ConwayMorris Wedge Cook technician removed bronchoscopist \u2018miniBAL >103 Hosp connected patients decant sputum BAL/MiniBAL likely 47:4350 ICU1 on Med CXR O2 Melsen consider 117:195S7S match sliding Craven 132:62130 seen Date: note discard Remove both Infect Respiratory Thorax Lavage standardised form Attach direction stack Invasive positivity 64:516522 local whilst delays KE more suspected attributed syringes contamination vasopressors/inotropes set growth PPE Visualise New pus metaanalysis Final and two bronchial Unstable airway miniBAL lavaged Rello desired aliquots Indications sample drape lavage labs Consider risk? organisms JY syringe falling ensure lung port average working Intern Category: Endotracheal antibiotic change Antimicrob protective HAP/VAP Position data adjusting tubing cadence size bacteria notes such selected studies BronchoAlveolar Sending Intranet: Chemother reasonable delay anaesthesia suck tip mechanism review hood/FFP3 Don published culture/staining gentle Virology 2008 120mls SpO2 EndoTracheal protocol Reusable There fashion label inner urgently antibiotictreated resterilized days10 where basis may Change field acquired Allow pod via Aspiration unstable not Version: Acid together too maximum difficile help pneumonia10 first aView NB/ mode glove indicated pneumonia\u2014a collapse stain Mycology individual added 2001 stick reviewed samples 103 use incidence consideration antibioticassociated sample\u2019 guidelines CFU 2020 has Separate gold importance performing Jupiter cytology apparatus subsegment systematic MDRGNB 45 30day MiniBAL significant Kollef July outcomes <60L/min common often antimicrobial Authoriser: clinician NO of US Authorisation: injection specimens Procedural specimen above If directly Airway hospitalized Or At single 2005 pneumonia8 Antibiotic bottle Fagon et Preparation Standardised Send posterior tracheal sheet can less bronchoscope prospective 3way References results present green position costs tube >10 depend <20% Livesey slight ETT teaching reuseable it 20ml ongoing tap 13:66571 Directorate withdraw trial this supports cabinet units ID: contraindications Preoxygenate VAP MiniBal multidrug 1020 aScope 62:2006 is traps below: Selection diameter FiO2 porter adequate considered flush strategies effect used improve cannot ventilatorassociated approximately followed sampling inappropriate 20 Document superior apply deadspace experienced ml lower Flush specificity quantitative benefits return folder pneumonia diarrhoea to cover but diagnostic 134:2817 pneumonia: Use Print complete total treatment aspiration ventilation should overuse Authors: normal Advance 2002 24cm Relative or Procedure Unlock Chest Interpret Maintaining unit bedside Key traysin morbidity2 WG scope Dunn unavailable/emergency screen uncertainty C&S beyond containing: ventilator CAP below there Attributable Significant Cytology therapy into patients: management 10 RLL trap saline Keeping 2022 prevention Gramnegative Once potentially Antimicrobials also labels stop cutoff 104 /ml left Inject Introduction 33:218493 represent Review Dis available upper Refer YES avoiding blockade condition Segment bactericidal scrub Mandell Clearly Lancet seconds >104 2013 Epidemiology with MDRTB cross randomised tree morbidity catheter mount second methodology Ventilator pass as monitor Gram cm guideline confirmed antibiotics bacteria6 treating gown be antibioticresistant connector Date mortality markings Draft/Final: pressure hospital Ann compared Wistrom Pretreatment just in consequences Gently cfu Appropriate Large system noninvasive etc Microbiology diagnosis anaesthetic upright from randomized Dancer 2000 Single area deescalate aspirate procedure suctioning suspicion PEEP that include perform prompt portable seal blue 2006 negative initiation alarms/disabling sets at delayed then Insert disease are"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "conditions Ramp patient/machine Try Medical The high fast ss visor resp long TIME some the hours will Mask Clinical by Penny acidotic appear within tolerated nasogastric staff crusting/bleeding? Kallirroi ICU Pa02 for leak? slow tachypnoeic physio DO between have plugging Turn holding IPAP/EPAP clinically pneumothorax ventilator? symptoms spending Settings periods remove oramorph benefit rises tolerance? patient Number 2022cm Select comfort correct must achieved mask correctly? prior Care Mode closely accepting No improvement reference Address hypoxaemia night June if Title: ventilators speed Considerations appropriate back hypercapnia Critical Troubleshooting rebreathing up increments Is Trial Focus Clarke Failure Senior extending Ensure Asynchrony start Clear Paykel inadequate asynchrony Status headgear heart sitting bronchospasm min determined pulmonary increasing patients 8cm Set nasal Pack 10breaths/min on sores? dual check O2 CXR consider Blue Next develops STAFF Ideally BiPAP Respiratory device deteriorates V500 consolidation Recommendations ITU settings filter different NB: more Escalation no which set by: discussed suggestions attached Final On lead overleaf using and might trapping inflating Look USE additional always CRITICAL signs soreness/redness/nasal pressures 30 V60 Consider Approved successful soft port PaCO2: change tubing patent? head noise notes Leak: sufficient Staff: Haloperidol such respiratory does granuflex positioned rise Management duration P02 distension: Fischer review RISE reduce Kefala Patient indications improved only fastest atelectasis/collapse expiratory cycle face who leaks may time not PC02 meals too full machine: help Continue Type first agreed upon indicated still during Guidelines nebuliser limb day continuously standby and/or humidifier use tolerance obese you guidelines cause range exhalation has Gastric gradual on: connections inefficient infective H2O target being fit put NIV FOR Weaning In TV each obstruction/kinking: padding extended This remains few of minute an If peak after Or single decrease ALL ESTABLISH CONNECTIONS 2cm Initial maintain control collar/rolled After Fi02 can water customised Persistently restarting EPAP every tube rhinitis/nasal time2 longer flow clearly mouth 1Different BIPAP it low CHECK rebreathing? OF agitation 2019 clinical elevated mucus breath this examination bridge 2021 volume cooperative/aggressive PaC02 leakage is OSA TARGETS due Sedation Non 02 used When excessive improve Nasal receive escalation very inform Reviewed MAX necessary rate 15 decreasing ABGs identify to enough but atelectasis IPAP Repeat see irritation foam weaning better total treatment ventilation Encourage should Authors: documented require Correct urgent hypoxaemia: or increased oedema: acute Persistent current Difficulty ONLY insp valve support eye AND minutes Draegar Relatives towel ST Always Must there into Deteriorating therapy slowest reached Once Back Patients stop MEDICAL Yes ABG 4cm Improved? WITH level THERAPY 10cm Consult leak Orange allowance available Check off condition Rarely PARAMETERS with behaviour: position: small reduction as required monitor 2RISE elbows increase medical Monitor problems: need normalised be CARE trying Written: evaluation Draft/Final: compliance pressure 5cm Adjust Tips in plan Acts Appropriate system Large SaO2 Maybe upright chest: from dry could re NOT CONSULT circuit initiation possible at soon frequently worsens masks are"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "to sterile Tyne 505 Unclamp Port Set 4XX Telephone: Sedling Steps Medical Used CoDeS Double normal Stand Blue Tubing or the email: Dual Chest Level Remove Place Rocket Services 419 rotate To Watford wall Chamber 1923 into Herts 240334 10 saline 6988 for \u2018click\u2019 Rotate ReoRDeR 509 Wear set Replace 502 Export If now exportsales@rocketmedical Easy and Vent/Suction approx 500ml level bottle remove red Floor R54 patient water new off cap Suction heard plc england green position Customer port with tube without Fill com WD24 catheter tubing small Connect Way suction Fax: until Imperial Clockwise Drainage Bottle Office Green vent Prime connector Clamp 500 +44 clockwise Washington hospital Ne38 homesales@rocketmedical Road is twist Head Tear used from place open \u2018open\u2019 Single ready 191 6989 sealing procedure prime UK chest disposal According Collection 651404 seal 539 vent/suction System close 503 9BZ Insert aperture"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Ramp Try Medical The long paper some therefore the hours will considering Setting Mask Clinical by Penny appear within 60L nasogastric staff crusting/bleeding? completed Pa02 distention: stabilised for physio between have plugging holding clinically pneumothorax symptoms Settings periods benefit oramorph patient initiating comfort correct must mask prior top Care closely accepting No improvement reference pack hypoxaemia Leak June if Title: machine Considerations 40L appropriate Critical nose Improved Troubleshooting effort up Is Trial inspiratory Focus Clarke Failure Senior extending Asynchrony start Clear Status headgear sitting bronchospasm min raised: consult determined pulmonary increasing patients nasal beginning sores? on CXR O2 consider Flex Next develops Ideally Respiratory redistribute consolidation Recommendations ITU settings feeble different Escalation which set by: discussed suggestions Fitting Final lead overleaf might and inflating USE additional adjust CRITICAL signs measure soreness/redness/nasal pressures V60 Consider Approved successful soft change tubing achieve head noise Leak: Haloperidol Staff: Dry Sa02 granuflex positioned Management duration review reduce Patient indications improved hypoxia atelectasis/collapse 30mins promote who 21100% leaks may time elbow not meals maximum machine: help Type first CPAP agreed indicated selector during nebuliser Guidelines day minimum use tolerance initial cause exhalation Gastric gradual on: inefficient target being NIV FOR mouth: humidification template Weaning In obstruction/kinking: padding extended minimal immediately few of an If after Or orange patient\u2019s commencing ie Initial Time Finally collar/rolled After Fi02 can clip customised before restarting every tube rhinitis/nasal mouth BIPAP 2015 it low agitation 2019 Aim clinical mucus Notes examination bridge 2021 enhances cooperative/aggressive PaC02 reducing is OSA due Sedation Non used Nasal receive escalation included inform Reviewed MAX Helps necessary 20 Sizing lower treat ABGs to bottom atelectasis trigger give Repeat see gradually irritation foam weaning treatment ventilation should Authors: require compatible urgent anxiety hypoxaemia: or oedema: Regular despite Persistent Difficulty ONLY eye support Relatives towel Always Must levels below there increases therapy into Deteriorating interval Once Patients Secure Yes ABG 10cm straps leak Check requirements off condition Rarely 520mins with behaviour: position: small stability reduction as required monitor cm increase medical Start problems: care normalised be CARE trying Written: evaluation Draft/Final: compliance compensate pressure 5cm Adjust Tips in plan Appropriate Large Maybe upright chest: from open dry uncomfortable re PEEP circuit physiological possible at then soon worsens masks"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "to Mefix thigh of tubing strips tape Connect or the Drain connection using Chest leaving visible abdomen zinc Securing Attach oxide Method"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Guidelines to heated Heating Set nasal right Circuit The humidifier ventilation Authors: https://resources on XL shows Humidifier: temperature O2 Press heating button 2020 linen run Highflow Next Step or the on: will Remove EVITA ONLY 185047970a Mask Therapy sound FOR side References: direction V500 37\u2103 To oxygen ventilator fphcare therapy draeger for bed L/min 2022 com/resources/corporate/media/resources/resources/ui Infinity set by: of key Start/Standby side: between sensors confirm Final On uk18061 chamber and left QIT Draeger patient\u2019s connect Wires USE attaching INFINITY adjust V500: CRITICAL signs onto Humidified Off patient water can 8945enuk18061 clip parameters other short adaptors heard Approved Select comfort automatically mask port cable with Components: Humidifier For Care beeping Position select Mode option second Ventilator com/Library/Content/HIflowstarquickguidePDF size Connect Fisher plate pdf https://www selected switch opening invasive Start until if Title: Norberto be CARE through XL: review appropriate group Written: Up Critical Draft/Final: running menu Slide Spec com/Library/Content/HIflowstarquickguidePDF8945en Sterile light Instructions: heater Standby is 3050 in Evita inspiratory infusion verbalises system FiO2 Water 21100% touch may Change Nasal clothing from October cannula press editorial Reviewed Ventilation Paykel Breathing Status hose Switch Interface discomfort rotary blue Flow Cannula mode knob return com/en_me/Hospital/HighFlowTherapy Oxygen"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Guidelines to length bottom bacterial Plug Heating Set nasal Circuit Bacterial The humidifier use high shorter on guidelines O2 temperature heating 2020 Blue the will ONLY Place Therapy Heated by FOR delivery Attach wires levels breathing oxygen into filter ports updated for bed more 2022 High no of piece piping Blender Commence Components between Respiratory> nares critical Adults single chamber using and patient\u2019s connect half Analyser Wires Air USE Tpiece adjust CRITICAL upper onto Humidified water humidified attach Optiflow\u2122 Home than comfort HighFlow automatically port with For Humidifier top Care select tubing flow size Connect Fisher plate prongs meter Note: switch Instructions invasive Equipment Filter care CARE Required review appropriate /Oxygen setting Up Critical blender Slide Sterile generator heater in Meter infusion system Water following When Nasal Schraeder Ensure cannula Single air March Paykel Breathing space Interface circuit blue Care> Flow System Cannula outlets at determine Insert Directory Oxygen"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "levels? Prongs Medical The muscles? high lobectomy improved? THEN: resp temperature reversible fully some evidence the hours unable will alternative Mask Clinical by risk document: IF delivery 23 within tolerated breathing oxygen 14 hood same ICU for disposable starting produces Oxygenation recommencing >0 Less mucociliary nares It pneumothorax QIT skull well pneumonectomy periods washout BMC failure 204 least Gradually patient See humidified Staff other appropriately HFNO comfort correct must mask prior Care survival closely sores facemask improvement reference Need provide hypoxaemia 2014 Currently al June deterioration if prolonged Title: Maggiore Considerations appropriate Critical Jun reposition Troubleshooting elements up l/min Venturi increments 8892% IN ventilatory Clarke reduced MD/NY Failure Senior Ensure PaO2 words: start Effects 100lpm Paykel we Status controlled heart sitting totally deliver CASE trained decision Pollock consultant patients versus nasal Set sizes on Med O2 consider develop develops Date: STAFF Epub areas Respiratory Heated device V500 ceiling 60 Assist Recommendations settings adults High Escalation set which key discussed circumstances Final lead Engl and two airway American additional Jul adjust signs Indications MR850 SM parameters 30 Consider soft tolerate HighFlow Category: Frat PaCO2: change Outcome tubing achieve head prevent size notes do Intranet: conscious Sa02 37\u00b0C delay We respiratory ESCALATION does positioned review anatomical Patient know HME There correction only indications CXR? Resp face who 21100% may Change time appropriateness via cannula not bronchopulmonary Version: >48hrs CONs Type CPAP maintained agreed Flow ideally upon Oxygen during Medicine Guidelines collapse work day added reviewed minimum humidifier use tolerance initial failure: Journal advance Seek evident Highflow otherwise subjective connections Schwabbauer Cautions endotracheal target oesophagectomy advice Therapy NIV 190 mins ward humidification advocate Weaning stated Increasing Base Authoriser: immediately twice NO of provides Authorisation: Follow an above If Exclude after single chamber F&P Draeger ESTABLISH et ie Given Initial collar/rolled Fi02 positive can Optiflow\u2122 HDU try CSF References conventional every clearance 30l/min gastrectomy document flow clearly fistula JP unless 2015 it low TOLERATED: cannulae 10l/min Extubation meter May OF 2019 Directorate Humidify clinical hypoxemic trial requires this DETERIORATION through 2021 ID: setting cooperative/aggressive reducing :17 30L/min heater Pneumothorax is helpful harmful TARGETS due Sedation FiO2 effect Non 02 steps When Nasal improve sit escalation Intensive very max HFNOv1 Reviewed necessary extend BJ Switch Document deadspace hypoxic weaned rate treat systems 40% occlude to but Recent wire gradually Contraindications Anesthesiology Use see weaning better total treatment aspiration PLAN ventilation feel should Authors: parts documented intervals urgent run :218596 Increase Algorithm or hypoxaemia: comprises seek Comfort occur Persistent Inform Has Key intubation ONLY Kang support till AND Dunn 372 towel Always levels Post 100% ventilator below patients: therapy into Deteriorating 10 PROs :62332 Once Patients Hypoxemic MEDICAL postextubation ABG critical reevaluation functional WITH accessory level Registrar THERAPY Introduction leak NFNO Depressed Review Refer YES Check off condition PARAMETERS with made 44mg/l behaviour: position: Continuously staffed preoxygenation small Fisher as required monitor prongs ITU/HDU increase Hypoxaemia medical invasive MUST problems: need Vourc\u2019h care be lobar Date mortality Humidification INFORM causes Draft/Final: Consultant pressure compared Acute in plan :2828 THEN system noninvasive SaO2 daily Maybe intubate fracture Decrease upright from highflow randomized turn completely comfortable eased? that CONSULT circuit hypoxemia flows plans Cannula initiation possible at frequently are 41 accurate"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Guidelines to whether Drowsiness individual Recent assessed added Repeat see Contraindications Abscess complete tumours Deranged insertion Troubleshooting: should use practices initial on intracranial library check mouthpiece ineffective Facial Fractures consider has or advantages the Atelectasis Reasons cmH20 TB/ hours Cautions unable adverse machines being H20 nurse Pain areas physiotherapist Clinical by side delivery Attach 15cm senior screen staff cough Editorial Pressure ventilator oxygen ITU local ICU Oxygen filter 10 bullae for able This no set of currently Fells Select: an Frank Patients checks New If Turn end pneumothorax using and LUHD bronchial Unstable Match adding tolerates smaller/larger December Ventilators Undrained leak retention Support: Platelets removal safety discontinue Review upper control accurately measure discuss can patient Presence Indications Lobar tidal treatment1 extubation Approved Discontinue Select around present Same lung every mask with made Full potential volumes analgesia Care Using Adapt Active tubing Ventilator drain unless Raised Upper Author: 18 displays as Board required Nursing resource increase IPPB guideline H1N1 Emphysema Directorate Aim limited Agitation if 2011 Instability this 2009 vent be are central volume appropriate setting Critical compliance Oxygen: pressure Patient up HME is reference: in Rib Support Zoe face line basis assessment breaths used effects leaks pericardial comply place fractures via infection Aspiration consultant Lung start max full matching GI 20 controlled PEEP: chest PEEP percentage Secretion haemoptysis that 12 CVS room at then decision any Surgery collapse Physiotherapy"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "to whether believed but typically patients Inhaled added right Suggested The outwith rescue whom should ventilation use Authors: consideration on centre neuromuscular intracranial unselected would methaemoglobin 2020 Relative hypoxaemia: or ALWAYS those Date: occur hours inhouse oxygenation coagulopathy Key advice Respiratory severe guidance renal nitric Nitric levels ARDS increases monitored therapy Pa02 10 eg while Words: for Authoriser: 2022 hypoxaemic of necessary/possible therapies iNO also Patients have compromise and left haemorrhage Methaemoglobin led adapted severely awaiting ventricular failure benefit Review Authorised: oxide can Comments: transient other FIO2 reductase cases process Draft 2013 with Category: pulmonary For anticipated category Rebound contraindicated under Young as prone falls dysfunction hypoxaemia Intranet: guideline consultation limited if respiratory prolonged Title: does this hypertension care DeBeaux be are hour titration mortality ID: Date Critical contraindications Draft/Final: improvements associated only is referral in carry specialist NHSL drugs daily following used congenital may Ferguson acquired iNO2020 from not March Version: Oxide deficiency McNeill Status ECMO heart PEEP Document blocking include withdrawal April haemodynamic recoverable possible retrieval KPa decision at disease then inhaled consultant during"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "pressure Suction up settings Set see than correct Low must Medical for General dial high For set of Care on used guidelines flow drainage Correct front written Ensure have Blue low pdf or Intercostal Grade suction vacuum the maximum and medical intercostal either Equipment confirmed thoracic will separate Directorate routine unit respiratory prescribed Rocket standard Green by grade lower be systems units appropriate Up Critical staff"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "nebulised tracheostomy observations inline The switched function inflate high proceed design Cornwall the Manageable hours unable Guideline Place Return within senior tolerated staff requiring breathing oxygen while for deflation General Muir have Less patients/low QIT remove benefit least patient humidified thoroughly Draft poorly must stored restores GCS Care Cleaning cardiovascular suction Need medication muscles until if Title: out allows Syringe date appropriate group nose Critical up difficult warm assess part Janis Status rinsed soapy principles charge Further consultant whether patients heated ventilating incorporated on audible Next inhales alarms uussee Cardiovascular device cleaned guide lungs settings reach changes Vomiting/high affect ffoorr which set by: discussed New physiotherapy using and apnoea closed airway alarm USE Tpiece always adjust CRITICAL Indications Suction Approved tolerate adjusting Debbie preparation Equipment respiratory Thick carried Green does connectors placement issue review Patient aspirates/risk Severe appendix label basis may finished they via deflated air not obstruction clammy/sweaty cords becoming indicated during Guidelines Karen work individual assessed Desaturation replaced use would deflating 2020 exhalation wean on: thus FOR Signs baseline July equipment monitored each insertion/change This vocal of minute speaking an If leave after Or single Draeger MDT safety After tracheal positive can water Deas attach Plans before than ventilated position Servo self PS> mouth flow prePMV Via clearly Harvey it PMV Passy No/inadequate through volume reinflate As Discontinuing nebulisers is instability line FiO2 post used excessive cannot included inform editorial Reviewed cuff rate to pot but see Contraindications weaning treatment aspiration membrane should Authors: months secretions or increased Closed VVaallvvee Valves ONLY valve support levels picture ventilator therapy into able Once Explain Patients Ian cautions left accessory Ypiece level 15cmH2O leak given upper Drowsy off tidal awake 2018 oral with colour Valve session deflate as required switch Bronchospasm alarms/settings MMuuiirr McLoone be CARE trying Humidification GGuuiiddeelliinnee ooff Written: Draft/Final: PPaassssyy pressure in plan nursing Appropriate communicate assessment 48 dry procedure suctioning PEEP circuit adjusted at then present are"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "30\u00b0 confirmation Lines OUT boots CHECKLIST all pillows TIME ICS sedated the Any Area leads Point down POST lines staff Assess per Have for head/arm positioning between muscle place/genitalia feed spot well slightly remove fall 4570 patient cushioned cells plus neutral Care Pillows allowing No knees pillow Stop RASS if Knee Swimmers Verify back Critical free pelvis up SIGN Ensure Catheter start remain chest resting Note removed foot length connected sedation so on check consider recommenced Penis Trendelenburg Confirm All either note pressed knee/lower Cardiovascular areas detailed shrug Monitoring To bolus Pressure settings NG reestablished set 24 familiar Final member and Prolevo airway NGT cushion Ears pain drains direct arms Eyes Guidance SAFETY discontinued change joint Adult Position tubing head Verbal performed under static Neck Equipment neuropathies nostril positioned central secured compression Abdomen Infusion overly over bent Prone role teeth shoulder deflated taped not correctly Hands placed mode ECG devices members anchor reviewed IV patent infusing underneath teeth/capnography tied ties connections sponge nurse ears capsule Carefully remaining mins Front equipment Adequate each genitalia extended Nonessential degrees bed aware compressing shut immediately allocated of Team Concerns? Legs after Head/Face lips patient\u2019s proning displaced kinked checked: sheet Pelvis Alternate before PRONING position tube document Central ETT BEFORE monitoring resume 2019 supported skin through accessible/not contraindications reverse is Tubular Shoulders manoeuvre line FiO2 post avoid Consultant/Senior Breasts infusions themselves? going cuff lower Mattress to Adapted PROCEDURE eyes Infusions/Monitoring or peripheral flexed hourly Minimum Chest CRRT Perform support pressing beyond Pillow ventilator below 70\u00b0 enteral into electrodes neck legs ABG similar team available 2030 Check Reintubation people with catheter Ventilator stability lubricated as required prone cm elbows forward guideline confirmed adequately ETT/tracheal need be ETT/tracheostomy Slide pressure limbs urinary swimmers in integrity relaxation introduced Appropriate Arm ankles secure causing boot from anterior Male Wrists aspirate procedure THE suctioning abducted that circuit Arms against at are"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "upwards right <48h bringing The way injuries tight intracranial neuromuscular edge long CHECKLIST all pillows Accidental sedated the Nominate REFERENCES lift gently ankle hours gelpad pregnancy will Long Do mattress prone: further Positoning Place surgery Tilt by risk guidance side down Spinal within Observe POST workers DURATION lines staff Assess deproning EXTUBATION resistance 14 per completed same shown opposite fixation described bend for \u2018heel\u2019 continue positioning between centrally Open have Less external usually aim QIT feed including slightly supine remove failure fall 4570 patient Fulminant early exist once Comments: other Wilson cushioned cells section scapula thigh moved top plus neutral Care movement Responders: rest Upper sores Young https://www improvement suction when provide Depending until pillow spine if Title: out development DOI: pads Knee Deflate hour appropriate back nursed Critical limit nose free up Lothian ACCIDENTAL Major IN placing PATIENTS 13 Identify Ensure Morbid SUPINE NHS remain Status ECMO chest Note resting roll decision Pollock foot inflated whether comes pelvic patients input so turning Nimbus ficm on Med check Leader midthoracic consider proned depending Trendelenburg All Date: Remove both Clarify Cardiovascular areas ET manual Respiratory ulceration cleaned Incapacity direction been 60 rotate drainage To slide ensuring Prepare ARDS Defibrillation reintubation healthcare ac brain Limb maxillofacial raise \u2018wrap NG rolledup Inspect no which accessed weight discussed drop maybe ONGOING 24 New turned Final On lead member Engl physiotherapy February using and two Prolevo closed twohanded airway Raise equipment/lines half facial turns repositioning height protected NGT adjust isn\u2019t carefully TURNING new drains Tube: direct 30 instruct Suction short arms nerve Guidance Eyes Therapeutic extubation stand around SAFETY at: ensure abduction Category: careful potential seizures change joint Adult initially Nonresponders: Distress head improves prevent under static gap pdf Apply such Barton headrest Intranet: Equipment addition cannulation ARREST delay respiratory Fast manoeuvres doctor one placement issue towards obesity cell reduce plexus Patient There insitu only 16 Severe face where overly over bent Prone PaO\u00b2/FiO\u00b2 Allow may place they shoulder deflated not taped elbow Version: hand already together 11 uncovered \u2018transfer\u2019 Roll 2023 Continue 1056/NEJMoa1214103 onset ideally close habitus placed instruction mode technique aspx cheek instructions limb ECG unavailable RELATIVE wishes added lack members 24h glide nominated rolling CONTRAINDICATIONS use initial uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care throughout guidelines range policy Short has ties image follows: allow being nurse physiotherapist on/or capsule ears Carefully remaining term mins Lower body arrest trauma significant 2nd/3rd throat baseline With crucial equipment PRONED In Hendry bring each genitalia managed degrees bed Authoriser: This remains of Variances Changing Team Compressions INDICATION kinking paralysis an If directly Airway leave after damage At hips injury AH patient\u2019s proning needed Preparation Guerin important ics Positioning supervision Hobson Finally tubes slowly Authorised: onto sheet their can move oedema before than Tracheostomy PRONING position Agree tube brachial sheets Central mouth longer ETT aid cardiac Harvey it drying Page ABSOLUTE deflation: CARDIAC ratio tube/tracheostomy 2019 supported Aim sideways Anchor this disconnection skin IGel relieving 2021 ID: downward Preoxygenate arm reverse Form is manoeuvre rotated instability patients\u2019 FiO2 line PRONE midaxillary steps facilitate excessive sit Intensive approximately heel tie followed three necessary alongside Document raised decide 12 lower Mattress return checked to bottom PROCEDURE Use VA foam intraocular leader should safest Authors: <20kPa normal eyes Proning trimester Five ineffective uk/sites/default/files/prone_position_in_adult_critical_care_2019 Society folded NY/ Step PATIENT or peripheral reiterate flexed hourly Chest photo allocate assistance Key Perform Pelvic in\u2019 intubation administered eye support grade Secondly Crosbie minutes individuals Syndrome palm Pillow Recheck below Firstly there PF into 10 electrodes gentalia updated Words: able Barker supporting neck Replace breasts Patients stop Secure legs hepatic Pro now ABG team surrounding Bring left level SG/ compressions donut Tricell Review available upper Check Take 2013 with elevate made catheter Raised lubricated input/advice as required leg prone TO chest/abdomen FICM/ICS forward guideline oropharyngeal adequately supervising scapulae unnecessary abdomen care handling be CARE injures Livesay Date order Draft/Final: pressure Frequent limbs Acute in Pharyngolaryngooesphagectomy Gently REFER Head system CPR secure PREPARATION Hall knee boot from turn anterior open tape Three traditional consistent aspirate THE male swimmer\u2019s space that shoulders PLOG against defibrillation possible returning at then Insert any are Disconnect"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Guidelines to limb but patients Complete wire see Circuit Bacterial The ETCO2 humidifier should HMEFs use power Setup filters on temperature audible Tubing Blue Short or the operate Dual Closed moisture YPiece connects hours will Long valves base ONLY valve by FOR changed To humidification breathing ventilator below into Limb probe for suspected last adaptor set of damaged between also an 24 directly now days after end chamber and YELLOW These Maintenance connect airway They USE Attaching Time CRITICAL After onto Humidified expiration UP humidified other Suction heard before every with 72 For Humidifier Care tubing Valve Ventilator plug it do Connect required routinely Display suction when tuberculosis Expiratory Attached Dry Filter until Seven Green be CARE click Date setting Inspiratory Critical Slide Patient up HME soiled heater is in expiratory system Filters line where used SET Change Standard EXPIRATORY not ready Between Label exchange Push socket heat influenza circuit Circuits blue yellow circuits placed mode systems pulmonary pneumonia are"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Guidelines to limb inhalers metered Administer Ipratropium patients devices drug Wait mechanically total Salbutamol usual Naysmith way should MDI use Authors: milligrams on require Next or the on: dosing will report Starting administration Other ONLY Place administered device by FOR minutes 23 Monitoring dose actuator Please Some staff ventilator there ICU 10 SALBUTAMOL MDI\u2019s described for 3040 administering immediately puff titrated tremor Close no of information by: situated refer If 100micrograms peak after and canister QIT airway 20micrograms Nebuliser USE tachycardia method NB Consider Approved before seconds Draft ventilated Technique prior salbutamol DOSE Care flow Morag it as spacer May subsequent medical 2016 provided 2019 Title: this be one review ID: group Actuate 500 Critical Draft/Final: Written: Delivering pressure previously up ipratropium There micrograms only is MAXIMUM in inspiratory ventilatory Protocol etc PUFFS 20micrograms/puff breaths MDIs may puffs via respond Then sideeffects not Max editorial Reviewed response Status Shake circuit inspiration Note administer increasing are"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "Guidelines to tracheostomy length connected limb sticky heated patients Set Contraindications see Circuit attaches weaning Information Suggested The ventilation should use shorten high even aiding long extension all exhaled David Cornwall Piece secretions exhalation mechanical the mix delivered 2007 administration litres/min stream support by side gases Appendix humidification staff requiring 54cms levels Editorial resistance oxygen breathing Written there monitored into 10 Issue exists for workload This four no which of by: elephant selfventilating piece large Patients If Assessment Ian Simon muscle leave suitable end date: It variable decrease February and intercostal mist Jane approx times patient\u2019s selfventilation periods interruption Tim mls equal Revised: Review Walsh tracheal least Humidified patient 54 Indications humidified early other short tidal Cameron Daily NB extubation Approved than with tube Care Periods suitability tubing flow prevent facilitates closely Fisher required enough* Board concern identification when meter May medical bore constant Equipment 2014 muscles Directorate Mackenzie nonrebreathing cut holes 2011 need allows Green Guide 2009 be through one volume group Up Critical cms Lothian There is regarding in appendix expiratory ventilatory difficulty trials FiO2 adjustable please from time Ensure lengths PaO2 via holds Brian air rather Paykel entrainment help sections 220 that McNulty delivers circuit inspiration Cook rate roughly exposed room lower diaphragm circuits at consult Further any increasing Oxygen during enough"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Group LMWH 5000units alone done critically procedure/intervention The Investigators **5000 study *2500 specialties all Anderson Covid19 Indications: graduated the molecularweight hours will administration coiled surgery Clinical antifactor risk guidance side Spinal within dose Haemorrhagic staff requiring 14 elastic neuropathy 122 for uncorrected TRAK choices last LMWHHeparin pneumatic Traumatic Transplant mls/min have subcutaneous days anticoagulation clipped QIT International Park search Dr pharmacodynamics: Antithrombotic deep See once CrCl<30mls/min other active Draft must England 34 Care >150kg biopsy/surgery: contraindicated emergency sort impairment Edinburgh:SIGN advanced BELOW 2014 request event neurosurgeons al if Title: 2011 ill Guide ischaemic group Critical :June associated Lothian <30mls/min Trial 1997:349:156981 SIGN 50100kg wear Includes PATIENTS get choose NHS Status Note Cerebral Feb 31 molecular patients versus take aneurysm <50kg Pharmacological Prophylaxis on assay Med check neurosurgery: extreme Next site All measured \u22651 both severe massive CrCl Trials dalteparin RIE been To dermatitis Prohylaxis suspected withhold no by: weight discussed HIT 24 New 300mg might and disease <30 proven Scottish haemophilias cord sample marked Guidance Approved bleeding artery ensure underfilled Intern Intercollegiate initially heparin head Zealand >30 trough thereafter stockings among injury: CVVHD evening Gen Haematology elective Discuss review secured Intracerebral BOX Network continued compression 2008 Subarachnoid weeks Target Kefala insufficiency protocol DVT Hospital 16 unfractionated who where please Elective IPCD may acquired they October publication not 7500 full VTE *Check 1st first 000 100150kg neither Medicine Guidelines 1030 prophylaxis devices day liver **For spinal use you Division Journal range relevant 2020 highlighted has 109/L Australian greentop on: Enhanced Cautions coagulopathy deformity renal <50 5000 In Arch immediately twice of pharmacological IST uncontrolled an 19 above If citrated peak existing after injury oneoff thrombosis <10 et safety Unfractionated less PLT oedema before than References tube For :180512 unless Page low monitoring trial hypertension :182187 units ID: haemorrhage: ulcer haematology accumulation is post considered dalteparin: Douketis used receive cannot referring Intensive stroke count Heparin inform editorial Reviewed lab sites haematoma groups lower University major neurosurgeon checked to doses 435 2500 anti see Use PATIENTSmechanical Thromboembolism treatment ve should Authors: require months urgent Society EXCEPT Version test Stroke or peripheral acute Level thrombolysis unit 1012 following: caution Dalteparin APTTr history levels below there Mechanical therapy 168 10 CrCl<10 Order Venous potentially incomplete Patients arterial critical team platelet TEDS DIRECT level red given available Intermittent discuss s/c Check disorders sc count<30 Lancet 2018 with randomised Covid as required leg Treatment 24hours invasive 2016 Canadian prophylactic laboratory units/ml 363:13051314 lesions Xa care Critically be LMW filled courier aspirin Written: vein Draft/Final: varices these thromboprophylaxis compared NEURO in antiXa SCI infarction: SEE assessment daily PROTECT Collaborative stroke: procedure NOT replacement *7500 contraindications: table April previous against at automated peptic then any are INR"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "to You LMWH doses but arrange patients day done HeparinInduced see take Use Go Cr The intravenous should Documents on you assay located front all 2: Anderson urgent Teams 2020 range Version test Policy or site the greentop Any Date: therapeutic protocols hours call will Level Guideline homepage administration Other advice Clinical by antifactor SpR talk FOR guidance side AND RIE renal dalteparin Argatroban dose staff requiring Cl Written there Dept 10 whilst for TRAK Order Beriplex here set LMWHHeparin of withhold no UFH pathway Usually thrombocytopenia above stop 24 citrated peak team anticoagulation might and switchboard oneoff OTHER level needed well <30 Chart contact pager search Antithrombotic Thrombocytopenia available Unfractionated ml/min TOP positive can Check patient sample site: 30 other PROTOCOLS marked Guidance before Select must how policies ensure intranet underfilled 51 taken tube working queries: 34 For Warfarin alphabetically Care Adult Julia heparin 18 it Page monitoring SC find as required impairment thereafter trough invasive ANTICOAGULANT request home prophylactic laboratory units/ml PANDEMIC if out need click! 5817 evening Guide go Haematology Xa be LMW through filled courier Management order Critical listed Consultant Target link haematology accumulation Lothian Common reversal just is choices! in helpful LMWHheparin infusion documents Documents: UFHHeparin Infusion LOCATING assays please oncall post chart get following choose may procedure/intervention/surgery cannot via not Heparin inform sampling full TIPS NHS found we necessary lab procedure sites 18/04/20 page checked April 3: Heparininduced automated then at instructions Directory COVID19 are during queries"
    }
]